Name	Gene(s)	Condition(s)	Clinical significance (Last reviewed)	Review status	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	
NM_001170535.2(ATAD3A):c.1582C>T (p.Arg528Trp)	ATAD3A	not provided|Harel-Yoon syndrome	Likely pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, single submitter	1	1464679	1	1529299	225696	227511
NM_002074.4(GNB1):c.230G>C (p.Gly77Ala)	GNB1	Mental retardation, autosomal dominant 42	Likely pathogenic	criteria provided, single submitter	1	1737951	1	1806512	431082	424605
NM_003036.3(SKI):c.103C>T (p.Pro35Ser)	SKI	Shprintzen-Goldberg syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2018)	criteria provided, conflicting interpretations	1	2160308	1	2228869	39786	48385
NM_015215.3(CAMTA1):c.3230A>G (p.Tyr1077Cys)	CAMTA1	Cerebellar ataxia, nonprogressive, with mental retardation	Likely pathogenic(Last reviewed: Apr 22, 2014)	criteria provided, single submitter	1	7796567	1	7736507	216897	213522
NM_015215.3(CAMTA1):c.3531C>G (p.Asn1177Lys)	CAMTA1	not specified	Likely benign	no assertion criteria provided	1	7797503	1	7737443	128565	134014
NM_016831.2(PER3):c.1240C>G (p.Pro414Ala)	PER3	Advanced sleep phase syndrome, familial, 3	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	1	7869953	1	7809893	242410	226735
NM_016831.2(PER3):c.1247A>G (p.His416Arg)	PER3	Advanced sleep phase syndrome, familial, 3	Pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	1	7869960	1	7809900	242411	226734
NM_012102.3(RERE):c.4304A>G (p.His1435Arg)	RERE	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	1	8418291	1	8358231	522858	513409
NM_005026.4(PIK3CD):c.1573G>A (p.Glu525Lys)	PIK3CD	Immunodeficiency 14	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	1	9780851	1	9720793	132807	136556
NM_005026.4(PIK3CD):c.3061G>A (p.Glu1021Lys)	PIK3CD	not specified|not provided|Immunodeficiency 14	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	1	9787030	1	9726972	88675	94255
NM_014874.3(MFN2):c.280C>T (p.Arg94Trp)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|Short stature|Failure to thrive|not provided|Abnormality of the dentition|Microcephaly|Abnormality of dental enamel|Hyperpigmentation of the skin|Alopecia of scalp|Distal muscle weakness|EMG abnormality|Decreased body weight|Scarring alopecia of scalp|Abnormal blistering of the skin|Nail dystrophy|Scarring	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	1	12052716	1	11992659	2276	17315
NM_014874.3(MFN2):c.281G>A (p.Arg94Gln)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	1	12052717	1	11992660	2268	17307
NM_014874.3(MFN2):c.310C>T (p.Arg104Trp)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B	Pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	1	12052746	1	11992689	2281	17320
NM_014874.3(MFN2):c.436C>T (p.Leu146Phe)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|not provided	Likely pathogenic(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	1	12056337	1	11996280	217163	213787
NM_001127660.1(MFN2):c.479T>G (p.Val160Gly)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	1	12057358	1	11997301	243073	244147
NM_014874.3(MFN2):c.494A>G (p.His165Arg)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	1	12057373	1	11997316	217164	213788
NM_014874.3(MFN2):c.707C>T (p.Thr236Met)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|Distal muscle weakness|Peripheral axonal neuropathy|Distal lower limb amyotrophy	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	1	12058934	1	11998877	217165	213789
NM_001127660.1(MFN2):c.730G>A (p.Val244Met)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	1	12059066	1	11999009	243066	244149
NM_001127660.1(MFN2):c.730G>T (p.Val244Leu)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	12059066	1	11999009	243057	244137
NM_001127660.1(MFN2):c.746C>T (p.Ser249Phe)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Pathogenic(Last reviewed: Sep 17, 2015)	criteria provided, single submitter	1	12059082	1	11999025	202171	198602
NM_014874.3(MFN2):c.1090C>T (p.Arg364Trp)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Hereditary motor and sensory neuropathy with optic atrophy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	1	12062090	1	12002033	2278	17317
NM_014874.3(MFN2):c.1126A>G (p.Met376Val)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Likely pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	1	12062126	1	12002069	217161	213790
NM_001127660.1(MFN2):c.1946G>C (p.Arg649Pro)	MFN2	Charcot-Marie-Tooth disease, type 2A2A	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	1	12067183	1	12007126	243067	244150
NM_014874.3(MFN2):c.2219G>C (p.Trp740Ser)	MFN2	Charcot-Marie-Tooth disease, type 2A2A|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	1	12071567	1	12011510	2269	17308
NM_003000.2(SDHB):c.716C>G (p.Ser239Cys)	SDHB	Pheochromocytoma	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	17349152	1	17022657	161385	171052
NM_003000.2(SDHB):c.575G>C (p.Cys192Ser)	SDHB	Gastrointestinal stroma tumor	Likely pathogenic(Last reviewed: Sep 13, 2013)	criteria provided, single submitter	1	17350535	1	17024040	44645	53812
NM_003000.2(SDHB):c.338G>C (p.Cys113Ser)	SDHB	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	1	17355180	1	17028685	219152	217064
NM_003000.2(SDHB):c.260T>C (p.Leu87Ser)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Conflicting interpretations of pathogenicity(Last reviewed: Apr 19, 2018)	criteria provided, conflicting interpretations	1	17359581	1	17033086	178686	172493
NM_003000.2(SDHB):c.251A>C (p.Asp84Ala)	SDHB	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	1	17359590	1	17033095	219153	217065
NM_003000.2(SDHB):c.170A>G (p.His57Arg)	SDHB	Gastrointestinal stroma tumor|Paraganglioma and gastric stromal sarcoma|Paragangliomas 4|Pheochromocytoma|not specified|not provided|Hereditary cancer-predisposing syndrome|Cowden syndrome	Benign/Likely benign(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	1	17371286	1	17044791	135192	138931
NM_003000.2(SDHB):c.137G>A (p.Arg46Gln)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not provided|Hereditary cancer-predisposing syndrome|SDHB-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	1	17371319	1	17044824	183793	181624
NM_003000.2(SDHB):c.79C>G (p.Arg27Gly)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	1	17371377	1	17044882	161386	171053
NM_003000.2(SDHB):c.32G>A (p.Arg11His)	SDHB	Gastrointestinal stroma tumor|Paragangliomas 4|Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Renal cell carcinoma, papillary, 1|not specified|Hereditary cancer-predisposing syndrome|Cowden syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	1	17380483	1	17053988	36768	45429
NM_015047.2(EMC1):c.1411G>C (p.Gly471Arg)	EMC1|EMC1-AS1	not specified|Cerebellar atrophy, visual impairment, and psychomotor retardation	Uncertain significance	criteria provided, single submitter	1	19561645	1	19235151	219102	216791
NM_001791.3(CDC42):c.191A>G (p.Tyr64Cys)	CDC42	not provided|Takenouchi-Kosaki syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	1	22412944	1	22086451	218950	215784
NM_006015.4(ARID1A):c.5114A>G (p.Asn1705Ser)	ARID1A	not specified	Likely benign	no assertion criteria provided	1	27102188	1	26775697	126311	131843
NM_003680.3(YARS):c.586G>C (p.Glu196Gln)	YARS	Charcot-Marie-Tooth disease, dominant intermediate C	Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	1	33263369	1	32797768	243071	244151
NM_004700.3(KCNQ4):c.140T>C (p.Leu47Pro)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Oct 20, 2017)	no assertion criteria provided	1	41249905	1	40784233	585006	576062
NM_004700.4(KCNQ4):c.796G>T (p.Asp266Tyr)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Dec 7, 2017)	no assertion criteria provided	1	41285106	1	40819434	591002	581958
NM_004700.3(KCNQ4):c.825G>C (p.Trp275Cys)	KCNQ4	Nonsyndromic hearing loss and deafness|not specified	Likely pathogenic(Last reviewed: Sep 10, 2018)	reviewed by expert panel	1	41285135	1	40819463	505302	496205
NM_004700.3(KCNQ4):c.827G>C (p.Trp276Ser)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	1	41285137	1	40819465	6242	21281
NM_004700.3(KCNQ4):c.853G>T (p.Gly285Cys)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss	Pathogenic(Last reviewed: Feb 17, 2011)	no assertion criteria provided	1	41285565	1	40819893	6244	21283
NM_004700.3(KCNQ4):c.853G>A (p.Gly285Ser)	KCNQ4	DFNA 2 Nonsyndromic Hearing Loss|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 11, 2018)	reviewed by expert panel	1	41285565	1	40819893	6241	21280
NM_006516.3(SLC2A1):c.1268A>G (p.Gln423Arg)	SLC2A1	not specified	Likely benign(Last reviewed: May 6, 2013)	criteria provided, single submitter	1	43393286	1	42927615	159923	167986
NM_006516.3(SLC2A1):c.1261T>C (p.Cys421Arg)	SLC2A1	GLUT1 deficiency syndrome 1	Pathogenic(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	1	43393293	1	42927622	565292	556476
NM_006516.3(SLC2A1):c.823G>A (p.Ala275Thr)	SLC2A1	GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2|not provided	Pathogenic(Last reviewed: Apr 25, 2017)	criteria provided, multiple submitters, no conflicts	1	43395308	1	42929637	16114	31153
NM_006516.3(SLC2A1):c.764A>C (p.Lys255Thr)	SLC2A1	not specified	Likely benign(Last reviewed: Mar 13, 2017)	criteria provided, multiple submitters, no conflicts	1	43395367	1	42929696	159929	167990
NM_006516.3(SLC2A1):c.746G>A (p.Arg249Gln)	SLC2A1	not specified	Likely benign(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	1	43395385	1	42929714	159927	167992
NM_006516.3(SLC2A1):c.377G>A (p.Arg126His)	SLC2A1	GLUT1 deficiency syndrome 1|Epilepsy, idiopathic generalized, susceptibility to, 12|not provided	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, multiple submitters, no conflicts	1	43396436	1	42930765	16111	31150
NM_006516.3(SLC2A1):c.376C>T (p.Arg126Cys)	SLC2A1	Dystonia 9|GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 2|GLUT1 deficiency syndrome 1, autosomal recessive|Epilepsy, idiopathic generalized, susceptibility to, 12|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	1	43396437	1	42930766	16118	31157
NM_006516.3(SLC2A1):c.100A>G (p.Asn34Asp)	SLC2A1	GLUT1 deficiency syndrome 1	Likely pathogenic(Last reviewed: Jun 6, 2013)	criteria provided, single submitter	1	43408911	1	42943240	159921	167995
NM_001128425.1(MUTYH):c.1187G>A (p.Gly396Asp)	MUTYH	Endometrial carcinoma|MYH-associated polyposis|Pilomatrixoma|Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas|Carcinoma of colon|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome|Small intestine carcinoid|MUTYH-associated polyposis	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	1	45797228	1	45331556	5294	20333
NM_012186.2(FOXE3):c.410G>A (p.Gly137Asp)	FOXE3|LINC01389	Aortic aneurysm, familial thoracic 11, susceptibility to|Acute aortic dissections|Familial thoracic aortic aneurysms	Likely pathogenic, risk factor(Last reviewed: Jan 6, 2018)	no assertion criteria provided	1	47882397	1	47416725	375652	362493
NM_012186.2(FOXE3):c.457G>C (p.Asp153His)	FOXE3|LINC01389	Aortic aneurysm, familial thoracic 11, susceptibility to|Acute aortic dissections|Familial thoracic aortic aneurysms	Likely pathogenic, risk factor(Last reviewed: Jan 6, 2018)	no assertion criteria provided	1	47882444	1	47416772	375651	362492
NM_174936.3(PCSK9):c.137G>T (p.Arg46Leu)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Low density lipoprotein cholesterol level quantitative trait locus 1|Familial hypercholesterolemia|not specified|Hypocholesterolemia	Conflicting interpretations of pathogenicity, association(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	1	55505647	1	55039974	2878	17917
NM_174936.3(PCSK9):c.169G>A (p.Glu57Lys)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55505679	1	55040006	548104	538521
NM_174936.3(PCSK9):c.185C>A (p.Ala62Asp)	PCSK9	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55505695	1	55040022	265918	260594
NM_174936.3(PCSK9):c.314G>A (p.Arg105Gln)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55509622	1	55043949	548107	538522
NM_174936.3(PCSK9):c.381T>A (p.Ser127Arg)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	1	55509689	1	55044016	2873	17912
NM_174936.3(PCSK9):c.386A>G (p.Asp129Gly)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	1	55509694	1	55044021	438332	431938
NM_174936.3(PCSK9):c.493C>T (p.Arg165Trp)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55512289	1	55046616	548110	538523
NM_174936.3(PCSK9):c.494G>A (p.Arg165Gln)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55512290	1	55046617	548111	538524
NM_174936.3(PCSK9):c.610G>A (p.Asp204Asn)	PCSK9	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	1	55518037	1	55052364	189308	187183
NM_174936.3(PCSK9):c.709C>T (p.Arg237Trp)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2017)	criteria provided, conflicting interpretations	1	55518374	1	55052701	265933	260609
NM_174936.3(PCSK9):c.1061A>T (p.Asn354Ile)	PCSK9	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55523068	1	55057395	438337	431943
NM_174936.3(PCSK9):c.1120G>C (p.Asp374His)	PCSK9	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55523127	1	55057454	265939	260615
NM_174936.3(PCSK9):c.1120G>T (p.Asp374Tyr)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	1	55523127	1	55057454	2875	17914
NM_174936.3(PCSK9):c.1251C>A (p.His417Gln)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	1	55523779	1	55058106	369875	354066
NM_174936.3(PCSK9):c.1327G>A (p.Ala443Thr)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	1	55523855	1	55058182	262900	249990
NM_174936.3(PCSK9):c.1399C>G (p.Pro467Ala)	PCSK9	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	1	55524216	1	55058543	265944	260620
NM_174936.3(PCSK9):c.1405C>T (p.Arg469Trp)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	1	55524222	1	55058549	201128	196756
NM_174936.3(PCSK9):c.1487G>A (p.Arg496Gln)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	1	55524304	1	55058631	438338	431944
NM_174936.3(PCSK9):c.1537A>G (p.Asn513Asp)	PCSK9	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	1	55525192	1	55059519	369876	354067
NM_174936.3(PCSK9):c.1792G>A (p.Ala598Thr)	PCSK9	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	1	55527158	1	55061485	548105	538526
NM_174936.3(PCSK9):c.1948G>A (p.Val650Ile)	PCSK9	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	1	55529126	1	55063453	369877	354068
NM_174936.3(PCSK9):c.2038C>T (p.Arg680Trp)	PCSK9	Hypercholesterolemia, autosomal dominant, 3|Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	1	55529216	1	55063543	375843	362660
NM_002227.3(JAK1):c.1901C>A (p.Ala634Asp)	JAK1	Lymphoblastic leukemia, acute, with lymphomatous features|Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	1	65312418	1	64846735	225075	226887
NM_144573.3(NEXN):c.1063G>C (p.Asp355His)	NEXN	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	1	78398976	1	77933291	492981	485931
NM_133496.4(SLC30A7):c.490_491delCAinsAG (p.His164Ser)	SLC30A7	Joubert syndrome 1	Pathogenic	no assertion criteria provided	1	101377773 - 101377774	1	100912217 - 100912218	375382	362132
NM_013386.4(SLC25A24):c.650G>A (p.Arg217His)	SLC25A24	Fontaine progeroid syndrome	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	1	108700103	1	108157481	370032	354272
NM_013386.4(SLC25A24):c.649C>T (p.Arg217Cys)	SLC25A24	Fontaine progeroid syndrome	Pathogenic	criteria provided, single submitter	1	108700104	1	108157482	369980	354197
NM_001408.2(CELSR2):c.6859G>A (p.Val2287Ile)	CELSR2	Idiopathic scoliosis	Uncertain significance(Last reviewed: Jan 27, 2017)	no assertion criteria provided	1	109812092	1	109269470	397652	384625
NM_004980.4(KCND3):c.1153T>C (p.Ser385Pro)	KCND3	Spinocerebellar ataxia 19	Pathogenic	no assertion criteria provided	1	112329682	1	111787060	375399	362133
NM_003051.3(SLC16A1):c.1470T>A (p.Asp490Glu)	SLC16A1	not specified|Hyperinsulinism, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	1	113456546	1	112913924	130315	135762
NM_002524.4(NRAS):c.34G>A (p.Gly12Ser)	NRAS	Malignant melanoma of skin|Multiple myeloma|Non-small cell lung cancer|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Rasopathy|Cutaneous melanoma|Neoplasm of the large intestine|Colorectal Neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	1	115258748	1	114716127	177778	172332
NM_004284.5(CHD1L):c.707G>A (p.Arg236His)	CHD1L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	1	146736211	1	147264552	224340	226070
NM_001256338.2(CHD1L):c.1594A>G (p.Ile532Val)	CHD1L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	1	146758162	1	147286485	224341	226071
NM_001256338.2(CHD1L):c.1666G>A (p.Ala556Thr)	CHD1L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	1	146759370	1	147287691	224339	226072
NM_005266.6(GJA5):c.586T>G (p.Cys196Gly)	GJA5	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	1	147230761	1	147758653	427968	419262
NM_005267.4(GJA8):c.151G>C (p.Asp51His)	GJA8	Cataract 1|Microphthalmia and cataract	Uncertain significance(Last reviewed: Sep 21, 2016)	criteria provided, single submitter	1	147380233	1	147908106	446264	439651
NM_005267.4(GJA8):c.827C>T (p.Ser276Phe)	GJA8	Cataract 1	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	1	147380909	1	147908782	427758	417647
NM_001083964.1(TDRKH):c.851G>A (p.Arg284His)	TDRKH	Distal spinal muscular atrophy	Likely pathogenic(Last reviewed: Dec 23, 2017)	no assertion criteria provided	1	151748973	1	151776497	518454	509044
NM_002016.1(FLG):c.4279G>A (p.Ala1427Thr)	FLG	Ichthyosis vulgaris	Uncertain significance(Last reviewed: Oct 20, 2014)	no assertion criteria provided	1	152283083	1	152310607	374307	361156
NM_000748.2(CHRNB2):c.1191G>C (p.Gln397His)	CHRNB2	Epilepsy, nocturnal frontal lobe, type 3|Autosomal dominant nocturnal frontal lobe epilepsy|not specified|Seizures|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	1	154544490	1	154572014	158330	167983
NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg)	ADAR	Symmetrical dyschromatosis of extremities|Aicardi-Goutieres syndrome 6	Likely pathogenic(Last reviewed: May 14, 2013)	criteria provided, single submitter	1	154560601	1	154588125	39458	48057
NM_006912.5(RIT1):c.284G>C (p.Gly95Ala)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	1	155874247	1	155904456	60509	75096
NM_006912.5(RIT1):c.270G>C (p.Met90Ile)	RIT1	not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	1	155874261	1	155904470	190305	188134
NM_006912.5(RIT1):c.270G>A (p.Met90Ile)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	1	155874261	1	155904470	120250	125844
NM_006912.5(RIT1):c.251C>T (p.Ala84Val)	RIT1	Noonan syndrome|not provided	Likely pathogenic(Last reviewed: Jun 1, 2017)	criteria provided, multiple submitters, no conflicts	1	155874280	1	155904489	183410	181506
NM_006912.5(RIT1):c.246T>A (p.Phe82Leu)	RIT1	not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	1	155874285	1	155904494	370035	354275
NM_006912.5(RIT1):c.242A>G (p.Glu81Gly)	RIT1	Noonan syndrome|not specified|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	1	155874289	1	155904498	183405	181511
NM_006912.5(RIT1):c.229G>C (p.Ala77Pro)	RIT1	Noonan syndrome|Noonan syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2016)	criteria provided, multiple submitters, no conflicts	1	155874530	1	155904739	228289	228269
NM_006912.5(RIT1):c.229G>A (p.Ala77Thr)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, multiple submitters, no conflicts	1	155874530	1	155904739	183403	181513
NM_006912.5(RIT1):c.170C>G (p.Ala57Gly)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	1	155874589	1	155904798	60506	75093
NM_006912.5(RIT1):c.104G>C (p.Ser35Thr)	RIT1	Noonan syndrome|not provided|Noonan syndrome 8	Pathogenic(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	1	155880449	1	155910658	183401	181515
NM_170707.3(LMNA):c.80C>G (p.Thr27Ser)	LMNA	Ventricular fibrillation, idiopathic	Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	1	156084789	1	156114998	217834	214482
NM_170707.3(LMNA):c.234G>T (p.Lys78Asn)	LMNA	Arrhythmogenic right ventricular cardiomyopathy, type 9	Likely pathogenic	criteria provided, single submitter	1	156084943	1	156115152	444011	437672
NM_170707.3(LMNA):c.244G>A (p.Glu82Lys)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	1	156084953	1	156115162	66882	77779
NM_001257374.2(LMNA):c.229C>T (p.Arg77Trp)	LMNA	Primary dilated cardiomyopathy|not provided	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	156104245	1	156134454	66906	77803
NM_001282624.1(LMNA):c.342C>G (p.Asn114Lys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	1	156104265	1	156134474	14483	29522
NM_170707.3(LMNA):c.608A>G (p.Glu203Gly)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	1	156104288	1	156134497	14484	29523
NM_170707.3(LMNA):c.695G>A (p.Gly232Glu)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Jun 19, 2015)	criteria provided, single submitter	1	156104651	1	156134860	66925	77822
NM_170707.3(LMNA):c.725C>T (p.Ala242Val)	LMNA	Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	1	156104681	1	156134890	48076	57240
NM_005572.3(LMNA):c.745C>T (p.Arg249Trp)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Congenital muscular dystrophy, LMNA-related|not provided	Pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	1	156104701	1	156134910	14524	29563
NM_170707.3(LMNA):c.746G>A (p.Arg249Gln)	LMNA	Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease type 2B1|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Charcot-Marie-Tooth disease, type 2|Muscular dystrophy|not provided	Pathogenic(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	1	156104702	1	156134911	66931	77828
NM_170707.3(LMNA):c.895A>G (p.Ile299Val)	LMNA	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Partial lipodystrophy, Dunnigan|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2017)	criteria provided, conflicting interpretations	1	156105062	1	156135271	48092	57256
NM_005572.3(LMNA):c.898G>A (p.Asp300Asn)	LMNA	not provided|Lipodystrophy	Likely pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	1	156105065	1	156135274	66952	77849
NM_170707.3(LMNA):c.949G>A (p.Glu317Lys)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	1	156105704	1	156135913	48093	57257
NM_001257374.2(LMNA):c.665G>A (p.Ser222Asn)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not specified|not provided	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	1	156105756	1	156135965	161292	171048
NM_005572.3(LMNA):c.1003C>T (p.Arg335Trp)	LMNA	Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease type 2B1|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Heart-hand syndrome, Slovenian type|Hutchinson-Gilford syndrome|Familial partial lipodystrophy 2|Mandibuloacral dysostosis|Limb-girdle muscular dystrophy, type 1B|Lethal tight skin contracture syndrome|Congenital muscular dystrophy, LMNA-related|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	1	156105758	1	156135967	36473	45135
NM_170707.3(LMNA):c.1129C>T (p.Arg377Cys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	1	156105884	1	156136093	48031	57195
NM_170707.3(LMNA):c.1303C>T (p.Arg435Cys)	LMNA	Primary dilated cardiomyopathy|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease, type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2017)	criteria provided, conflicting interpretations	1	156106150	1	156136359	66802	77699
NM_005572.3(LMNA):c.1385A>C (p.Gln462Pro)	LMNA	Benign scapuloperoneal muscular dystrophy with cardiomyopathy	Likely pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	1	156106716	1	156136925	488542	481410
NM_170707.3(LMNA):c.1445G>A (p.Arg482Gln)	LMNA	Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease, type 2|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|not provided|Partial lipodystrophy, Dunnigan|Laminopathy|Monogenic diabetes	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	1	156106776	1	156136985	14486	29525
NM_170707.3(LMNA):c.1517A>C (p.His506Pro)	LMNA	Charcot-Marie-Tooth disease, type 2|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	1	156106932	1	156137141	242003	238151
NM_170707.3(LMNA):c.1580G>A (p.Arg527His)	LMNA	Mandibuloacral dysostosis|Mandibuloacral dysplasia with type A lipodystrophy, atypical|Charcot-Marie-Tooth disease, type 2|Mandibuloacral dysplasia|not provided	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	1	156106995	1	156137204	14499	29538
NM_170707.3(LMNA):c.1621C>T (p.Arg541Cys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	1	156107457	1	156137666	48046	57210
NM_170707.3(LMNA):c.1622G>A (p.Arg541His)	LMNA	Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	1	156107458	1	156137667	66860	77757
NM_005572.3(LMNA):c.1711C>A (p.Arg571Ser)	LMNA	Dilated cardiomyopathy 1A|Charcot-Marie-Tooth disease, type 2|not provided	Uncertain significance(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	1	156107547	1	156137756	14485	29524
NM_170707.3(LMNA):c.1804G>A (p.Gly602Ser)	LMNA	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Insulin resistance syndrome, type A|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	1	156108384	1	156138593	48052	57216
NM_001257374.2(LMNA):c.1534C>T (p.Arg512Cys)	LMNA	Charcot-Marie-Tooth disease	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	156108450	1	156138659	161293	171049
NM_001257374.2(LMNA):c.1556G>A (p.Gly519Asp)	LMNA	not provided|Metabolic disease	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	156108472	1	156138681	66873	77770
NM_170707.3(LMNA):c.1930C>T (p.Arg644Cys)	LMNA	Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|Charcot-Marie-Tooth disease, type 2|Variant of unknown significance|Charcot-Marie-Tooth disease|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	156108510	1	156138719	14527	29566
NM_170707.3(LMNA):c.1931G>A (p.Arg644His)	LMNA	Congenital muscular dystrophy|Charcot-Marie-Tooth disease, type 2|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, multiple submitters, no conflicts	1	156108511	1	156138720	161291	171050
NM_001193300.1(SEMA4A):c.1301T>C (p.Met434Thr)	SEMA4A	not provided|Colorectal cancer	Uncertain significance(Last reviewed: Mar 4, 2015)	criteria provided, single submitter	1	156142783	1	156172992	96033	101927
NM_003126.3(SPTA1):c.137G>T (p.Gly46Val)	SPTA1	Elliptocytosis 2	Likely pathogenic(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	1	158655025	1	158685235	12850	27889
NM_000702.3(ATP1A2):c.340G>A (p.Gly114Ser)	ATP1A2	Familial hemiplegic migraine|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	1	160093165	1	160123375	128485	133934
NM_000702.3(ATP1A2):c.2438T>A (p.Met813Lys)	ATP1A2	Familial hemiplegic migraine type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	1	160105782	1	160135992	204898	201097
NM_001098398.1(COPA):c.728A>G (p.Asp243Gly)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	1	160283894	1	160314104	199255	196415
NM_001098398.1(COPA):c.721G>A (p.Glu241Lys)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	1	160283901	1	160314111	199256	196416
NM_001098398.1(COPA):c.698G>A (p.Arg233His)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	1	160293229	1	160323439	199254	196414
NM_001098398.1(COPA):c.690G>T (p.Lys230Asn)	COPA	Autoimmune interstitial lung, joint, and kidney disease	Pathogenic(Last reviewed: Apr 20, 2015)	criteria provided, single submitter	1	160293237	1	160323447	218941	215775
NM_000530.7(MPZ):c.499G>C (p.Gly167Arg)	MPZ	Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease dominant intermediate 3|Roussy-Lévy syndrome|Dejerine-Sottas disease|Congenital hypomyelinating neuropathy 1, autosomal recessive|Dejerine-Sottas syndrome, autosomal dominant	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	1	161276204	1	161306414	14170	29209
NM_000530.7(MPZ):c.451C>A (p.Pro151Thr)	MPZ	Charcot-Marie-Tooth disease type 2I|Charcot-Marie-Tooth disease type 2J|Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease dominant intermediate 3|Roussy-Lévy syndrome|Dejerine-Sottas disease|Congenital hypomyelinating neuropathy 1, autosomal recessive	Likely pathogenic(Last reviewed: Feb 19, 2013)	criteria provided, single submitter	1	161276252	1	161306462	216963	213517
NM_000530.7(MPZ):c.410G>A (p.Gly137Asp)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Sep 3, 2015)	criteria provided, single submitter	1	161276536	1	161306746	217233	213793
NM_000530.7(MPZ):c.403A>C (p.Ile135Leu)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	1	161276543	1	161306753	243089	244171
NM_000530.7(MPZ):c.293G>A (p.Arg98His)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided|Decreased nerve conduction velocity|Sensory neuropathy|Pes cavus|Distal muscle weakness|Distal lower limb amyotrophy	Pathogenic/Likely pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	1	161276653	1	161306863	14176	29215
NM_000530.7(MPZ):c.293G>C (p.Arg98Pro)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, multiple submitters, no conflicts	1	161276653	1	161306863	14174	29213
NM_000530.7(MPZ):c.292C>T (p.Arg98Cys)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	1	161276654	1	161306864	14175	29214
NM_000530.7(MPZ):c.270C>A (p.Asp90Glu)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I	Pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	1	161276676	1	161306886	14167	29206
NM_000530.7(MPZ):c.242A>G (p.His81Arg)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|not provided	Pathogenic(Last reviewed: May 28, 2015)	criteria provided, single submitter	1	161276704	1	161306914	14179	29218
NM_000530.7(MPZ):c.233C>T (p.Ser78Leu)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type 1b, with focally folded myelin sheaths|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	1	161277049	1	161307259	14188	29227
NM_000530.7(MPZ):c.116A>C (p.His39Pro)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	1	161277166	1	161307376	217232	213794
NM_000530.7(MPZ):c.90C>G (p.Ile30Met)	MPZ	Charcot-Marie-Tooth disease, demyelinating, type 1b|Charcot-Marie-Tooth disease, type I|not provided	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	1	161277192	1	161307402	217235	213795
NM_001035511.1(SDHC):c.8C>T (p.Ala3Val)	SDHC	Gastrointestinal stroma tumor|Pheochromocytoma|Paragangliomas 3|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	1	161284203	1	161314413	161387	171051
NM_003001.3(SDHC):c.*84G>C	SDHC	Pheochromocytoma|Paragangliomas 3|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 7, 2018)	criteria provided, multiple submitters, no conflicts	1	161332307	1	161362517	41773	50212
NM_000261.1(MYOC):c.1111T>C (p.Tyr371His)	MYOC	Primary open angle glaucoma	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	1	171605469	1	171636329	242274	243828
NM_000488.3(SERPINC1):c.1256C>T (p.Ala419Val)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	1	173873166	1	173904028	18038	33077
NM_000488.3(SERPINC1):c.1246G>T (p.Ala416Ser)	SERPINC1	Reduced antithrombin III activity|not specified|Antithrombin deficiency	Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	1	173873176	1	173904038	18023	33062
NM_000488.3(SERPINC1):c.886G>C (p.Ala296Pro)	SERPINC1	Antithrombin deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	173878957	1	173909819	161390	171055
NM_000488.3(SERPINC1):c.482G>A (p.Arg161Gln)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	173881079	1	173911941	18030	33069
NM_000488.3(SERPINC1):c.236G>A (p.Arg79His)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	173883863	1	173914725	18014	33053
NM_000488.3(SERPINC1):c.218C>T (p.Pro73Leu)	SERPINC1	Reduced antithrombin III activity|Antithrombin deficiency	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	1	173883881	1	173914743	18011	33050
NM_003285.2(TNR):c.1774A>G (p.Thr592Ala)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175355171	1	175386035	224861	226703
NM_003285.2(TNR):c.538A>C (p.Asn180His)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175372714	1	175403578	224863	226705
NM_003285.2(TNR):c.496A>G (p.Thr166Ala)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175375355	1	175406219	224864	226706
NM_003285.2(TNR):c.463T>A (p.Cys155Ser)	TNR	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	1	175375388	1	175406252	224865	226707
NM_001194999.1(MR1):c.116A>G (p.His39Arg)	MR1	not specified	Likely benign	no assertion criteria provided	1	181018236	1	181049100	129620	135066
NM_003783.3(B3GALT2):c.367T>G (p.Tyr123Asp)	B3GALT2|CDC73	Hyperparathyroidism 2	Likely benign(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	193150326	1	193181196	226036	227841
NM_000069.2(CACNA1S):c.5570G>A (p.Ser1857Asn)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified|not provided|Malignant hyperthermia	Likely benign(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	1	201009011	1	201039883	254850	249594
NM_000069.2(CACNA1S):c.4060A>T (p.Thr1354Ser)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2018)	criteria provided, conflicting interpretations	1	201020165	1	201051037	161208	171056
NM_000069.2(CACNA1S):c.3256C>T (p.Arg1086Cys)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Hypokalemic periodic paralysis	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	1	201029944	1	201060816	21035	33887
NM_000069.2(CACNA1S):c.2992G>A (p.Asp998Asn)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 6, 2017)	criteria provided, conflicting interpretations	1	201031133	1	201062005	225282	227189
NM_000069.2(CACNA1S):c.1583G>A (p.Arg528His)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|not provided	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	1	201047043	1	201077915	17625	32664
NM_000069.2(CACNA1S):c.1547C>T (p.Ser516Leu)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	1	201047079	1	201077951	225281	227190
NM_000069.2(CACNA1S):c.530C>T (p.Ser177Leu)	CACNA1S	Hypokalemic periodic paralysis 1|Malignant hyperthermia susceptibility type 5|Malignant hyperthermia susceptibility|Hypokalemic periodic paralysis|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	201061111	1	201091983	199686	196500
NM_000364.3(TNNT2):c.878G>A (p.Arg293His)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	1	201328348	1	201359220	43677	52846
NM_000364.3(TNNT2):c.877C>T (p.Arg293Cys)	TNNT2	Familial hypertrophic cardiomyopathy 2|Familial hypertrophic cardiomyopathy 1|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2017)	criteria provided, conflicting interpretations	1	201328349	1	201359221	43676	52845
NM_001001430.2(TNNT2):c.833G>C (p.Arg278Pro)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial hypertrophic cardiomyopathy 1|Familial restrictive cardiomyopathy 3|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 17, 2018)	criteria provided, conflicting interpretations	1	201328372	1	201359244	177635	172355
NM_001001430.2(TNNT2):c.833G>A (p.Arg278His)	TNNT2	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Feb 11, 2015)	criteria provided, single submitter	1	201328372	1	201359244	43674	52843
NM_000364.3(TNNT2):c.853C>T (p.Arg285Cys)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial hypertrophic cardiomyopathy 1|Familial restrictive cardiomyopathy 3|Costello syndrome|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	201328373	1	201359245	12411	27450
NM_000364.3(TNNT2):c.833A>T (p.Asn278Ile)	TNNT2	Familial hypertrophic cardiomyopathy 2	Likely pathogenic	criteria provided, single submitter	1	201328760	1	201359632	217495	214101
NM_000364.3(TNNT2):c.753G>T (p.Glu251Asp)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Primary familial hypertrophic cardiomyopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 28, 2017)	criteria provided, conflicting interpretations	1	201330455	1	201361327	43667	52836
NM_000364.3(TNNT2):c.673G>T (p.Val225Leu)	TNNT2	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Jun 4, 2015)	criteria provided, multiple submitters, no conflicts	1	201331078	1	201361950	43662	52831
NM_000364.3(TNNT2):c.653T>C (p.Ile218Thr)	TNNT2	Familial hypertrophic cardiomyopathy 2	Likely pathogenic	criteria provided, single submitter	1	201331098	1	201361970	217496	214102
NM_001001430.2(TNNT2):c.518G>A (p.Arg173Gln)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	1	201332476	1	201363348	43649	52818
NM_001001430.2(TNNT2):c.517C>T (p.Arg173Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|not provided	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	1	201332477	1	201363349	228409	228285
NM_001001430.2(TNNT2):c.514G>T (p.Ala172Ser)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Apr 28, 2016)	criteria provided, single submitter	1	201332480	1	201363352	181612	178935
NM_001001430.2(TNNT2):c.450C>A (p.Asn150Lys)	TNNT2	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Dec 17, 2014)	criteria provided, single submitter	1	201333435	1	201364307	192311	190101
NM_001001430.2(TNNT2):c.430C>T (p.Arg144Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Dilated cardiomyopathy 1DD	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2017)	criteria provided, conflicting interpretations	1	201333455	1	201364327	132943	136692
NM_001001430.2(TNNT2):c.421C>T (p.Arg141Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Cardiomyopathy|not provided|Familial isolated dilated cardiomyopathy	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	1	201333464	1	201364336	12414	27453
NM_000364.3(TNNT2):c.430C>G (p.Arg144Gly)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Feb 21, 2014)	criteria provided, single submitter	1	201333485	1	201364357	43639	52808
NM_001001430.2(TNNT2):c.392G>A (p.Arg131Gln)	TNNT2	Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	1	201333493	1	201364365	43637	52806
NM_001001430.2(TNNT2):c.391C>T (p.Arg131Trp)	TNNT2	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	1	201333494	1	201364366	12415	27454
NM_000364.3(TNNT2):c.382G>A (p.Glu128Lys)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 14, 2013)	criteria provided, single submitter	1	201334348	1	201365220	43634	52803
NM_001001430.2(TNNT2):c.330T>G (p.Phe110Leu)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2017)	criteria provided, multiple submitters, no conflicts	1	201334370	1	201365242	177807	172501
NM_001001430.2(TNNT2):c.291G>T (p.Lys97Asn)	TNNT2	Primary familial hypertrophic cardiomyopathy|not specified	Likely pathogenic(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	201334409	1	201365281	43631	52800
NM_001001430.2(TNNT2):c.281G>A (p.Arg94His)	TNNT2	Familial hypertrophic cardiomyopathy 2|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	1	201334419	1	201365291	43628	52797
NM_001001430.2(TNNT2):c.280C>T (p.Arg94Cys)	TNNT2	Familial hypertrophic cardiomyopathy 2|Familial restrictive cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	1	201334420	1	201365292	165549	172503
NM_001001430.2(TNNT2):c.275G>A (p.Arg92Gln)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	1	201334425	1	201365297	12409	27448
NM_000364.3(TNNT2):c.304C>T (p.Arg102Trp)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	1	201334426	1	201365298	43627	52796
NM_000364.3(TNNT2):c.294T>G (p.Asp98Glu)	TNNT2	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jun 4, 2015)	criteria provided, single submitter	1	201334738	1	201365610	43625	52794
NM_001001430.2(TNNT2):c.257A>C (p.Asp86Ala)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	1	201334745	1	201365617	43626	52795
NM_001001430.2(TNNT2):c.244G>A (p.Gly82Arg)	TNNT2	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2016)	criteria provided, multiple submitters, no conflicts	1	201334758	1	201365630	177644	172365
NM_001001430.2(TNNT2):c.236T>A (p.Ile79Asn)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	1	201334766	1	201365638	12408	27447
NM_000364.3(TNNT2):c.260C>T (p.Pro87Leu)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Sep 23, 2017)	criteria provided, multiple submitters, no conflicts	1	201334772	1	201365644	43619	52788
NM_000364.3(TNNT2):c.113C>T (p.Ala38Val)	TNNT2	Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Familial restrictive cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Increased left ventricular wall thickness	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	1	201337340	1	201368212	43675	52844
NM_002725.3(PRELP):c.778G>A (p.Gly260Arg)	PRELP	PRELP-related osteosclerosis	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	1	203453090	1	203483962	584444	575486
NM_015375.2(DSTYK):c.2368C>T (p.Arg790Cys)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205119907	1	205150779	224359	226073
NM_199462.2(DSTYK):c.1775G>A (p.Arg592Gln)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205131207	1	205162079	224356	226075
NM_015375.2(DSTYK):c.1253A>G (p.Asp418Gly)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205138362	1	205169234	224361	226076
NM_015375.2(DSTYK):c.358G>A (p.Asp120Asn)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205156842	1	205187714	224357	226077
NM_199462.2(DSTYK):c.53C>T (p.Pro18Leu)	DSTYK	Congenital anomalies of kidney and urinary tract 1, susceptibility to	Uncertain significance	criteria provided, single submitter	1	205180611	1	205211483	224358	226078
NM_025179.3(PLXNA2):c.2206G>A (p.Gly736Ser)	PLXNA2	atypical cerebral palsy	Likely pathogenic	criteria provided, single submitter	1	208257817	1	208084472	431732	425204
NM_006147.3(IRF6):c.113T>C (p.Ile38Thr)	IRF6	Van der Woude syndrome	Pathogenic	criteria provided, single submitter	1	209974646	1	209801301	397639	384611
NM_002238.3(KCNH1):c.1405G>A (p.Gly469Arg)	KCNH1	Zimmermann-Laband syndrome 1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	1	210977485	1	210804143	183418	181517
NM_003238.4(TGFB2):c.458G>A (p.Arg153His)	TGFB2	Loeys-Dietz syndrome 4	Likely pathogenic(Last reviewed: Nov 12, 2014)	no assertion criteria provided	1	218578622	1	218405280	374302	361158
NM_032890.4(DISP1):c.743C>T (p.Ala248Val)	DISP1	Holoprosencephaly sequence	Uncertain significance	criteria provided, single submitter	1	223164941	1	222991599	397657	384630
NM_002107.4(H3F3A):c.377A>G (p.Gln126Arg)	H3F3A	Inborn genetic diseases|H3F3A-related condition	Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	1	226259146	1	226071445	520774	511233
NM_052843.3(OBSCN):c.727G>C (p.Gly243Arg)	OBSCN|OBSCN-AS1	Inborn genetic diseases	Uncertain significance	criteria provided, single submitter	1	228400211	1	228212510	225073	226875
NM_001100.3(ACTA1):c.739G>C (p.Gly247Arg)	ACTA1	Nemaline myopathy 3|not provided|ACTA1 gene related myopathy	Pathogenic(Last reviewed: Jun 9, 2017)	criteria provided, single submitter	1	229567810	1	229432063	381639	364928
NM_001100.3(ACTA1):c.539T>C (p.Leu180Pro)	ACTA1	Nemaline myopathy 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	229568094	1	229432347	560935	552039
NM_001100.3(ACTA1):c.478G>A (p.Gly160Ser)	ACTA1	Nemaline myopathy 3|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	1	229568155	1	229432408	420707	405080
NM_001100.3(ACTA1):c.442G>A (p.Gly148Ser)	ACTA1	Nemaline myopathy 3	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	1	229568315	1	229432568	93549	99454
NM_001100.3(ACTA1):c.133G>T (p.Val45Phe)	ACTA1	Nemaline myopathy 3	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	1	229568624	1	229432877	93548	99453
NM_001100.3(ACTA1):c.109G>T (p.Val37Leu)	ACTA1	Nemaline myopathy 3	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	1	229568754	1	229433007	464114	447779
NM_001100.3(ACTA1):c.82G>C (p.Ala28Pro)	ACTA1	Nemaline myopathy 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	1	229568781	1	229433034	560936	552040
NM_001103.3(ACTN2):c.343G>A (p.Val115Met)	ACTN2	not specified	Uncertain significance(Last reviewed: Oct 16, 2014)	criteria provided, single submitter	1	236882295	1	236718995	43936	53105
NM_001103.3(ACTN2):c.355G>A (p.Ala119Thr)	ACTN2	Dilated cardiomyopathy 1AA|Cardiomyopathy|Familial hypertrophic cardiomyopathy 23	Pathogenic(Last reviewed: Dec 2, 2014)	criteria provided, single submitter	1	236882307	1	236719007	162727	172928
NM_001103.3(ACTN2):c.1369C>T (p.Arg457Cys)	ACTN2	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jun 22, 2015)	criteria provided, single submitter	1	236908039	1	236744739	217833	214483
NM_001103.3(ACTN2):c.2147C>T (p.Thr716Met)	ACTN2	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1AA|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 9, 2017)	criteria provided, conflicting interpretations	1	236918491	1	236755191	35650	44315
NM_001035.2(RYR2):c.556G>A (p.Val186Met)	RYR2	Ventricular tachycardia, polymorphic	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	1	237540715	1	237377415	161382	171057
NM_001035.2(RYR2):c.1258C>T (p.Arg420Trp)	RYR2	Arrhythmogenic right ventricular dysplasia, familial, 2|Catecholaminergic polymorphic ventricular tachycardia type 1|not provided|Ventricular fibrillation|Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 2|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	1	237608788	1	237445488	201214	196540
NM_001035.2(RYR2):c.1298T>C (p.Leu433Pro)	RYR2	Arrhythmogenic right ventricular dysplasia, familial, 2|Long QT syndrome|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic(Last reviewed: Feb 4, 2015)	criteria provided, single submitter	1	237617696	1	237454396	12959	27998
NM_001035.2(RYR2):c.1392C>A (p.His464Gln)	RYR2	not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	1	237617790	1	237454490	427953	419263
NM_001035.2(RYR2):c.1396C>G (p.Pro466Ala)	RYR2	not specified|Ventricular tachycardia, polymorphic	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	1	237617794	1	237454494	161383	171058
NM_001035.2(RYR2):c.3038G>A (p.Arg1013Gln)	RYR2	Catecholaminergic polymorphic ventricular tachycardia type 1|not specified|not provided|Cardiovascular phenotype|Catecholaminergic polymorphic ventricular tachycardia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	1	237711862	1	237548562	161381	171059
NM_001035.2(RYR2):c.4186G>A (p.Asp1396Asn)	RYR2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	1	237755064	1	237591764	427954	419264
NM_001035.2(RYR2):c.4196C>A (p.Thr1399Lys)	RYR2	Arrhythmogenic right ventricular dysplasia, familial 1	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	1	237755074	1	237591774	226037	227842
NM_001035.2(RYR2):c.4235A>G (p.Asp1412Gly)	RYR2	Brugada syndrome 1	Uncertain significance(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	1	237755113	1	237591813	492987	485930
NM_001035.2(RYR2):c.5822G>A (p.Arg1941His)	RYR2	Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	1	237780692	1	237617392	375865	362734
NM_001035.2(RYR2):c.7493C>T (p.Ala2498Val)	RYR2	Catecholaminergic polymorphic ventricular tachycardia type 1	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	1	237811894	1	237648594	161380	171060
NM_001035.2(RYR2):c.11996T>C (p.Met3999Thr)	RYR2	Ventricular tachycardia, catecholaminergic polymorphic, 2	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	1	237947008	1	237783708	427948	419265
NM_001035.2(RYR2):c.13666G>A (p.Ala4556Thr)	RYR2	not provided|Ventricular tachycardia, polymorphic	Uncertain significance(Last reviewed: Mar 25, 2018)	criteria provided, single submitter	1	237955507	1	237792207	161384	171061
NM_001035.2(RYR2):c.14650A>G (p.Met4884Val)	RYR2	Sudden cardiac death	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	1	237991740	1	237828440	427951	419266
NM_001035.2(RYR2):c.14876G>A (p.Arg4959Gln)	RYR2	Catecholaminergic polymorphic ventricular tachycardia type 1|not provided|Catecholaminergic polymorphic ventricular tachycardia	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	1	237995919	1	237832619	201365	196751
NM_000143.3(FH):c.1127A>C (p.Gln376Pro)	FH	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	1	241665852	1	241502552	42094	51260
NM_000143.3(FH):c.521C>G (p.Pro174Arg)	FH	Fumarase deficiency|Multiple cutaneous leiomyomas|not provided|Hereditary cancer-predisposing syndrome|Multiple Cutaneous and Uterine Leiomyomas	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	1	241675301	1	241512001	29705	38660
NM_005465.4(AKT3):c.548T>A (p.Val183Asp)	AKT3	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	Likely pathogenic	criteria provided, single submitter	1	243800926	1	243637624	273671	263837
NM_004895.4(NLRP3):c.2182A>G (p.Ser728Gly)	NLRP3	Chronic infantile neurological, cutaneous and articular syndrome|Familial amyloid nephropathy with urticaria AND deafness|Familial cold urticaria|not specified|Familial cold autoinflammatory syndrome|Cryopyrin associated periodic syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	1	247592912	1	247429610	234290	231483
NM_003597.4(KLF11):c.185A>G (p.Gln62Arg)	KLF11	Maturity onset diabetes mellitus in young|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	10186419	2	10046292	129431	134877
NM_003597.4(KLF11):c.410A>G (p.Asp137Gly)	KLF11	not specified|Monogenic diabetes	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	10187874	2	10047747	129430	134876
NM_003597.4(KLF11):c.467G>T (p.Gly156Val)	KLF11	not provided	Uncertain significance(Last reviewed: Jun 27, 2013)	criteria provided, single submitter	2	10187931	2	10047804	129432	134878
NM_000384.2(APOB):c.13451C>T (p.Thr4484Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	2	21224843	2	21001971	255978	250516
NM_000384.2(APOB):c.13160A>T (p.Glu4387Val)	APOB	Familial hypercholesterolemia|not specified	Uncertain significance	criteria provided, single submitter	2	21225134	2	21002262	369883	354069
NM_000384.2(APOB):c.13013G>A (p.Ser4338Asn)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	2	21225281	2	21002409	128418	133867
NM_000384.2(APOB):c.12940A>G (p.Ile4314Val)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	2	21225354	2	21002482	237739	238599
NM_000384.2(APOB):c.12809G>C (p.Arg4270Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2017)	criteria provided, conflicting interpretations	2	21225485	2	21002613	255977	250517
NM_000384.2(APOB):c.12794T>C (p.Val4265Ala)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21225500	2	21002628	237738	238600
NM_000384.2(APOB):c.12697T>A (p.Ser4233Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	2	21225597	2	21002725	255976	250518
NM_000384.2(APOB):c.12541G>A (p.Glu4181Lys)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	21225753	2	21002881	128417	133866
NM_000384.2(APOB):c.12382G>A (p.Val4128Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	2	21225912	2	21003040	384812	366335
NM_000384.2(APOB):c.12343G>A (p.Val4115Ile)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21225951	2	21003079	544070	517691
NM_000384.2(APOB):c.12310C>A (p.Leu4104Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21225984	2	21003112	334079	285073
NM_000384.2(APOB):c.11965C>T (p.Arg3989Cys)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21227263	2	21004391	369878	354070
NM_000384.2(APOB):c.11833A>G (p.Thr3945Ala)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	2	21227503	2	21004631	334091	285075
NM_000384.2(APOB):c.11509G>T (p.Ala3837Ser)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21228231	2	21005359	548035	538529
NM_000384.2(APOB):c.11477C>T (p.Thr3826Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2018)	criteria provided, conflicting interpretations	2	21228263	2	21005391	237735	238603
NM_000384.2(APOB):c.11401T>A (p.Ser3801Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	2	21228339	2	21005467	237734	238604
NM_000384.2(APOB):c.11362G>A (p.Glu3788Lys)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypercholesterolemia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	2	21228378	2	21005506	334100	287155
NM_000384.2(APOB):c.11356C>T (p.Leu3786Phe)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21228384	2	21005512	548034	538530
NM_000384.2(APOB):c.10913G>A (p.Arg3638Gln)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	2	21228827	2	21005955	128416	133865
NM_000384.2(APOB):c.10780T>C (p.Trp3594Arg)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2017)	criteria provided, conflicting interpretations	2	21228960	2	21006088	369881	354071
NM_000384.2(APOB):c.10580G>A (p.Arg3527Gln)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not provided|Hypobetalipoproteinemia, familial, 1|Hypobetalipoproteinemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	2	21229160	2	21006288	17890	32929
NM_000384.2(APOB):c.10579C>T (p.Arg3527Trp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	2	21229161	2	21006289	40223	48709
NM_000384.2(APOB):c.10508C>T (p.Ser3503Leu)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21229232	2	21006360	548033	538531
NM_000384.2(APOB):c.10367C>T (p.Ser3456Phe)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21229373	2	21006501	548032	538532
NM_000384.2(APOB):c.10294C>G (p.Gln3432Glu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	2	21229446	2	21006574	180279	178500
NM_000384.2(APOB):c.10186G>A (p.Ala3396Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B	Likely pathogenic(Last reviewed: Oct 19, 2017)	no assertion criteria provided	2	21229554	2	21006682	444010	437671
NM_000384.2(APOB):c.10182G>T (p.Lys3394Asn)	APOB	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	2	21229558	2	21006686	438310	431948
NM_000384.2(APOB):c.10061C>G (p.Ala3354Gly)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 21, 2017)	criteria provided, conflicting interpretations	2	21229679	2	21006807	369882	354072
NM_000384.2(APOB):c.10037G>T (p.Ser3346Ile)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21229703	2	21006831	189299	187184
NM_000384.2(APOB):c.9883T>C (p.Tyr3295His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21229857	2	21006985	334108	287185
NM_000384.2(APOB):c.9880T>C (p.Ser3294Pro)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	2	21229860	2	21006988	255990	250523
NM_000384.2(APOB):c.9835A>G (p.Ser3279Gly)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	2	21229905	2	21007033	218452	215238
NM_000384.2(APOB):c.9811G>A (p.Gly3271Ser)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	21229929	2	21007057	334109	287196
NM_000384.2(APOB):c.9694A>G (p.Lys3232Glu)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230046	2	21007174	548073	538533
NM_000384.2(APOB):c.9639C>A (p.Asn3213Lys)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21230101	2	21007229	402375	389497
NM_000384.2(APOB):c.9633C>A (p.Asn3211Lys)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230107	2	21007235	548072	538534
NM_000384.2(APOB):c.9175C>T (p.Arg3059Cys)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2017)	criteria provided, conflicting interpretations	2	21230565	2	21007693	69508	80399
NM_000384.2(APOB):c.9095C>A (p.Thr3032Asn)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21230645	2	21007773	548069	538537
NM_000384.2(APOB):c.8693T>C (p.Leu2898Pro)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21231047	2	21008175	548066	538538
NM_000384.2(APOB):c.8550T>G (p.Ile2850Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	2	21231190	2	21008318	402376	389499
NM_000384.2(APOB):c.8462C>T (p.Pro2821Leu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21231278	2	21008406	218451	215239
NM_000384.2(APOB):c.8353A>C (p.Asn2785His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	2	21231387	2	21008515	218450	215240
NM_000384.2(APOB):c.8216C>T (p.Pro2739Leu)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	2	21231524	2	21008652	128426	133875
NM_000384.2(APOB):c.7696G>A (p.Glu2566Lys)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	2	21232044	2	21009172	189300	187185
NM_000384.2(APOB):c.7615G>A (p.Val2539Ile)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2018)	criteria provided, conflicting interpretations	2	21232125	2	21009253	334125	287224
NM_000384.2(APOB):c.7367C>A (p.Ala2456Asp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	2	21232373	2	21009501	255987	250526
NM_000384.2(APOB):c.7330C>T (p.Arg2444Cys)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21232410	2	21009538	369884	354073
NM_000384.2(APOB):c.7285T>A (p.Ser2429Thr)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1|Hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2017)	criteria provided, conflicting interpretations	2	21232455	2	21009583	218448	215242
NM_000384.2(APOB):c.7134C>A (p.Ser2378Arg)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21232606	2	21009734	189301	187186
NM_000384.2(APOB):c.6943G>A (p.Glu2315Lys)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21232797	2	21009925	548064	538540
NM_000384.2(APOB):c.6895G>C (p.Asp2299His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	2	21232845	2	21009973	252485	246910
NM_000384.2(APOB):c.6815A>G (p.His2272Arg)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21232925	2	21010053	548063	538541
NM_000384.2(APOB):c.6125T>C (p.Met2042Thr)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21233615	2	21010743	334133	287583
NM_000384.2(APOB):c.5863G>A (p.Val1955Met)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21233877	2	21011005	548062	538542
NM_000384.2(APOB):c.5741A>G (p.Asn1914Ser)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21233999	2	21011127	218447	215243
NM_000384.2(APOB):c.5715G>A (p.Met1905Ile)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21234025	2	21011153	548061	538543
NM_000384.2(APOB):c.5690G>A (p.Arg1897His)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21234050	2	21011178	265888	260635
NM_000384.2(APOB):c.5654A>G (p.Tyr1885Cys)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21234086	2	21011214	189303	187188
NM_000384.2(APOB):c.5646C>G (p.Ser1882Arg)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21234094	2	21011222	548060	538544
NM_000384.2(APOB):c.5560G>A (p.Asp1854Asn)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21234180	2	21011308	548058	538546
NM_000384.2(APOB):c.5066G>A (p.Arg1689His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	2	21234674	2	21011802	189304	187189
NM_000384.2(APOB):c.4663A>G (p.Ile1555Val)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21235077	2	21012205	431500	425004
NM_000384.2(APOB):c.4532C>T (p.Thr1511Ile)	APOB	Familial hypercholesterolemia|not specified	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21235208	2	21012336	450695	443153
NM_000384.2(APOB):c.4111G>A (p.Ala1371Thr)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21236137	2	21013265	548055	538547
NM_000384.2(APOB):c.3851G>A (p.Arg1284Gln)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21236397	2	21013525	548054	538548
NM_000384.2(APOB):c.3656C>T (p.Thr1219Ile)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21237985	2	21015113	548053	538549
NM_000384.2(APOB):c.3634C>A (p.Leu1212Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	2	21238007	2	21015135	218444	215246
NM_000384.2(APOB):c.3595G>A (p.Asp1199Asn)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21238046	2	21015174	334152	287263
NM_000384.2(APOB):c.3491G>C (p.Arg1164Thr)	APOB	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	2	21238259	2	21015387	265885	260638
NM_000384.2(APOB):c.3427C>T (p.Pro1143Ser)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21238323	2	21015451	237744	238615
NM_000384.2(APOB):c.3383G>A (p.Arg1128His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|not provided|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	2	21238367	2	21015495	281142	265379
NM_000384.2(APOB):c.3337G>C (p.Asp1113His)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	2	21238413	2	21015541	218443	215247
NM_000384.2(APOB):c.3052G>A (p.Ala1018Thr)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21241933	2	21019061	548048	538551
NM_000384.2(APOB):c.2981C>T (p.Pro994Leu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	2	21242613	2	21019741	237743	238616
NM_000384.2(APOB):c.2968G>A (p.Ala990Thr)	APOB	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21242626	2	21019754	431493	425011
NM_000384.2(APOB):c.2950G>A (p.Ala984Thr)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21242644	2	21019772	548046	538553
NM_000384.2(APOB):c.2630C>T (p.Pro877Leu)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21245889	2	21023017	490389	483249
NM_000384.2(APOB):c.2585T>C (p.Val862Ala)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2017)	criteria provided, conflicting interpretations	2	21246416	2	21023544	189305	187190
NM_000384.2(APOB):c.2308G>A (p.Val770Ile)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21247933	2	21025061	548045	538554
NM_000384.2(APOB):c.2222C>A (p.Thr741Asn)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	2	21249682	2	21026810	218442	215248
NM_000384.2(APOB):c.1853C>T (p.Ala618Val)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	21250914	2	21028042	128420	133869
NM_000384.2(APOB):c.1648G>C (p.Asp550His)	APOB	Hypercholesterolemia, autosomal dominant, type B|not specified|Hypobetalipoproteinemia, familial, 1|Hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2017)	criteria provided, conflicting interpretations	2	21251380	2	21028508	375860	362735
NM_000384.2(APOB):c.1594C>T (p.Arg532Trp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21252534	2	21029662	255979	250533
NM_000384.2(APOB):c.1493C>T (p.Thr498Ile)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21252635	2	21029763	548039	538559
NM_000384.2(APOB):c.1402A>G (p.Asn468Asp)	APOB	Familial hypercholesterolemia	Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21252838	2	21029966	548038	538560
NM_000384.2(APOB):c.1198C>T (p.Arg400Cys)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21255380	2	21032508	369880	354074
NM_000384.2(APOB):c.1061A>G (p.Glu354Gly)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21256234	2	21033362	334175	285211
NM_000384.2(APOB):c.889C>T (p.Arg297Cys)	APOB	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21257703	2	21034831	548067	538562
NM_000384.2(APOB):c.830G>T (p.Gly277Val)	APOB	Familial hypercholesterolemia	Uncertain significance	criteria provided, single submitter	2	21257762	2	21034890	369879	354075
NM_000384.2(APOB):c.689G>T (p.Gly230Val)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21259976	2	21037104	404401	392489
NM_000384.2(APOB):c.607A>G (p.Ile203Val)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21260058	2	21037186	334179	284515
NM_000384.2(APOB):c.606A>T (p.Glu202Asp)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypercholesterolemia|not provided|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	21260059	2	21037187	235263	236950
NM_000384.2(APOB):c.581C>T (p.Thr194Met)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|Hypobetalipoproteinemia, familial, 1	Benign/Likely benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	2	21260084	2	21037212	334181	284527
NM_000384.2(APOB):c.499C>T (p.Pro167Ser)	APOB	Familial hypercholesterolemia	Likely benign	criteria provided, single submitter	2	21260868	2	21037996	189306	187191
NM_000384.2(APOB):c.433C>T (p.Pro145Ser)	APOB	Hypercholesterolemia, autosomal dominant, type B|Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified|Hypobetalipoproteinemia, familial, 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	21260934	2	21038062	334184	287334
NM_000384.2(APOB):c.293C>T (p.Thr98Ile)	APOB	Familial hypobetalipoproteinemia|Familial hypercholesterolemia|not specified	Benign/Likely benign(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	2	21263900	2	21041028	128422	133871
NM_000384.2(APOB):c.218C>A (p.Ala73Asp)	APOB|LOC106560211	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	2	21265252	2	21042380	548044	538563
NM_194248.2(OTOF):c.[3928_3930dupAAG];[5098G>C]	OTOF	Deafness, autosomal recessive 9	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2|2	26686837	2|2	26463969	424790	57417|213537
NM_014946.3(SPAST):c.631G>A (p.Val211Ile)	SPAST	Spastic paraplegia 4, autosomal dominant	Likely pathogenic(Last reviewed: Aug 16, 2018)	no assertion criteria provided	2	32323909	2	32098840	560537	551616
NM_014946.3(SPAST):c.1169T>A (p.Met390Lys)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	2	32352087	2	32127018	488605	481473
NM_014946.3(SPAST):c.1232T>C (p.Leu411Ser)	SPAST	Spastic paraplegia 4, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	32353535	2	32128466	561116	552065
NM_014946.3(SPAST):c.1477G>C (p.Asp493His)	SPAST	Spastic paraplegia 4, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2017)	criteria provided, conflicting interpretations	2	32362241	2	32137172	417628	404606
NM_014946.3(SPAST):c.1477G>T (p.Asp493Tyr)	SPAST	Spastic paraplegia 4, autosomal dominant	Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	2	32362241	2	32137172	417627	404605
NM_014946.3(SPAST):c.1484C>T (p.Ala495Val)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	2	32362248	2	32137179	488606	481474
NM_014946.3(SPAST):c.1496G>A (p.Arg499His)	SPAST	Spastic paraplegia 4, autosomal dominant|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	2	32366975	2	32141906	240950	238767
NM_014946.3(SPAST):c.1625A>G (p.Asp542Gly)	SPAST	Spastic paraplegia 4, autosomal dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2017)	criteria provided, conflicting interpretations	2	32370014	2	32144945	217003	213538
NM_014946.3(SPAST):c.1685G>A (p.Arg562Gln)	SPAST	Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 24, 2014)	criteria provided, single submitter	2	32370074	2	32145005	217004	213539
NM_005633.3(SOS1):c.1656G>C (p.Arg552Ser)	SOS1	Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	2	39249913	2	39022772	12872	27911
NM_005633.3(SOS1):c.1655G>C (p.Arg552Thr)	SOS1	Noonan syndrome|not provided|Rasopathy|Abnormality of the aortic valve	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	2	39249914	2	39022773	40682	49152
NM_005633.3(SOS1):c.1654A>G (p.Arg552Gly)	SOS1	Gingival fibromatosis 1|Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39249915	2	39022774	12871	27910
NM_005633.3(SOS1):c.1642A>C (p.Ser548Arg)	SOS1	Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39249927	2	39022786	40678	49148
NM_005633.3(SOS1):c.1322G>A (p.Cys441Tyr)	SOS1	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	2	39250247	2	39023106	40673	49143
NM_005633.3(SOS1):c.1310T>C (p.Ile437Thr)	SOS1	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	2	39250259	2	39023118	45345	54512
NM_005633.3(SOS1):c.979A>G (p.Ile327Val)	SOS1	Noonan syndrome 4	Uncertain significance(Last reviewed: Jun 11, 2017)	criteria provided, single submitter	2	39262448	2	39035307	444007	437668
NM_005633.3(SOS1):c.929G>A (p.Arg310His)	SOS1	Noonan syndrome|not specified|Gingival fibromatosis	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	39262577	2	39035436	45381	54548
NM_005633.3(SOS1):c.925G>T (p.Asp309Tyr)	SOS1	Noonan syndrome|not provided	Pathogenic(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	2	39262581	2	39035440	45379	54546
NM_005633.3(SOS1):c.806T>C (p.Met269Thr)	SOS1	Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39278343	2	39051202	40662	49132
NM_005633.3(SOS1):c.806T>G (p.Met269Arg)	SOS1	Noonan syndrome 4|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Sep 16, 2017)	criteria provided, multiple submitters, no conflicts	2	39278343	2	39051202	12870	27909
NM_005633.3(SOS1):c.749T>C (p.Val250Ala)	SOS1	not specified|not provided|Rasopathy	Benign(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39278400	2	39051259	40660	49130
NM_005633.3(SOS1):c.508A>G (p.Lys170Glu)	SOS1	Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39283845	2	39056704	40651	49121
NM_005633.3(SOS1):c.322G>A (p.Glu108Lys)	SOS1	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	2	39285837	2	39058696	40649	49119
NM_016932.4(SIX2):c.707C>T (p.Pro236Leu)	SIX2	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	2	45233478	2	45006339	224349	226079
NM_001305625.1(CALM2):c.306C>G (p.Asn102Lys)	CALM2	Long QT syndrome 15	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, single submitter	2	47388869	2	47161730	488476	481344
NM_002354.2(EPCAM):c.267G>C (p.Gln89His)	EPCAM	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2017)	criteria provided, conflicting interpretations	2	47601029	2	47373890	127848	133305
NM_000251.2(MSH2):c.4G>A (p.Ala2Thr)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	47630334	2	47403195	41650	50089
NM_000251.2(MSH2):c.138C>G (p.His46Gln)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Nov 24, 2015)	reviewed by expert panel	2	47630468	2	47403329	90654	96129
NM_000251.2(MSH2):c.435T>G (p.Ile145Met)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47637301	2	47410162	91097	96572
NM_000251.2(MSH2):c.499G>C (p.Asp167His)	MSH2	Lynch syndrome I|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	47637365	2	47410226	91112	96587
NM_000251.2(MSH2):c.763A>G (p.Ser255Gly)	MSH2	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2018)	criteria provided, conflicting interpretations	2	47639670	2	47412531	231904	232544
NM_000251.2(MSH2):c.815C>T (p.Ala272Val)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47641430	2	47414291	41651	50090
NM_000251.2(MSH2):c.913G>A (p.Ala305Thr)	MSH2	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47641528	2	47414389	91243	96718
NM_000251.2(MSH2):c.929T>G (p.Leu310Arg)	MSH2	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47641544	2	47414405	91246	96721
NM_000251.2(MSH2):c.968C>G (p.Ser323Cys)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47643460	2	47416321	91260	96735
NM_000251.2(MSH2):c.1045C>G (p.Pro349Ala)	MSH2	Lynch syndrome|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47643537	2	47416398	90512	95987
NM_000251.2(MSH2):c.1418C>T (p.Ser473Leu)	MSH2	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47690201	2	47463062	90660	96135
NM_000251.2(MSH2):c.1748A>G (p.Asn583Ser)	MSH2	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47698190	2	47471051	41645	50084
NM_000251.2(MSH2):c.1787A>G (p.Asn596Ser)	MSH2	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47702191	2	47475052	41646	50085
NM_000251.2(MSH2):c.1832T>A (p.Val611Glu)	MSH2	Lynch syndrome	Likely pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	2	47702236	2	47475097	549765	540528
NM_000251.2(MSH2):c.1906G>C (p.Ala636Pro)	MSH2	Lynch syndrome I|Colorectal cancer, hereditary, nonpolyposis, type 1|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47702310	2	47475171	1764	16803
NM_000251.2(MSH2):c.1927G>A (p.Glu643Lys)	MSH2	Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	2	47702331	2	47475192	161299	171076
NM_000251.2(MSH2):c.2074G>T (p.Gly692Trp)	MSH2	Lynch syndrome I|Lynch syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2017)	criteria provided, conflicting interpretations	2	47703574	2	47476435	428464	419395
NM_000251.2(MSH2):c.2203A>G (p.Ile735Val)	MSH2	Lynch syndrome I|Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	2	47703703	2	47476564	161300	171077
NM_000251.2(MSH2):c.2437A>G (p.Met813Val)	MSH2	Lynch syndrome I|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	47705637	2	47478498	90972	96447
NM_000251.2(MSH2):c.2768T>A (p.Val923Glu)	MSH2	Lynch syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	47710051	2	47482912	91043	96518
NM_000179.2(MSH6):c.59C>T (p.Ala20Val)	MSH6	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 5|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal / endometrial cancer|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	48010431	2	47783292	89540	95014
NM_000179.2(MSH6):c.383G>T (p.Arg128Leu)	MSH6	Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48018188	2	47791049	89473	94947
NM_000179.2(MSH6):c.431G>T (p.Ser144Ile)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48018236	2	47791097	41596	50035
NM_000179.2(MSH6):c.854G>T (p.Ser285Ile)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48025976	2	47798837	89571	95045
NM_000179.2(MSH6):c.1346T>C (p.Leu449Pro)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48026468	2	47799329	89189	94663
NM_000179.2(MSH6):c.1403G>A (p.Arg468His)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48026525	2	47799386	89192	94666
NM_000179.2(MSH6):c.1526T>C (p.Val509Ala)	MSH6	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48026648	2	47799509	41588	50027
NM_000179.2(MSH6):c.1822A>G (p.Ile608Val)	MSH6	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	2	48026944	2	47799805	182626	180063
NM_000179.2(MSH6):c.2342C>T (p.Pro781Leu)	MSH6	Lynch syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	2	48027464	2	47800325	433914	427175
NM_000179.2(MSH6):c.2398G>C (p.Val800Leu)	MSH6	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Jun 13, 2018)	reviewed by expert panel	2	48027520	2	47800381	89279	94753
NM_000179.2(MSH6):c.2408A>G (p.Asp803Gly)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027530	2	47800391	89281	94755
NM_000179.2(MSH6):c.2561A>T (p.Lys854Met)	MSH6	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027683	2	47800544	89289	94763
NM_000179.2(MSH6):c.2633T>C (p.Val878Ala)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal / endometrial cancer|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48027755	2	47800616	8931	23970
NM_000179.2(MSH6):c.3259C>T (p.Pro1087Ser)	MSH6	Lynch syndrome|Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48030645	2	47803506	89360	94834
NM_000179.2(MSH6):c.3299C>T (p.Thr1100Met)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Inborn genetic diseases|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48030685	2	47803546	89369	94843
NM_000179.2(MSH6):c.3431T>G (p.Met1144Arg)	MSH6	Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2018)	criteria provided, conflicting interpretations	2	48030817	2	47803678	220619	221299
NM_000179.2(MSH6):c.3722G>A (p.Cys1241Tyr)	MSH6	Lynch syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2018)	criteria provided, conflicting interpretations	2	48033418	2	47806279	428361	419567
NM_000179.2(MSH6):c.3961A>G (p.Arg1321Gly)	MSH6	Hereditary nonpolyposis colorectal cancer type 5|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, early onset|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	2	48033750	2	47806611	89490	94964
NM_000233.3(LHCGR):c.1732G>T (p.Asp578Tyr)	LHCGR|STON1-GTF2A1L	Gonadotropin-independent familial sexual precocity	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	2	48915204	2	48688065	36468	45131
NM_000233.3(LHCGR):c.1691A>G (p.Asp564Gly)	LHCGR|STON1-GTF2A1L	Gonadotropin-independent familial sexual precocity|not provided	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	2	48915245	2	48688106	14412	29451
NM_001135659.2(NRXN1):c.162G>A (p.Met54Ile)	NRXN1	Ovarian dysgenesis 3	Likely benign	no assertion criteria provided	2	51255250	2	51028112	375625	362439
NM_001039348.2(EFEMP1):c.1033C>T (p.Arg345Trp)	EFEMP1	Doyne honeycomb retinal dystrophy|Malattia leventinese|not provided	Pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	2	56098226	2	55871091	8072	23111
NM_022173.2(TIA1):c.1070A>G (p.Asn357Ser)	TIA1	Welander distal myopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	2	70439942	2	70212810	261567	250766
NM_001615.3(ACTG2):c.118C>T (p.Arg40Cys)	ACTG2	Visceral myopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, multiple submitters, no conflicts	2	74128556	2	73901429	132799	136548
NM_001615.3(ACTG2):c.119G>A (p.Arg40His)	ACTG2	Visceral myopathy|Visceral neuropathy, familial, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	2	74128557	2	73901430	132802	136551
NM_001615.3(ACTG2):c.134T>C (p.Met45Thr)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	74129494	2	73902367	218309	215005
NM_001615.3(ACTG2):c.187C>G (p.Arg63Gly)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Dec 20, 2016)	criteria provided, multiple submitters, no conflicts	2	74129547	2	73902420	218310	215006
NM_001615.3(ACTG2):c.400T>A (p.Tyr134Asn)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	74136215	2	73909088	132805	136554
NM_001615.3(ACTG2):c.443G>T (p.Arg148Leu)	ACTG2	Visceral myopathy	Likely pathogenic(Last reviewed: Mar 28, 2014)	no assertion criteria provided	2	74136258	2	73909131	180620	178786
NM_001615.3(ACTG2):c.532C>T (p.Arg178Cys)	ACTG2	Visceral myopathy|not provided	Pathogenic(Last reviewed: Apr 26, 2016)	criteria provided, multiple submitters, no conflicts	2	74140692	2	73913565	132800	136549
NM_001615.3(ACTG2):c.533G>A (p.Arg178His)	ACTG2	Visceral myopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, multiple submitters, no conflicts	2	74140693	2	73913566	132801	136550
NM_001615.3(ACTG2):c.593G>A (p.Gly198Asp)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Mar 27, 2014)	criteria provided, single submitter	2	74140753	2	73913626	218312	215008
NM_001615.3(ACTG2):c.613G>A (p.Ala205Thr)	ACTG2	Visceral myopathy	Pathogenic(Last reviewed: Aug 21, 2015)	criteria provided, single submitter	2	74140773	2	73913646	369682	353891
NM_001615.3(ACTG2):c.769C>T (p.Arg257Cys)	ACTG2	Visceral myopathy|Visceral neuropathy, familial, autosomal dominant|not provided|Megacystis|Inborn genetic diseases|Chronic intestinal pseudoobstruction	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	2	74141962	2	73914835	132803	136552
NM_017849.3(TMEM127):c.268G>A (p.Val90Met)	TMEM127	Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2018)	criteria provided, conflicting interpretations	2	96920712	2	96254974	136209	139913
NM_017849.3(TMEM127):c.217G>C (p.Gly73Arg)	TMEM127	Pheochromocytoma|Hereditary Paraganglioma-Pheochromocytoma Syndromes	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	2	96930903	2	96265165	126965	132478
NM_005270.4(GLI2):c.1426G>C (p.Ala476Pro)	GLI2	Culler-Jones syndrome	Uncertain significance(Last reviewed: Sep 16, 2017)	criteria provided, single submitter	2	121736067	2	120978491	443998	437660
NM_005270.4(GLI2):c.4654A>T (p.Thr1552Ser)	GLI2	Holoprosencephaly 9	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	2	121748144	2	120990568	374267	361165
NM_000312.3(PROC):c.52G>A (p.Gly18Ser)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	2	128177570	2	127419994	161337	171062
NM_000312.3(PROC):c.125G>A (p.Arg42His)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128178913	2	127421337	161333	171063
NM_000312.3(PROC):c.160A>T (p.Ser54Cys)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128178948	2	127421372	161338	171064
NM_000312.3(PROC):c.322C>A (p.His108Asn)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128180669	2	127423093	161335	171065
NM_000312.3(PROC):c.340G>C (p.Gly114Arg)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128180687	2	127423111	161341	171066
NM_000312.3(PROC):c.565C>T (p.Arg189Trp)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	2	128183690	2	127426114	161342	171067
NM_000312.3(PROC):c.580C>T (p.Arg194Cys)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jan 23, 2016)	criteria provided, single submitter	2	128183705	2	127426129	161339	171068
NM_000312.3(PROC):c.631C>T (p.Arg211Trp)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal recessive|Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic/Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	2	128183756	2	127426180	659	15698
NM_000312.3(PROC):c.1010C>T (p.Thr337Ile)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	2	128186146	2	127428570	161340	171069
NM_000312.3(PROC):c.1201G>A (p.Asp401Asn)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128186337	2	127428761	161334	171070
NM_000312.3(PROC):c.1234G>A (p.Gly412Ser)	PROC	Thrombophilia, hereditary, due to protein C deficiency, autosomal dominant	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	2	128186370	2	127428794	161336	171071
NM_014795.3(ZEB2):c.3146A>C (p.His1049Pro)	ZEB2	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	2	145147517	2	144389950	254205	248720
NM_014795.3(ZEB2):c.3141G>C (p.Arg1047Ser)	ZEB2	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	2	145147522	2	144389955	160324	168022
NM_014795.3(ZEB2):c.2932G>T (p.Asp978Tyr)	ZEB2	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jul 17, 2012)	criteria provided, single submitter	2	145154114	2	144396547	217029	213524
NM_014795.3(ZEB2):c.2329C>T (p.His777Tyr)	ZEB2	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	2	145156425	2	144398858	160320	168026
NM_014795.3(ZEB2):c.2141C>T (p.Pro714Leu)	ZEB2	Mowat-Wilson syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	2	145156613	2	144399046	95627	101525
NM_014795.3(ZEB2):c.1480C>T (p.Pro494Ser)	ZEB2	Mowat-Wilson syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	2	145157274	2	144399707	95622	101520
NM_004522.2(KIF5C):c.709G>A (p.Glu237Lys)	KIF5C	not provided|Cortical dysplasia, complex, with other brain malformations 2	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	2	149803532	2	148947018	140740	150453
NM_001105.4(ACVR1):c.772A>G (p.Arg258Gly)	ACVR1	Progressive myositis ossificans|Brainstem glioma|Adenocarcinoma of stomach	Likely pathogenic(Last reviewed: Nov 27, 2012)	criteria provided, single submitter	2	158626898	2	157770386	216885	213526
NM_022168.4(IFIH1):c.2336G>A (p.Arg779His)	IFIH1	Hyperreflexia|not provided|Clonus|Aicardi-Goutieres syndrome 7|Neonatal hypotonia|Abnormal upper motor neuron morphology|Abnormality of the basal ganglia|Developmental regression|Abnormality of the cerebral white matter	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	2	163130423	2	162273913	137622	141325
NM_006922.3(SCN3A):c.626T>C (p.Leu209Pro)	SCN3A	atypical cerebral palsy	Likely pathogenic	criteria provided, single submitter	2	166020196	2	165163686	431726	425209
NM_021007.2(SCN2A):c.56G>A (p.Arg19Lys)	SCN2A	Benign familial neonatal-infantile seizures|not specified|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	2	166152389	2	165295879	130224	135671
NM_001040143.1(SCN2A):c.634A>G (p.Asn212Asp)	SCN2A	Early infantile epileptic encephalopathy 11	Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	2	166165703	2	165309193	488391	481228
NM_021007.2(SCN2A):c.788C>T (p.Ala263Val)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided|Epileptic encephalopathy|SCN2A-related condition	Pathogenic(Last reviewed: Nov 12, 2017)	criteria provided, multiple submitters, no conflicts	2	166166923	2	165310413	29888	38843
NM_021007.2(SCN2A):c.1280C>A (p.Ala427Asp)	SCN2A	not provided	Uncertain significance(Last reviewed: Jul 23, 2013)	criteria provided, single submitter	2	166170515	2	165314005	130212	135659
NM_021007.2(SCN2A):c.2558G>A (p.Arg853Gln)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	2	166198975	2	165342465	194555	191718
NM_021007.2(SCN2A):c.2635G>A (p.Gly879Arg)	SCN2A	Early infantile epileptic encephalopathy 11	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	2	166201137	2	165344627	206969	201335
NM_021007.2(SCN2A):c.2687C>T (p.Ala896Val)	SCN2A	Early infantile epileptic encephalopathy 11|Epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	2	166201189	2	165344679	375508	362318
NM_021007.2(SCN2A):c.2723A>G (p.Lys908Arg)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not specified|not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	2	166201225	2	165344715	130219	135666
NM_021007.2(SCN2A):c.2960G>T (p.Ser987Ile)	SCN2A	Episodic ataxia|Early infantile epileptic encephalopathy 11|Seizures|not provided|Vertigo	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2016)	criteria provided, multiple submitters, no conflicts	2	166210742	2	165354232	206978	201345
NM_021007.2(SCN2A):c.3631G>A (p.Glu1211Lys)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	2	166223837	2	165367327	29886	38841
NM_021007.2(SCN2A):c.4877G>A (p.Arg1626Gln)	SCN2A	Early infantile epileptic encephalopathy 11|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	166245193	2	165388683	207017	201391
NM_021007.2(SCN2A):c.5645G>A (p.Arg1882Gln)	SCN2A	Benign familial neonatal-infantile seizures|Early infantile epileptic encephalopathy 11|not provided|Epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	166245961	2	165389451	196039	193200
NM_001165963.1(SCN1A):c.5864T>C (p.Ile1955Thr)	SCN1A|LOC102724058	Familial hemiplegic migraine|Epilepsy|not specified|not provided|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	2	166847921	2	165991411	93660	99564
NM_001165963.2(SCN1A):c.5351T>A (p.Val1784Asp)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Uncertain significance(Last reviewed: Nov 7, 2017)	no assertion criteria provided	2	166848434	2	165991924	488186	481145
NM_001165963.1(SCN1A):c.5351T>C (p.Val1784Ala)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	2	166848434	2	165991924	374394	361169
NM_006920.4(SCN1A):c.4909C>T (p.Arg1637Cys)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Pathogenic(Last reviewed: Nov 25, 2014)	criteria provided, single submitter	2	166848843	2	165992333	68641	79533
NM_006920.4(SCN1A):c.4690C>T (p.Arg1564Cys)	SCN1A|LOC102724058	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2017)	criteria provided, conflicting interpretations	2	166850785	2	165994275	68636	79528
NM_001165963.2(SCN1A):c.4040T>A (p.Ile1347Asn)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	2	166859226	2	166002716	488378	481229
NM_006920.4(SCN1A):c.3891A>T (p.Glu1297Asp)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy|not specified|not provided|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2018)	criteria provided, conflicting interpretations	2	166866307	2	166009797	68534	79426
NM_001165963.2(SCN1A):c.3512C>T (p.Pro1171Leu)	SCN1A|LOC102724058	Severe myoclonic epilepsy in infancy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	2	166872155	2	166015645	561103	552054
NM_001165963.1(SCN1A):c.3199G>A (p.Ala1067Thr)	SCN1A|LOC102724058	Familial hemiplegic migraine|Epilepsy|Generalized epilepsy with febrile seizures plus|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 31, 2017)	criteria provided, multiple submitters, no conflicts	2	166892788	2	166036278	36753	45414
NM_006920.4(SCN1A):c.2804G>A (p.Arg935His)	SCN1A	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	2	166894395	2	166037885	68523	79415
NM_006920.4(SCN1A):c.2803C>T (p.Arg935Cys)	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	2	166894396	2	166037886	68604	79496
NM_001165963.1(SCN1A):c.2792G>A (p.Arg931His)	SCN1A	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	2	166894440	2	166037930	189869	187795
NM_001165963.1(SCN1A):c.1709G>A (p.Ser570Asn)	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2	Uncertain significance(Last reviewed: Jan 25, 2015)	no assertion criteria provided	2	166900513	2	166044003	374331	361170
NM_006920.4(SCN1A):c.1625G>A (p.Arg542Gln)	SCN1A	Autistic disorder of childhood onset|Severe myoclonic epilepsy in infancy|not specified|Seizure disorder|Early infantile epileptic encephalopathy|Rolandic epilepsy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	2	166901590	2	166045080	68588	79480
NM_001165963.1(SCN1A):c.1264G>A (p.Val422Met)	SCN1A	Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	2	166903393	2	166046883	282973	267210
NM_006920.4(SCN1A):c.1216G>T (p.Val406Phe)	SCN1A	Severe myoclonic epilepsy in infancy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 30, 2015)	criteria provided, conflicting interpretations	2	166903441	2	166046931	68587	79479
NM_006920.4(SCN1A):c.1178G>A (p.Arg393His)	SCN1A	Severe myoclonic epilepsy in infancy|not provided|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	2	166903479	2	166046969	68506	79398
NM_001165963.1(SCN1A):c.505T>C (p.Ser169Pro)	SCN1A	Severe myoclonic epilepsy in infancy|not provided	Likely pathogenic(Last reviewed: Apr 10, 2014)	criteria provided, single submitter	2	166911245	2	166054735	206740	201622
NM_002977.3(SCN9A):c.5723A>G (p.Asp1908Gly)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	2	167055393	2	166198883	94092	99992
NM_002977.3(SCN9A):c.4787C>T (p.Thr1596Ile)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not provided	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	2	167056329	2	166199819	130271	135718
NM_002977.3(SCN9A):c.4010A>G (p.Tyr1337Cys)	SCN9A|SCN1A-AS1	not provided	Uncertain significance(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	2	167085364	2	166228854	130268	135715
NM_002977.3(SCN9A):c.3476T>C (p.Ile1159Thr)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 11, 2018)	criteria provided, conflicting interpretations	2	167099130	2	166242620	130263	135710
NM_002977.3(SCN9A):c.3329G>A (p.Arg1110Gln)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	2	167108385	2	166251875	130262	135709
NM_002977.3(SCN9A):c.2971G>T (p.Val991Leu)	SCN9A|SCN1A-AS1	Primary erythromelalgia|Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2017)	criteria provided, conflicting interpretations	2	167129256	2	166272746	94090	39316
NM_002977.3(SCN9A):c.2969A>G (p.Tyr990Cys)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia|Rolandic epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2017)	criteria provided, conflicting interpretations	2	167129258	2	166272748	130260	135707
NM_002977.3(SCN9A):c.2794A>C (p.Met932Leu)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|Congenital Indifference to Pain	Benign/Likely benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	2	167133540	2	166277030	94089	39315
NM_002977.3(SCN9A):c.2159T>A (p.Ile720Lys)	SCN9A|SCN1A-AS1	Primary erythromelalgia|Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	2	167137018	2	166280508	30357	39313
NM_002977.3(SCN9A):c.1828C>A (p.Pro610Thr)	SCN9A|SCN1A-AS1	Primary erythromelalgia|Hereditary sensory and autonomic neuropathy type IIA|Generalized epilepsy with febrile seizures plus, type 7|not specified|not provided|Inherited Erythromelalgia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2018)	criteria provided, conflicting interpretations	2	167141109	2	166284599	21344	34196
NM_002977.3(SCN9A):c.1469G>A (p.Ser490Asn)	SCN9A|SCN1A-AS1	Hereditary sensory and autonomic neuropathy type IIA|Paroxysmal extreme pain disorder|Severe myoclonic epilepsy in infancy|Generalized epilepsy with febrile seizures plus, type 7|Generalized epilepsy with febrile seizures plus|Small fiber neuropathy|not specified|not provided|Congenital Indifference to Pain|Familial Febrile Seizures|Inherited Erythromelalgia	Benign/Likely benign(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	2	167142979	2	166286469	130258	135705
NM_001322046.1(FASTKD1):c.2230T>A (p.Tyr744Asn)	FASTKD1	Glaucoma 1, open angle, B	Pathogenic(Last reviewed: Jul 20, 2017)	no assertion criteria provided	2	170387959	2	169531449	548952	539434
NM_000079.3(CHRNA1):c.737C>T (p.Ser246Phe)	CHRNA1	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: Jun 15, 1999)	no assertion criteria provided	2	175618272	2	174753544	135655	139373
NM_000079.3(CHRNA1):c.737C>A (p.Ser246Tyr)	CHRNA1	Myasthenic syndrome, slow-channel congenital	Pathogenic(Last reviewed: Jun 15, 1999)	no assertion criteria provided	2	175618272	2	174753544	135654	139372
NM_001822.5(CHN1):c.661T>C (p.Tyr221His)	CHN1	Duane syndrome type 2	Pathogenic(Last reviewed: Apr 10, 2017)	criteria provided, single submitter	2	175689213	2	174824485	559835	550557
NM_133378.4(TTN):c.61120G>A (p.Glu20374Lys)	TTN|TTN-AS1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	2	179442329	2	178577602	96298	102192
NM_133378.4(TTN):c.[38532C>A];[52301A>G]	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Familial hypertrophic cardiomyopathy 9	Likely pathogenic(Last reviewed: Apr 24, 2012)	criteria provided, single submitter	2|2	179456541	2|2	178591814	424805	56322|213530
NM_133378.4(TTN):c.41249T>C (p.Ile13750Thr)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	2	179479288	2	178614561	47025	56190
NM_133378.4(TTN):c.41023C>T (p.Pro13675Ser)	TTN|TTN-AS1	Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2017)	criteria provided, conflicting interpretations	2	179479607	2	178614880	47024	56189
NM_001256850.1(TTN):c.39358C>T (p.Pro13120Ser)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Familial hypertrophic cardiomyopathy 9|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	2	179494968	2	178630241	178217	173163
NM_133378.4(TTN):c.32854G>C (p.Val10952Leu)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2018)	criteria provided, conflicting interpretations	2	179506964	2	178642237	130666	136112
NM_001267550.2(TTN):c.31762G>A (p.Val10588Ile)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	2	179556743	2	178692016	223361	225090
NM_001267550.2(TTN):c.31594G>T (p.Val10532Phe)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179558336	2	178693609	223349	225078
NM_001267550.2(TTN):c.27607G>A (p.Glu9203Lys)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179577042	2	178712315	223269	225000
NM_133378.4(TTN):c.3100G>A (p.Val1034Met)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G|Limb-girdle muscular dystrophy, type 2J|Distal myopathy Markesbery-Griggs type|Hereditary myopathy with early respiratory failure|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	2	179647533	2	178782806	46910	56075
NM_001256850.1(TTN):c.2926T>C (p.Trp976Arg)	TTN	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1G	Pathogenic(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	2	179647707	2	178782980	12651	27690
NM_001267550.2(TTN):c.2494G>T (p.Ala832Ser)	TTN	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	2	179649078	2	178784351	223341	225070
NM_002500.4(NEUROD1):c.590C>A (p.Pro197His)	NEUROD1	Maturity onset diabetes mellitus in young|not specified|Monogenic diabetes	Benign/Likely benign(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	2	182542998	2	181678271	129763	135209
NM_000090.3(COL3A1):c.505C>T (p.Leu169Phe)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|Aortic aneurysm|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	2	189851842	2	188987116	161216	171072
NM_000090.3(COL3A1):c.754G>T (p.Gly252Cys)	COL3A1	Ehlers-Danlos syndrome	Likely pathogenic(Last reviewed: Apr 6, 2015)	criteria provided, single submitter	2	189855042	2	188990316	228249	228909
NM_000090.3(COL3A1):c.812G>A (p.Arg271Gln)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Benign/Likely benign(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	2	189855743	2	188991017	161215	171073
NM_000090.3(COL3A1):c.1550C>T (p.Pro517Leu)	COL3A1	Ehlers-Danlos syndrome, type 4|Thoracic aortic aneurysm and aortic dissection|not specified|not provided	Likely benign(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	2	189860458	2	188995732	161217	171074
NM_000090.3(COL3A1):c.1856C>T (p.Pro619Leu)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	2	189862102	2	188997376	333057	286480
NM_000090.3(COL3A1):c.3133G>A (p.Ala1045Thr)	COL3A1	Ehlers-Danlos syndrome, type 4|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2018)	criteria provided, conflicting interpretations	2	189871110	2	189006384	197477	194638
NM_000090.3(COL3A1):c.3626G>C (p.Gly1209Ala)	COL3A1	Ehlers-Danlos syndrome, type 4	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2016)	criteria provided, conflicting interpretations	2	189873750	2	189009024	225283	227191
NM_000090.3(COL3A1):c.3938A>G (p.Lys1313Arg)	COL3A1	Ehlers-Danlos syndrome, type 4|Ehlers-Danlos syndrome|Loeys-Dietz syndrome|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	2	189875018	2	189010292	161218	171075
NM_007315.3(STAT1):c.820C>T (p.Arg274Trp)	STAT1	Mycobacterial and viral infections, susceptibility to, autosomal recessive|Immunodeficiency 31C|Immunodeficiency 31a	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	2	191859911	2	190995185	30083	39038
NM_018897.2(DNAH7):c.10753T>C (p.Phe3585Leu)	DNAH7	Seizures|Hypoplasia of the corpus callosum|Dyspnea|Abnormality of the basal ganglia|Abnormal muscle tone	Pathogenic	no assertion criteria provided	2	196651859	2	195787135	375378	362134
NM_020760.3(HECW2):c.4334A>G (p.Glu1445Gly)	HECW2	not provided|Neurodevelopmental disorder with hypotonia, seizures, and absent language	Uncertain significance(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	2	197084837	2	196220113	242326	243871
NM_002156.4(HSPD1):c.1607C>T (p.Ala536Val)	HSPD1	Spastic paraplegia 13	Likely pathogenic(Last reviewed: Apr 15, 2014)	criteria provided, single submitter	2	198351885	2	197487161	216941	213533
NM_015265.3(SATB2):c.1169C>T (p.Thr390Ile)	SATB2	Chromosome 2q32-q33 deletion syndrome	Likely pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	2	200213428	2	199348705	216996	213534
NM_033066.2(MPP4):c.946T>C (p.Trp316Arg)	MPP4	Global developmental delay|Seizures|High palate|Wide nasal bridge|Strabismus|Intellectual disability|Global developmental delay|Generalized hypotonia	Pathogenic	no assertion criteria provided	2	202539978	2	201675255	375383	362135
NM_006891.3(CRYGD):c.70C>T (p.Pro24Ser)	CRYGD|LOC100507443	Cataract 4	Pathogenic(Last reviewed: Sep 1, 2007)	no assertion criteria provided	2	208989018	2	208124294	16942	31981
NM_000465.3(BARD1):c.1409A>G (p.Asn470Ser)	BARD1	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 23, 2018)	criteria provided, conflicting interpretations	2	215632365	2	214767641	141739	151453
NM_020814.2(MARCH4):c.631A>G (p.Lys211Glu)	MARCH4	Frontotemporal dementia	Uncertain significance	no assertion criteria provided	2	217148338	2	216283615	427847	418804
NM_020814.2(MARCH4):c.39G>C (p.Trp13Cys)	MARCH4	Frontotemporal dementia	Likely benign	no assertion criteria provided	2	217234945	2	216370222	427848	418805
NM_025216.2(WNT10A):c.682T>A (p.Phe228Ile)	WNT10A	Odontoonychodermal dysplasia|Schopf-Schulz-Passarge syndrome|Tooth agenesis, selective, 4|not specified|not provided|Selective tooth agenesis|Inborn genetic diseases|Hypohidrotic ectodermal dysplasia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2017)	criteria provided, conflicting interpretations	2	219755011	2	218890289	4462	19501
NM_001927.3(DES):c.38C>T (p.Ser13Phe)	DES	Primary dilated cardiomyopathy|Myofibrillar myopathy 1|not provided	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	2	220283222	2	219418500	44260	53427
NM_001927.3(DES):c.347A>G (p.Asn116Ser)	DES	Myofibrillar myopathy 1|not provided	Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, multiple submitters, no conflicts	2	220283531	2	219418809	66411	77308
NM_001927.3(DES):c.638C>T (p.Ala213Val)	DES	Myofibrillar myopathy 1|Myofibrillar myopathy|not specified|not provided|Muscular dystrophy, limb-girdle, type 2R|Congenital diaphragmatic hernia|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	2	220284876	2	219420154	44265	53432
NM_001927.3(DES):c.893C>T (p.Ser298Leu)	DES	Myofibrillar myopathy 1|Cardiomyopathy|not provided|Muscular dystrophy, limb-girdle, type 2R|Dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	2	220285374	2	219420652	66423	77320
NM_001927.3(DES):c.1216C>T (p.Arg406Trp)	DES	Myofibrillar myopathy 1|not provided|Muscular dystrophy, limb-girdle, type 2R	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	2	220286254	2	219421532	16826	31865
NM_001927.3(DES):c.1255C>T (p.Pro419Ser)	DES	Myofibrillar myopathy 1|not provided	Likely pathogenic(Last reviewed: Mar 7, 2016)	criteria provided, single submitter	2	220288509	2	219423787	39718	48317
NM_001927.3(DES):c.1360C>T (p.Arg454Trp)	DES	Dilated cardiomyopathy 1I|Primary dilated cardiomyopathy|Myofibrillar myopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Muscular dystrophy, limb-girdle, type 2R	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	2	220290456	2	219425734	66402	77299
NM_001927.3(DES):c.1375G>A (p.Val459Ile)	DES	Primary dilated cardiomyopathy|Myofibrillar myopathy 1|not specified|not provided|Muscular dystrophy, limb-girdle, type 2R|Scapuloperoneal weakness|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant|Myofibrillar Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	2	220290674	2	219425952	44252	53419
NM_004438.4(EPHA4):c.2242G>A (p.Ala748Thr)	EPHA4	atypical cerebral palsy	Likely pathogenic	criteria provided, single submitter	2	222301223	2	221436503	431727	425211
NM_181459.3(PAX3):c.1195C>G (p.His399Asp)	PAX3	Waardenburg syndrome type 1	Likely benign(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223066888	2	222202169	488039	481047
NM_181457.3(PAX3):c.944C>A (p.Thr315Lys)	PAX3	Waardenburg syndrome type 1|Craniofacial deafness hand syndrome|Waardenburg syndrome|not specified|Congenital diaphragmatic hernia	Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2017)	criteria provided, conflicting interpretations	2	223085955	2	222221236	218940	215772
NM_181457.3(PAX3):c.668G>A (p.Arg223Gln)	PAX3	Waardenburg syndrome	Pathogenic(Last reviewed: Jun 23, 2015)	criteria provided, single submitter	2	223096921	2	222232202	228387	228932
NM_181459.3(PAX3):c.256A>T (p.Ile86Phe)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: May 15, 2018)	no assertion criteria provided	2	223161762	2	222297043	545018	535282
NM_181459.3(PAX3):c.142G>C (p.Gly48Arg)	PAX3	Waardenburg syndrome type 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	2	223161876	2	222297157	488038	481053
NM_181459.3(PAX3):c.142G>T (p.Gly48Cys)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	2	223161876	2	222297157	488032	481052
NM_181459.3(PAX3):c.124G>C (p.Gly42Arg)	PAX3	Waardenburg syndrome type 1	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	2	223161894	2	222297175	488034	481054
NM_001103146.1(GIGYF2):c.2378C>T (p.Ala793Val)	GIGYF2	Parkinson disease 11	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	2	233684544	2	232819834	216934	213536
NM_004369.3(COL6A3):c.3844G>A (p.Val1282Met)	COL6A3	Bethlem myopathy 1|Collagen VI-related myopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2016)	criteria provided, conflicting interpretations	2	238280816	2	237372173	266039	260862
NM_004321.7(KIF1A):c.38G>A (p.Arg13His)	KIF1A	Spastic paraplegia 30, autosomal recessive|Hereditary sensory and autonomic neuropathy type IIC|Mental retardation, autosomal dominant 9|not provided|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	2	241737132	2	240797715	209165	205730
NM_002222.5(ITPR1):c.800C>T (p.Thr267Met)	ITPR1	Spinocerebellar ataxia 29|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2018)	criteria provided, conflicting interpretations	3	4687357	3	4645673	208786	205242
NM_002222.5(ITPR1):c.830G>T (p.Ser277Ile)	ITPR1	Spinocerebellar ataxia 29	Likely pathogenic(Last reviewed: Oct 1, 2013)	criteria provided, single submitter	3	4687387	3	4645703	216945	213552
NM_001099952.2(ITPR1):c.7640G>C (p.Gly2547Ala)	ITPR1	Spinocerebellar ataxia 29	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	3	4856819	3	4815135	243076	244153
NM_033337.2(CAV3):c.80G>A (p.Arg27Gln)	CAV3|SSUH2	Elevated serum creatine phosphokinase|Limb-girdle muscular dystrophy, type 1C|Rippling muscle disease 2|Long QT syndrome|Distal myopathy, Tateyama type|not provided	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	3	8775642	3	8733956	8283	23322
NM_033337.2(CAV3):c.166G>A (p.Gly56Ser)	CAV3	Limb-girdle muscular dystrophy, type 1C|Limb-girdle muscular dystrophy|Long QT syndrome|Distal myopathy, Tateyama type|not specified|not provided|Cardiovascular phenotype|Limb-Girdle Muscular Dystrophy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 8, 2017)	criteria provided, conflicting interpretations	3	8787263	3	8745577	8278	23317
NM_000551.3(VHL):c.154G>A (p.Glu52Lys)	VHL	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	3	10183685	3	10142001	161402	171078
NM_000551.3(VHL):c.235C>T (p.Arg79Cys)	VHL	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Polycythemia	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	3	10183766	3	10142082	161400	171079
NM_000551.3(VHL):c.242C>T (p.Pro81Leu)	VHL	Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	3	10183773	3	10142089	36899	45560
NM_000551.3(VHL):c.256C>T (p.Pro86Ser)	VHL	Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 29, 2018)	criteria provided, multiple submitters, no conflicts	3	10183787	3	10142103	178692	173736
NM_000551.3(VHL):c.293A>C (p.Tyr98Ser)	VHL	Pheochromocytoma|Von Hippel-Lindau syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2016)	no assertion criteria provided	3	10183824	3	10142140	219160	217068
NM_000551.3(VHL):c.319C>G (p.Arg107Gly)	VHL	Von Hippel-Lindau syndrome	Pathogenic(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	3	10183850	3	10142166	43599	52768
NM_000551.3(VHL):c.320G>C (p.Arg107Pro)	VHL	Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2016)	criteria provided, multiple submitters, no conflicts	3	10183851	3	10142167	36900	45561
NM_000551.3(VHL):c.371C>T (p.Thr124Ile)	VHL|LOC107303340	Von Hippel-Lindau syndrome|not provided	Likely pathogenic(Last reviewed: Jan 23, 2017)	criteria provided, multiple submitters, no conflicts	3	10188228	3	10146544	36902	45563
NM_000551.3(VHL):c.388G>C (p.Val130Leu)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 16, 2016)	criteria provided, multiple submitters, no conflicts	3	10188245	3	10146561	2229	17268
NM_000551.3(VHL):c.479A>T (p.Glu160Val)	VHL|LOC107303340	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	3	10191486	3	10149802	219157	217069
NM_000551.3(VHL):c.499C>T (p.Arg167Trp)	VHL|LOC107303340	Erythrocytosis, familial, 2|Pheochromocytoma|Von Hippel-Lindau syndrome|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	3	10191506	3	10149822	2218	17257
NM_000551.3(VHL):c.500G>A (p.Arg167Gln)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	3	10191507	3	10149823	2216	17255
NM_000551.3(VHL):c.509T>C (p.Val170Ala)	VHL|LOC107303340	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	3	10191516	3	10149832	219159	217070
NM_000551.3(VHL):c.524A>G (p.Tyr175Cys)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	3	10191531	3	10149847	36905	45566
NM_000551.3(VHL):c.538A>G (p.Ile180Val)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	3	10191545	3	10149861	161401	171080
NM_000551.3(VHL):c.548C>G (p.Ser183Trp)	VHL|LOC107303340	Pheochromocytoma	Likely pathogenic(Last reviewed: Dec 1, 2015)	no assertion criteria provided	3	10191555	3	10149871	219158	217071
NM_000551.3(VHL):c.556G>A (p.Glu186Lys)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, multiple submitters, no conflicts	3	10191563	3	10149879	161403	171081
NM_000551.3(VHL):c.562C>G (p.Leu188Val)	VHL|LOC107303340	Erythrocytosis, familial, 2|Pheochromocytoma|Von Hippel-Lindau syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	3	10191569	3	10149885	2225	17264
NM_000551.3(VHL):c.598C>T (p.Arg200Trp)	VHL|LOC107303340	Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Acute leukemia of ambiguous lineage	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	3	10191605	3	10149921	2232	17271
NM_003042.3(SLC6A1):c.131G>A (p.Arg44Gln)	SLC6A1|SLC6A1-AS1	Myoclonic-atonic epilepsy	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	3	11059028	3	11017342	192368	190155
NM_015869.4(PPARG):c.34C>G (p.Pro12Ala)	PPARG	Obesity|Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension|not specified|Familial partial lipodystrophy	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	12393125	3	12351626	130019	135465
NM_015869.4(PPARG):c.1348A>C (p.Lys450Gln)	PPARG	not provided	Uncertain significance(Last reviewed: Oct 17, 2013)	criteria provided, single submitter	3	12475474	3	12433975	130018	135464
NM_002880.3(RAF1):c.1472C>T (p.Thr491Ile)	RAF1	Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12627244	3	12585745	21342	34194
NM_002880.3(RAF1):c.1457A>G (p.Asp486Gly)	RAF1	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	3	12627259	3	12585760	40618	49088
NM_002880.3(RAF1):c.1423T>C (p.Phe475Leu)	RAF1	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	3	12627293	3	12585794	40617	49087
NM_002880.3(RAF1):c.788T>G (p.Val263Gly)	RAF1	Noonan syndrome|not provided|Rasopathy	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645681	3	12604182	40607	49077
NM_002880.3(RAF1):c.782C>T (p.Pro261Leu)	RAF1	Noonan syndrome 5|Noonan syndrome|not provided	Pathogenic(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	3	12645687	3	12604188	120246	125840
NM_002880.3(RAF1):c.781C>T (p.Pro261Ser)	RAF1	Noonan syndrome 5|Primary familial hypertrophic cardiomyopathy|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645688	3	12604189	13958	28997
NM_002880.3(RAF1):c.775T>C (p.Ser259Pro)	RAF1	Noonan syndrome	Likely pathogenic(Last reviewed: Oct 8, 2015)	criteria provided, single submitter	3	12645694	3	12604195	228288	229012
NM_002880.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	LEOPARD syndrome 2|Malignant melanoma of skin|Noonan syndrome 5|Noonan syndrome with multiple lentigines|Lung adenocarcinoma|Noonan syndrome|not provided|Rasopathy|Cardiomyopathy, dilated, 1NN|Neoplasm of the large intestine|Inborn genetic diseases|Colorectal Neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645699	3	12604200	13957	28996
NM_002880.3(RAF1):c.769T>C (p.Ser257Pro)	RAF1	Primary familial hypertrophic cardiomyopathy|Noonan syndrome|not provided|Rasopathy|Cutaneous melanoma	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	3	12645700	3	12604201	40600	49070
NM_002880.3(RAF1):c.766A>G (p.Arg256Gly)	RAF1	Noonan syndrome|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	3	12645703	3	12604204	44631	53798
NM_002880.3(RAF1):c.524A>G (p.His175Arg)	RAF1	Noonan syndrome	Pathogenic(Last reviewed: May 23, 2013)	criteria provided, single submitter	3	12650322	3	12608823	40594	49064
NM_024334.2(TMEM43):c.504A>T (p.Lys168Asn)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14174427	3	14132927	46148	55313
NM_024334.2(TMEM43):c.536T>C (p.Met179Thr)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	3	14175262	3	14133762	46150	55315
NM_024334.2(TMEM43):c.797G>A (p.Arg266Gln)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	3	14177323	3	14135823	36872	45533
NM_024334.2(TMEM43):c.853C>T (p.Leu285Phe)	TMEM43	not provided	Uncertain significance(Last reviewed: Oct 23, 2013)	criteria provided, single submitter	3	14177379	3	14135879	130595	136041
NM_024334.2(TMEM43):c.1073C>T (p.Ser358Leu)	TMEM43	Arrhythmogenic right ventricular cardiomyopathy, type 5|Arrhythmogenic right ventricular cardiomyopathy|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	3	14183165	3	14141665	734	15773
NM_001128177.1(THRB):c.1351T>G (p.Phe451Val)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Likely pathogenic(Last reviewed: Jan 22, 2016)	criteria provided, single submitter	3	24164410	3	24122919	375302	362074
NM_001252634.1(THRB):c.1313G>A (p.Arg438His)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jan 20, 2012)	no assertion criteria provided	3	24164448	3	24122957	12559	27598
NM_001128177.1(THRB):c.1286G>A (p.Arg429Gln)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: May 21, 2018)	criteria provided, single submitter	3	24164475	3	24122984	548123	538610
NM_001128177.1(THRB):c.1021C>G (p.Leu341Val)	THRB	Thyroid hormone resistance, generalized, autosomal dominant	Likely pathogenic(Last reviewed: Apr 5, 2017)	no assertion criteria provided	3	24169113	3	24127622	429021	420977
NM_001252634.1(THRB):c.1012C>T (p.Arg338Trp)	THRB	Thyroid hormone resistance, selective pituitary|Thyroid hormone resistance, generalized, autosomal dominant	Pathogenic(Last reviewed: Jun 25, 2013)	no assertion criteria provided	3	24169122	3	24127631	12558	27597
NM_001252634.1(THRB):c.959G>A (p.Arg320His)	THRB	Thyroid hormone resistance, generalized, autosomal dominant|Inborn genetic diseases	Uncertain significance(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	3	24169175	3	24127684	12553	27592
NM_001024847.2(TGFBR2):c.1060G>A (p.Ala354Thr)	TGFBR2	Loeys-Dietz syndrome 1|not specified	Uncertain significance(Last reviewed: Aug 19, 2014)	criteria provided, multiple submitters, no conflicts	3	30713660	3	30672168	161395	171082
NM_003242.5(TGFBR2):c.1151A>G (p.Asn384Ser)	TGFBR2	Loeys-Dietz syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	3	30713826	3	30672334	36860	45521
NM_003242.5(TGFBR2):c.1159G>A (p.Val387Met)	TGFBR2	Marfan syndrome|Congenital aneurysm of ascending aorta|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Dilatation of the thoracic aorta|Thoracic aortic dissection	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	3	30713834	3	30672342	44651	53818
NM_003242.5(TGFBR2):c.1238T>A (p.Leu413Gln)	TGFBR2	Loeys-Dietz syndrome 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	30713913	3	30672421	561131	552072
NM_001024847.2(TGFBR2):c.1456T>C (p.Cys486Arg)	TGFBR2	Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	3	30715723	3	30674231	393299	380155
NM_003242.5(TGFBR2):c.1408T>G (p.Tyr470Asp)	TGFBR2	Loeys-Dietz syndrome 2|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2015)	criteria provided, multiple submitters, no conflicts	3	30729887	3	30688395	217016	213550
NM_003242.5(TGFBR2):c.1591G>A (p.Ala531Thr)	TGFBR2	Thoracic aortic aneurysm and aortic dissection	Likely pathogenic(Last reviewed: Aug 19, 2014)	criteria provided, single submitter	3	30732978	3	30691486	165399	173916
NM_001024847.2(TGFBR2):c.1732T>A (p.Ser578Thr)	TGFBR2	Marfan syndrome|Congenital aneurysm of ascending aorta|Loeys-Dietz syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	3	30733044	3	30691552	161394	171083
NM_000249.3(MLH1):c.109G>C (p.Glu37Gln)	MLH1	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2018)	criteria provided, conflicting interpretations	3	37035147	3	36993656	231565	232880
NM_000249.3(MLH1):c.199G>A (p.Gly67Arg)	MLH1	Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37038192	3	36996701	89992	95466
NM_000249.3(MLH1):c.350C>T (p.Thr117Met)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37045935	3	37004444	17094	32133
NM_000249.3(MLH1):c.793C>T (p.Arg265Cys)	MLH1	Lynch syndrome II|Carcinoma of colon|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37058999	3	37017508	29654	38609
NM_000249.3(MLH1):c.803A>G (p.Glu268Gly)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37059009	3	37017518	90382	95856
NM_000249.3(MLH1):c.836T>G (p.Val279Gly)	MLH1	Lynch syndrome	Likely benign(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	3	37059042	3	37017551	446501	440016
NM_000249.3(MLH1):c.977T>C (p.Val326Ala)	MLH1	Lynch syndrome I|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37061893	3	37020402	42496	51666
NM_000249.3(MLH1):c.1013A>G (p.Asn338Ser)	MLH1	Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37061929	3	37020438	89605	95079
NM_000249.3(MLH1):c.1148T>C (p.Met383Thr)	MLH1	Lynch syndrome II|Ovarian cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Jun 24, 2018)	criteria provided, multiple submitters, no conflicts	3	37067237	3	37025746	127609	133066
NM_000249.3(MLH1):c.1153C>T (p.Arg385Cys)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Nov 24, 2015)	reviewed by expert panel	3	37067242	3	37025751	89653	95127
NM_000249.3(MLH1):c.1321G>A (p.Ala441Thr)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37067410	3	37025919	89696	95170
NM_000249.3(MLH1):c.1474G>A (p.Ala492Thr)	MLH1	Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37070339	3	37028848	89750	95224
NM_000249.3(MLH1):c.1637A>G (p.Lys546Arg)	MLH1	Lynch syndrome II|Lynch syndrome|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	3	37081755	3	37040264	127617	133074
NM_000249.3(MLH1):c.1853A>C (p.Lys618Thr)	MLH1	Lynch syndrome I|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37089131	3	37047640	89906	95380
NM_000249.3(MLH1):c.1937A>G (p.Tyr646Cys)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090048	3	37048557	36545	45207
NM_000249.3(MLH1):c.1963A>G (p.Ile655Val)	MLH1	Endometrial carcinoma|Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090074	3	37048583	41637	50076
NM_000249.3(MLH1):c.1964T>C (p.Ile655Thr)	MLH1	Lynch syndrome II|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Uncertain significance(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090075	3	37048584	41638	50077
NM_000249.3(MLH1):c.2066A>G (p.Gln689Arg)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37090471	3	37048980	90016	95490
NM_000249.3(MLH1):c.2252A>G (p.Lys751Arg)	MLH1	Lynch syndrome II|Lynch syndrome|not specified|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|Hereditary nonpolyposis colon cancer	Likely benign(Last reviewed: Sep 5, 2013)	reviewed by expert panel	3	37092125	3	37050634	90100	95574
NM_000335.4(SCN5A):c.5958C>A (p.Asn1986Lys)	SCN5A	Atrial fibrillation|Atrial fibrillation, familial, 10|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	3	38591902	3	38550411	30045	39000
NM_000335.4(SCN5A):c.5900T>G (p.Ile1967Ser)	SCN5A	Brugada syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	38591960	3	38550469	68017	78909
NM_000335.4(SCN5A):c.5870G>A (p.Arg1957Gln)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	3	38591990	3	38550499	68015	78907
NM_000335.4(SCN5A):c.5848G>T (p.Val1950Leu)	SCN5A	Atrial fibrillation|Long QT syndrome|Brugada syndrome|not specified|not provided|Ventricular tachycardia|Ventricular tachycardia|Pulmonary valve stenosis (rare)|Cardiovascular phenotype|Ventricular tachycardia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	3	38592012	3	38550521	36765	45426
NM_198056.2(SCN5A):c.5849A>G (p.Tyr1950Cys)	SCN5A	Brugada syndrome|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	3	38592014	3	38550523	216841	212332
NM_000335.4(SCN5A):c.5708C>T (p.Ser1903Leu)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided|Death in infancy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 11, 2017)	criteria provided, conflicting interpretations	3	38592152	3	38550661	48310	57473
NM_000335.4(SCN5A):c.5686C>T (p.Arg1896Trp)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	3	38592174	3	38550683	68003	78895
NM_000335.4(SCN5A):c.5665G>A (p.Glu1889Lys)	SCN5A	Long QT syndrome|not specified	Uncertain significance(Last reviewed: Aug 21, 2017)	criteria provided, single submitter	3	38592195	3	38550704	375856	362737
NM_198056.2(SCN5A):c.5540G>A (p.Arg1847His)	SCN5A	Brugada syndrome 1|Brugada syndrome|not specified	Uncertain significance(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	3	38592323	3	38550832	48309	57472
NM_000335.4(SCN5A):c.5504T>C (p.Ile1835Thr)	SCN5A	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1E|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 20, 2018)	criteria provided, conflicting interpretations	3	38592356	3	38550865	39445	48044
NM_000335.4(SCN5A):c.5474G>A (p.Arg1825His)	SCN5A	Long QT syndrome 3|SUDDEN INFANT DEATH SYNDROME|Brugada syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	3	38592386	3	38550895	9389	24428
NM_000335.4(SCN5A):c.5357G>A (p.Ser1786Asn)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2018)	criteria provided, conflicting interpretations	3	38592503	3	38551012	67988	78880
NM_198056.2(SCN5A):c.5350G>A (p.Glu1784Lys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Long QT syndrome 1|Sinus node disease|Brugada syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	3	38592513	3	38551022	9377	24416
NM_000335.4(SCN5A):c.5333C>T (p.Thr1778Met)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 17, 2017)	criteria provided, multiple submitters, no conflicts	3	38592527	3	38551036	67985	78877
NM_000335.4(SCN5A):c.5126C>T (p.Ser1709Leu)	SCN5A	Brugada syndrome 1|Paroxysmal familial ventricular fibrillation 1|Brugada syndrome|not provided|Ventricular fibrillation|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	3	38592734	3	38551243	9383	24422
NM_000335.4(SCN5A):c.4591G>A (p.Val1531Ile)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|Congenital long QT syndrome	Likely benign(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	3	38595989	3	38554498	67912	78805
NM_198056.2(SCN5A):c.3956G>T (p.Gly1319Val)	SCN5A	Long QT syndrome 3|Brugada syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	3	38603913	3	38562422	67838	78731
NM_000335.4(SCN5A):c.3919C>T (p.Leu1307Phe)	SCN5A	Brugada syndrome|not specified|not provided|Brugada syndrome, lidocaine-induced|Cardiovascular phenotype	Benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	3	38603947	3	38562456	67836	38448
NM_000335.4(SCN5A):c.3908C>T (p.Thr1303Met)	SCN5A	Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	3	38603958	3	38562467	67835	78729
NM_198056.2(SCN5A):c.3878T>C (p.Phe1293Ser)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2017)	criteria provided, conflicting interpretations	3	38603991	3	38562500	67833	78727
NM_000335.4(SCN5A):c.3832G>A (p.Val1278Ile)	SCN5A	Primary dilated cardiomyopathy|Brugada syndrome|not specified	Uncertain significance(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	3	38607905	3	38566414	67829	78723
NM_198056.2(SCN5A):c.3795G>T (p.Lys1265Asn)	SCN5A	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	3	38607945	3	38566454	427973	419267
NM_000335.4(SCN5A):c.3296C>T (p.Ala1099Val)	SCN5A|LOC110121269	Long QT syndrome|Brugada syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	3	38620916	3	38579425	67789	78684
NM_000335.4(SCN5A):c.2944T>C (p.Cys982Arg)	SCN5A|LOC110121269	Sudden cardiac death|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	3	38622706	3	38581215	67769	78664
NM_000335.4(SCN5A):c.2497G>A (p.Gly833Arg)	SCN5A	Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	3	38627472	3	38585981	67734	78629
NM_198056.2(SCN5A):c.2441G>A (p.Arg814Gln)	SCN5A	Brugada syndrome|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	3	38627528	3	38586037	67732	78627
NM_198056.2(SCN5A):c.2254G>A (p.Gly752Arg)	SCN5A	Brugada syndrome|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, multiple submitters, no conflicts	3	38639228	3	38597737	67723	78618
NM_000335.4(SCN5A):c.2074C>A (p.Gln692Lys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2018)	criteria provided, conflicting interpretations	3	38639408	3	38597917	67712	78607
NM_000335.4(SCN5A):c.2066G>A (p.Arg689His)	SCN5A	Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	3	38639416	3	38597925	67710	78605
NM_198056.2(SCN5A):c.1943C>T (p.Pro648Leu)	SCN5A	Long QT syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	3	38640489	3	38598998	48292	57455
NM_000335.4(SCN5A):c.1855C>T (p.Leu619Phe)	SCN5A	Long QT syndrome|Brugada syndrome|not provided	Likely pathogenic(Last reviewed: Oct 17, 2016)	criteria provided, single submitter	3	38645238	3	38603747	67693	78588
NM_000335.4(SCN5A):c.1852C>T (p.Leu618Phe)	SCN5A	Brugada syndrome|not specified|not provided|Long QT syndrome, drug-associated|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	3	38645241	3	38603750	67692	78587
NM_000335.4(SCN5A):c.1844G>A (p.Gly615Glu)	SCN5A	Long QT syndrome 3|Brugada syndrome|not specified|Congenital long QT syndrome|Death in infancy|Death in early adulthood|Long QT syndrome, drug-associated|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2018)	criteria provided, conflicting interpretations	3	38645249	3	38603758	67691	78586
NM_000335.4(SCN5A):c.1714G>T (p.Ala572Ser)	SCN5A	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: Mar 31, 2016)	criteria provided, multiple submitters, no conflicts	3	38645379	3	38603888	67682	78577
NM_000335.4(SCN5A):c.1712G>T (p.Ser571Ile)	SCN5A	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	3	38645381	3	38603890	67681	78576
NM_198056.2(SCN5A):c.1567C>T (p.Arg523Cys)	SCN5A	Brugada syndrome 1|Long QT syndrome 3|Progressive familial heart block type 1A|Paroxysmal familial ventricular fibrillation 1|Dilated cardiomyopathy 1E|Wolff-Parkinson-White pattern|Atrial fibrillation, familial, 10|Brugada syndrome|not specified|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2018)	criteria provided, conflicting interpretations	3	38645526	3	38604035	67667	78562
NM_000335.4(SCN5A):c.1384G>A (p.Glu462Lys)	SCN5A	Long QT syndrome|Brugada syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: May 4, 2017)	criteria provided, single submitter	3	38646354	3	38604863	67660	78556
NM_000335.4(SCN5A):c.1336G>A (p.Glu446Lys)	SCN5A	Primary dilated cardiomyopathy|Brugada syndrome|not specified|Cardiovascular phenotype|Dilated cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	3	38647444	3	38605953	67656	78552
NM_000335.4(SCN5A):c.1282G>A (p.Glu428Lys)	SCN5A	Atrial fibrillation|Atrial fibrillation, familial, 10|not specified	Uncertain significance(Last reviewed: Sep 8, 2016)	criteria provided, single submitter	3	38647498	3	38606007	30048	39003
NM_000335.4(SCN5A):c.865G>A (p.Gly289Ser)	SCN5A	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	38651294	3	38609803	68050	78941
NM_000335.4(SCN5A):c.694G>A (p.Val232Ile)	SCN5A	Brugada syndrome|not specified|not provided|Brugada syndrome, lidocaine-induced|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2017)	criteria provided, conflicting interpretations	3	38655243	3	38613752	68037	24446
NM_000335.4(SCN5A):c.673C>T (p.Arg225Trp)	SCN5A	Long QT syndrome 3|Cardiac conduction defect, nonspecific|Brugada syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	3	38655264	3	38613773	68032	78924
NM_000335.4(SCN5A):c.659C>T (p.Thr220Ile)	SCN5A	Long QT syndrome 3|Sick sinus syndrome 1, autosomal recessive|Dilated cardiomyopathy 1E|Brugada syndrome|not specified|not provided|Familial dilated cardiomyopathy|Nodal rhythm|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2018)	criteria provided, conflicting interpretations	3	38655278	3	38613787	9396	24435
NM_000335.4(SCN5A):c.414G>A (p.Met138Ile)	SCN5A	Atrial fibrillation	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	38663959	3	38622468	67865	78758
NM_001904.3(CTNNB1):c.1163T>C (p.Leu388Pro)	CTNNB1	Mental retardation, autosomal dominant 19	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	41274913	3	41233422	560986	552075
NM_001904.3(CTNNB1):c.1271T>G (p.Leu424Arg)	CTNNB1	Mental retardation, autosomal dominant 19	Likely pathogenic(Last reviewed: Aug 26, 2014)	criteria provided, single submitter	3	41275105	3	41233614	216915	213551
NM_020208.3(SLC6A20):c.596C>T (p.Thr199Met)	SLC6A20	Hyperglycinuria|Iminoglycinuria, digenic	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	45814094	3	45772602	4845	19884
NM_000258.2(MYL3):c.530A>G (p.Glu177Gly)	MYL3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	3	46899903	3	46858413	36648	45310
NM_000258.2(MYL3):c.466G>A (p.Val156Met)	MYL3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Increased left ventricular wall thickness|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	3	46900980	3	46859490	31778	40438
NM_000258.2(MYL3):c.461G>A (p.Arg154His)	MYL3	Familial hypertrophic cardiomyopathy 8|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2017)	criteria provided, conflicting interpretations	3	46900985	3	46859495	14062	29101
NM_000258.2(MYL3):c.460C>T (p.Arg154Cys)	MYL3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	3	46900986	3	46859496	43124	52294
NM_000258.2(MYL3):c.235G>A (p.Val79Ile)	MYL3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 7, 2018)	criteria provided, single submitter	3	46902238	3	46860748	161329	171084
NM_000258.2(MYL3):c.170C>G (p.Ala57Gly)	MYL3	Familial hypertrophic cardiomyopathy 8|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 6, 2018)	criteria provided, conflicting interpretations	3	46902303	3	46860813	31780	40440
NM_138615.2(DHX30):c.1478G>A (p.Arg493His)	DHX30	Seizures|Short stature|Unsteady gait|Microcephaly|Strabismus|Oculomotor apraxia|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: May 21, 2018)	no assertion criteria provided	3	47888040	3	47846550	375374	362138
NM_138615.2(DHX30):c.1685A>G (p.His562Arg)	DHX30	Global developmental delay|Hearing impairment|Sleep disturbance|Muscular hypotonia of the trunk|Delayed speech and language development|Microcephaly|Strabismus|Global developmental delay|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic	criteria provided, single submitter	3	47888247	3	47846757	402130	389102
NM_138615.2(DHX30):c.2344C>T (p.Arg782Trp)	DHX30	Global developmental delay|Short stature|Failure to thrive|Hirsutism|EEG abnormality|Microcephaly|Intellectual disability|Global developmental delay|Generalized hypotonia|NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Pathogenic(Last reviewed: May 21, 2018)	no assertion criteria provided	3	47889727	3	47848237	375373	362139
NM_014966.3(DHX30):c.2606G>A (p.Arg869Gln)	DHX30	NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE	Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	3	47890261	3	47848771	523233	513885
NM_000094.3(COL7A1):c.7867G>T (p.Gly2623Cys)	COL7A1	Pretibial epidermolysis bullosa	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	3	48605531	3	48568098	17429	32468
NM_003280.2(TNNC1):c.430A>G (p.Asn144Asp)	TNNC1	Dilated cardiomyopathy 1Z|Familial hypertrophic cardiomyopathy 13|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	3	52485431	3	52451415	181567	179071
NM_003392.4(WNT5A):c.206G>A (p.Cys69Tyr)	WNT5A	Robinow syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	55513527	3	55479499	162613	172291
NM_000333.3(ATXN7):c.791A>G (p.Lys264Arg)	ATXN7	not specified	Likely benign	no assertion criteria provided	3	63967900	3	63982224	128519	133968
NM_000333.3(ATXN7):c.2584G>A (p.Val862Met)	ATXN7	not specified	Likely benign	no assertion criteria provided	3	63982082	3	63996406	128518	133967
NM_198859.3(PRICKLE2):c.1813G>T (p.Val605Phe)	PRICKLE2|PRICKLE2-AS1	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|Epilepsy, progressive myoclonic 5	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	3	64085449	3	64099773	30733	39690
NM_032682.5(FOXP1):c.1574G>A (p.Arg525Gln)	FOXP1	Mental retardation with language impairment and with or without autistic features|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	3	71021784	3	70972633	521111	511508
NM_032682.5(FOXP1):c.1541G>A (p.Arg514His)	FOXP1	Mental retardation with language impairment and with or without autistic features|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	3	71021817	3	70972666	211040	207083
NM_032682.5(FOXP1):c.643C>G (p.Pro215Ala)	FOXP1	not specified|Intellectual Disability with Language Impairment and Autistic Features|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	3	71096114	3	71046963	129109	134555
NM_032682.5(FOXP1):c.98G>C (p.Arg33Pro)	FOXP1	not specified	Likely benign(Last reviewed: Dec 11, 2013)	criteria provided, single submitter	3	71247435	3	71198284	129107	134553
NM_002942.4(ROBO2):c.335C>T (p.Ala112Val)	ROBO2	Vesicoureteral reflux 2	Uncertain significance	criteria provided, single submitter	3	77147438	3	77098287	224346	226081
NM_002942.4(ROBO2):c.2431C>T (p.Arg811Trp)	ROBO2	Vesicoureteral reflux 2|Vesicoureteral reflux	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	3	77629200	3	77580049	224345	226082
NM_000313.3(PROS1):c.1907A>G (p.Tyr636Cys)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93593213	3	93874369	161348	171085
NM_000313.3(PROS1):c.1762A>G (p.Thr588Ala)	PROS1	Protein S deficiency|Thrombophilia due to protein S deficiency, autosomal recessive	Benign(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	3	93595918	3	93877074	161344	171086
NM_000313.3(PROS1):c.1747A>C (p.Asn583His)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93595933	3	93877089	161349	171087
NM_000313.3(PROS1):c.1594A>G (p.Thr532Ala)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93598057	3	93879213	161350	171088
NM_000313.3(PROS1):c.1528G>A (p.Val510Met)	PROS1	Protein S deficiency|Thrombophilia due to protein S deficiency, autosomal recessive	Benign(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	3	93598123	3	93879279	161343	171089
NM_000313.3(PROS1):c.1331C>T (p.Pro444Leu)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93603733	3	93884889	161351	171090
NM_000313.3(PROS1):c.1095T>G (p.Asn365Lys)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93611837	3	93892993	161352	171091
NM_000313.3(PROS1):c.946C>T (p.Arg316Cys)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93615439	3	93896595	161345	171092
NM_000313.3(PROS1):c.698G>A (p.Arg233Lys)	PROS1	Protein S deficiency|Thrombophilia due to protein S deficiency, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	3	93619677	3	93900833	161346	171093
NM_000313.3(PROS1):c.676T>A (p.Cys226Ser)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	3	93619699	3	93900855	161353	171094
NM_000313.3(PROS1):c.431C>A (p.Thr144Asn)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	3	93624903	3	93906059	161347	171095
NM_000313.3(PROS1):c.284G>A (p.Gly95Glu)	PROS1	Protein S deficiency	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	3	93629525	3	93910681	161354	171096
NM_000097.5(CPOX):c.1339C>T (p.Arg447Cys)	CPOX	Hereditary coproporphyria|Coproporphyria	Pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	3	98299553	3	98580709	459	15498
NM_006070.5(TFG):c.854C>T (p.Pro285Leu)	TFG	Neuropathy, hereditary motor and sensory, Okinawa type|not provided|Spastic paraplegia 57, autosomal recessive	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	3	100467026	3	100748182	37089	45764
NM_033254.3(BOC):c.1667G>A (p.Gly556Glu)	BOC	Holoprosencephaly sequence	Uncertain significance(Last reviewed: May 10, 2017)	criteria provided, single submitter	3	112997069	3	113278222	523664	514312
NM_001690.3(ATP6V1A):c.1123C>A (p.Pro375Thr)	ATP6V1A	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3	Likely pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	3	113513948	3	113795101	584428	575487
NM_001164342.2(ZBTB20):c.1786C>T (p.His596Tyr)	ZBTB20	Primrose syndrome	Pathogenic	no assertion criteria provided	3	114069139	3	114350292	375372	362137
NM_000388.3(CASR):c.496A>G (p.Ser166Gly)	CASR	Hypocalciuric hypercalcemia, familial, type 1|Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1	Conflicting interpretations of pathogenicity(Last reviewed: Sep 25, 2017)	criteria provided, conflicting interpretations	3	121980378	3	122261531	35800	44464
NM_000388.3(CASR):c.1525G>A (p.Gly509Arg)	CASR	Familial hypocalciuric hypercalcemia	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	3	121994806	3	122275959	35778	44442
NM_000388.3(CASR):c.2243C>A (p.Pro748His)	CASR	Familial hypocalciuric hypercalcemia|not provided	Likely pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	3	122003044	3	122284197	35788	44452
NM_000388.3(CASR):c.2339C>A (p.Thr780Asn)	CASR	Hypocalciuric hypercalcemia, familial, type 1	Uncertain significance	no assertion criteria provided	3	122003140	3	122284293	431488	424993
NM_183357.2(ADCY5):c.1252C>T (p.Arg418Trp)	ADCY5	Dyskinesia, familial, with facial myokymia|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	3	123071311	3	123352464	162090	171808
NM_053025.3(MYLK):c.4681G>C (p.Glu1561Gln)	MYLK	Aortic aneurysm, familial thoracic 7|not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	3	123359290	3	123640443	427738	417440
NM_053025.3(MYLK):c.4292C>T (p.Pro1431Leu)	MYLK	Aortic aneurysm, familial thoracic 7	Uncertain significance(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	3	123368038	3	123649191	225287	227192
NM_053025.3(MYLK):c.3184G>T (p.Ala1062Ser)	MYLK	Aortic aneurysm, familial thoracic 7|not specified|Familial aortic aneurysms	Uncertain significance(Last reviewed: Oct 2, 2017)	criteria provided, multiple submitters, no conflicts	3	123419131	3	123700284	375866	362736
NM_053025.3(MYLK):c.2533C>T (p.Arg845Cys)	MYLK	Aortic aneurysm, familial thoracic 6|Aortic aneurysm, familial thoracic 7|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	3	123419782	3	123700935	226038	227843
NM_053025.3(MYLK):c.2149G>T (p.Asp717Tyr)	MYLK	Aortic aneurysm, familial thoracic 7|Thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2018)	criteria provided, conflicting interpretations	3	123426842	3	123707995	216969	213544
NM_053025.3(MYLK):c.1321C>T (p.Pro441Ser)	MYLK	Aortic aneurysm, familial thoracic 7	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	3	123451938	3	123733091	488557	481425
NM_032638.4(GATA2):c.1113C>A (p.Asn371Lys)	GATA2	Lymphedema, primary, with myelodysplasia|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency	Likely pathogenic(Last reviewed: Jul 16, 2013)	criteria provided, single submitter	3	128200692	3	128481849	216931	213546
NM_176876.2(P2RY12):c.794G>C (p.Arg265Pro)	P2RY12|MED12L	Platelet-type bleeding disorder 8	Pathogenic(Last reviewed: May 25, 2017)	criteria provided, single submitter	3	151055840	3	151338052	548443	538927
NM_006218.3(PIK3CA):c.2740G>A (p.Gly914Arg)	PIK3CA	Megalencephaly cutis marmorata telangiectatica congenita|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	3	178947865	3	179230077	39703	48302
NM_021629.3(GNB4):c.229G>A (p.Gly77Arg)	GNB4	Charcot-Marie-Tooth disease, dominant intermediate F	Conflicting interpretations of pathogenicity(Last reviewed: Jan 31, 2018)	criteria provided, conflicting interpretations	3	179134319	3	179416531	488522	481390
NM_177989.3(ACTL6A):c.553G>C (p.Glu185Gln)	ACTL6A	Global developmental delay|Delayed speech and language development|Global developmental delay	Uncertain significance(Last reviewed: Jun 11, 2017)	criteria provided, single submitter	3	179294612	3	179576824	545508	536013
NM_017644.3(KLHL24):c.1A>G (p.Met1Val)	KLHL24	Epidermolysis bullosa simplex, Koebner type|not provided|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, multiple submitters, no conflicts	3	183368145	3	183650357	264648	259241
NM_017644.3(KLHL24):c.2T>C (p.Met1Thr)	KLHL24	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, single submitter	3	183368146	3	183650358	370042	354282
NM_017644.3(KLHL24):c.3G>T (p.Met1Ile)	KLHL24	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	3	183368147	3	183650359	264647	259240
NM_017644.3(KLHL24):c.3G>A (p.Met1Ile)	KLHL24	Epidermolysis bullosa simplex, Koebner type|Epidermolysis bullosa simplex, generalized, with scarring and hair loss	Pathogenic(Last reviewed: Sep 1, 2016)	criteria provided, single submitter	3	183368147	3	183650359	264646	259239
NM_004366.5(CLCN2):c.515G>A (p.Arg172Gln)	CLCN2	Hyperaldosteronism, familial, type II	Pathogenic(Last reviewed: Sep 25, 2017)	no assertion criteria provided	3	184075850	3	184358062	441164	434794
NM_004366.5(CLCN2):c.71G>A (p.Gly24Asp)	CLCN2	Hyperaldosteronism, familial, type II|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, multiple submitters, no conflicts	3	184076912	3	184359124	427066	414926
NM_003722.4(TP63):c.1037C>G (p.Ala346Gly)	TP63	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	Pathogenic(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	3	189586413	3	189868624	208418	204641
NM_021032.4(FGF12):c.334G>A (p.Gly112Ser)	FGF12	Epileptic encephalopathy, early infantile, 47	Likely pathogenic(Last reviewed: Mar 26, 2017)	criteria provided, single submitter	3	192053230	3	192335441	522854	513415
NM_015560.2(OPA1):c.1146A>G (p.Ile382Met)	OPA1	Abortive cerebellar ataxia|Dominant hereditary optic atrophy|Optic nerve hypoplasia|not provided|Optic Atrophy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2017)	criteria provided, conflicting interpretations	3	193361167	3	193643378	50866	59852
NM_005781.4(TNK2):c.2930C>T (p.Ala977Val)	TNK2	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195594092	3	195867221	224858	226708
NM_005781.4(TNK2):c.2630G>A (p.Arg877His)	TNK2	Parkinson disease, age at onset, susceptibility to|not specified|Parkinson disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	3	195594494	3	195867623	224859	226709
NM_005781.4(TNK2):c.1912G>A (p.Val638Met)	TNK2	Parkinson disease, age at onset, susceptibility to|Autosomal recessive infantile epilepsy|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195595212	3	195868341	88849	94418
NM_005781.4(TNK2):c.1088T>C (p.Val363Ala)	TNK2	Parkinson disease, age at onset, susceptibility to|Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	3	195605390	3	195878519	224860	226710
NM_022042.3(SLC26A1):c.1487T>G (p.Leu496Arg)	IDUA|SLC26A1	Epileptic encephalopathy	Uncertain significance(Last reviewed: Oct 16, 2014)	no assertion criteria provided	4	983240	4	989452	374260	361181
NM_000142.4(FGFR3):c.742C>T (p.Arg248Cys)	FGFR3	Achondroplasia|Multiple myeloma|Squamous cell carcinoma of the head and neck|Thanatophoric dysplasia type 1|Keratosis, seborrheic|Epidermal nevus|Lung adenocarcinoma|Skeletal dysplasia|Squamous cell lung carcinoma|Skeletal dysplasia with acanthosis nigricans|Short stature|Growth delay|not provided|Short ribs|Narrow chest|Growth delay|Small for gestational age|Bell-shaped thorax|Skeletal dysplasia|Femoral bowing|Bowed humerus|Transitional cell carcinoma of the bladder|Disproportionate short-limb short stature|Lethal short-limbed short stature|Lower limb undergrowth|Upper limb undergrowth|Carcinoma	Pathogenic(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	4	1803564	4	1801837	16332	31371
NM_000142.4(FGFR3):c.1172C>A (p.Ala391Glu)	FGFR3	Crouzon syndrome with acanthosis nigricans|not provided|Craniosynostosis|Inborn genetic diseases|Carcinoma	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	4	1806153	4	1804426	16329	31368
NM_001099433.1(JAKMIP1):c.1756G>C (p.Asp586His)	JAKMIP1	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	4	6055827	4	6054100	254206	248721
NM_006005.3(WFS1):c.683G>A (p.Arg228His)	WFS1	Cataract 41|Diabetes mellitus AND insipidus with optic atrophy AND deafness|WFS1-Related Disorders|Diabetes mellitus type 2|Wolfram-like syndrome, autosomal dominant|not specified|not provided	Uncertain significance(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	4	6293695	4	6291968	198190	195351
NM_006005.3(WFS1):c.1886G>A (p.Arg629Gln)	WFS1	Nonsyndromic hearing loss and deafness|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 21, 2014)	criteria provided, conflicting interpretations	4	6303408	4	6301681	45443	54610
NM_006005.3(WFS1):c.2051C>T (p.Ala684Val)	WFS1	Diabetes mellitus AND insipidus with optic atrophy AND deafness|Wolfram-like syndrome, autosomal dominant|Nonsyndromic hearing loss and deafness|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	4	6303573	4	6301846	30556	39513
NM_006005.3(WFS1):c.2054G>C (p.Arg685Pro)	WFS1	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Feb 28, 2012)	criteria provided, single submitter	4	6303576	4	6301849	45446	54613
NM_006005.3(WFS1):c.2141A>C (p.Asn714Thr)	WFS1	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Aug 15, 2013)	criteria provided, single submitter	4	6303663	4	6301936	45447	54614
NM_006005.3(WFS1):c.2146G>A (p.Ala716Thr)	WFS1	WFS1-Related Disorders|Nonsyndromic hearing loss and deafness|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	4	6303668	4	6301941	4520	19559
NM_006005.3(WFS1):c.2389G>A (p.Asp797Asn)	WFS1	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: May 3, 2017)	criteria provided, single submitter	4	6303911	4	6302184	517360	496379
NM_006005.3(WFS1):c.2470G>A (p.Glu824Lys)	WFS1	not specified|not provided	Uncertain significance(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	4	6303992	4	6302265	166612	173982
NM_006005.3(WFS1):c.2508G>C (p.Lys836Asn)	WFS1	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Apr 3, 2016)	criteria provided, single submitter	4	6304030	4	6302303	228313	229205
NM_006005.3(WFS1):c.2590G>A (p.Glu864Lys)	WFS1	WFS1-Related Disorders|Wolfram-like syndrome, autosomal dominant|Nonsyndromic hearing loss and deafness|not provided|DFNA6/14/38 Nonsyndromic Low-Frequency Sensorineural Hearing Loss	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	4	6304112	4	6302385	4526	19565
NM_020041.2(SLC2A9):c.1138C>T (p.Arg380Trp)	SLC2A9	Renal hypouricemia 2	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	4	9892311	4	9890687	4596	19635
NM_003924.3(PHOX2B):c.385G>A (p.Glu129Lys)	PHOX2B	Congenital central hypoventilation	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	4	41749410	4	41747393	561080	552081
NM_000222.2(KIT):c.464C>T (p.Pro155Leu)	KIT	Gastrointestinal stroma tumor|Gastrointestinal stromal tumor, familial	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	4	55564576	4	54698410	225286	227193
NM_000222.2(KIT):c.532G>A (p.Ala178Thr)	KIT	Gastrointestinal stroma tumor|not provided|Piebaldism	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	4	55564644	4	54698478	161259	171097
NM_000222.2(KIT):c.821C>T (p.Thr274Met)	KIT	Gastrointestinal stroma tumor|Gastrointestinal stromal tumor, familial|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	4	55569954	4	54703788	41604	50043
NM_000222.2(KIT):c.952A>G (p.Met318Val)	KIT	Gastrointestinal stroma tumor|Piebaldism	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	4	55573290	4	54707124	161260	171098
NM_000222.2(KIT):c.2000T>G (p.Leu667Arg)	KIT	Partial albinism	Likely pathogenic	criteria provided, single submitter	4	55595510	4	54729344	393590	380482
NM_012108.3(STAP1):c.139A>G (p.Thr47Ala)	STAP1	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	4	68436820	4	67571102	189309	187192
NM_031889.2(ENAM):c.92T>G (p.Leu31Arg)	ENAM	Amelogenesis imperfecta - hypoplastic autosomal dominant - local	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2017)	no assertion criteria provided	4	71497424	4	70631707	374930	361835
NM_000297.3(PKD2):c.1492C>T (p.His498Tyr)	PKD2	Polycystic kidney disease 2	Uncertain significance	no assertion criteria provided	4	88967966	4	88046814	559506	550230
NM_000297.3(PKD2):c.2534G>C (p.Arg845Pro)	PKD2	Polycystic kidney disease 2	Uncertain significance	no assertion criteria provided	4	88995975	4	88074823	403719	390696
NM_153427.2(PITX2):c.274G>C (p.Ala92Pro)	PITX2	Axenfeld-Rieger syndrome type 1	Uncertain significance(Last reviewed: Nov 7, 2014)	no assertion criteria provided	4	111539823	4	110618667	375439	362191
NM_153427.2(PITX2):c.271C>G (p.Arg91Gly)	PITX2	Axenfeld-Rieger syndrome type 1	Uncertain significance(Last reviewed: Nov 21, 2014)	no assertion criteria provided	4	111539826	4	110618670	375438	362192
NM_153427.2(PITX2):c.191C>T (p.Pro64Leu)	PITX2	Axenfeld-Rieger syndrome type 1	Pathogenic(Last reviewed: Nov 18, 2014)	no assertion criteria provided	4	111542381	4	110621225	375437	362194
NM_001148.4(ANK2):c.3652C>T (p.Pro1218Ser)	ANK2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	4	114257793	4	113336637	427962	419268
NM_001148.4(ANK2):c.4373A>G (p.Glu1458Gly)	ANK2	Cardiac arrhythmia, ankyrin B-related|Long QT syndrome 4|Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2018)	criteria provided, conflicting interpretations	4	114269433	4	113348277	18056	33095
NM_001148.4(ANK2):c.6078A>T (p.Lys2026Asn)	ANK2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	4	114275852	4	113354696	427963	419269
NM_001148.4(ANK2):c.10243A>G (p.Thr3415Ala)	ANK2	Congenital long QT syndrome	Uncertain significance	criteria provided, single submitter	4	114280017	4	113358861	219174	217191
NM_201999.2(ELF2):c.10G>A (p.Ala4Thr)	ELF2	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	4	140058846	4	139137692	431175	424698
NM_006439.4(MAB21L2):c.145G>A (p.Glu49Lys)	LRBA|MAB21L2	Microphthalmia/coloboma and skeletal dysplasia syndrome	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	4	151504326	4	150583174	139622	143245
NM_006439.4(MAB21L2):c.151C>T (p.Arg51Cys)	LRBA|MAB21L2	Microphthalmia/coloboma and skeletal dysplasia syndrome	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	4	151504332	4	150583180	139621	143244
NM_006439.4(MAB21L2):c.152G>A (p.Arg51His)	LRBA|MAB21L2	Microphthalmia/coloboma and skeletal dysplasia syndrome	Likely pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	4	151504333	4	150583181	139620	143243
NM_018359.4(UFSP2):c.1277A>C (p.Asp426Ala)	UFSP2	Beukes hip dysplasia|SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	4	186324694	4	185403540	437868	431489
NM_004168.3(SDHA):c.1A>G (p.Met1Val)	SDHA	Mitochondrial complex II deficiency|Paragangliomas 5|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	5	218471	5	218356	239661	239796
NM_004172.4(SLC1A3):c.657G>C (p.Glu219Asp)	SLC1A3	Episodic ataxia|not specified	Benign(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	5	36677083	5	36676981	130326	135773
NM_133433.3(NIPBL):c.3G>T (p.Met1Ile)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36953801	5	36953699	159103	168298
NM_133433.3(NIPBL):c.206T>C (p.Leu69Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	5	36955715	5	36955613	159045	168307
NM_133433.3(NIPBL):c.332G>A (p.Ser111Asn)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36958307	5	36958205	159079	168310
NM_133433.3(NIPBL):c.535G>A (p.Ala179Thr)	NIPBL	not specified|not provided|Cornelia de Lange Syndrome	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	5	36962301	5	36962199	96343	102237
NM_133433.3(NIPBL):c.737A>G (p.Asp246Gly)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36971104	5	36971002	159229	168321
NM_133433.3(NIPBL):c.781T>G (p.Ser261Ala)	NIPBL	not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 7, 2016)	criteria provided, multiple submitters, no conflicts	5	36972056	5	36971954	159237	168324
NM_133433.3(NIPBL):c.1150A>G (p.Asn384Asp)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976159	5	36976057	159029	168335
NM_133433.3(NIPBL):c.1151A>G (p.Asn384Ser)	NIPBL	not specified|Cornelia de Lange Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	5	36976160	5	36976058	159030	168336
NM_133433.3(NIPBL):c.1477A>G (p.Lys493Glu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36976486	5	36976384	159036	168341
NM_133433.3(NIPBL):c.1526C>G (p.Ser509Cys)	NIPBL	not specified	Likely benign(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	5	36984808	5	36984706	99922	105811
NM_133433.3(NIPBL):c.1591A>G (p.Thr531Ala)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36984873	5	36984771	159039	168344
NM_133433.3(NIPBL):c.1965G>T (p.Glu655Asp)	NIPBL	not specified|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Feb 2, 2017)	criteria provided, multiple submitters, no conflicts	5	36985247	5	36985145	99924	105813
NM_133433.3(NIPBL):c.1985A>G (p.Lys662Arg)	NIPBL	Cornelia de Lange syndrome 1|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	5	36985267	5	36985165	96331	102225
NM_015384.4(NIPBL):c.2021A>G (p.Asn674Ser)	NIPBL	Cornelia de Lange syndrome 1|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	5	36985303	5	36985201	96333	102227
NM_133433.3(NIPBL):c.2065A>T (p.Asn689Tyr)	NIPBL	Cornelia de Lange syndrome 1|Cornelia de Lange Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	36985347	5	36985245	159044	168348
NM_133433.3(NIPBL):c.2294G>A (p.Arg765Lys)	NIPBL	Cornelia de Lange syndrome 1|not specified|not provided|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2017)	criteria provided, conflicting interpretations	5	36985576	5	36985474	159051	168354
NM_133433.3(NIPBL):c.2447G>A (p.Arg816His)	NIPBL	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2017)	criteria provided, conflicting interpretations	5	36985729	5	36985627	96334	102228
NM_133433.3(NIPBL):c.2471C>T (p.Ser824Leu)	NIPBL	Cornelia de Lange syndrome 1|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2017)	criteria provided, conflicting interpretations	5	36985753	5	36985651	159056	168359
NM_133433.3(NIPBL):c.2592T>A (p.Asp864Glu)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36985874	5	36985772	99925	105814
NM_133433.3(NIPBL):c.2903A>G (p.Asn968Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36986185	5	36986083	159066	168369
NM_133433.3(NIPBL):c.3103C>G (p.Pro1035Ala)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	36986385	5	36986283	159071	168373
NM_133433.3(NIPBL):c.3109A>G (p.Lys1037Glu)	NIPBL	Cornelia de Lange syndrome 1|not specified	Uncertain significance(Last reviewed: Mar 21, 2016)	criteria provided, multiple submitters, no conflicts	5	36986391	5	36986289	159072	168374
NM_133433.3(NIPBL):c.3369A>C (p.Arg1123Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Apr 9, 2013)	criteria provided, single submitter	5	37000539	5	37000437	159080	168380
NM_133433.3(NIPBL):c.3440G>A (p.Arg1147Gln)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37000610	5	37000508	159082	168382
NM_133433.3(NIPBL):c.3616A>G (p.Ile1206Val)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37001132	5	37001030	159091	168388
NM_133433.3(NIPBL):c.3818T>G (p.Ile1273Ser)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003412	5	37003310	159095	168392
NM_133433.3(NIPBL):c.3851A>G (p.Asn1284Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37003445	5	37003343	159096	168393
NM_133433.3(NIPBL):c.3868G>A (p.Glu1290Lys)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37006471	5	37006369	159101	168398
NM_133433.3(NIPBL):c.4421G>C (p.Arg1474Thr)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37008825	5	37008723	159115	168411
NM_133433.3(NIPBL):c.4422G>T (p.Arg1474Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37010189	5	37010087	99929	105818
NM_133433.3(NIPBL):c.4439T>G (p.Met1480Arg)	NIPBL	Cornelia de Lange syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	5	37010206	5	37010104	159116	168412
NM_133433.3(NIPBL):c.4535A>T (p.Asn1512Ile)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37010302	5	37010200	159117	168413
NM_133433.3(NIPBL):c.5327A>T (p.Gln1776Leu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37020978	5	37020876	159140	168435
NM_133433.3(NIPBL):c.5330T>G (p.Ile1777Ser)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022154	5	37022052	159144	168439
NM_133433.3(NIPBL):c.5366G>A (p.Arg1789Gln)	NIPBL	Cornelia de Lange syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Aug 27, 2017)	criteria provided, conflicting interpretations	5	37022190	5	37022088	99932	105821
NM_133433.3(NIPBL):c.5456G>A (p.Arg1819Gln)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022374	5	37022272	99933	105822
NM_133433.3(NIPBL):c.5464G>T (p.Asp1822Tyr)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022382	5	37022280	159151	168445
NM_133433.3(NIPBL):c.5465A>G (p.Asp1822Gly)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022383	5	37022281	159152	168446
NM_133433.3(NIPBL):c.5483G>A (p.Arg1828Gln)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 21, 2014)	criteria provided, multiple submitters, no conflicts	5	37022401	5	37022299	159154	168448
NM_133433.3(NIPBL):c.5566A>G (p.Arg1856Gly)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37022484	5	37022382	99934	105823
NM_133433.3(NIPBL):c.5690A>G (p.Asn1897Ser)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37024802	5	37024700	159155	168449
NM_133433.3(NIPBL):c.5732A>C (p.Gln1911Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37026353	5	37026251	159159	168453
NM_133433.3(NIPBL):c.5762A>G (p.Asn1921Ser)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37026383	5	37026281	159160	168454
NM_133433.3(NIPBL):c.5923G>T (p.Val1975Phe)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37036541	5	37036439	159163	168457
NM_133433.3(NIPBL):c.5944A>C (p.Ile1982Leu)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Nov 11, 2013)	criteria provided, single submitter	5	37036562	5	37036460	159165	168459
NM_133433.3(NIPBL):c.5981A>G (p.Asn1994Ser)	NIPBL	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038713	5	37038611	159166	168460
NM_133433.3(NIPBL):c.6037A>C (p.Ser2013Arg)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038769	5	37038667	159168	168461
NM_133433.3(NIPBL):c.6067C>A (p.His2023Asn)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038799	5	37038697	159169	168462
NM_133433.3(NIPBL):c.6068A>G (p.His2023Arg)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038800	5	37038698	159170	168463
NM_133433.3(NIPBL):c.6071C>A (p.Ala2024Glu)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37038803	5	37038701	159171	168464
NM_133433.3(NIPBL):c.6145A>G (p.Lys2049Glu)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044485	5	37044383	159176	168467
NM_133433.3(NIPBL):c.6158T>C (p.Leu2053Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044498	5	37044396	159177	168468
NM_133433.3(NIPBL):c.6170T>C (p.Leu2057Pro)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044510	5	37044408	159179	168469
NM_133433.3(NIPBL):c.6182C>T (p.Pro2061Leu)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044522	5	37044420	159180	168470
NM_133433.3(NIPBL):c.6242G>T (p.Gly2081Val)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044582	5	37044480	159181	168471
NM_133433.3(NIPBL):c.6250G>T (p.Val2084Leu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044738	5	37044636	159183	168473
NM_133433.3(NIPBL):c.6266T>G (p.Val2089Gly)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044754	5	37044652	159184	168474
NM_133433.3(NIPBL):c.6316G>C (p.Val2106Leu)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37044804	5	37044702	159185	168475
NM_133433.3(NIPBL):c.6322G>A (p.Ala2108Thr)	NIPBL	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2016)	criteria provided, conflicting interpretations	5	37044810	5	37044708	159187	168477
NM_133433.3(NIPBL):c.6343G>A (p.Gly2115Ser)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: May 19, 2014)	criteria provided, single submitter	5	37044831	5	37044729	159189	168478
NM_133433.3(NIPBL):c.6478G>T (p.Asp2160Tyr)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37045679	5	37045577	159195	168482
NM_133433.3(NIPBL):c.6568A>G (p.Thr2190Ala)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37046280	5	37046178	159198	168484
NM_133433.3(NIPBL):c.6590G>A (p.Gly2197Glu)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37048604	5	37048502	159202	168488
NM_133433.3(NIPBL):c.6613A>G (p.Ser2205Gly)	NIPBL	not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2016)	criteria provided, conflicting interpretations	5	37048627	5	37048525	159203	168489
NM_133433.3(NIPBL):c.6646T>C (p.Tyr2216His)	NIPBL	Cornelia de Lange syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 4, 2018)	criteria provided, conflicting interpretations	5	37048660	5	37048558	159205	168491
NM_133433.3(NIPBL):c.6707A>T (p.Asn2236Ile)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	5	37048721	5	37048619	159208	168494
NM_133433.3(NIPBL):c.6892C>T (p.Arg2298Cys)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	5	37049341	5	37049239	159210	168495
NM_133433.3(NIPBL):c.6892C>G (p.Arg2298Gly)	NIPBL	Cornelia de Lange syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37049341	5	37049239	99938	105827
NM_133433.3(NIPBL):c.6893G>A (p.Arg2298His)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	5	37049342	5	37049240	159211	168496
NM_133433.3(NIPBL):c.6935G>T (p.Gly2312Val)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37049384	5	37049282	159212	168497
NM_133433.3(NIPBL):c.7012G>C (p.Ala2338Pro)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2016)	criteria provided, multiple submitters, no conflicts	5	37051938	5	37051836	159217	168502
NM_133433.3(NIPBL):c.7024C>T (p.Leu2342Phe)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37051950	5	37051848	159218	168503
NM_133433.3(NIPBL):c.7141G>A (p.Gly2381Ser)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37052546	5	37052444	159222	168507
NM_133433.3(NIPBL):c.7168G>A (p.Ala2390Thr)	NIPBL	Cornelia de Lange syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	5	37052573	5	37052471	159223	168508
NM_133433.3(NIPBL):c.7301A>G (p.Asn2434Ser)	NIPBL	Cornelia de Lange syndrome 1|not provided	Likely pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	5	37057325	5	37057223	99939	105828
NM_133433.3(NIPBL):c.7306G>A (p.Ala2436Thr)	NIPBL	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37057330	5	37057228	159226	168511
NM_133433.3(NIPBL):c.7625G>A (p.Gly2542Asp)	NIPBL	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37059207	5	37059105	159232	168516
NM_133433.3(NIPBL):c.7727A>G (p.Tyr2576Cys)	NIPBL	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37060987	5	37060885	99941	105830
NM_133433.3(NIPBL):c.8173G>C (p.Ala2725Pro)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064752	5	37064650	159242	168523
NM_133433.3(NIPBL):c.8225G>T (p.Gly2742Val)	NIPBL|CPLANE1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064804	5	37064702	159243	168524
NM_133433.3(NIPBL):c.8336C>T (p.Thr2779Met)	NIPBL|CPLANE1	Cornelia de Lange syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064915	5	37064813	159246	168527
NM_133433.3(NIPBL):c.8408C>G (p.Ser2803Cys)	NIPBL|CPLANE1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	37064987	5	37064885	159247	168528
NM_002202.2(ISL1):c.137C>G (p.Ala46Gly)	ISL1	Exstrophy-epispadias complex	Uncertain significance(Last reviewed: Sep 30, 2016)	criteria provided, single submitter	5	50680483	5	51384649	374407	361293
NM_005921.1(MAP3K1):c.770C>T (p.Pro257Leu)	MAP3K1	46,XY sex reversal, type 6	Likely pathogenic(Last reviewed: May 14, 2013)	criteria provided, single submitter	5	56155678	5	56859851	216959	213561
NM_005921.1(MAP3K1):c.1923G>A (p.Met641Ile)	MAP3K1	46,XY sex reversal, type 6	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	5	56171095	5	56875268	268092	263526
NM_001243953.1(KIF2A):c.382T>C (p.Ser128Pro)	KIF2A	Cortical dysplasia, complex, with other brain malformations 3	Uncertain significance(Last reviewed: Dec 8, 2017)	no assertion criteria provided	5	61648462	5	62352635	523636	514284
NM_001098511.2(KIF2A):c.938G>A (p.Gly313Glu)	KIF2A	Cortical dysplasia, complex, with other brain malformations 3	Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	5	61657134	5	62361307	584429	575489
NM_181523.2(PIK3R1):c.978G>A (p.Met326Ile)	PIK3R1	not specified|not provided	Benign/Likely benign(Last reviewed: May 2, 2017)	criteria provided, multiple submitters, no conflicts	5	67588148	5	68292320	135039	138778
NM_181523.2(PIK3R1):c.1106C>T (p.Thr369Ile)	PIK3R1	SHORT syndrome	Likely pathogenic(Last reviewed: May 29, 2014)	criteria provided, single submitter	5	67589015	5	68293187	159719	168533
NM_181523.2(PIK3R1):c.1460T>C (p.Phe487Ser)	PIK3R1	SHORT syndrome	Likely pathogenic(Last reviewed: Jun 12, 2015)	criteria provided, single submitter	5	67590398	5	68294570	209182	205745
NM_181523.2(PIK3R1):c.1945C>T (p.Arg649Trp)	PIK3R1	SHORT syndrome|not provided|Agammaglobulinemia 7, autosomal recessive|Immunodeficiency 36	Pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	5	67592129	5	68296301	60763	75301
NM_002397.4(MEF2C):c.1403C>T (p.Ser468Phe)	MEF2C|MEF2C-AS2	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	88018440	5	88722623	158885	168540
NM_001193350.1(MEF2C):c.860C>T (p.Ser287Leu)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	5	88025139	5	88729322	438583	432211
NM_002397.4(MEF2C):c.68A>G (p.Lys23Arg)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Likely pathogenic(Last reviewed: Jul 28, 2014)	criteria provided, single submitter	5	88100605	5	88804788	209171	205746
NM_001131005.2(MEF2C):c.9A>T (p.Arg3Ser)	MEF2C	Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	Pathogenic(Last reviewed: Dec 20, 2013)	no assertion criteria provided	5	88119597	5	88823780	218315	215010
NM_032119.3(ADGRV1):c.380T>G (p.Leu127Arg)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	5	89914925	5	90619108	46321	55486
NM_032119.3(ADGRV1):c.581C>A (p.Pro194His)	ADGRV1	not specified|not provided	Benign(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	5	89920969	5	90625152	46341	55506
NM_032119.3(ADGRV1):c.746G>A (p.Arg249Lys)	ADGRV1	not specified|not provided|Usher syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	5	89923101	5	90627284	46374	55539
NM_032119.4(ADGRV1):c.1652T>C (p.Val551Ala)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 30, 2018)	criteria provided, multiple submitters, no conflicts	5	89925169	5	90629352	46286	55451
NM_032119.3(ADGRV1):c.1797A>T (p.Arg599Ser)	ADGRV1	not specified|not provided	Uncertain significance(Last reviewed: Feb 5, 2016)	criteria provided, single submitter	5	89925314	5	90629497	158647	168545
NM_032119.3(ADGRV1):c.1855T>G (p.Leu619Val)	ADGRV1	Febrile seizures, familial, 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	5	89930946	5	90635129	158649	168546
NM_032119.3(ADGRV1):c.2456G>A (p.Ser819Asn)	ADGRV1	Febrile seizures, familial, 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2017)	criteria provided, conflicting interpretations	5	89938761	5	90642944	158650	168547
NM_032119.4(ADGRV1):c.3151G>T (p.Asp1051Tyr)	ADGRV1	Febrile seizures, familial, 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	5	89943443	5	90647626	46311	55476
NM_032119.3(ADGRV1):c.3191A>C (p.Glu1064Ala)	ADGRV1	Febrile seizures, familial, 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	5	89943483	5	90647666	46312	55477
NM_032119.4(ADGRV1):c.3279G>T (p.Leu1093Phe)	ADGRV1	not specified	Benign(Last reviewed: Jul 21, 2014)	criteria provided, multiple submitters, no conflicts	5	89943571	5	90647754	46313	55478
NM_032119.4(ADGRV1):c.3289G>A (p.Gly1097Ser)	ADGRV1	not specified	Benign(Last reviewed: Jun 30, 2015)	criteria provided, multiple submitters, no conflicts	5	89943581	5	90647764	158651	168548
NM_032119.3(ADGRV1):c.5747C>T (p.Thr1916Ile)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	5	89979485	5	90683668	158653	168550
NM_032119.3(ADGRV1):c.5780C>T (p.Thr1927Met)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 14, 2013)	criteria provided, multiple submitters, no conflicts	5	89979518	5	90683701	46339	55504
NM_032119.4(ADGRV1):c.5851G>A (p.Val1951Ile)	ADGRV1	not specified	Benign(Last reviewed: Jun 26, 2014)	criteria provided, multiple submitters, no conflicts	5	89979589	5	90683772	46343	55508
NM_032119.3(ADGRV1):c.5953A>G (p.Asn1985Asp)	ADGRV1	not specified	Benign(Last reviewed: Apr 25, 2014)	criteria provided, multiple submitters, no conflicts	5	89979691	5	90683874	46344	55509
NM_032119.3(ADGRV1):c.5960C>T (p.Pro1987Leu)	ADGRV1	not specified	Benign(Last reviewed: Jun 22, 2014)	criteria provided, multiple submitters, no conflicts	5	89979698	5	90683881	46345	55510
NM_032119.4(ADGRV1):c.6012G>T (p.Leu2004Phe)	ADGRV1	not specified	Benign(Last reviewed: Apr 25, 2014)	criteria provided, multiple submitters, no conflicts	5	89979750	5	90683933	46346	55511
NM_032119.3(ADGRV1):c.6133G>A (p.Gly2045Arg)	ADGRV1	Febrile seizures, familial, 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2018)	criteria provided, conflicting interpretations	5	89979871	5	90684054	46348	55513
NM_032119.3(ADGRV1):c.6289C>T (p.Arg2097Cys)	ADGRV1	not specified	Benign(Last reviewed: Dec 16, 2015)	criteria provided, multiple submitters, no conflicts	5	89981611	5	90685794	46350	55515
NM_032119.4(ADGRV1):c.6695A>G (p.Tyr2232Cys)	ADGRV1	not specified	Benign(Last reviewed: Mar 23, 2010)	criteria provided, multiple submitters, no conflicts	5	89985882	5	90690065	46356	55521
NM_032119.3(ADGRV1):c.7034A>G (p.Asn2345Ser)	ADGRV1	not specified	Benign(Last reviewed: Mar 16, 2007)	criteria provided, multiple submitters, no conflicts	5	89988504	5	90692687	46360	55525
NM_032119.3(ADGRV1):c.7751A>G (p.Asn2584Ser)	ADGRV1	not specified	Benign(Last reviewed: Jun 19, 2009)	criteria provided, multiple submitters, no conflicts	5	89990324	5	90694507	46379	55544
NM_032119.3(ADGRV1):c.7813T>G (p.Leu2605Val)	ADGRV1	not specified|not provided	Benign(Last reviewed: Oct 27, 2016)	criteria provided, multiple submitters, no conflicts	5	89990386	5	90694569	46380	55545
NM_032119.3(ADGRV1):c.8291C>T (p.Ser2764Leu)	ADGRV1	not specified	Benign(Last reviewed: Apr 29, 2014)	criteria provided, multiple submitters, no conflicts	5	90000210	5	90704393	46387	55552
NM_032119.3(ADGRV1):c.8407G>A (p.Ala2803Thr)	ADGRV1	not specified|not provided	Benign/Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	5	90001237	5	90705420	46389	55554
NM_032119.4(ADGRV1):c.8876G>A (p.Arg2959Gln)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	5	90006849	5	90711032	46400	55565
NM_032119.3(ADGRV1):c.9280G>A (p.Val3094Ile)	ADGRV1	not specified	Benign(Last reviewed: Apr 10, 2012)	criteria provided, single submitter	5	90012379	5	90716562	46403	55568
NM_032119.4(ADGRV1):c.9650C>T (p.Ala3217Val)	ADGRV1	Usher syndrome, type 2C|Febrile seizures, familial, 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2018)	criteria provided, conflicting interpretations	5	90016778	5	90720961	158655	168552
NM_032119.4(ADGRV1):c.9743G>A (p.Gly3248Asp)	ADGRV1	not specified	Benign(Last reviewed: Jan 8, 2013)	criteria provided, multiple submitters, no conflicts	5	90016871	5	90721054	46407	55572
NM_032119.3(ADGRV1):c.10411G>A (p.Glu3471Lys)	ADGRV1	not specified|not provided	Benign(Last reviewed: Apr 20, 2017)	criteria provided, multiple submitters, no conflicts	5	90024735	5	90728918	46248	55413
NM_032119.4(ADGRV1):c.10577T>C (p.Met3526Thr)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	5	90040890	5	90745073	46249	55414
NM_032119.3(ADGRV1):c.11338C>T (p.Arg3780Cys)	ADGRV1	Febrile seizures, familial, 4	Uncertain significance(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	5	90049607	5	90753790	158644	168555
NM_032119.4(ADGRV1):c.11599G>A (p.Glu3867Lys)	ADGRV1	not specified	Benign(Last reviewed: Nov 22, 2015)	criteria provided, multiple submitters, no conflicts	5	90052289	5	90756472	46257	55422
NM_032119.3(ADGRV1):c.12032G>T (p.Gly4011Val)	ADGRV1	Febrile seizures, familial, 4	Uncertain significance(Last reviewed: Oct 30, 2013)	criteria provided, single submitter	5	90055317	5	90759500	158646	168557
NM_032119.3(ADGRV1):c.12592G>A (p.Val4198Met)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 14, 2017)	criteria provided, multiple submitters, no conflicts	5	90073786	5	90777969	46262	55427
NM_032119.4(ADGRV1):c.13037C>T (p.Pro4346Leu)	ADGRV1	not specified	Benign/Likely benign(Last reviewed: Feb 8, 2016)	criteria provided, multiple submitters, no conflicts	5	90074869	5	90779052	46265	55430
NM_032119.4(ADGRV1):c.14029T>C (p.Phe4677Leu)	ADGRV1	not specified|not provided	Benign(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	5	90085654	5	90789837	46269	55434
NM_032119.4(ADGRV1):c.14515C>G (p.Gln4839Glu)	ADGRV1	not specified|not provided	Benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	5	90087161	5	90791344	46271	55436
NM_032119.3(ADGRV1):c.14905T>C (p.Trp4969Arg)	ADGRV1	not specified|not provided	Benign(Last reviewed: Aug 30, 2017)	criteria provided, multiple submitters, no conflicts	5	90103487	5	90807670	46274	55439
NM_032119.3(ADGRV1):c.16031A>G (p.Glu5344Gly)	ADGRV1	not specified	Benign(Last reviewed: Mar 6, 2013)	criteria provided, multiple submitters, no conflicts	5	90107108	5	90811291	46282	55447
NM_032119.4(ADGRV1):c.16279G>A (p.Val5427Met)	ADGRV1	not specified	Benign(Last reviewed: Jul 15, 2014)	criteria provided, multiple submitters, no conflicts	5	90119324	5	90823507	46285	55450
NM_032119.3(ADGRV1):c.17626G>A (p.Val5876Ile)	ADGRV1	not specified	Benign(Last reviewed: Sep 6, 2018)	criteria provided, multiple submitters, no conflicts	5	90151589	5	90855772	46291	55456
NM_032119.3(ADGRV1):c.18475A>G (p.Met6159Val)	ADGRV1	not specified	Benign(Last reviewed: Jul 2, 2015)	criteria provided, multiple submitters, no conflicts	5	90445889	5	91150072	46298	55463
NM_005654.5(NR2F1):c.335G>A (p.Arg112Lys)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	5	92921064	5	93585358	126496	132020
NM_005654.5(NR2F1):c.339C>A (p.Ser113Arg)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	5	92921068	5	93585362	126494	132018
NM_005654.5(NR2F1):c.344G>C (p.Arg115Pro)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2015)	criteria provided, single submitter	5	92921073	5	93585367	126493	132017
NM_005654.5(NR2F1):c.382T>C (p.Cys128Arg)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Likely pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	5	92921111	5	93585405	216974	213562
NM_005654.5(NR2F1):c.413G>A (p.Cys138Tyr)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Pathogenic	no assertion criteria provided	5	92921142	5	93585436	375371	362143
NM_005654.5(NR2F1):c.755T>C (p.Leu252Pro)	NR2F1	Bosch-Boonstra-Schaaf optic atrophy syndrome	Likely pathogenic(Last reviewed: Feb 6, 2014)	criteria provided, single submitter	5	92923914	5	93588208	126495	132019
NM_000038.5(APC):c.295C>T (p.Arg99Trp)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	5	112102960	5	112767263	135695	139407
NM_000038.5(APC):c.388A>G (p.Ser130Gly)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112103053	5	112767356	41505	49944
NM_000038.5(APC):c.449A>G (p.Lys150Arg)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	5	112111352	5	112775655	141928	151642
NM_000038.5(APC):c.607C>G (p.Gln203Glu)	APC	Desmoid disease, hereditary|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	5	112116562	5	112780865	41509	49948
NM_000038.5(APC):c.1240C>T (p.Arg414Cys)	APC	Gardner syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|APC-Associated Polyposis Disorders	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	5	112154969	5	112819272	797	15836
NM_000038.5(APC):c.2204C>T (p.Ala735Val)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of the liver|Familial adenomatous polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112173495	5	112837798	41521	49960
NM_000038.5(APC):c.2658G>T (p.Gln886His)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	5	112173949	5	112838252	135694	139406
NM_000038.5(APC):c.2847G>T (p.Met949Ile)	APC	Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112174138	5	112838441	161206	171099
NM_000038.5(APC):c.2942C>G (p.Pro981Arg)	APC	Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 25, 2018)	criteria provided, multiple submitters, no conflicts	5	112174233	5	112838536	127282	132739
NM_000038.5(APC):c.3479C>A (p.Thr1160Lys)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	5	112174770	5	112839073	41503	49942
NM_000038.5(APC):c.4237A>G (p.Met1413Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112175528	5	112839831	133510	137249
NM_000038.5(APC):c.4336G>A (p.Ala1446Thr)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Likely benign(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	5	112175627	5	112839930	127294	132751
NM_000038.5(APC):c.4360A>G (p.Lys1454Glu)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma|APC-Associated Polyposis Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	5	112175651	5	112839954	127295	132752
NM_000038.5(APC):c.4420G>A (p.Ala1474Thr)	APC	Familial adenomatous polyposis 1|not specified|Hereditary cancer-predisposing syndrome|Colorectal adenoma|APC-Associated Polyposis Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	5	112175711	5	112840014	133530	137269
NM_000038.5(APC):c.4732T>G (p.Cys1578Gly)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	5	112176023	5	112840326	140839	150553
NM_000038.5(APC):c.4918C>T (p.Arg1640Trp)	APC	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	5	112176209	5	112840512	142246	151960
NM_000038.5(APC):c.5026A>G (p.Arg1676Gly)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112176317	5	112840620	127302	132759
NM_000038.5(APC):c.5140G>A (p.Asp1714Asn)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112176431	5	112840734	135706	139418
NM_000038.5(APC):c.5528C>T (p.Pro1843Leu)	APC	Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	5	112176819	5	112841122	127306	132763
NM_000038.5(APC):c.5801C>T (p.Pro1934Leu)	APC	Familial multiple polyposis syndrome|Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	5	112177092	5	112841395	135709	139421
NM_000038.5(APC):c.6724A>G (p.Ser2242Gly)	APC	Desmoid disease, hereditary|Familial multiple polyposis syndrome|Carcinoma of colon|Familial adenomatous polyposis 1|Neoplasm of stomach|not specified|not provided|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2018)	criteria provided, conflicting interpretations	5	112178015	5	112842318	41510	49949
NM_000038.5(APC):c.6985A>G (p.Ile2329Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	5	112178276	5	112842579	135716	139428
NM_000038.5(APC):c.7235A>G (p.Lys2412Arg)	APC	Colorectal cancer, susceptibility to|Familial adenomatous polyposis 1	Uncertain significance(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	5	112178526	5	112842829	224554	226321
NM_000038.5(APC):c.7399C>A (p.Pro2467Thr)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	5	112178690	5	112842993	127318	132775
NM_000038.5(APC):c.7717A>G (p.Ile2573Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	5	112179008	5	112843311	41536	49975
NM_000038.5(APC):c.7778A>G (p.Asn2593Ser)	APC	Familial adenomatous polyposis 1|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Uncertain significance(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	5	112179069	5	112843372	161205	171100
NM_000038.5(APC):c.8266A>G (p.Ile2756Val)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	5	112179557	5	112843860	135724	139436
NM_000038.5(APC):c.8383G>A (p.Ala2795Thr)	APC	Familial adenomatous polyposis 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Colorectal adenoma	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	5	112179674	5	112843977	141047	150761
NM_002317.6(LOX):c.893T>G (p.Met298Arg)	LOX|SRFBP1	Thoracic aortic aneurysm and aortic dissection|Aortic aneurysm, familial thoracic 10	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	5	121409850	5	122074155	228806	229233
NM_002317.5(LOX):c.839G>T (p.Ser280Ile)	LOX|SRFBP1	Aortic aneurysm, familial thoracic 10|Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Oct 24, 2016)	no assertion criteria provided	5	121411138	5	122075443	267291	262311
NM_002317.5(LOX):c.800A>C (p.Gln267Pro)	LOX|SRFBP1	Aortic aneurysm, familial thoracic 10|Acute aortic dissections|Familial thoracic aortic aneurysms	Pathogenic(Last reviewed: Oct 24, 2016)	no assertion criteria provided	5	121411177	5	122075482	267293	262313
NM_002317.5(LOX):c.235G>A (p.Ala79Thr)	LOX	Inborn genetic diseases|Acute aortic dissections|Familial thoracic aortic aneurysms	Uncertain significance(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	5	121413446	5	122077751	521345	511551
NM_001999.3(FBN2):c.8347G>C (p.Glu2783Gln)	FBN2	Congenital contractural arachnodactyly|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	5	127597445	5	128261753	129054	134500
NM_001999.3(FBN2):c.7739C>T (p.Ser2580Leu)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	5	127609633	5	128273941	129051	134497
NM_001999.3(FBN2):c.7145G>A (p.Arg2382Gln)	FBN2	Congenital contractural arachnodactyly|not specified	Uncertain significance(Last reviewed: Jan 18, 2014)	criteria provided, single submitter	5	127614527	5	128278835	213426	209679
NM_001999.3(FBN2):c.6931A>G (p.Met2311Val)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign(Last reviewed: May 1, 2017)	criteria provided, multiple submitters, no conflicts	5	127622491	5	128286799	129046	134492
NM_001999.3(FBN2):c.3973G>A (p.Asp1325Asn)	FBN2	Congenital contractural arachnodactyly	Likely pathogenic(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	5	127670862	5	128335170	446528	440046
NM_001999.3(FBN2):c.2893G>A (p.Val965Ile)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	5	127685135	5	128349443	129039	134485
NM_001999.3(FBN2):c.2161G>A (p.Gly721Ser)	FBN2	Congenital contractural arachnodactyly|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 21, 2017)	criteria provided, conflicting interpretations	5	127704962	5	128369269	129037	134483
NM_001999.3(FBN2):c.203C>T (p.Ala68Val)	FBN2	Congenital contractural arachnodactyly|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	5	127873094	5	128537401	94020	99922
NM_005732.3(RAD50):c.5C>T (p.Ser2Phe)	RAD50	Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 27, 2018)	criteria provided, conflicting interpretations	5	131893021	5	132557329	527368	521027
NM_000358.2(TGFBI):c.[1637C>A;1652C>A]	TGFBI	Lattice corneal dystrophy Type I	Pathogenic(Last reviewed: Nov 1, 2004)	no assertion criteria provided	5|5	135392443	5|5	136056754	7874	22913|38388
NM_006790.2(MYOT):c.122T>C (p.Ile41Thr)	MYOT	not provided	Uncertain significance(Last reviewed: Jan 4, 2017)	criteria provided, multiple submitters, no conflicts	5	137206462	5	137870773	129682	135128
NM_006790.2(MYOT):c.149A>G (p.Gln50Arg)	MYOT	Spheroid body myopathy|Limb-girdle muscular dystrophy, type 1A|Myofibrillar myopathy 3|not specified|Limb-Girdle Muscular Dystrophy, Dominant|Myofibrillar Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	5	137206489	5	137870800	129683	135129
NM_005859.4(PURA):c.299T>C (p.Leu100Pro)	PURA	Global developmental delay|Seizures|Delayed speech and language development|Intellectual disability|Global developmental delay|Neonatal hypotonia|Mental retardation, autosomal dominant 31	Likely pathogenic(Last reviewed: Aug 5, 2017)	criteria provided, single submitter	5	139494065	5	140114480	156407	166186
NM_002109.5(HARS):c.1067G>A (p.Ser356Asn)	HARS	Usher syndrome, type 3B|Charcot-Marie-Tooth disease, axonal, type 2w	Uncertain significance(Last reviewed: Sep 2, 2017)	criteria provided, single submitter	5	140056366	5	140676781	446301	439705
NM_002109.5(HARS):c.464T>G (p.Val155Gly)	HARS	Charcot-Marie-Tooth disease, axonal, type 2w	Uncertain significance	no assertion criteria provided	5	140058645	5	140679060	446299	439703
NM_002109.5(HARS):c.397G>T (p.Val133Phe)	HARS	Charcot-Marie-Tooth disease, axonal, type 2w	Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	5	140058712	5	140679127	548118	538605
NM_003122.4(SPINK1):c.194G>A (p.Arg65Gln)	SPINK1	Hereditary pancreatitis|not specified|not provided	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	5	147207585	5	147828022	36779	45440
NM_005211.3(CSF1R):c.2342C>T (p.Ala781Val)	CSF1R	Hereditary diffuse leukoencephalopathy with spheroids	Pathogenic(Last reviewed: Nov 8, 2013)	criteria provided, single submitter	5	149435882	5	150056319	162118	171839
NM_002609.3(PDGFRB):c.1996A>C (p.Asn666His)	PDGFRB	Inborn genetic diseases	Likely pathogenic	criteria provided, single submitter	5	149503840	5	150124277	208692	205249
NM_002609.3(PDGFRB):c.1699A>G (p.Lys567Glu)	PDGFRB	Infantile myofibromatosis 1	Pathogenic(Last reviewed: Dec 1, 2016)	no assertion criteria provided	5	149505116	5	150125553	375237	361944
NM_002609.3(PDGFRB):c.1681C>T (p.Arg561Cys)	PDGFRB	Infantile myofibromatosis 1|not provided|Infantile myofibromatosis	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	5	149505134	5	150125571	55848	70502
NM_001135244.1(TCOF1):c.1705G>A (p.Glu569Lys)	TCOF1	Treacher Collins syndrome 1	Likely pathogenic(Last reviewed: Apr 4, 2016)	no assertion criteria provided	5	149755284	5	150375721	433551	427123
NM_001135243.1(TCOF1):c.1993G>C (p.Ala665Pro)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149755744	5	150376181	130566	136012
NM_001135243.1(TCOF1):c.2245C>T (p.Pro749Ser)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	5	149756088	5	150376525	130568	136014
NM_001135243.1(TCOF1):c.2660T>C (p.Val887Ala)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149759096	5	150379533	130569	136015
NM_001135243.1(TCOF1):c.2765C>T (p.Ser922Leu)	TCOF1	Treacher Collins syndrome 1|not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	5	149759201	5	150379638	130570	136016
NM_001135243.1(TCOF1):c.3527C>G (p.Pro1176Arg)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149772280	5	150392717	130571	136017
NM_001135243.1(TCOF1):c.4169C>T (p.Ala1390Val)	TCOF1	not specified|Treacher Collins Syndrome, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	149776232	5	150396669	130574	136020
NM_001135243.1(TCOF1):c.4292G>C (p.Gly1431Ala)	TCOF1	Treacher Collins syndrome 1|not specified|Treacher Collins Syndrome, Dominant	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	5	149776355	5	150396792	130575	136021
NM_181776.2(SLC36A2):c.260G>T (p.Gly87Val)	SLC36A2	Hyperglycinuria|Iminoglycinuria, digenic	Pathogenic(Last reviewed: Dec 1, 2008)	no assertion criteria provided	5	150723155	5	151343594	2384	17423
NM_000337.5(SGCD):c.32G>A (p.Arg11Gln)	SGCD	Dilated cardiomyopathy 1L|Primary dilated cardiomyopathy|Limb-girdle muscular dystrophy, type 2F|not specified|not provided	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	5	155771527	5	156344517	196256	193417
NM_000337.5(SGCD):c.226G>T (p.Gly76Cys)	SGCD	Limb-girdle muscular dystrophy, type 2F	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	5	155935644	5	156508634	161391	171101
NM_000337.5(SGCD):c.848A>G (p.Gln283Arg)	SGCD	Familial hypertrophic cardiomyopathy 1|Limb-girdle muscular dystrophy, type 2F|Delta-sarcoglycanopathy|not specified|not provided|Dilated Cardiomyopathy, Dominant|Limb-Girdle Muscular Dystrophy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2017)	criteria provided, conflicting interpretations	5	156186376	5	156759365	43358	52528
NM_021911.2(GABRB2):c.904G>A (p.Val302Met)	GABRB2	not provided|EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2	Likely pathogenic(Last reviewed: Mar 17, 2018)	criteria provided, multiple submitters, no conflicts	5	160758063	5	161331056	427157	414996
NM_000806.5(GABRA1):c.789G>A (p.Met263Ile)	GABRA1	Epileptic encephalopathy, early infantile, 19	Likely pathogenic(Last reviewed: Feb 2, 2017)	no assertion criteria provided	5	161317989	5	161890983	402327	389307
NM_000816.3(GABRG2):c.1310G>T (p.Arg437Leu)	GABRG2	not provided	Uncertain significance(Last reviewed: Mar 24, 2014)	criteria provided, single submitter	5	161580280	5	162153274	129126	134572
NM_004387.3(NKX2-5):c.461A>G (p.Glu154Gly)	NKX2-5	Atrial septal defect 7 with or without atrioventricular conduction defects	Pathogenic(Last reviewed: Jan 1, 2014)	no assertion criteria provided	5	172660086	5	173233083	156158	165957
NM_022455.4(NSD1):c.142A>G (p.Met48Val)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562246	5	177135245	159265	168109
NM_022455.4(NSD1):c.352C>G (p.Pro118Ala)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562456	5	177135455	159309	168111
NM_022455.4(NSD1):c.395G>C (p.Cys132Ser)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562499	5	177135498	159317	168112
NM_022455.4(NSD1):c.760C>T (p.Leu254Phe)	NSD1	Beckwith-Wiedemann syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	5	176562864	5	177135863	159441	168113
NM_022455.4(NSD1):c.767C>T (p.Ala256Val)	NSD1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176562871	5	177135870	159442	168114
NM_022455.4(NSD1):c.1471G>A (p.Glu491Lys)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176636871	5	177209870	159267	168122
NM_022455.4(NSD1):c.1495G>A (p.Ala499Thr)	NSD1	Beckwith-Wiedemann syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 11, 2017)	criteria provided, conflicting interpretations	5	176636895	5	177209894	159268	168123
NM_022455.4(NSD1):c.1558G>A (p.Ala520Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|Sotos syndrome 1|not specified|Sotos syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2017)	criteria provided, conflicting interpretations	5	176636958	5	177209957	159269	168124
NM_022455.4(NSD1):c.1690G>T (p.Ala564Ser)	NSD1	Beckwith-Wiedemann syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	5	176637090	5	177210089	159270	168125
NM_022455.4(NSD1):c.1840G>T (p.Val614Leu)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176637240	5	177210239	96042	101936
NM_022455.4(NSD1):c.2071G>A (p.Ala691Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	5	176637471	5	177210470	159279	168134
NM_022455.4(NSD1):c.2176T>C (p.Ser726Pro)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176637576	5	177210575	96043	101937
NM_022455.4(NSD1):c.2242A>G (p.Asn748Asp)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176637642	5	177210641	159282	168137
NM_022455.4(NSD1):c.2399T>C (p.Met800Thr)	NSD1	Sotos syndrome 1|not provided	Uncertain significance(Last reviewed: Apr 4, 2013)	criteria provided, multiple submitters, no conflicts	5	176637799	5	177210798	96046	101940
NM_022455.4(NSD1):c.2450C>T (p.Ser817Phe)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2017)	criteria provided, conflicting interpretations	5	176637850	5	177210849	96047	101941
NM_022455.4(NSD1):c.2696T>C (p.Ile899Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome	Likely benign(Last reviewed: May 18, 2017)	criteria provided, multiple submitters, no conflicts	5	176638096	5	177211095	159290	168145
NM_022455.4(NSD1):c.2944G>C (p.Gly982Arg)	NSD1	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638344	5	177211343	159293	168148
NM_022455.4(NSD1):c.3089T>C (p.Leu1030Ser)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638489	5	177211488	159299	168154
NM_022455.4(NSD1):c.3106G>C (p.Ala1036Pro)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	5	176638506	5	177211505	159301	168156
NM_022455.4(NSD1):c.3187A>G (p.Thr1063Ala)	NSD1	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	5	176638587	5	177211586	96053	101947
NM_022455.4(NSD1):c.3271C>A (p.Leu1091Ile)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176638671	5	177211670	159304	168159
NM_022455.4(NSD1):c.3564G>C (p.Arg1188Ser)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	5	176638964	5	177211963	159310	168163
NM_022455.4(NSD1):c.3722G>C (p.Ser1241Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 22, 2017)	criteria provided, multiple submitters, no conflicts	5	176639122	5	177212121	159313	168166
NM_022455.4(NSD1):c.3803G>A (p.Arg1268Gln)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2017)	criteria provided, conflicting interpretations	5	176662828	5	177235827	159314	168167
NM_022455.4(NSD1):c.3992A>G (p.Asp1331Gly)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176665308	5	177238307	159319	168171
NM_022455.4(NSD1):c.4328A>G (p.Asn1443Ser)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176671221	5	177244220	159325	168177
NM_022455.4(NSD1):c.4363A>G (p.Lys1455Glu)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176671256	5	177244255	159326	168178
NM_022455.4(NSD1):c.4520C>T (p.Thr1507Met)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	5	176675204	5	177248203	159335	168187
NM_022455.4(NSD1):c.4564G>T (p.Asp1522Tyr)	NSD1	Sotos syndrome 1|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	5	176675248	5	177248247	159338	168190
NM_022455.4(NSD1):c.4564G>A (p.Asp1522Asn)	NSD1	Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	5	176675248	5	177248247	159337	168189
NM_172349.2(NSD1):c.3964C>T (p.His1322Tyr)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	5	176683957	5	177256956	488392	481233
NM_022455.4(NSD1):c.4817G>A (p.Cys1606Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684003	5	177257002	159345	168197
NM_022455.4(NSD1):c.4844A>C (p.Tyr1615Ser)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684030	5	177257029	159346	168198
NM_022455.4(NSD1):c.4855T>G (p.Cys1619Gly)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684041	5	177257040	159348	168200
NM_022455.4(NSD1):c.4855T>A (p.Cys1619Ser)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684041	5	177257040	159347	168199
NM_022455.4(NSD1):c.4883T>C (p.Met1628Thr)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684069	5	177257068	159349	168201
NM_022455.4(NSD1):c.4892A>G (p.Lys1631Arg)	NSD1	Sotos syndrome 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2017)	criteria provided, conflicting interpretations	5	176684078	5	177257077	96061	101955
NM_022455.4(NSD1):c.4907C>T (p.Ser1636Phe)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684093	5	177257092	159350	168202
NM_022455.4(NSD1):c.4966G>T (p.Gly1656Cys)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176684152	5	177257151	159353	168203
NM_022455.4(NSD1):c.4987C>T (p.Arg1663Cys)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176687010	5	177260009	159355	168207
NM_022455.4(NSD1):c.5021G>A (p.Cys1674Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: May 31, 2013)	criteria provided, single submitter	5	176687044	5	177260043	159356	168208
NM_022455.4(NSD1):c.5198G>A (p.Cys1733Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176694614	5	177267613	159361	168213
NM_022455.4(NSD1):c.5375G>A (p.Gly1792Glu)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696674	5	177269673	159364	168216
NM_022455.4(NSD1):c.5390T>C (p.Leu1797Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696689	5	177269688	159365	168217
NM_022455.4(NSD1):c.5419A>C (p.Thr1807Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696718	5	177269717	159367	168219
NM_022455.4(NSD1):c.5432G>A (p.Arg1811Gln)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696731	5	177269730	159370	168222
NM_022455.4(NSD1):c.5471A>G (p.Asp1824Gly)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176696770	5	177269769	159371	168223
NM_022455.4(NSD1):c.5740C>T (p.Arg1914Cys)	NSD1	Sotos syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2016)	criteria provided, multiple submitters, no conflicts	5	176707683	5	177280682	159375	168227
NM_022455.4(NSD1):c.5741G>C (p.Arg1914Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707684	5	177280683	159376	168228
NM_022455.4(NSD1):c.5798A>G (p.Asn1933Ser)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707741	5	177280740	159377	168229
NM_022455.4(NSD1):c.5809T>C (p.Ser1937Pro)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707752	5	177280751	159380	168232
NM_022455.4(NSD1):c.5862G>C (p.Trp1954Cys)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707805	5	177280804	159381	168233
NM_022455.4(NSD1):c.5869C>T (p.Arg1957Trp)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707812	5	177280811	159382	168234
NM_022455.4(NSD1):c.5885T>C (p.Ile1962Thr)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176707828	5	177280827	159383	168235
NM_022455.4(NSD1):c.5918G>T (p.Gly1973Val)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709491	5	177282490	159387	168239
NM_022455.4(NSD1):c.5927T>A (p.Ile1976Lys)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176709500	5	177282499	159388	168240
NM_022455.4(NSD1):c.5951G>A (p.Arg1984Gln)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	5	176709524	5	177282523	159390	168242
NM_022455.4(NSD1):c.5989T>C (p.Tyr1997His)	NSD1	Sotos syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2016)	criteria provided, multiple submitters, no conflicts	5	176709562	5	177282561	159392	168244
NM_022455.4(NSD1):c.6014G>A (p.Arg2005Gln)	NSD1	Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	5	176710792	5	177283791	159395	168247
NM_022455.4(NSD1):c.6019A>T (p.Ile2007Phe)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Oct 21, 2014)	criteria provided, single submitter	5	176710797	5	177283796	369685	353894
NM_022455.4(NSD1):c.6043T>C (p.Tyr2015His)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710821	5	177283820	159396	168248
NM_022455.4(NSD1):c.6049C>T (p.Arg2017Trp)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	5	176710827	5	177283826	159397	168249
NM_022455.4(NSD1):c.6050G>A (p.Arg2017Gln)	NSD1	Hypertelorism|Preeclampsia|Sotos syndrome 1|Global developmental delay|Scoliosis|Tall stature|Overgrowth|Pointed chin|not provided|Hypoplasia of the corpus callosum|Delayed speech and language development|Macrocephalus|Hypertelorism|High forehead|Osteopenia|Global developmental delay|Delayed gross motor development|Increased body weight|High anterior hairline|Preeclampsia	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	5	176710828	5	177283827	159398	168250
NM_022455.4(NSD1):c.6059A>G (p.Asn2020Ser)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710837	5	177283836	159399	168251
NM_022455.4(NSD1):c.6080G>C (p.Cys2027Ser)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710858	5	177283857	159401	168253
NM_022455.4(NSD1):c.6086C>T (p.Thr2029Ile)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176710864	5	177283863	159402	168254
NM_022455.4(NSD1):c.6356A>G (p.Asp2119Gly)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719052	5	177292051	159413	168265
NM_022455.4(NSD1):c.6377A>T (p.Asp2126Val)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719073	5	177292072	159415	168267
NM_022455.4(NSD1):c.6413G>A (p.Cys2138Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Aug 21, 2013)	criteria provided, single submitter	5	176719109	5	177292108	159417	168269
NM_022455.4(NSD1):c.6418A>G (p.Lys2140Glu)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719114	5	177292113	159418	168270
NM_022455.4(NSD1):c.6455G>A (p.Arg2152Gln)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176719151	5	177292150	159422	168274
NM_022455.4(NSD1):c.6476G>A (p.Cys2159Tyr)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720845	5	177293844	159424	168276
NM_022455.4(NSD1):c.6485A>C (p.His2162Pro)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720854	5	177293853	159426	168278
NM_022455.4(NSD1):c.6500G>A (p.Cys2167Tyr)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720869	5	177293868	159427	168279
NM_022455.4(NSD1):c.6557A>G (p.His2186Arg)	NSD1	Sotos syndrome 1	Likely pathogenic(Last reviewed: Jun 26, 2014)	criteria provided, single submitter	5	176720926	5	177293925	159430	168282
NM_022455.4(NSD1):c.6604T>A (p.Cys2202Ser)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176720973	5	177293972	159432	168284
NM_022455.4(NSD1):c.6637C>G (p.Leu2213Val)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721006	5	177294005	159434	168286
NM_022455.4(NSD1):c.6640G>A (p.Glu2214Lys)	NSD1	Sotos syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721009	5	177294008	159435	168287
NM_022455.4(NSD1):c.6656G>A (p.Arg2219His)	NSD1	Sotos syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721025	5	177294024	159436	168288
NM_022455.4(NSD1):c.6750G>A (p.Met2250Ile)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176721119	5	177294118	96070	101964
NM_022455.4(NSD1):c.6782T>C (p.Met2261Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176721151	5	177294150	96071	101965
NM_022455.4(NSD1):c.7391G>A (p.Arg2464His)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721760	5	177294759	159438	168290
NM_022455.4(NSD1):c.7403G>A (p.Arg2468Gln)	NSD1	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	5	176721772	5	177294771	159439	168291
NM_022455.4(NSD1):c.7576C>T (p.Pro2526Ser)	NSD1	Beckwith-Wiedemann syndrome|Sotos syndrome 1|not provided	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	5	176721945	5	177294944	96077	101971
NM_022455.4(NSD1):c.7597C>G (p.Leu2533Val)	NSD1	Beckwith-Wiedemann syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2016)	criteria provided, conflicting interpretations	5	176721966	5	177294965	96078	101972
NM_022455.4(NSD1):c.7636G>A (p.Ala2546Thr)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	5	176722005	5	177295004	96079	101973
NM_022455.4(NSD1):c.7850T>C (p.Leu2617Ser)	NSD1	Beckwith-Wiedemann syndrome|Weaver syndrome|Sotos syndrome 1|not specified|Sotos syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	5	176722219	5	177295218	96082	101976
NM_000505.3(F12):c.983C>A (p.Thr328Lys)	F12|SLC34A1	Hereditary angioneurotic edema with normal C1 esterase inhibitor activity|not provided|Hereditary angioneurotic edema	Pathogenic(Last reviewed: Mar 31, 2017)	criteria provided, multiple submitters, no conflicts	5	176831232	5	177404231	1169	16208
NM_003900.4(SQSTM1):c.1175C>T (p.Pro392Leu)	SQSTM1	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|Paget disease of bone, familial|not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Paget disease of bone	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	5	179263445	5	179836445	8108	23147
NM_001453.3(FOXC1):c.256C>T (p.Leu86Phe)	FOXC1	Axenfeld-Rieger syndrome type 3|not provided	Pathogenic(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	6	1610936	6	1610701	265478	259842
NM_001453.3(FOXC1):c.268G>A (p.Ala90Thr)	FOXC1	Axenfeld-Rieger syndrome type 3	Uncertain significance(Last reviewed: Mar 17, 2015)	no assertion criteria provided	6	1610948	6	1610713	375422	362198
NM_001453.3(FOXC1):c.269C>A (p.Ala90Asp)	FOXC1	Axenfeld-Rieger syndrome type 3	Uncertain significance(Last reviewed: Aug 22, 2016)	criteria provided, single submitter	6	1610949	6	1610714	375423	362199
NM_001453.3(FOXC1):c.457A>C (p.Thr153Pro)	FOXC1	Axenfeld-Rieger syndrome type 3	Uncertain significance(Last reviewed: Jul 7, 2015)	no assertion criteria provided	6	1611137	6	1610902	375425	362201
NM_001069.2(TUBB2A):c.1033A>T (p.Ile345Phe)	TUBB2A	Cortical dysplasia, complex, with other brain malformations 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2015)	criteria provided, multiple submitters, no conflicts	6	3154402	6	3154168	212495	207399
NM_001069.2(TUBB2A):c.872A>C (p.Gln291Pro)	TUBB2A	Cortical dysplasia, complex, with other brain malformations 5	Likely pathogenic(Last reviewed: Jan 28, 2014)	criteria provided, single submitter	6	3154563	6	3154329	217024	213570
NM_178012.4(TUBB2B):c.1139G>T (p.Arg380Leu)	TUBB2B	Polymicrogyria, asymmetric	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	6	3225184	6	3224950	160177	168560
NM_178012.4(TUBB2B):c.965C>T (p.Ser322Phe)	TUBB2B	Polymicrogyria, asymmetric	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	6	3225358	6	3225124	160187	168561
NM_178012.4(TUBB2B):c.859C>T (p.Pro287Ser)	TUBB2B	Polymicrogyria, asymmetric	Uncertain significance(Last reviewed: Dec 24, 2013)	criteria provided, single submitter	6	3225464	6	3225230	160186	168562
NM_178012.4(TUBB2B):c.767A>G (p.Asn256Ser)	TUBB2B	Polymicrogyria, asymmetric	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2018)	no assertion criteria provided	6	3225556	6	3225322	39721	48320
NM_178012.4(TUBB2B):c.602G>C (p.Cys201Ser)	TUBB2B	not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2017)	criteria provided, conflicting interpretations	6	3225721	6	3225487	160183	168565
NM_178012.4(TUBB2B):c.126G>T (p.Leu42Phe)	TUBB2B	Polymicrogyria, asymmetric	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	6	3226835	6	3226601	160179	168569
NM_178012.4(TUBB2B):c.33G>C (p.Gln11His)	TUBB2B	Polymicrogyria, asymmetric|not provided	Likely pathogenic(Last reviewed: Jun 8, 2016)	criteria provided, single submitter	6	3227745	6	3227511	431080	424603
NM_001008844.2(DSP):c.88G>A (p.Val30Met)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|not provided|Right ventricular cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	6	7542236	6	7542003	16846	31885
NM_004415.3(DSP):c.1696G>A (p.Ala566Thr)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|Keratosis palmoplantaris striata II|not specified|Palmoplantar blistering|Skin fragility with non-scarring blistering|Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	6	7570791	6	7570558	161226	171102
NM_001008844.2(DSP):c.1778A>G (p.Asn593Ser)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	6	7571692	6	7571459	44867	54034
NM_001008844.2(DSP):c.2422C>T (p.Arg808Cys)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	6	7575014	6	7574781	44874	54041
NM_004415.3(DSP):c.4166G>A (p.Ser1389Asn)	DSP	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	6	7580589	6	7580356	427965	419270
NM_004415.2(DSP):c.4372C>G (p.Arg1458Gly)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Left ventricular noncompaction cardiomyopathy|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	6	7580795	6	7580562	44906	54073
NM_004415.2(DSP):c.4609C>T (p.Arg1537Cys)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Sudden unexplained death	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	6	7581032	6	7580799	44917	54084
NM_004415.3(DSP):c.4803G>A (p.Met1601Ile)	DSP	Arrhythmogenic right ventricular cardiomyopathy	Likely pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	6	7581226	6	7580993	222578	224326
NM_004415.3(DSP):c.5051A>G (p.His1684Arg)	DSP	Progressive familial heart block	Likely pathogenic(Last reviewed: Jan 29, 2017)	criteria provided, single submitter	6	7581474	6	7581241	431487	424552
NM_004415.3(DSP):c.5218G>A (p.Glu1740Lys)	DSP	Primary dilated cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Migraine|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Dilated cardiomyopathy|Migraine|Hemiplegia|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	6	7581641	6	7581408	44926	54093
NM_004415.3(DSP):c.5324G>T (p.Arg1775Ile)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Arrhythmogenic right ventricular cardiomyopathy|not specified	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	6	7581747	6	7581514	161227	171103
NM_001008844.2(DSP):c.3716G>A (p.Arg1239His)	DSP	Primary dilated cardiomyopathy|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	6	7583008	6	7582775	161225	171104
NM_004415.3(DSP):c.5570A>C (p.Lys1857Thr)	DSP	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	6	7583065	6	7582832	427966	419271
NM_004415.3(DSP):c.6881C>G (p.Ala2294Gly)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular cardiomyopathy, type 8|Ectodermal dysplasia skin fragility syndrome|Epidermolysis bullosa, lethal acantholytic|Skin fragility woolly hair syndrome|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	6	7584376	6	7584143	44943	54110
NM_001008844.2(DSP):c.5326G>C (p.Gly1776Arg)	DSP	Dilated cardiomyopathy with woolly hair and keratoderma	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	6	7584618	6	7584385	161228	171105
NM_004415.3(DSP):c.7186T>A (p.Tyr2396Asn)	DSP	Ventricular fibrillation, idiopathic	Uncertain significance(Last reviewed: Aug 12, 2015)	criteria provided, single submitter	6	7584681	6	7584448	217831	214485
NM_004415.3(DSP):c.8014C>G (p.Gln2672Glu)	DSP	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	6	7585509	6	7585276	427967	419272
NM_001042425.1(TFAP2A):c.751A>G (p.Arg251Gly)	TFAP2A|TFAP2A-AS2	Branchiooculofacial syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	6	10404742	6	10404509	17937	32976
NM_001042425.1(TFAP2A):c.637C>A (p.Arg213Ser)	TFAP2A|TFAP2A-AS2	Branchiooculofacial syndrome	Pathogenic	criteria provided, single submitter	6	10404856	6	10404623	192350	190138
NM_001042425.1(TFAP2A):c.629T>A (p.Val210Asp)	TFAP2A|TFAP2A-AS2	Branchiooculofacial syndrome	Pathogenic	criteria provided, single submitter	6	10404864	6	10404631	192351	190139
NM_002114.3(HIVEP1):c.4089G>C (p.Met1363Ile)	HIVEP1	Seizures|Hearing impairment|Obsessive-compulsive behavior|Attention deficit hyperactivity disorder|Attention deficit hyperactivity disorder	Pathogenic	no assertion criteria provided	6	12124117	6	12123884	375377	362144
NM_000332.3(ATXN1):c.2257C>T (p.Pro753Ser)	ATXN1	not specified	Likely benign	no assertion criteria provided	6	16306751	6	16306520	128499	133948
NM_000332.3(ATXN1):c.675G>C (p.Gln225His)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327867	6	16327636	128504	133953
NM_000332.3(ATXN1):c.645G>T (p.Gln215His)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327897	6	16327666	128503	133952
NM_000332.3(ATXN1):c.639G>T (p.Gln213His)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327903	6	16327672	128502	133951
NM_000332.3(ATXN1):c.633T>G (p.His211Gln)	ATXN1|LOC108663993	not specified	Likely benign	no assertion criteria provided	6	16327909	6	16327678	128501	133950
NM_015895.4(GMNN):c.50A>G (p.Lys17Arg)	GMNN	Meier-Gorlin syndrome|Meier-gorlin syndrome 6	Likely pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	6	24777524	6	24777296	204001	200399
NM_001293212.1(TUBB):c.920C>T (p.Pro307Leu)	TUBB	not provided|Cortical dysplasia, complex, with other brain malformations 6	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	6	30691699	6	30723922	438586	432213
NM_019105.6(TNXB):c.12506G>A (p.Arg4169His)	TNXB|LOC106780803	Vesicoureteral reflux 8	Uncertain significance	criteria provided, single submitter	6	32009669	6	32041892	224352	226083
NM_019105.6(TNXB):c.10039G>A (p.Ala3347Thr)	TNXB	Vesicoureteral reflux 8	Uncertain significance	criteria provided, single submitter	6	32016140	6	32048363	224353	226084
NM_019105.6(TNXB):c.6074A>T (p.Asp2025Val)	TNXB	Ehlers-Danlos syndrome, type 3	Likely pathogenic(Last reviewed: Feb 5, 2013)	criteria provided, single submitter	6	32036313	6	32068536	217018	213571
NM_080680.2(COL11A2):c.3100C>T (p.Arg1034Cys)	COL11A2	Deafness, autosomal dominant 13|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, single submitter	6	33139540	6	33171763	17124	32163
NM_006245.3(PPP2R5D):c.592G>A (p.Glu198Lys)	MEA1|PPP2R5D	not provided|Inborn genetic diseases|Mental retardation, autosomal dominant 35	Pathogenic/Likely pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, multiple submitters, no conflicts	6	42975003	6	43007265	190286	188114
NM_001253.3(CDC5L):c.1802A>G (p.Lys601Arg)	CDC5L	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	6	44394370	6	44426633	224338	226085
NM_003221.3(TFAP2B):c.854G>A (p.Arg285Gln)	TFAP2B	Char syndrome	Pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	6	50805720	6	50838007	8043	23082
NM_004999.3(MYO6):c.535G>T (p.Asp179Tyr)	MYO6	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Aug 30, 2017)	criteria provided, single submitter	6	76545655	6	75835938	517508	496916
NM_004999.3(MYO6):c.737A>G (p.His246Arg)	MYO6	Sensorineural deafness with hypertrophic cardiomyopathy|Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Jul 30, 2015)	criteria provided, single submitter	6	76551016	6	75841299	8581	23620
NM_004999.3(MYO6):c.1383G>C (p.Glu461Asp)	MYO6	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: May 4, 2016)	criteria provided, single submitter	6	76568620	6	75858903	178931	174146
NM_015021.2(ZNF292):c.6578A>C (p.Tyr2193Ser)	ZNF292	ZNF292-related neurodevelopmental condition	Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	6	87969925	6	87260207	522860	513423
NM_001105206.2(LAMA4):c.105C>G (p.Asp35Glu)	LAMA4|LOC101927640	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	6	112575248	6	112254046	492988	485932
NM_002667.4(PLN):c.25C>T (p.Arg9Cys)	PLN|CEP85L	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1P|not provided	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, multiple submitters, no conflicts	6	118880109	6	118558946	13636	28675
NM_001178035.1(CEP85L):c.191C>T (p.Ser64Phe)	CEP85L	Lissencephaly	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	118953666	6	118632503	438602	432212
NM_000165.5(GJA1):c.226C>A (p.Arg76Ser)	GJA1	Oculodentodigital dysplasia|not provided	Likely pathogenic(Last reviewed: May 12, 2016)	criteria provided, multiple submitters, no conflicts	6	121768219	6	121447073	16997	32036
NM_015093.5(TAB2):c.2051G>A (p.Cys684Tyr)	TAB2	Congenital heart defects, multiple types, 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	6	149730824	6	149409688	561115	552096
NM_033071.3(SYNE1):c.26077C>A (p.Leu8693Met)	ESR1|SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152443744	6	152122609	130436	135882
NM_033071.3(SYNE1):c.26065G>A (p.Gly8689Ser)	ESR1|SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 7, 2017)	criteria provided, multiple submitters, no conflicts	6	152443756	6	152122621	130435	135881
NM_033071.3(SYNE1):c.26060G>A (p.Arg8687Gln)	ESR1|SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152443761	6	152122626	130434	135880
NM_033071.3(SYNE1):c.25916C>T (p.Thr8639Ile)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152453291	6	152132156	130433	135879
NM_033071.3(SYNE1):c.24755G>C (p.Gly8252Ala)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	6	152469188	6	152148053	130428	135874
NM_033071.3(SYNE1):c.24289G>T (p.Ala8097Ser)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152470752	6	152149617	130426	135872
NM_033071.3(SYNE1):c.22303A>G (p.Ser7435Gly)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	6	152532702	6	152211567	130422	135868
NM_033071.3(SYNE1):c.21691T>G (p.Phe7231Val)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Sep 26, 2016)	criteria provided, multiple submitters, no conflicts	6	152540278	6	152219143	130419	135865
NM_033071.3(SYNE1):c.17126G>A (p.Arg5709Gln)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	6	152629631	6	152308496	130411	135858
NM_033071.3(SYNE1):c.16064C>T (p.Thr5355Met)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	6	152640110	6	152318975	130410	135857
NM_033071.3(SYNE1):c.14830T>A (p.Leu4944Met)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152647681	6	152326546	130408	135855
NM_033071.3(SYNE1):c.13894G>A (p.Asp4632Asn)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Aug 13, 2018)	criteria provided, multiple submitters, no conflicts	6	152651713	6	152330578	130406	135853
NM_033071.3(SYNE1):c.13573T>A (p.Ser4525Thr)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	6	152652034	6	152330899	130404	135851
NM_033071.3(SYNE1):c.12394G>A (p.Glu4132Lys)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	6	152655330	6	152334195	130402	135849
NM_033071.3(SYNE1):c.12229G>C (p.Asp4077His)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	6	152658062	6	152336927	130401	135848
NM_033071.3(SYNE1):c.12150G>T (p.Lys4050Asn)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jul 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152658141	6	152337006	130400	135847
NM_033071.3(SYNE1):c.12149A>G (p.Lys4050Arg)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152658142	6	152337007	130399	135846
NM_033071.3(SYNE1):c.11967G>T (p.Glu3989Asp)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152665261	6	152344126	130397	135844
NM_033071.3(SYNE1):c.11576A>C (p.Lys3859Thr)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	6	152671865	6	152350730	130394	135841
NM_033071.3(SYNE1):c.10619G>A (p.Arg3540His)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, multiple submitters, no conflicts	6	152679518	6	152358383	130391	135838
NM_033071.3(SYNE1):c.10228G>A (p.Gly3410Ser)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	6	152683397	6	152362262	130389	135836
NM_033071.3(SYNE1):c.10043T>C (p.Val3348Ala)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Dec 19, 2017)	criteria provided, multiple submitters, no conflicts	6	152686105	6	152364970	130387	135834
NM_033071.3(SYNE1):c.9911C>T (p.Thr3304Met)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	6	152688435	6	152367300	130454	135900
NM_033071.3(SYNE1):c.8405C>T (p.Ala2802Val)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152708310	6	152387175	130452	135898
NM_033071.3(SYNE1):c.8357T>G (p.Ile2786Ser)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	6	152708358	6	152387223	130451	135897
NM_033071.3(SYNE1):c.6491A>G (p.Lys2164Arg)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	6	152730273	6	152409138	130448	135894
NM_033071.3(SYNE1):c.5211T>A (p.Asp1737Glu)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	6	152746593	6	152425458	130446	135892
NM_033071.3(SYNE1):c.4778C>A (p.Thr1593Lys)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 17, 2017)	criteria provided, multiple submitters, no conflicts	6	152751278	6	152430143	130445	135891
NM_033071.3(SYNE1):c.3911C>T (p.Ala1304Val)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 15, 2017)	criteria provided, multiple submitters, no conflicts	6	152763328	6	152442193	130443	135889
NM_033071.3(SYNE1):c.3871C>T (p.Arg1291Trp)	SYNE1	not specified|not provided	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	6	152763368	6	152442233	130442	135888
NM_033071.3(SYNE1):c.3125T>C (p.Val1042Ala)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152772264	6	152451129	130438	135884
NM_033071.3(SYNE1):c.2674T>G (p.Leu892Val)	SYNE1	Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	6	152777095	6	152455960	130437	135883
NM_033071.3(SYNE1):c.2548C>T (p.Arg850Cys)	SYNE1	Spinocerebellar ataxia, autosomal recessive 8|Emery-Dreifuss muscular dystrophy 4, autosomal dominant|Emery-Dreifuss muscular dystrophy|Cerebellar ataxia|not specified	Benign/Likely benign(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	6	152779933	6	152458798	130431	135877
NM_017519.2(ARID1B):c.17G>A (p.Gly6Asp)	ARID1B	Coffin-Siris syndrome 1	Likely pathogenic(Last reviewed: Mar 26, 2015)	no assertion criteria provided	6	157099080	6	156777946	374256	361185
NM_020732.3(ARID1B):c.1375G>A (p.Ala459Thr)	ARID1B	Coffin Siris/Intellectual Disability	Uncertain significance(Last reviewed: Jul 8, 2013)	criteria provided, single submitter	6	157100438	6	156779304	126315	131847
NM_020732.3(ARID1B):c.1678A>G (p.Ile560Val)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jul 1, 2016)	criteria provided, single submitter	6	157150496	6	156829362	126316	131848
NM_020732.3(ARID1B):c.2896G>A (p.Gly966Ser)	ARID1B	not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	6	157488190	6	157167056	126323	131855
NM_020732.3(ARID1B):c.4495A>T (p.Met1499Leu)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 13, 2016)	criteria provided, single submitter	6	157522223	6	157201089	126333	131865
NM_020732.3(ARID1B):c.5207A>C (p.Glu1736Ala)	ARID1B	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 23, 2016)	criteria provided, multiple submitters, no conflicts	6	157527482	6	157206348	126335	131867
NM_182924.3(MICALL2):c.851C>G (p.Pro284Arg)	MICALL2	Joubert syndrome 1	Pathogenic	no assertion criteria provided	7	1484855	7	1445219	375381	362148
NM_000535.6(PMS2):c.2149G>A (p.Val717Met)	PMS2	Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2018)	criteria provided, conflicting interpretations	7	6022480	7	5982849	41709	50148
NM_000535.6(PMS2):c.137G>T (p.Ser46Ile)	PMS2	Turcot syndrome|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Pituitary carcinoma|Hereditary nonpolyposis colon cancer	Likely pathogenic(Last reviewed: Mar 14, 2014)	reviewed by expert panel	7	6045549	7	6005918	9245	24284
NM_000535.6(PMS2):c.1A>G (p.Met1Val)	PMS2	Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 4|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer	Likely pathogenic(Last reviewed: Jun 30, 2017)	reviewed by expert panel	7	6048650	7	6009019	91323	96798
NM_000474.3(TWIST1):c.352C>G (p.Arg118Gly)	TWIST1	Saethre-Chotzen syndrome	Likely pathogenic	no assertion criteria provided	7	19156593	7	19116970	438352	431983
NM_002047.3(GARS):c.998A>T (p.Glu333Val)	GARS	Charcot-Marie-Tooth disease type 2D|Distal hereditary motor neuronopathy type 5	Likely pathogenic(Last reviewed: Aug 6, 2013)	criteria provided, single submitter	7	30651828	7	30612212	216930	213574
NM_002047.3(GARS):c.1904C>T (p.Ser635Leu)	GARS	Charcot-Marie-Tooth disease type 2D	Pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, single submitter	7	30671863	7	30632247	209157	205754
NM_001191058.3(PDE1C):c.958G>T (p.Ala320Ser)	PDE1C	Autosomal dominant non-syndromic sensorineural deafness type DFNA|DEAFNESS, AUTOSOMAL DOMINANT 74	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	no assertion criteria provided	7	31890328	7	31850714	433528	427102
NM_003718.4(CDK13):c.2524A>G (p.Asn842Asp)	CDK13	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Likely pathogenic(Last reviewed: Dec 8, 2016)	criteria provided, single submitter	7	40085605	7	40046006	522794	513425
NM_003718.4(CDK13):c.4097G>A (p.Arg1366His)	CDK13	Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder	Uncertain significance(Last reviewed: May 9, 2018)	no assertion criteria provided	7	40134137	7	40094538	545696	536188
NM_000162.3(GCK):c.1358C>T (p.Ser453Leu)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, multiple submitters, no conflicts	7	44184775	7	44145176	36200	44864
NM_000162.3(GCK):c.1307T>A (p.Ile436Asn)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44184826	7	44145227	36195	44859
NM_000162.3(GCK):c.1240A>G (p.Lys414Glu)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	7	44185109	7	44145510	36188	44852
NM_000162.3(GCK):c.1160C>T (p.Ala387Val)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: Dec 3, 2015)	criteria provided, multiple submitters, no conflicts	7	44185189	7	44145590	36182	44846
NM_000162.3(GCK):c.1130G>A (p.Arg377His)	GCK	Maturity-onset diabetes of the young,  type 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2017)	criteria provided, conflicting interpretations	7	44185219	7	44145620	36176	44840
NM_033507.2(GCK):c.1033G>T (p.Asp345Tyr)	GCK	Maturity-onset diabetes of the young,  type 2	Uncertain significance(Last reviewed: Jun 25, 2017)	criteria provided, multiple submitters, no conflicts	7	44185319	7	44145720	219179	217193
NM_000162.3(GCK):c.971T>C (p.Leu324Pro)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44186110	7	44146511	36270	44934
NM_000162.3(GCK):c.944T>A (p.Leu315His)	GCK	Maturity-onset diabetes of the young,  type 2	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44186137	7	44146538	36266	44930
NM_000162.3(GCK):c.907C>T (p.Arg303Trp)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, multiple submitters, no conflicts	7	44186174	7	44146575	36264	44928
NM_000162.3(GCK):c.787T>C (p.Ser263Pro)	GCK	Maturity-onset diabetes of the young,  type 2|Maternal diabetes|not provided	Likely pathogenic(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	7	44187325	7	44147726	36258	44922
NM_000162.3(GCK):c.768G>C (p.Glu256Asp)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44187344	7	44147745	36255	44919
NM_000162.3(GCK):c.758T>C (p.Val253Ala)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44187354	7	44147755	36252	44916
NM_000162.3(GCK):c.704T>C (p.Met235Thr)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44187408	7	44147809	36248	44912
NM_000162.3(GCK):c.683C>T (p.Thr228Met)	GCK	Permanent neonatal diabetes mellitus|Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	7	44187429	7	44147830	16134	31173
NM_000162.3(GCK):c.676G>A (p.Val226Met)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Oct 11, 2017)	criteria provided, multiple submitters, no conflicts	7	44189362	7	44149763	36243	44907
NM_000162.3(GCK):c.661G>A (p.Glu221Lys)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	7	44189377	7	44149778	36241	44905
NM_000162.3(GCK):c.659G>A (p.Cys220Tyr)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44189379	7	44149780	36240	44904
NM_000162.3(GCK):c.605T>C (p.Met202Thr)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2018)	criteria provided, conflicting interpretations	7	44189433	7	44149834	36233	44897
NM_000162.3(GCK):c.563C>T (p.Ala188Val)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44189584	7	44149985	36229	44893
NM_000162.3(GCK):c.542T>C (p.Val181Ala)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44189605	7	44150006	36228	44892
NM_000162.3(GCK):c.449T>C (p.Phe150Ser)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 22, 2015)	criteria provided, multiple submitters, no conflicts	7	44190589	7	44150990	36218	44882
NM_000162.3(GCK):c.214G>A (p.Gly72Arg)	GCK	Maturity-onset diabetes of the young,  type 2|not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	7	44192019	7	44152420	36209	44873
NM_000162.3(GCK):c.131G>A (p.Gly44Asp)	GCK	Maturity-onset diabetes of the young,  type 2	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	44192977	7	44153378	36196	44860
NM_172079.2(CAMK2B):c.416C>T (p.Pro139Leu)	CAMK2B	Intellectual disability|Inborn genetic diseases|MENTAL RETARDATION, AUTOSOMAL DOMINANT 54	Pathogenic/Likely pathogenic(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	7	44283125	7	44243526	430922	424467
NM_006060.6(IKZF1):c.64G>A (p.Asp22Asn)	IKZF1	Immunodeficiency, common variable, 13	Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	7	50367257	7	50327661	548932	539419
NM_006060.5(IKZF1):c.584A>G (p.His195Arg)	IKZF1	Immunodeficiency, common variable, 13	Pathogenic(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	7	50450400	7	50382702	428611	420430
NM_006060.6(IKZF1):c.814G>A (p.Ala272Thr)	IKZF1	Immunodeficiency, common variable, 13	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	7	50459525	7	50391827	548705	539189
NM_005228.4(EGFR):c.977G>T (p.Cys326Phe)	EGFR	Cowden syndrome 1	Pathogenic(Last reviewed: Aug 24, 2016)	no assertion criteria provided	7	55223610	7	55155917	254143	248610
NM_015570.3(AUTS2):c.1603C>T (p.His535Tyr)	AUTS2	Mental retardation, autosomal dominant 26	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	7	70231234	7	70766248	584456	575490
NM_001540.4(HSPB1):c.407G>T (p.Arg136Leu)	HSPB1	Charcot-Marie-Tooth disease type 2F|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	7	75933161	7	76303844	217230	213813
NM_001110354.1(ZP3):c.400G>A (p.Ala134Thr)	ZP3	Empty follicle syndrome|OOCYTE MATURATION DEFECT 3	Pathogenic(Last reviewed: Oct 9, 2017)	no assertion criteria provided	7	76058919	7	76429602	437933	431554
NM_012301.3(MAGI2):c.3400C>G (p.Leu1134Val)	MAGI2	not provided	Uncertain significance(Last reviewed: Apr 24, 2013)	criteria provided, single submitter	7	77756537	7	78127220	129553	134999
NM_012301.3(MAGI2):c.2723C>A (p.Pro908His)	MAGI2	not specified	Likely benign	no assertion criteria provided	7	77789464	7	78160147	129562	135008
NM_012301.3(MAGI2):c.2213G>A (p.Arg738Gln)	MAGI2	not specified	Benign/Likely benign(Last reviewed: Aug 21, 2015)	criteria provided, multiple submitters, no conflicts	7	77824247	7	78194930	129559	135005
NM_012301.3(MAGI2):c.893A>G (p.Asn298Ser)	MAGI2	not specified	Benign(Last reviewed: Mar 28, 2013)	criteria provided, single submitter	7	78130966	7	78501649	129556	135002
NM_012301.3(MAGI2):c.878C>T (p.Thr293Ile)	MAGI2	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2014)	criteria provided, conflicting interpretations	7	78130981	7	78501664	129555	135001
NM_005751.4(AKAP9):c.510G>C (p.Glu170Asp)	AKAP9	Brugada syndrome 1|Long QT syndrome 11|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	7	91622303	7	91992989	190518	188434
NM_005751.4(AKAP9):c.2478A>G (p.Ile826Met)	AKAP9	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	91631709	7	92002395	427976	419277
NM_005751.4(AKAP9):c.11682G>T (p.Gln3894His)	AKAP9	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	91737943	7	92108629	427961	419278
NM_000089.3(COL1A2):c.838G>A (p.Gly280Ser)	COL1A2	Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|Osteogenesis imperfecta|not provided	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	7	94038679	7	94409367	35957	44621
NM_000089.3(COL1A2):c.875G>T (p.Gly292Val)	COL1A2	Osteogenesis imperfecta type I	Pathogenic	no assertion criteria provided	7	94038716	7	94409404	430639	424019
NM_000089.3(COL1A2):c.1991G>A (p.Gly664Asp)	COL1A2	Osteogenesis imperfecta	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	7	94047830	7	94418518	35939	44603
NM_000089.3(COL1A2):c.2512G>A (p.Gly838Ser)	COL1A2	Osteogenesis imperfecta, recessive perinatal lethal	Likely pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	7	94052377	7	94423065	369668	353896
NM_000089.3(COL1A2):c.2957C>T (p.Pro986Leu)	COL1A2	Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta type III|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	7	94055323	7	94426011	216909	213575
NM_000089.3(COL1A2):c.3034G>A (p.Gly1012Ser)	COL1A2	Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta, recessive perinatal lethal|Osteogenesis imperfecta type III|Ehlers-Danlos syndrome, classic type|Osteogenesis imperfecta type I|Osteogenesis imperfecta	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, multiple submitters, no conflicts	7	94055771	7	94426459	216908	213576
NM_000089.3(COL1A2):c.3089G>A (p.Gly1030Asp)	COL1A2	Osteogenesis imperfecta with normal sclerae, dominant form	Pathogenic	no assertion criteria provided	7	94055826	7	94426514	431081	424604
NM_000245.3(MET):c.71G>A (p.Gly24Glu)	MET	Renal cell carcinoma, papillary, 1|not specified|Hereditary cancer-predisposing syndrome|Lymphoedema	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	116339209	7	116699155	134649	138388
NM_000245.3(MET):c.2975C>T (p.Thr992Ile)	MET	Renal cell carcinoma, papillary, 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Congenital diaphragmatic hernia|Neoplasm|Carcinoma	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	116411990	7	116771936	41624	50063
NM_000492.3(CFTR):c.640C>G (p.Leu214Val)	CFTR	Hereditary pancreatitis	Uncertain significance(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	7	117175362	7	117535308	448901	442477
NM_001366110.1(PAX4):c.986A>C (p.His329Pro)	PAX4	Maturity onset diabetes mellitus in young|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	127251188	7	127611134	129878	135324
NM_001366110.1(PAX4):c.599G>A (p.Arg200His)	PAX4	Maturity onset diabetes mellitus in young|not specified|Monogenic diabetes	Benign/Likely benign(Last reviewed: May 19, 2017)	criteria provided, multiple submitters, no conflicts	7	127253550	7	127613496	129875	135321
NM_001366110.1(PAX4):c.515G>A (p.Arg172Gln)	PAX4	Maturity onset diabetes mellitus in young|not provided	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	127253857	7	127613803	129874	135320
NM_001366110.1(PAX4):c.421C>T (p.Arg141Trp)	PAX4	Maturity onset diabetes mellitus in young|Diabetes mellitus, ketosis-prone, susceptibility to|not specified|Monogenic diabetes	Benign/Likely benign, risk factor(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	7	127254551	7	127614497	13791	28830
NM_001458.4(FLNC):c.643G>A (p.Val215Met)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	7	128477255	7	128837201	424399	406963
NM_001458.4(FLNC):c.2450T>C (p.Ile817Thr)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, multiple submitters, no conflicts	7	128482908	7	128842854	228692	229553
NM_001458.4(FLNC):c.2501C>T (p.Thr834Met)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	7	128482959	7	128842905	129083	134529
NM_001458.4(FLNC):c.3547_3548delGCinsCT (p.Ala1183Leu)	FLNC	Cardiomyopathy, familial hypertrophic, 26	Likely pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	7	128485066 - 128485067	7	128845012 - 128845013	430733	424271
NM_001458.4(FLNC):c.3557C>T (p.Ala1186Val)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	7	128485076	7	128845022	427928	419002
NM_001458.4(FLNC):c.3757G>A (p.Val1253Ile)	FLNC	Myofibrillar myopathy, filamin C-related|Myopathy, distal, 4|not specified|Cardiomyopathy, familial hypertrophic, 26|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	7	128485276	7	128845222	129086	134532
NM_001458.4(FLNC):c.4700G>A (p.Arg1567Gln)	FLNC	not specified|not provided	Benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	7	128488734	7	128848680	129091	134537
NM_001458.4(FLNC):c.5377G>A (p.Val1793Met)	FLNC|FLNC-AS1	not provided	Uncertain significance(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	7	128490516	7	128850462	129092	134538
NM_001458.4(FLNC):c.6892C>T (p.Pro2298Ser)	FLNC|FLNC-AS1	Cardiomyopathy, restrictive	Likely pathogenic(Last reviewed: May 23, 2018)	criteria provided, single submitter	7	128494631	7	128854577	544829	535269
NM_001127487.1(FLNC):c.6988G>A (p.Asp2330Asn)	FLNC|FLNC-AS1	Cardiomyopathy, familial hypertrophic, 26	Uncertain significance(Last reviewed: Sep 10, 2017)	no assertion criteria provided	7	128494918	7	128854864	438581	432202
NM_001006630.1(CHRM2):c.1189A>G (p.Ile397Val)	CHRM2|LOC349160	Cardiomyopathy	Uncertain significance	criteria provided, single submitter	7	136700801	7	137016054	219175	217192
NM_004333.4(BRAF):c.2135C>A (p.Ala712Asp)	BRAF	Rasopathy	Likely pathogenic(Last reviewed: Mar 16, 2015)	criteria provided, single submitter	7	140434563	7	140734763	162795	174175
NM_004333.4(BRAF):c.1914T>A (p.Asp638Glu)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	7	140449165	7	140749365	13981	29020
NM_004333.4(BRAF):c.1802A>C (p.Lys601Thr)	BRAF	Chronic lymphocytic leukemia|Malignant melanoma of skin|Lung adenocarcinoma|Rasopathy|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)	no assertion criteria provided	7	140453133	7	140753333	44818	53985
NM_004333.4(BRAF):c.1801A>C (p.Lys601Gln)	BRAF	not provided|Rasopathy	Pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	7	140453134	7	140753334	41446	49884
NM_004333.4(BRAF):c.1787G>T (p.Gly596Val)	BRAF	Multiple myeloma|Lung adenocarcinoma|not provided|Rasopathy|Glioblastoma|Transitional cell carcinoma of the bladder|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453148	7	140753348	40387	48857
NM_004333.4(BRAF):c.1785T>G (p.Phe595Leu)	BRAF	not provided|Rasopathy|Cutaneous melanoma|Neoplasm|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453150	7	140753350	177672	174042
NM_004333.4(BRAF):c.1741A>G (p.Asn581Asp)	BRAF	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140453987	7	140754187	13979	29018
NM_004333.4(BRAF):c.1720C>T (p.His574Tyr)	BRAF	Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 2, 2013)	criteria provided, single submitter	7	140454008	7	140754208	44810	53977
NM_004333.4(BRAF):c.1695T>G (p.Asp565Glu)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: Jul 22, 2015)	criteria provided, multiple submitters, no conflicts	7	140454033	7	140754233	40383	48853
NM_004333.4(BRAF):c.1600G>C (p.Gly534Arg)	BRAF	Cardiofaciocutaneous syndrome 1|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	7	140476806	7	140777006	13980	29019
NM_004333.4(BRAF):c.1593G>C (p.Trp531Cys)	BRAF	Noonan syndrome 1|Noonan syndrome 7|Rasopathy	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	7	140476813	7	140777013	29808	38763
NM_004333.4(BRAF):c.1592G>T (p.Trp531Leu)	BRAF	Cardiofaciocutaneous syndrome 1	Likely pathogenic(Last reviewed: Aug 6, 2017)	criteria provided, single submitter	7	140476814	7	140777014	40379	48849
NM_004333.4(BRAF):c.1501G>A (p.Glu501Lys)	BRAF	Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 29, 2015)	criteria provided, multiple submitters, no conflicts	7	140477807	7	140778007	13977	29016
NM_004333.4(BRAF):c.1454T>C (p.Leu485Ser)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	7	140477854	7	140778054	40370	48840
NM_004333.4(BRAF):c.1447A>C (p.Lys483Gln)	BRAF	Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	7	140477861	7	140778061	40369	48839
NM_004333.5(BRAF):c.1406G>A (p.Gly469Glu)	BRAF	Cardiofaciocutaneous syndrome 1|Malignant melanoma of skin|Multiple myeloma|Lung adenocarcinoma|Squamous cell lung carcinoma|not specified|not provided|Rasopathy|Cutaneous melanoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Cardio-facio-cutaneous syndrome|Colorectal Neoplasms|Adenocarcinoma of prostate	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140481402	7	140781602	13974	29013
NM_004333.4(BRAF):c.1237G>A (p.Val413Met)	BRAF	not specified	Uncertain significance(Last reviewed: Oct 20, 2011)	criteria provided, single submitter	7	140482898	7	140783098	44799	53966
NM_004333.4(BRAF):c.793G>C (p.Gly265Arg)	BRAF	Noonan syndrome|Rasopathy	Likely pathogenic(Last reviewed: Mar 14, 2017)	criteria provided, multiple submitters, no conflicts	7	140501279	7	140801479	44832	53999
NM_004333.4(BRAF):c.785A>C (p.Gln262Pro)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	7	140501287	7	140801487	44831	53998
NM_004333.4(BRAF):c.770A>G (p.Gln257Arg)	BRAF	Cardiofaciocutaneous syndrome 1|not specified|not provided|Rasopathy|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140501302	7	140801502	13973	29012
NM_004333.4(BRAF):c.736G>C (p.Ala246Pro)	BRAF	Cardiofaciocutaneous syndrome 1|Noonan syndrome|not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140501336	7	140801536	13965	29004
NM_004333.4(BRAF):c.735A>T (p.Leu245Phe)	BRAF	Noonan syndrome with multiple lentigines|not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	7	140501337	7	140801537	40348	48818
NM_004333.4(BRAF):c.730A>C (p.Thr244Pro)	BRAF	not provided|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	7	140501342	7	140801542	40346	48816
NM_004333.4(BRAF):c.722C>A (p.Thr241Lys)	BRAF	Noonan syndrome	Pathogenic(Last reviewed: Jun 7, 2013)	criteria provided, single submitter	7	140501350	7	140801550	44829	53996
NM_002769.4(PRSS1):c.86A>T (p.Asn29Ile)	PRSS1|TRB	Hereditary pancreatitis|not provided	Pathogenic(Last reviewed: Jul 1, 2018)	criteria provided, multiple submitters, no conflicts	7	142458451	7	142750600	11877	26916
NM_002769.4(PRSS1):c.365G>A (p.Arg122His)	PRSS1|TRB	Hereditary pancreatitis|not provided	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	7	142459789	7	142751938	11876	26915
NM_004456.4(EZH2):c.2236A>G (p.Arg746Gly)	EZH2	Weaver syndrome	Likely pathogenic(Last reviewed: May 16, 2013)	criteria provided, single submitter	7	148504758	7	148807666	158584	168571
NM_004456.4(EZH2):c.2213C>A (p.Ala738Asp)	EZH2	Weaver syndrome	Likely pathogenic(Last reviewed: Jul 18, 2017)	no assertion criteria provided	7	148504781	7	148807689	430846	424390
NM_004456.4(EZH2):c.2050C>T (p.Arg684Cys)	EZH2	Weaver syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	7	148506462	7	148809370	158582	168573
NM_004456.4(EZH2):c.1876G>A (p.Val626Met)	EZH2	Weaver syndrome	Pathogenic(Last reviewed: Apr 9, 2014)	criteria provided, single submitter	7	148508788	7	148811696	158579	168576
NM_004456.4(EZH2):c.553G>C (p.Asp185His)	EZH2	Weaver syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	7	148525904	7	148828812	134224	137963
NM_000238.3(KCNH2):c.3224C>T (p.Pro1075Leu)	KCNH2	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	7	150644071	7	150946983	67481	78377
NM_000238.3(KCNH2):c.3203A>G (p.Gln1068Arg)	KCNH2	Long QT syndrome|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	7	150644092	7	150947004	67480	78376
NM_000238.3(KCNH2):c.3140G>T (p.Arg1047Leu)	KCNH2	Cardiac arrhythmia|Long QT syndrome 2|Long QT syndrome|not specified|not provided|Torsades de pointes|Cardiovascular phenotype|Sudden unexplained death	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2018)	criteria provided, conflicting interpretations	7	150644428	7	150947340	36429	45092
NM_000238.3(KCNH2):c.3139C>T (p.Arg1047Cys)	KCNH2	Long QT syndrome|not specified	Uncertain significance(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	7	150644429	7	150947341	161255	171106
NM_000238.3(KCNH2):c.3124C>G (p.Leu1042Val)	KCNH2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	150644444	7	150947356	427971	419273
NM_000238.3(KCNH2):c.2948C>T (p.Thr983Ile)	KCNH2	Long QT syndrome|not specified|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2018)	criteria provided, conflicting interpretations	7	150644711	7	150947623	67455	78351
NM_000238.3(KCNH2):c.2843G>A (p.Arg948His)	KCNH2	Long QT syndrome 2|not provided|Congenital long QT syndrome	Pathogenic/Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	7	150644816	7	150947728	67443	78339
NM_000238.3(KCNH2):c.2660G>A (p.Arg887His)	KCNH2	Long QT syndrome 2|Long QT syndrome|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2018)	criteria provided, conflicting interpretations	7	150645564	7	150948476	67423	78319
NM_000238.3(KCNH2):c.2653C>T (p.Arg885Cys)	KCNH2	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	7	150645571	7	150948483	67422	78318
NM_000238.3(KCNH2):c.2606C>T (p.Pro869Leu)	KCNH2	Brugada syndrome 1|not specified	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	7	150645618	7	150948530	200473	197194
NM_000238.3(KCNH2):c.2536C>G (p.Pro846Ala)	KCNH2	Long QT syndrome 2	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	7	150646000	7	150948912	161254	171107
NM_000238.3(KCNH2):c.2371C>T (p.Arg791Trp)	KCNH2	Long QT syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	7	150647283	7	150950195	67391	78287
NM_000238.3(KCNH2):c.2255G>A (p.Arg752Gln)	KCNH2	Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome	Likely pathogenic(Last reviewed: Apr 12, 2015)	criteria provided, single submitter	7	150647399	7	150950311	14435	29474
NM_000238.3(KCNH2):c.2254C>T (p.Arg752Trp)	KCNH2	Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	7	150647400	7	150950312	67379	78275
NM_000238.3(KCNH2):c.2131A>G (p.Ile711Val)	KCNH2	Long QT syndrome|not provided|Congenital long QT syndrome	Pathogenic(Last reviewed: Nov 26, 2013)	criteria provided, single submitter	7	150648023	7	150950935	67367	78263
NM_000238.3(KCNH2):c.1952T>G (p.Met651Arg)	KCNH2	Long QT syndrome 2	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	7	150648202	7	150951114	427945	419275
NM_000238.3(KCNH2):c.1786C>G (p.Pro596Ala)	KCNH2	Long QT syndrome 2	Pathogenic(Last reviewed: Nov 4, 2015)	criteria provided, single submitter	7	150648695	7	150951607	218093	214747
NM_000238.3(KCNH2):c.1750G>A (p.Gly584Ser)	KCNH2	Short QT syndrome 1|Long QT syndrome 2|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	7	150648731	7	150951643	67261	78157
NM_000238.3(KCNH2):c.1603G>A (p.Val535Met)	KCNH2	Long QT syndrome 2|Long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 4, 2016)	criteria provided, multiple submitters, no conflicts	7	150648878	7	150951790	161256	171108
NM_000238.3(KCNH2):c.1280A>G (p.Tyr427Cys)	KCNH2	Long QT syndrome 1|Congenital long QT syndrome	Likely pathogenic(Last reviewed: Mar 16, 2017)	criteria provided, single submitter	7	150649790	7	150952702	67179	78075
NM_000238.3(KCNH2):c.1039C>T (p.Pro347Ser)	KCNH2	Long QT syndrome 2|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	7	150654468	7	150957380	67163	78059
NM_000238.3(KCNH2):c.982C>T (p.Arg328Cys)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	7	150654525	7	150957437	67552	78448
NM_000238.3(KCNH2):c.778G>C (p.Ala260Pro)	KCNH2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	7	150655285	7	150958197	427970	419276
NM_000238.3(KCNH2):c.442C>T (p.Arg148Trp)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	7	150656690	7	150959602	67505	78401
NM_000238.3(KCNH2):c.422C>T (p.Pro141Leu)	KCNH2	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	7	150656710	7	150959622	67504	78400
NM_000238.3(KCNH2):c.343G>A (p.Val115Met)	KCNH2	Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Aug 24, 2016)	criteria provided, single submitter	7	150656789	7	150959701	67496	78392
NM_000238.3(KCNH2):c.197G>A (p.Cys66Tyr)	KCNH2	Long QT syndrome 2	Likely pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	7	150671909	7	150974821	545688	536180
NM_016203.3(PRKAG2):c.1592G>A (p.Arg531Gln)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	7	151257696	7	151560610	6852	21891
NM_016203.3(PRKAG2):c.1454A>C (p.Lys485Thr)	PRKAG2	Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, single submitter	7	151261294	7	151564208	438860	432490
NM_016203.3(PRKAG2):c.1199C>A (p.Thr400Asn)	PRKAG2	Familial hypertrophic cardiomyopathy 6|Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	7	151265836	7	151568750	6849	21888
NM_016203.3(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	7	151273498	7	151576412	6846	21885
NM_016203.3(PRKAG2):c.879C>A (p.Phe293Leu)	PRKAG2	Familial hypertrophic cardiomyopathy 6|Cardiomyopathy	Likely pathogenic(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	7	151273524	7	151576438	36698	45359
NM_016203.3(PRKAG2):c.298G>A (p.Gly100Ser)	PRKAG2	Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not specified|Wolff-Parkinson-White syndrome|PRKAG2 cardiac syndrome|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2018)	criteria provided, conflicting interpretations	7	151478406	7	151781320	36697	45358
NM_170606.2(KMT2C):c.3917A>G (p.Asp1306Gly)	KMT2C	Intellectual disability	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	7	151902235	7	152205150	561044	552114
NM_005431.1(XRCC2):c.641G>A (p.Arg214Gln)	XRCC2	not provided|Colorectal cancer	Uncertain significance(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	7	152345929	7	152648844	127961	133418
NM_005431.1(XRCC2):c.620A>G (p.Glu207Gly)	XRCC2	not specified|Hereditary cancer-predisposing syndrome|Colon cancer|Hereditary Cancer Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	7	152345950	7	152648865	127960	133417
NM_000193.3(SHH):c.1171G>A (p.Ala391Thr)	SHH	Holoprosencephaly 3	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	7	155595812	7	155803118	430943	424484
NM_000193.3(SHH):c.796C>T (p.Leu266Phe)	SHH	Holoprosencephaly 3	Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	7	155596187	7	155803493	545580	536079
NM_000193.3(SHH):c.629G>A (p.Gly210Asp)	SHH	Single median maxillary incisor	Uncertain significance(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	7	155596354	7	155803660	545581	536080
NM_000193.3(SHH):c.468C>A (p.Ser156Arg)	SHH	Holoprosencephaly sequence	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	7	155599084	7	155806390	545462	535722
NM_001715.2(BLK):c.139C>G (p.Leu47Val)	BLK	not provided	Uncertain significance(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	8	11403576	8	11546067	128524	133973
NM_001715.2(BLK):c.211G>A (p.Ala71Thr)	BLK	Maturity onset diabetes mellitus in young|Maturity-onset diabetes of the young, type 11|not specified|Monogenic diabetes	Conflicting interpretations of pathogenicity(Last reviewed: Apr 21, 2017)	criteria provided, conflicting interpretations	8	11405576	8	11548067	12319	27358
NM_000237.3(LPL):c.904T>C (p.Cys302Arg)	LPL	Hyperapobetalipoproteinemia	Likely pathogenic(Last reviewed: Jun 1, 2016)	criteria provided, single submitter	8	19813480	8	19955969	424622	411513
NM_000742.3(CHRNA2):c.1234G>A (p.Glu412Lys)	CHRNA2	not specified|not provided|Nocturnal frontal lobe epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: May 26, 2017)	criteria provided, conflicting interpretations	8	27320726	8	27463209	128736	134185
NM_000742.3(CHRNA2):c.373A>G (p.Thr125Ala)	CHRNA2	not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	8	27324822	8	27467305	128739	134188
NM_000742.3(CHRNA2):c.65C>T (p.Thr22Ile)	CHRNA2	not specified|Seizures|Nocturnal frontal lobe epilepsy	Benign(Last reviewed: Jul 7, 2016)	criteria provided, multiple submitters, no conflicts	8	27328511	8	27470994	128740	134189
NM_001831.3(CLU):c.608C>T (p.Thr203Ile)	CLU	Alzheimer's disease	Likely benign	no assertion criteria provided	8	27462662	8	27605145	428612	420431
NM_023110.2(FGFR1):c.2206T>C (p.Cys736Arg)	FGFR1	Kallmann syndrome 2	Uncertain significance(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	8	38271522	8	38414004	478915	472259
NM_023110.2(FGFR1):c.2084C>T (p.Thr695Ile)	FGFR1	Kallmann syndrome 2	Pathogenic(Last reviewed: Oct 24, 2013)	no assertion criteria provided	8	38271772	8	38414254	132648	136396
NM_023110.2(FGFR1):c.1921G>A (p.Asp641Asn)	FGFR1	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38272353	8	38414835	517666	508757
NM_023110.2(FGFR1):c.1880G>C (p.Arg627Thr)	FGFR1	Hartsfield syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 9, 2018)	criteria provided, conflicting interpretations	8	38272394	8	38414876	223245	224976
NM_023110.2(FGFR1):c.1869C>G (p.Asp623Glu)	FGFR1	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38272405	8	38414887	522553	513166
NM_023110.2(FGFR1):c.1604T>A (p.Met535Lys)	FGFR1	Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38274883	8	38417365	496784	488207
NM_023110.2(FGFR1):c.1460G>A (p.Gly487Asp)	FGFR1	Kallmann syndrome 2|Hartsfield syndrome	Pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	8	38275480	8	38417962	132647	136395
NM_023110.2(FGFR1):c.880G>A (p.Glu294Lys)	FGFR1	Holoprosencephaly sequence	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, single submitter	8	38282083	8	38424565	517665	508756
NM_023110.2(FGFR1):c.790A>C (p.Asn264His)	FGFR1	Kallmann syndrome 2	Pathogenic(Last reviewed: Oct 24, 2013)	no assertion criteria provided	8	38282173	8	38424655	132646	136394
NM_023110.2(FGFR1):c.454G>A (p.Ala152Thr)	FGFR1	Hartsfield syndrome	Benign(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	8	38285606	8	38428088	522557	513170
NM_023110.2(FGFR1):c.443G>A (p.Arg148His)	FGFR1	Kallmann syndrome 2|not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	8	38285869	8	38428351	132645	136393
NM_023110.2(FGFR1):c.304G>A (p.Val102Ile)	FGFR1	Kallmann syndrome 2|Pfeiffer syndrome|Hartsfield syndrome	Benign(Last reviewed: Feb 26, 2018)	criteria provided, multiple submitters, no conflicts	8	38287254	8	38429736	522603	513216
NM_001160223.1(RNF170):c.640A>G (p.Ile214Val)	RNF170	Ataxia, sensory, autosomal dominant	Likely pathogenic(Last reviewed: Mar 6, 2014)	criteria provided, single submitter	8	42711439	8	42856296	130158	135605
NM_017780.3(CHD7):c.307T>A (p.Ser103Thr)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	8	61654298	8	60741739	95782	101679
NM_017780.3(CHD7):c.350G>A (p.Gly117Asp)	CHD7	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61654341	8	60741782	158291	168590
NM_017780.3(CHD7):c.361G>A (p.Gly121Ser)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61654352	8	60741793	158293	168591
NM_017780.3(CHD7):c.856A>G (p.Arg286Gly)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	8	61654847	8	60742288	158328	168592
NM_017780.3(CHD7):c.2096G>A (p.Ser699Asn)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	8	61693989	8	60781430	560975	552126
NM_017780.3(CHD7):c.2230G>A (p.Gly744Ser)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	8	61707678	8	60795119	158282	168597
NM_017780.3(CHD7):c.2830C>A (p.Arg944Ser)	CHD7	CHARGE association	Uncertain significance(Last reviewed: May 3, 2013)	criteria provided, single submitter	8	61734481	8	60821922	158286	168603
NM_017780.3(CHD7):c.4760C>T (p.Pro1587Leu)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61754521	8	60841962	158299	168615
NM_017780.3(CHD7):c.5401C>A (p.His1801Asn)	CHD7	Kallmann syndrome 5	Likely pathogenic(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	8	61761710	8	60849151	430606	423254
NM_017780.3(CHD7):c.5404G>A (p.Gly1802Ser)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	8	61761713	8	60849154	488387	481235
NM_017780.3(CHD7):c.5450T>G (p.Phe1817Cys)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61763097	8	60850538	158301	168617
NM_017780.3(CHD7):c.6250A>G (p.Ser2084Gly)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61765534	8	60852975	158308	168624
NM_017780.3(CHD7):c.6287A>G (p.His2096Arg)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Sep 5, 2016)	criteria provided, multiple submitters, no conflicts	8	61765571	8	60853012	158309	168625
NM_017780.3(CHD7):c.6356A>G (p.Asp2119Gly)	CHD7	CHARGE association	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61765640	8	60853081	158310	168626
NM_017780.3(CHD7):c.6478G>A (p.Ala2160Thr)	CHD7	CHARGE association|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	8	61765762	8	60853203	158311	168627
NM_017780.3(CHD7):c.6843T>G (p.Asp2281Glu)	CHD7	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61766989	8	60854430	158312	168628
NM_017780.3(CHD7):c.7294G>T (p.Val2432Leu)	CHD7	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	8	61769133	8	60856574	158315	168631
NM_017780.3(CHD7):c.7579A>C (p.Met2527Leu)	CHD7	CHARGE association|Hypogonadism with anosmia|Kallmann syndrome 5|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	8	61769418	8	60856859	158317	168633
NM_017780.3(CHD7):c.8063T>G (p.Ile2688Arg)	CHD7	CHARGE association	Likely pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	8	61775198	8	60862639	374318	361191
NM_017780.3(CHD7):c.8416C>G (p.Leu2806Val)	CHD7	CHARGE association|Hypogonadism with anosmia|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	8	61777914	8	60865355	95814	101711
NM_000503.5(EYA1):c.1748T>C (p.Leu583Pro)	EYA1	Melnick-Fraser syndrome	Likely pathogenic(Last reviewed: Dec 28, 2012)	criteria provided, single submitter	8	72111606	8	71199371	48106	57270
NM_000503.5(EYA1):c.1579T>A (p.Tyr527Asn)	EYA1	Melnick-Fraser syndrome	Likely pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	8	72127640	8	71215405	48103	57267
NM_000503.5(EYA1):c.1276G>A (p.Gly426Ser)	EYA1	Melnick-Fraser syndrome|Otofaciocervical syndrome 1|Branchiootorenal Spectrum Disorders|Branchiootorenal syndrome with cataract|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	8	72129011	8	71216776	7938	22977
NM_002677.5(PMP2):c.128T>A (p.Ile43Asn)	PMP2	Peripheral neuropathy|CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	8	82357170	8	81444935	243087	244158
NM_002485.4(NBN):c.1262T>C (p.Leu421Ser)	NBN	Familial cancer of breast|Microcephaly, normal intelligence and immunodeficiency|Aplastic anemia|Acute lymphoid leukemia|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	8	90967646	8	89955418	127009	132522
NM_001001557.3(GDF6):c.1271A>G (p.Lys424Arg)	GDF6	Klippel-Feil syndrome 1, autosomal dominant|Klippel Feil syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	8	97156888	8	96144660	8373	23412
NM_024915.3(GRHL2):c.1081G>A (p.Val361Met)	GRHL2	not specified	Uncertain significance(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	8	102611362	8	101599134	517614	497107
NM_006265.2(RAD21):c.1808T>C (p.Leu603Pro)	RAD21	Cornelia de Lange syndrome 4	Likely pathogenic(Last reviewed: Oct 16, 2012)	criteria provided, single submitter	8	117859827	8	116847588	216988	213578
NM_004519.3(KCNQ3):c.1241A>G (p.Glu414Gly)	KCNQ3	Benign familial neonatal seizures 2|Benign familial neonatal seizures|not specified|Seizures|Benign familial neonatal seizures|Benign Neonatal Epilepsy	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	8	133175736	8	132163489	21409	34261
NM_001282534.1(KCNK9):c.392G>A (p.Arg131His)	KCNK9	Birk Barel mental retardation dysmorphism syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	8	140631234	8	139618991	372887	359719
NM_021951.2(DMRT1):c.332G>T (p.Arg111Met)	DMRT1	46,XY sex reversal, type 4	Likely pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	9	842170	9	842170	393463	380285
NM_003070.4(SMARCA2):c.482C>T (p.Pro161Leu)	SMARCA2	Coffin Siris/Intellectual Disability	Uncertain significance(Last reviewed: Feb 14, 2014)	criteria provided, single submitter	9	2039592	9	2039592	126350	131882
NM_003070.4(SMARCA2):c.683A>C (p.Gln228Pro)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2039793	9	2039793	126351	131883
NM_003070.4(SMARCA2):c.1600G>T (p.Asp534Tyr)	SMARCA2	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Jul 22, 2014)	criteria provided, single submitter	9	2060894	9	2060894	217002	213590
NM_003070.4(SMARCA2):c.2267C>T (p.Thr756Ile)	SMARCA2	Nicolaides-Baraitser syndrome|not provided	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	2081914	9	2081914	68760	79652
NM_003070.4(SMARCA2):c.2348C>T (p.Ser783Leu)	SMARCA2	Nicolaides-Baraitser syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	2081995	9	2081995	561113	552140
NM_003070.4(SMARCA2):c.2552A>G (p.Asp851Gly)	SMARCA2	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Sep 2, 2016)	no assertion criteria provided	9	2086854	9	2086854	267266	262269
NM_003070.4(SMARCA2):c.3482A>G (p.His1161Arg)	SMARCA2	Nicolaides-Baraitser syndrome	Likely pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	9	2115847	9	2115847	217001	213591
NM_003070.4(SMARCA2):c.4638C>G (p.Asp1546Glu)	SMARCA2	Nicolaides-Baraitser syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	2191309	9	2191309	126349	131881
NM_001190737.1(NFIB):c.1067C>T (p.Ser356Leu)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly	Uncertain significance	criteria provided, single submitter	9	14120617	9	14120618	560030	550746
NM_001190737.2(NFIB):c.395T>C (p.Leu132Pro)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14307155	9	14307156	560027	550743
NM_001190737.2(NFIB):c.376A>G (p.Lys126Glu)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14307174	9	14307175	560026	550742
NM_001190737.2(NFIB):c.341A>C (p.Lys114Thr)	NFIB	Macrocephalus|Intellectual disability|Macrocephaly|MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT	Pathogenic	criteria provided, single submitter	9	14307209	9	14307210	560025	550741
NM_144966.5(FREM1):c.1394G>C (p.Gly465Ala)	FREM1	Marles Greenberg Persaud syndrome|not specified|Congenital diaphragmatic hernia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	9	14842658	9	14842660	218939	215773
NM_000459.4(TEK):c.2545C>T (p.Arg849Trp)	TEK	Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	9	27206760	9	27206762	9293	24332
NM_000459.4(TEK):c.2690A>C (p.Tyr897Ser)	TEK	Multiple Cutaneous and Mucosal Venous Malformations	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	9	27212708	9	27212710	9294	24333
NM_000459.4(TEK):c.3347T>C (p.Ile1116Thr)	TEK	Multiple Cutaneous and Mucosal Venous Malformations	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	27229202	9	27229204	561130	552141
NM_001135005.2(DNAJB5):c.43C>T (p.Pro15Ser)	DNAJB5	Peripheral neuropathy|Skeletal myopathy|Peripheral neuropathy	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	9	34990670	9	34990673	243086	244161
NM_007126.4(VCP):c.463C>G (p.Arg155Gly)	VCP	Inclusion body myopathy with early-onset paget disease and frontotemporal dementia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	9	35065361	9	35065364	217028	213592
NM_138691.2(TMC1):c.1714G>A (p.Asp572Asn)	TMC1	Deafness, autosomal dominant 36|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Jun 8, 2015)	criteria provided, single submitter	9	75431077	9	72816161	4102	19141
NM_002140.4(HNRNPK):c.253G>A (p.Glu85Lys)	HNRNPK	not specified|AU-KLINE SYNDROME	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	9	86590381	9	83975466	452520	444522
NM_006415.3(SPTLC1):c.1072G>C (p.Glu358Gln)	SPTLC1	Neuropathy hereditary sensory and autonomic type 1	Likely pathogenic(Last reviewed: Aug 22, 2014)	criteria provided, single submitter	9	94809463	9	92047181	209194	205763
NM_015250.3(BICD2):c.1931C>A (p.Ala644Asp)	BICD2	Spinal muscular atrophy, lower extremity predominant 2, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	95480996	9	92718714	560962	552142
NM_000264.4(PTCH1):c.3947A>G (p.Tyr1316Cys)	PTCH1	Gorlin syndrome|Irido-corneo-trabecular dysgenesis|Rieger syndrome|not provided|Hereditary cancer-predisposing syndrome|Rieger anomaly|Peters anomaly|Rieger anomaly	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	9	98209591	9	95447309	132723	136471
NM_000264.4(PTCH1):c.3422C>T (p.Ala1141Val)	PTCH1	Gorlin syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	9	98215787	9	95453505	161355	171114
NM_000264.4(PTCH1):c.3241G>A (p.Val1081Met)	PTCH1	Gorlin syndrome|not specified|Hereditary cancer-predisposing syndrome|Anophthalmia - microphthalmia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 18, 2018)	criteria provided, conflicting interpretations	9	98218623	9	95456341	135097	138836
NM_000264.4(PTCH1):c.3191C>T (p.Thr1064Met)	PTCH1	Gorlin syndrome|Anophthalmia - microphthalmia	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	9	98218673	9	95456391	221931	223628
NM_000264.3(PTCH1):c.3155C>T (p.Thr1052Met)	PTCH1	Gorlin syndrome|Holoprosencephaly 7|Holoprosencephaly sequence|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	9	98220308	9	95458026	8224	23263
NM_000264.4(PTCH1):c.2945G>A (p.Arg982Gln)	PTCH1	Gorlin syndrome|Congenital heart disease	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	9	98220518	9	95458236	161356	171115
NM_000264.4(PTCH1):c.2695A>G (p.Ile899Val)	PTCH1	Irido-corneo-trabecular dysgenesis	Likely pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	9	98224146	9	95461864	221968	223629
NM_000264.4(PTCH1):c.2332A>C (p.Thr778Pro)	PTCH1|LOC100507346	Anophthalmia - microphthalmia	Likely pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	9	98229626	9	95467344	221969	223630
NM_000264.3(PTCH1):c.2306C>T (p.Thr769Ile)	PTCH1|LOC100507346	Gorlin syndrome	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	9	98229652	9	95467370	226039	227846
NM_000264.4(PTCH1):c.1234G>T (p.Ala412Ser)	PTCH1	Gorlin syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	9	98240450	9	95478168	161357	171116
NM_000264.4(PTCH1):c.521C>T (p.Ala174Val)	PTCH1	Gorlin syndrome	Uncertain significance(Last reviewed: Nov 30, 2017)	criteria provided, multiple submitters, no conflicts	9	98248030	9	95485748	225289	227194
NM_005458.7(GABBR2):c.1699G>A (p.Ala567Thr)	GABBR2	Rett syndrome|Inborn genetic diseases|NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS	Pathogenic(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	9	101133817	9	98371535	446211	439573
NM_024642.4(GALNT12):c.907G>A (p.Asp303Asn)	GALNT12	Adenomatous polyposis coli, attenuated|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2018)	criteria provided, conflicting interpretations	9	101594229	9	98831947	224569	226331
NM_004612.3(TGFBR1):c.640G>A (p.Gly214Ser)	TGFBR1	Loeys-Dietz syndrome 1	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	9	101900206	9	99137924	488621	481489
NM_004612.3(TGFBR1):c.848A>G (p.His283Arg)	TGFBR1	Loeys-Dietz syndrome 1|Thoracic aortic aneurysm and aortic dissection	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	9	101904860	9	99142578	477563	459531
NM_001130916.2(TGFBR1):c.1202A>G (p.Asn401Ser)	TGFBR1	Loeys-Dietz syndrome 1|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	9	101911508	9	99149226	161393	171117
NM_000177.4(GSN):c.640G>A (p.Asp214Asn)	GSN	Meretoja syndrome|not provided	Pathogenic(Last reviewed: Apr 13, 2017)	criteria provided, single submitter	9	124073097	9	121310819	16180	31219
NM_004959.4(NR5A1):c.1210T>G (p.Tyr404Asp)	NR5A1	46,XY sex reversal, type 3	Pathogenic(Last reviewed: May 27, 2014)	criteria provided, single submitter	9	127245213	9	124482934	216976	213584
NM_004959.4(NR5A1):c.274C>T (p.Arg92Trp)	NR5A1	46,XY sex reversal, type 3|46,XX sex reversal 4	Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2018)	criteria provided, conflicting interpretations	9	127262965	9	124500686	265792	260482
NM_001174146.1(LMX1B):c.305A>G (p.Tyr102Cys)	LMX1B	Nail-patella syndrome	Pathogenic	no assertion criteria provided	9	129377827	9	126615548	587694	578652
NM_003165.3(STXBP1):c.416C>T (p.Pro139Leu)	STXBP1	Early infantile epileptic encephalopathy 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	9	130423471	9	127661192	207415	202287
NM_003165.3(STXBP1):c.433T>C (p.Tyr145His)	STXBP1	Early infantile epileptic encephalopathy 4	Likely pathogenic(Last reviewed: Dec 11, 2012)	criteria provided, single submitter	9	130425487	9	127663208	160073	168751
NM_003165.3(STXBP1):c.533C>T (p.Thr178Ile)	STXBP1	Early infantile epileptic encephalopathy 4	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	130425587	9	127663308	561118	552130
NM_003165.3(STXBP1):c.714C>A (p.Asp238Glu)	STXBP1	Early infantile epileptic encephalopathy 4	Uncertain significance(Last reviewed: May 20, 2014)	criteria provided, single submitter	9	130428495	9	127666216	160074	168752
NM_001032221.3(STXBP1):c.734A>G (p.His245Arg)	STXBP1	Early infantile epileptic encephalopathy 4|not specified|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	9	130428515	9	127666236	160070	168753
NM_000118.3(ENG):c.1844C>T (p.Ser615Leu)	ENG	Osler hemorrhagic telangiectasia syndrome|not specified|not provided|Haemorrhagic telangiectasia 1|Juvenile Polyposis	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	9	130578230	9	127815951	161229	171109
NM_000118.3(ENG):c.1510G>A (p.Val504Met)	ENG|LOC102723566	Osler hemorrhagic telangiectasia syndrome|not specified|Haemorrhagic telangiectasia 1|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	9	130580575	9	127818296	161231	171110
NM_000118.3(ENG):c.1282A>C (p.Asn428His)	ENG|LOC102723566	Osler hemorrhagic telangiectasia syndrome	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	9	130581930	9	127819651	226040	227844
NM_000118.3(ENG):c.1274C>T (p.Ala425Val)	ENG|LOC102723566	Haemorrhagic telangiectasia 1	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	9	130581938	9	127819659	161230	171111
NM_000118.3(ENG):c.640G>A (p.Gly214Ser)	ENG	Primary pulmonary hypertension|Osler hemorrhagic telangiectasia syndrome|Haemorrhagic telangiectasia 1	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	9	130588023	9	127825744	161233	171112
NM_000118.3(ENG):c.596G>A (p.Arg199His)	ENG	Osler hemorrhagic telangiectasia syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	9	130588067	9	127825788	226041	227845
NM_000118.3(ENG):c.392C>T (p.Pro131Leu)	ENG	Osler hemorrhagic telangiectasia syndrome|not specified|Haemorrhagic telangiectasia 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2017)	criteria provided, conflicting interpretations	9	130588920	9	127826641	161232	171113
NM_001130438.2(SPTAN1):c.1603C>A (p.Gln535Lys)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	9	131344788	9	128582509	159996	168761
NM_001130438.2(SPTAN1):c.1677C>G (p.His559Gln)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131344999	9	128582720	159997	168762
NM_001130438.2(SPTAN1):c.1697G>A (p.Arg566Gln)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Jun 13, 2014)	criteria provided, single submitter	9	131345019	9	128582740	159998	168763
NM_001130438.2(SPTAN1):c.2674G>T (p.Ala892Ser)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	9	131348140	9	128585861	160003	168768
NM_001130438.2(SPTAN1):c.3193C>T (p.Arg1065Cys)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	9	131355299	9	128593020	160006	168771
NM_001130438.2(SPTAN1):c.3899T>C (p.Ile1300Thr)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131367609	9	128605330	160011	168776
NM_001130438.2(SPTAN1):c.4199A>T (p.Gln1400Leu)	SPTAN1	Early infantile epileptic encephalopathy 5|not specified|Seizures|not provided|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2018)	criteria provided, conflicting interpretations	9	131370183	9	128607904	160012	168777
NM_001130438.2(SPTAN1):c.5023T>A (p.Phe1675Ile)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131374505	9	128612226	160014	168779
NM_001130438.2(SPTAN1):c.5981A>G (p.Glu1994Gly)	SPTAN1	Early infantile epileptic encephalopathy 5	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	9	131386755	9	128624476	160019	168784
NM_007313.2(ABL1):c.734A>G (p.Tyr245Cys)	ABL1	Congenital heart disease|Failure to thrive|Abnormality of skeletal morphology|CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME	Pathogenic(Last reviewed: Dec 11, 2016)	criteria provided, single submitter	9	133738277	9	130862890	374795	361696
NM_007313.2(ABL1):c.1066G>A (p.Ala356Thr)	ABL1	Congenital heart disease|Failure to thrive|not provided|Abnormality of skeletal morphology|CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	9	133748348	9	130872961	374794	361695
NM_000368.4(TSC1):c.2194C>T (p.His732Tyr)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|Focal cortical dysplasia of Taylor type 2B|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	9	135779052	9	132903665	5103	20142
NM_000368.4(TSC1):c.1760A>G (p.Lys587Arg)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	9	135781205	9	132905818	5099	20138
NM_000368.4(TSC1):c.965T>C (p.Met322Thr)	TSC1	Lymphangiomyomatosis|Tuberous sclerosis 1|Bladder cancer, somatic|Focal cortical dysplasia type II|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	9	135786904	9	132911517	41700	50139
NM_000368.4(TSC1):c.346T>G (p.Leu116Val)	TSC1	Tuberous sclerosis 1|Focal cortical dysplasia type II|Autism spectrum disorder|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2018)	criteria provided, conflicting interpretations	9	135800991	9	132925604	64814	75743
NM_001807.4(CEL):c.362T>G (p.Leu121Arg)	CEL	not specified|Monogenic diabetes	Benign(Last reviewed: Mar 10, 2017)	criteria provided, multiple submitters, no conflicts	9	135940439	9	133065052	128684	134133
NM_001807.4(CEL):c.1969T>G (p.Ser657Ala)	CEL	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	9	135946849	9	133071462	128687	134136
NM_001807.4(CEL):c.1975G>C (p.Ala659Pro)	CEL	not provided|Glomerulonephritis|Autoimmunity|Chronic gastritis|Gastritis|Crescentic glomerulonephritis|Chronic kidney disease|Thyroiditis|Type I diabetes mellitus|Autosomal dominant inheritance|Diabetes mellitus|X-linked dominant inheritance	Uncertain significance(Last reviewed: Feb 24, 2014)	criteria provided, multiple submitters, no conflicts	9	135946855	9	133071468	128688	134137
NM_001807.4(CEL):c.2101T>G (p.Ser701Ala)	CEL	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	9	135946981	9	133071594	128691	134140
NM_000093.4(COL5A1):c.406C>T (p.Pro136Ser)	COL5A1	Ehlers-Danlos syndrome, type 2|Ehlers-Danlos syndrome, classic type	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2017)	criteria provided, conflicting interpretations	9	137591883	9	134700037	209143	205759
NM_020822.2(KCNT1):c.59G>C (p.Gly20Ala)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Benign/Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, multiple submitters, no conflicts	9	138594163	9	135702317	129366	134812
NM_020822.2(KCNT1):c.800T>C (p.Met267Thr)	KCNT1	Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	138650300	9	135758454	561039	552136
NM_020822.2(KCNT1):c.862G>A (p.Gly288Ser)	KCNT1	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	9	138651532	9	135759686	126421	131953
NM_020822.2(KCNT1):c.1066C>T (p.Arg356Trp)	KCNT1	Early infantile epileptic encephalopathy 14|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	9	138656907	9	135765061	389450	370985
NM_020822.2(KCNT1):c.1283G>A (p.Arg428Gln)	KCNT1	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	9	138657552	9	135765706	39593	48192
NM_020822.2(KCNT1):c.1421G>A (p.Arg474His)	KCNT1	Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	9	138660694	9	135768848	39595	48194
NM_020822.2(KCNT1):c.1879A>G (p.Ile627Val)	KCNT1	not specified|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2017)	criteria provided, conflicting interpretations	9	138662812	9	135770966	129354	134800
NM_020822.2(KCNT1):c.2210C>T (p.Thr737Met)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5	Benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	9	138664762	9	135772916	129356	134802
NM_020822.2(KCNT1):c.2795T>C (p.Phe932Ser)	KCNT1	Early infantile epileptic encephalopathy 14	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	138671270	9	135779424	561038	552137
NM_020822.2(KCNT1):c.2800G>A (p.Ala934Thr)	KCNT1	Early infantile epileptic encephalopathy 14|not provided	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	9	138671275	9	135779429	39594	48193
NM_020822.2(KCNT1):c.2882G>A (p.Arg961His)	KCNT1	not provided|Focal epilepsy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2018)	criteria provided, conflicting interpretations	9	138675910	9	135784064	129360	134806
NM_020822.2(KCNT1):c.3388G>A (p.Ala1130Thr)	KCNT1	not specified|Seizures|Early infantile epileptic encephalopathy 14|Epilepsy, nocturnal frontal lobe, 5|not provided	Benign/Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	9	138678253	9	135786407	129364	134810
NM_007327.3(GRIN1):c.1340C>T (p.Pro447Leu)	GRIN1	not provided	Uncertain significance(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	9	140055741	9	137161289	129178	134624
NM_007327.3(GRIN1):c.1858G>C (p.Gly620Arg)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	9	140056962	9	137162510	209159	205760
NM_007327.3(GRIN1):c.1964T>A (p.Leu655Gln)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	140057142	9	137162690	561020	552138
NM_007327.3(GRIN1):c.2479G>A (p.Gly827Arg)	GRIN1	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	9	140058246	9	137163794	487503	480554
NM_024757.4(EHMT1):c.128C>G (p.Ala43Gly)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	9	140611120	9	137716668	96139	102033
NM_024757.4(EHMT1):c.148G>A (p.Ala50Thr)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 20, 2017)	criteria provided, multiple submitters, no conflicts	9	140611140	9	137716688	128976	134423
NM_024757.4(EHMT1):c.316C>G (p.Gln106Glu)	EHMT1	Chromosome 9q deletion syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	9	140611308	9	137716856	128981	134428
NM_024757.4(EHMT1):c.1162G>A (p.Ala388Thr)	EHMT1	Chromosome 9q deletion syndrome|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	9	140638534	9	137744082	128975	134422
NM_024757.4(EHMT1):c.1865A>G (p.Asn622Ser)	EHMT1	Chromosome 9q deletion syndrome|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	9	140671143	9	137776691	128977	134424
NM_024757.4(EHMT1):c.2426C>T (p.Pro809Leu)	EHMT1	not provided	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	9	140685343	9	137790891	128978	134425
NM_024757.4(EHMT1):c.2516G>T (p.Gly839Val)	EHMT1	Chromosome 9q deletion syndrome	Likely pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	9	140693275	9	137798823	522804	513433
NM_001202468.1(ZMYND11):c.1262G>A (p.Ser421Asn)	ZMYND11	not provided|Intellectual disability|Mental retardation, autosomal dominant 30	Likely pathogenic(Last reviewed: Jan 19, 2016)	criteria provided, single submitter	10	294310	10	248370	225254	227161
NM_000724.3(CACNB2):c.215C>T (p.Ala72Val)	CACNB2	Brugada syndrome 4|Ventricular fibrillation, idiopathic|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	10	18787330	10	18498401	161209	171118
NM_000724.3(CACNB2):c.425C>T (p.Ser142Phe)	CACNB2	Brugada syndrome 4|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	10	18789874	10	18500945	161210	171119
NM_000724.3(CACNB2):c.476G>C (p.Ser159Thr)	CACNB2	Brugada syndrome 4|Early repolarization associated with ventricular fibrillation|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	10	18795447	10	18506518	161211	171120
NM_000724.3(CACNB2):c.1015G>A (p.Val339Ile)	CACNB2|NSUN6	Brugada syndrome|not specified	Uncertain significance(Last reviewed: Jun 23, 2016)	criteria provided, single submitter	10	18823130	10	18534201	161214	171121
NM_201590.2(CACNB2):c.1114G>A (p.Ala372Thr)	CACNB2|NSUN6	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	10	18825099	10	18536170	427977	419279
NM_000724.3(CACNB2):c.1346C>T (p.Thr449Ile)	CACNB2|NSUN6	Brugada syndrome 4|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2018)	criteria provided, conflicting interpretations	10	18828181	10	18539252	161212	171122
NM_000724.3(CACNB2):c.1611C>A (p.Asp537Glu)	CACNB2|NSUN6	Brugada syndrome 4|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Aug 11, 2017)	criteria provided, conflicting interpretations	10	18828446	10	18539517	161213	171123
NM_020975.4(RET):c.166C>A (p.Leu56Met)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	10	43595999	10	43100551	36723	45384
NM_020630.4(RET):c.539G>A (p.Arg180Gln)	RET	Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2017)	criteria provided, conflicting interpretations	10	43597991	10	43102543	161360	171124
NM_020975.4(RET):c.785T>C (p.Val262Ala)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	10	43600559	10	43105111	41845	50284
NM_020630.5(RET):c.961G>A (p.Gly321Arg)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	10	43601917	10	43106469	24881	36222
NM_020975.4(RET):c.1201A>T (p.Ser401Cys)	RET	Multiple endocrine neoplasia, type 2|Congenital anomalies of kidney and urinary tract	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	10	43604616	10	43109168	224354	226087
NM_020630.4(RET):c.1424G>A (p.Arg475Gln)	RET	Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	10	43606815	10	43111367	135188	138927
NM_020975.4(RET):c.1531G>A (p.Glu511Lys)	RET	Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	10	43607555	10	43112107	24883	36224
NM_020630.4(RET):c.1852T>G (p.Cys618Gly)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	10	43609096	10	43113648	13905	28944
NM_020975.4(RET):c.1853G>C (p.Cys618Ser)	RET	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not provided	Pathogenic(Last reviewed: Apr 8, 2018)	criteria provided, multiple submitters, no conflicts	10	43609097	10	43113649	13914	28953
NM_020975.4(RET):c.1858T>G (p.Cys620Gly)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	10	43609102	10	43113654	24905	36246
NM_020975.5(RET):c.1900T>C (p.Cys634Arg)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Thyroid carcinoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	10	43609948	10	43114500	13917	28956
NM_020975.4(RET):c.1901G>T (p.Cys634Phe)	RET	Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	10	43609949	10	43114501	13911	28950
NM_020975.4(RET):c.1901G>C (p.Cys634Ser)	RET	Pheochromocytoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2	Pathogenic(Last reviewed: May 4, 2018)	no assertion criteria provided	10	43609949	10	43114501	13910	28949
NM_020975.4(RET):c.1901G>A (p.Cys634Tyr)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	10	43609949	10	43114501	13909	28948
NM_020975.4(RET):c.1902C>G (p.Cys634Trp)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Neoplasm of the thyroid gland	Pathogenic(Last reviewed: Mar 30, 2018)	criteria provided, multiple submitters, no conflicts	10	43609950	10	43114502	13918	28957
NM_020630.5(RET):c.1942G>A (p.Val648Ile)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unknown|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	10	43609990	10	43114542	13949	28988
NM_020975.4(RET):c.1946C>T (p.Ser649Leu)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome|Elevated basal serum calcitonin	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	10	43609994	10	43114546	24928	36269
NM_020630.4(RET):c.1996A>G (p.Lys666Glu)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	10	43610044	10	43114596	24931	36272
NM_020630.4(RET):c.1998G>T (p.Lys666Asn)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2018)	criteria provided, conflicting interpretations	10	43610046	10	43114598	24932	36273
NM_020630.4(RET):c.2081G>A (p.Arg694Gln)	RET	Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	10	43610129	10	43114681	161358	171125
NM_020630.5(RET):c.2372A>T (p.Tyr791Phe)	RET	Familial cancer of breast|Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Renal adysplasia|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	10	43613908	10	43118460	13936	28975
NM_020975.4(RET):c.[2410G>A;2832C>G]	RET	Medullary thyroid carcinoma	Pathogenic(Last reviewed: Jun 15, 2016)	criteria provided, single submitter	10|10	43614996	10|10	43119548	618965	28984|610366
NM_020975.4(RET):c.2410G>A (p.Val804Met)	RET	Congenital central hypoventilation|Hirschsprung disease 1|Multiple endocrine neoplasia, type 2b|Pheochromocytoma|Renal adysplasia|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	10	43614996	10	43119548	37102	28984
NM_020630.4(RET):c.2452G>A (p.Glu818Lys)	RET	Multiple endocrine neoplasia, type 2b|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 14, 2017)	criteria provided, multiple submitters, no conflicts	10	43615038	10	43119590	24943	36284
NM_020630.4(RET):c.2522C>T (p.Pro841Leu)	RET	Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Hirschsprung disease|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	10	43615108	10	43119660	24947	36288
NM_020630.4(RET):c.2656C>T (p.Arg886Trp)	RET	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|not specified|not provided	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	10	43615577	10	43120129	24960	36301
NM_020975.4(RET):c.2671T>G (p.Ser891Ala)	RET	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2b|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia IIA	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	10	43615592	10	43120144	13951	28990
NM_020630.4(RET):c.3116C>T (p.Pro1039Leu)	RET	Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Central hypoventilation syndrome, congenital, with hirschsprung disease|Multiple endocrine neoplasia, type 2|Hirschsprung disease|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	10	43622099	10	43126651	13948	28987
NM_020975.5(RET):c.3191T>C (p.Met1064Thr)	RET	Multiple endocrine neoplasia, type 2|Hirschsprung disease|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 2, 2018)	criteria provided, multiple submitters, no conflicts	10	43623563	10	43128115	161359	171126
NM_032578.3(MYPN):c.458A>G (p.Lys153Arg)	MYPN	Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy 1KK	Likely pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	10	69881653	10	68121896	31812	40472
NM_032578.3(MYPN):c.802C>T (p.Pro268Ser)	MYPN	Cardiomyopathy, restrictive	Uncertain significance	criteria provided, single submitter	10	69881997	10	68122240	444869	438509
NM_015634.3(KIF1BP):c.196G>A (p.Gly66Ser)	KIF1BP	Goldberg-Shprintzen megacolon syndrome|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	10	70748784	10	68989028	158696	168843
NM_015634.3(KIF1BP):c.518T>C (p.Met173Thr)	KIF1BP	not specified|not provided	Benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	10	70760271	10	69000515	158697	168844
NM_015634.3(KIF1BP):c.925G>A (p.Glu309Lys)	KIF1BP	Goldberg-Shprintzen megacolon syndrome	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	70770706	10	69010950	158700	168845
NM_152710.3(TBATA):c.157C>T (p.Arg53Cys)	TBATA	Hirschsprung disease 1	Likely pathogenic(Last reviewed: Sep 26, 2016)	no assertion criteria provided	10	72541677	10	70781921	375275	362046
NM_014000.2(VCL):c.220A>G (p.Met74Val)	VCL	Hypertrophic cardiomyopathy	Likely benign(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	10	75802892	10	74043134	427981	419280
NM_014000.2(VCL):c.1531G>T (p.Asp511Tyr)	VCL	Familial hypertrophic cardiomyopathy 15	Likely pathogenic	criteria provided, single submitter	10	75854207	10	74094449	217497	214108
NM_014000.2(VCL):c.2046A>T (p.Leu682Phe)	VCL	Dilated cardiomyopathy 1W|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	10	75863601	10	74103843	166551	175019
NM_012330.3(KAT6B):c.3544G>A (p.Glu1182Lys)	KAT6B	Mental retardation, autosomal dominant	Likely benign	no assertion criteria provided	10	76784887	10	75025129	377388	364270
NM_002247.3(KCNMA1):c.2984A>G (p.Asn995Ser)	KCNMA1|KCNMA1-AS1	Generalized epilepsy and paroxysmal dyskinesia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2018)	criteria provided, conflicting interpretations	10	78651467	10	76891709	265313	259940
NM_002247.3(KCNMA1):c.2193C>A (p.Asp731Glu)	KCNMA1|KCNMA1-AS1	not provided	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, single submitter	10	78713676	10	76953918	129322	134768
NM_002247.3(KCNMA1):c.1060G>A (p.Gly354Ser)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	10	78870002	10	77110244	561037	552146
NM_002247.3(KCNMA1):c.1054A>G (p.Thr352Ala)	KCNMA1	Generalized epilepsy and paroxysmal dyskinesia	Likely pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	10	78870008	10	77110250	216948	213600
NM_033022.3(RPS24):c.148A>C (p.Thr50Pro)	RPS24	Diamond-Blackfan anemia 3	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, single submitter	10	79795347	10	78035589	549764	540530
NM_007078.2(LDB3):c.91C>T (p.Arg31Trp)	LDB3	Myofibrillar myopathy, ZASP-related|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	10	88428539	10	86668782	201857	198308
NM_001080116.1(LDB3):c.290A>G (p.Gln97Arg)	LDB3	Familial hypertrophic cardiomyopathy 1|Myofibrillar myopathy, ZASP-related	Uncertain significance(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	10	88439883	10	86680126	217828	214486
NM_004329.2(BMPR1A):c.1243G>A (p.Glu415Lys)	BMPR1A	Juvenile polyposis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Gastrointestinal polyposis|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	10	88681353	10	86921596	41779	50218
NM_004329.2(BMPR1A):c.1327C>T (p.Arg443Cys)	BMPR1A	Juvenile polyposis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	10	88681437	10	86921680	133717	137456
NM_004329.2(BMPR1A):c.1433G>A (p.Arg478His)	BMPR1A	Juvenile polyposis syndrome|Hereditary mixed polyposis syndrome 2|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2018)	criteria provided, conflicting interpretations	10	88683223	10	86923466	41780	50219
NM_005271.4(GLUD1):c.1493C>T (p.Ser498Leu)	GLUD1	Hyperinsulinism-hyperammonemia syndrome|not provided	Pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, multiple submitters, no conflicts	10	88817449	10	87057692	16122	31161
NM_000314.6(PTEN):c.-9C>G	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 9, 2016)	reviewed by expert panel	10	89624218	10	87864461	92808	98715
NM_000314.6(PTEN):c.35A>C (p.Asn12Thr)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89624261	10	87864504	427586	416933
NM_000314.6(PTEN):c.40A>G (p.Arg14Gly)	PTEN	PTEN hamartoma tumor syndrome|not provided	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89624266	10	87864509	427589	416934
NM_000314.6(PTEN):c.44G>A (p.Arg15Lys)	PTEN	PTEN hamartoma tumor syndrome|not provided	Uncertain significance(Last reviewed: Jan 3, 2018)	reviewed by expert panel	10	89624270	10	87864513	404147	397912
NM_000314.6(PTEN):c.103A>G (p.Met35Val)	PTEN	PTEN hamartoma tumor syndrome|not provided|Inborn genetic diseases	Likely pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89653805	10	87894048	231916	233842
NM_000314.6(PTEN):c.131G>A (p.Gly44Asp)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89653833	10	87894076	427582	416935
NM_000314.6(PTEN):c.182A>G (p.His61Arg)	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, multiple submitters, no conflicts	10	89685287	10	87925530	189402	187337
NM_000314.7(PTEN):c.235G>A (p.Ala79Thr)	PTEN	Endometrial carcinoma|Macrocephaly/autism syndrome|Meningioma, familial|Squamous cell carcinoma of the head and neck|Bannayan-Riley-Ruvalcaba syndrome|Malignant tumor of prostate|Follicular thyroid carcinoma|VACTERL association with hydrocephalus|Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Cutaneous malignant melanoma 1|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89690828	10	87931071	41682	50121
NM_000314.6(PTEN):c.284C>T (p.Pro95Leu)	PTEN	PTEN hamartoma tumor syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2018)	criteria provided, conflicting interpretations	10	89692800	10	87933043	189403	187345
NM_000314.6(PTEN):c.320A>T (p.Asp107Val)	PTEN	PTEN hamartoma tumor syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	10	89692836	10	87933079	372481	359885
NM_000314.6(PTEN):c.338G>T (p.Ser113Ile)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Aug 1, 2012)	no assertion criteria provided	10	89692854	10	87933097	139567	143197
NM_000314.7(PTEN):c.368A>G (p.His123Arg)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89692884	10	87933127	7816	22855
NM_000314.6(PTEN):c.369C>G (p.His123Gln)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89692885	10	87933128	427587	416940
NM_000314.6(PTEN):c.379G>A (p.Gly127Arg)	PTEN	PTEN hamartoma tumor syndrome|not provided	Likely pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	10	89692895	10	87933138	139568	143198
NM_000314.6(PTEN):c.386G>A (p.Gly129Glu)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided	Pathogenic(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	10	89692902	10	87933145	7812	22851
NM_000314.6(PTEN):c.389G>A (p.Arg130Gln)	PTEN	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Small cell lung cancer|PTEN hamartoma tumor syndrome|Squamous cell lung carcinoma|Cowden syndrome 1|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of the breast|Glioblastoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Neoplasm|Ovarian Neoplasms|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89692905	10	87933148	7829	22868
NM_000314.7(PTEN):c.395G>A (p.Gly132Asp)	PTEN	PTEN hamartoma tumor syndrome|not provided	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89692911	10	87933154	92822	98729
NM_000314.6(PTEN):c.401T>C (p.Met134Thr)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89692917	10	87933160	427588	416941
NM_000314.6(PTEN):c.407G>A (p.Cys136Tyr)	PTEN	PTEN hamartoma tumor syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89692923	10	87933166	189406	187355
NM_000314.6(PTEN):c.464A>G (p.Tyr155Cys)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2017)	criteria provided, conflicting interpretations	10	89692980	10	87933223	404168	398057
NM_000314.6(PTEN):c.470A>G (p.Glu157Gly)	PTEN	Macrocephaly/autism syndrome|PTEN hamartoma tumor syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2017)	criteria provided, conflicting interpretations	10	89692986	10	87933229	427593	416944
NM_000314.7(PTEN):c.510T>A (p.Ser170Arg)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711892	10	87952135	7815	22854
NM_000314.6(PTEN):c.517C>T (p.Arg173Cys)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Neoplasm of brain|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89711899	10	87952142	189500	187363
NM_000314.6(PTEN):c.518G>A (p.Arg173His)	PTEN	PTEN hamartoma tumor syndrome|not provided|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	10	89711900	10	87952143	376032	362911
NM_000314.7(PTEN):c.520T>A (p.Tyr174Asn)	PTEN	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Apr 6, 2018)	reviewed by expert panel	10	89711902	10	87952145	142220	151934
NM_000314.6(PTEN):c.521A>G (p.Tyr174Cys)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Sep 26, 2018)	reviewed by expert panel	10	89711903	10	87952146	220007	222000
NM_000314.6(PTEN):c.605C>T (p.Thr202Ile)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89711987	10	87952230	427595	416946
NM_000314.6(PTEN):c.737C>T (p.Pro246Leu)	PTEN	PTEN hamartoma tumor syndrome|Cowden syndrome 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	10	89717712	10	87957955	142269	151983
NM_000314.6(PTEN):c.821G>T (p.Trp274Leu)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89720670	10	87960913	427600	416952
NM_000314.6(PTEN):c.892C>G (p.Gln298Glu)	PTEN	Endometrial carcinoma|Macrocephaly/autism syndrome|Meningioma, familial|Squamous cell carcinoma of the head and neck|Bannayan-Riley-Ruvalcaba syndrome|Malignant tumor of prostate|Follicular thyroid carcinoma|VACTERL association with hydrocephalus|Glioma susceptibility 2|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Cutaneous malignant melanoma 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	10	89720741	10	87960984	127695	133152
NM_000314.6(PTEN):c.1004G>A (p.Arg335Gln)	PTEN	PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	10	89720853	10	87961096	427580	416953
NM_000314.6(PTEN):c.1171C>T (p.Pro391Ser)	PTEN	PTEN hamartoma tumor syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 8, 2017)	reviewed by expert panel	10	89725188	10	87965431	187673	183064
NM_001613.2(ACTA2):c.720G>C (p.Lys240Asn)	ACTA2|ACTA2-AS1	Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection	Likely pathogenic(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	10	90699352	10	88939595	162701	175327
NM_001613.2(ACTA2):c.536G>A (p.Arg179His)	ACTA2	Aortic aneurysm, familial thoracic 6|Multisystemic smooth muscle dysfunction syndrome|Moyamoya disease 5|Thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype|alterations of great arteries and veins|Connective tissue disorder	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	10	90701066	10	88941309	29598	38552
NM_001613.2(ACTA2):c.353G>A (p.Arg118Gln)	ACTA2	Aortic aneurysm, familial thoracic 6|Thoracic aortic aneurysm and aortic dissection|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	10	90703570	10	88943813	199670	197398
NM_183374.3(CYP26C1):c.356A>C (p.Gln119Pro)	CYP26C1	Optic nerve hypoplasia	Likely benign	criteria provided, single submitter	10	94821918	10	93062161	496733	488179
NM_002860.3(ALDH18A1):c.755G>A (p.Arg252Gln)	ALDH18A1	Cutis laxa-corneal clouding-oligophrenia syndrome|Spastic paraplegia 9|Cutis laxa, autosomal dominant 3	Pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	10	97392769	10	95633012	217117	213762
NM_001002261.3(ZFYVE27):c.244G>A (p.Val82Ile)	ZFYVE27	not specified|Spastic paraplegia|Spastic paraplegia, autosomal dominant	Benign/Likely benign(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	10	99502897	10	97743140	130785	136231
NM_001002261.3(ZFYVE27):c.413G>T (p.Gly138Val)	ZFYVE27	not specified|Spastic paraplegia, autosomal dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	10	99504630	10	97744873	130787	136233
NM_003988.4(PAX2):c.511T>C (p.Ser171Pro)	PAX2	Familial hypoplastic, glomerulocystic kidney	Uncertain significance	criteria provided, single submitter	10	102541017	10	100781260	224355	226086
NM_033164.3(FGF8):c.464A>G (p.Asn155Ser)	FGF8	Holoprosencephaly sequence	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	10	103530324	10	101770567	545460	535720
NM_033164.3(FGF8):c.436G>T (p.Val146Phe)	FGF8	Holoprosencephaly sequence	Likely pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	10	103530352	10	101770595	545456	535716
NM_033163.3(FGF8):c.451G>A (p.Gly151Ser)	FGF8	Kallmann syndrome 6	Likely pathogenic(Last reviewed: May 1, 2013)	no assertion criteria provided	10	103530370	10	101770613	140612	150303
NM_033163.3(FGF8):c.356C>T (p.Thr119Met)	FGF8	Holoprosencephaly sequence|Semilobar holoprosencephaly	Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	10	103531308	10	101771551	235081	236855
NM_033164.3(FGF8):c.130C>T (p.Arg44Trp)	FGF8	Holoprosencephaly sequence	Benign(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	10	103534913	10	101775156	545461	535721
NM_005445.3(SMC3):c.377A>G (p.Glu126Gly)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	112338412	10	110578654	159987	168815
NM_005445.3(SMC3):c.587T>C (p.Ile196Thr)	SMC3	Cornelia de Lange syndrome 3	Likely pathogenic(Last reviewed: Aug 30, 2014)	criteria provided, single submitter	10	112341720	10	110581962	209193	205764
NM_005445.3(SMC3):c.707G>C (p.Arg236Pro)	SMC3	Cornelia de Lange syndrome 3	Likely pathogenic(Last reviewed: Feb 24, 2014)	criteria provided, single submitter	10	112341840	10	110582082	159990	168818
NM_005445.3(SMC3):c.1280A>G (p.Lys427Arg)	SMC3	Cornelia de Lange syndrome 3|Cornelia de Lange Syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2016)	criteria provided, conflicting interpretations	10	112344129	10	110584371	159966	168822
NM_005445.3(SMC3):c.1964G>A (p.Gly655Asp)	SMC3	Cornelia de Lange syndrome 3	Likely pathogenic(Last reviewed: Jan 13, 2014)	criteria provided, single submitter	10	112356156	10	110596398	159970	168826
NM_005445.3(SMC3):c.2264C>T (p.Pro755Leu)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	112358044	10	110598286	159972	168828
NM_005445.3(SMC3):c.2710T>C (p.Trp904Arg)	SMC3	Cornelia de Lange syndrome 3	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	10	112361460	10	110601702	159982	168837
NM_001134363.2(RBM20):c.1244G>A (p.Ser415Asn)	RBM20	Dilated cardiomyopathy 1DD	Uncertain significance(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	10	112541611	10	110781853	548140	538625
NM_001134363.2(RBM20):c.1364C>T (p.Ser455Leu)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 5, 2018)	criteria provided, conflicting interpretations	10	112544125	10	110784367	43971	53139
NM_001134363.2(RBM20):c.1906C>A (p.Arg636Ser)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	10	112572061	10	110812303	270	15309
NM_001134363.2(RBM20):c.1907G>A (p.Arg636His)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not provided|Familial dilated cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	10	112572062	10	110812304	271	15310
NM_001134363.2(RBM20):c.1913C>T (p.Pro638Leu)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Dilated cardiomyopathy 1DD|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	10	112572068	10	110812310	268	15307
NM_001134363.2(RBM20):c.2147G>A (p.Arg716Gln)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not specified	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	10	112572302	10	110812544	43986	53154
NM_001134363.2(RBM20):c.2662G>A (p.Asp888Asn)	RBM20	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1DD|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	10	112581039	10	110821281	43995	53163
NM_001134363.2(RBM20):c.2746G>A (p.Glu916Lys)	RBM20	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: May 9, 2014)	criteria provided, single submitter	10	112581123	10	110821365	179425	174600
NM_007373.3(SHOC2):c.4A>G (p.Ser2Gly)	SHOC2	Noonan syndrome 3|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome|not specified|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	10	112724120	10	110964362	6821	21860
NM_004281.3(BAG3):c.626C>T (p.Pro209Leu)	BAG3	Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided	Pathogenic(Last reviewed: Oct 23, 2017)	criteria provided, multiple submitters, no conflicts	10	121431885	10	119672373	5981	21020
NM_004281.3(BAG3):c.634C>A (p.His212Asn)	BAG3	Dilated cardiomyopathy 1HH	Uncertain significance(Last reviewed: Jul 4, 2018)	criteria provided, single submitter	10	121431893	10	119672381	548141	538626
NM_004281.3(BAG3):c.1363G>A (p.Glu455Lys)	BAG3	Primary dilated cardiomyopathy|Myofibrillar myopathy, BAG3-related|Dilated cardiomyopathy 1HH|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	10	121436429	10	119676917	44778	53945
NM_001005463.2(EBF3):c.577A>G (p.Lys193Glu)	EBF3	Oromandibular-limb hypogenesis spectrum	Likely pathogenic	no assertion criteria provided	10	131676091	10	129877827	267357	262525
NM_001005463.2(EBF3):c.512G>A (p.Gly171Asp)	EBF3	Neurogenic bladder|Renal dysplasia|Generalized hypotonia|Broad-based gait|Developmental regression	Pathogenic	no assertion criteria provided	10	131755564	10	129957300	375375	362152
NM_001005463.2(EBF3):c.488G>A (p.Arg163Gln)	EBF3	Robin sequence|Global developmental delay|Expressive language delay|Pierre-Robin sequence|Intellectual disability|Inborn genetic diseases|Ataxia|Muscular hypotonia|Hypotonia, ataxia, and delayed development syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	10	131755588	10	129957324	268156	263783
NM_001005463.2(EBF3):c.488G>T (p.Arg163Leu)	EBF3	Global developmental delay|Expressive language delay|not provided|Intellectual disability|Ataxia|Muscular hypotonia|Hypotonia, ataxia, and delayed development syndrome	Pathogenic(Last reviewed: May 4, 2017)	criteria provided, multiple submitters, no conflicts	10	131755588	10	129957324	268155	263782
NM_005343.3(HRAS):c.350A>G (p.Lys117Arg)	HRAS|LRRC56	Costello syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	533553	11	533553	12605	27644
NM_005343.3(HRAS):c.175_176delGCinsCT (p.Ala59Leu)	HRAS|LRRC56	Costello syndrome	Likely pathogenic(Last reviewed: Aug 14, 2014)	criteria provided, single submitter	11	533880 - 533881	11	533880 - 533881	179260	174803
NM_005343.3(HRAS):c.37G>T (p.Gly13Cys)	HRAS|LRRC56	Liver cancer|Chronic lymphocytic leukemia|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Noonan syndrome|not provided|Rasopathy|Neoplasm of the breast|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Neoplasm|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Malignant neoplasm of body of uterus	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	534286	11	534286	12606	27645
NM_005343.3(HRAS):c.35_36delGCinsAA (p.Gly12Glu)	HRAS|LRRC56	Costello syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	11	534287 - 534288	11	534287 - 534288	163690	174805
NM_005343.3(HRAS):c.34G>T (p.Gly12Cys)	HRAS|LRRC56	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Epidermal nevus|Lung adenocarcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Neoplasm of the breast|Glioblastoma|Bladder carcinoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Nevus sebaceous|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, multiple submitters, no conflicts	11	534289	11	534289	12613	27652
NM_176795.4(HRAS):c.34G>A (p.Gly12Ser)	HRAS|LRRC56	Liver cancer|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Costello syndrome|Lung adenocarcinoma|Myopathy, congenital, with excess of muscle spindles|Acute myeloid leukemia|Myelodysplastic syndrome|Epidermal nevus with urothelial cancer, somatic|Nevus sebaceous|NEVUS SEBACEOUS, SOMATIC|not provided|Rasopathy|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Nevus sebaceous|Neoplasm of the large intestine|Carcinoma of esophagus|Nevus, woolly hair|Colorectal Neoplasms|Uterine cervical neoplasms|Neoplasm of the thyroid gland|Papillary renal cell carcinoma, sporadic|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	11	534289	11	534289	12602	27641
NM_021008.3(DEAF1):c.791A>C (p.Gln264Pro)	DEAF1	Mental retardation, autosomal dominant 24	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	686871	11	686871	133292	137031
NM_021008.3(DEAF1):c.737G>C (p.Arg246Thr)	DEAF1	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	11	686925	11	686925	437396	430956
NM_021008.3(DEAF1):c.700T>A (p.Trp234Arg)	DEAF1	Mental retardation, autosomal dominant 24	Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	11	686962	11	686962	437398	430958
NM_021008.3(DEAF1):c.634G>A (p.Gly212Ser)	DEAF1	not provided|Mental retardation, autosomal dominant 24	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2017)	criteria provided, multiple submitters, no conflicts	11	687941	11	687941	375554	362364
NM_000207.2(INS):c.125T>C (p.Val42Ala)	INS|INS-IGF2	Maturity-onset diabetes of the young, type 10	Likely pathogenic	no assertion criteria provided	11	2182077	11	2160847	253331	247779
NM_000207.2(INS):c.94G>A (p.Gly32Ser)	INS|INS-IGF2	Permanent neonatal diabetes mellitus|Diabetes mellitus, insulin-dependent, 2|Neonatal diabetes mellitus	Pathogenic(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	11	2182108	11	2160878	21122	33974
NM_000218.2(KCNQ1):c.458C>T (p.Thr153Met)	KCNQ1	Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	11	2549229	11	2527999	67075	77971
NM_000218.2(KCNQ1):c.532G>A (p.Ala178Thr)	KCNQ1	Long QT syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	11	2591912	11	2570682	53061	67729
NM_000218.2(KCNQ1):c.535G>A (p.Gly179Ser)	KCNQ1	Long QT syndrome 1|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	11	2591915	11	2570685	53063	67731
NM_000218.2(KCNQ1):c.583C>T (p.Arg195Trp)	KCNQ1	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Mar 5, 2015)	criteria provided, multiple submitters, no conflicts	11	2591963	11	2570733	67087	77983
NM_000218.2(KCNQ1):c.613G>A (p.Val205Met)	KCNQ1	Long QT syndrome 1|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	11	2592563	11	2571333	37255	45847
NM_000218.2(KCNQ1):c.674C>T (p.Ser225Leu)	KCNQ1	Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome	Pathogenic/Likely pathogenic(Last reviewed: Feb 27, 2018)	criteria provided, multiple submitters, no conflicts	11	2592624	11	2571394	53083	67751
NM_000218.2(KCNQ1):c.820A>G (p.Ile274Val)	KCNQ1	SUDDEN INFANT DEATH SYNDROME|Long QT syndrome|not specified|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	11	2594115	11	2572885	67109	78005
NM_000218.2(KCNQ1):c.877C>T (p.Arg293Cys)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2018)	criteria provided, conflicting interpretations	11	2594172	11	2572942	67117	78013
NM_000218.2(KCNQ1):c.898G>A (p.Ala300Thr)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	11	2594193	11	2572963	3128	18167
NM_000218.2(KCNQ1):c.1096C>T (p.Arg366Trp)	KCNQ1	Long QT syndrome 1|Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	11	2606505	11	2585275	52955	67623
NM_000218.2(KCNQ1):c.1179G>T (p.Lys393Asn)	KCNQ1	short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|not provided|Familial atrial fibrillation|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2017)	criteria provided, conflicting interpretations	11	2608850	11	2587620	67020	77916
NM_000218.2(KCNQ1):c.1189C>T (p.Arg397Trp)	KCNQ1	Long QT syndrome 1|Wolff-Parkinson-White pattern|short QT syndrome|Long QT syndrome|Romano-Ward syndrome|not specified|Congenital long QT syndrome|Familial atrial fibrillation|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	2608860	11	2587630	52970	67638
NM_000218.2(KCNQ1):c.1352G>A (p.Arg451Gln)	KCNQ1	Long QT syndrome|not specified|not provided	Uncertain significance(Last reviewed: Sep 2, 2016)	criteria provided, single submitter	11	2610043	11	2588813	67029	77925
NM_000218.2(KCNQ1):c.1354C>T (p.Arg452Trp)	KCNQ1	Long QT syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	11	2610045	11	2588815	52980	67648
NM_000218.2(KCNQ1):c.1378G>A (p.Gly460Ser)	KCNQ1	SUDDEN INFANT DEATH SYNDROME|not provided	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	11	2610069	11	2588839	67031	77927
NM_000218.2(KCNQ1):c.1553G>A (p.Arg518Gln)	KCNQ1	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, single submitter	11	2790112	11	2768882	67036	77932
NM_000218.2(KCNQ1):c.1576A>G (p.Lys526Glu)	KCNQ1	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: Mar 21, 2016)	criteria provided, single submitter	11	2790135	11	2768905	52995	67663
NM_000218.2(KCNQ1):c.1616G>A (p.Arg539Gln)	KCNQ1	Long QT syndrome 1|Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2017)	criteria provided, conflicting interpretations	11	2797215	11	2775985	67042	77938
NM_000218.2(KCNQ1):c.1781G>A (p.Arg594Gln)	KCNQ1	Long QT syndrome|Romano-Ward syndrome|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 11, 2018)	criteria provided, multiple submitters, no conflicts	11	2799254	11	2778024	53018	67686
NM_000218.2(KCNQ1):c.1799C>T (p.Thr600Met)	KCNQ1|KCNQ1-AS1	Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 18, 2018)	criteria provided, conflicting interpretations	11	2869001	11	2847771	67057	77953
NM_000218.2(KCNQ1):c.1831G>A (p.Asp611Asn)	KCNQ1|KCNQ1-AS1	Long QT syndrome 1|Long QT syndrome|not provided|Congenital long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	2869033	11	2847803	67059	77955
NM_000218.2(KCNQ1):c.1885G>A (p.Gly629Ser)	KCNQ1|KCNQ1-AS1	Brugada syndrome	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	11	2869087	11	2847857	427960	419283
NM_139132.3(NUP98):c.4985A>G (p.Asn1662Ser)	NUP98	Hirschsprung disease 1	Likely pathogenic(Last reviewed: Sep 27, 2016)	no assertion criteria provided	11	3697585	11	3676355	375277	362048
NM_003156.3(STIM1):c.910C>T (p.Arg304Trp)	STIM1	Myopathy with tubular aggregates|Stormorken syndrome	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	11	4095850	11	4074620	132887	136636
NM_003156.3(STIM1):c.1588C>T (p.Arg530Cys)	STIM1	Myopathy with tubular aggregates|Stormorken syndrome|Immune dysfunction with T-cell inactivation due to calcium entry defect 2	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2017)	criteria provided, conflicting interpretations	11	4112558	11	4091328	461723	461913
NM_000525.3(KCNJ11):c.149G>A (p.Arg50Gln)	KCNJ11	Neonatal diabetes mellitus|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, multiple submitters, no conflicts	11	17409490	11	17387943	36431	45094
NM_000352.4(ABCC8):c.4564G>A (p.Val1522Met)	ABCC8	Neonatal diabetes mellitus	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	17415288	11	17393741	35622	44287
NM_000352.4(ABCC8):c.4451G>A (p.Gly1484Glu)	ABCC8	Persistent hyperinsulinemic hypoglycemia of infancy	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	17415907	11	17394360	35620	44285
NM_000352.4(ABCC8):c.4136G>T (p.Arg1379Leu)	ABCC8	Neonatal diabetes mellitus	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	11	17417461	11	17395914	35615	44280
NM_000352.4(ABCC8):c.3545G>A (p.Arg1182Gln)	ABCC8	Transient neonatal diabetes mellitus 2|Neonatal diabetes mellitus	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, multiple submitters, no conflicts	11	17426071	11	17404524	35611	44276
NM_001112741.1(KCNC1):c.959G>A (p.Arg320His)	KCNC1	Epilepsy, progressive myoclonic 7	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	11	17793600	11	17772053	162519	172192
NM_001112741.1(KCNC1):c.1262C>T (p.Ala421Val)	KCNC1	not provided|Epilepsy, progressive myoclonic 7	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	11	17793903	11	17772356	488536	481404
NM_003476.4(CSRP3):c.536C>T (p.Thr179Met)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	11	19204266	11	19182719	163007	175833
NM_003476.4(CSRP3):c.437G>A (p.Arg146His)	CSRP3	Familial hypertrophic cardiomyopathy 12|Dilated cardiomyopathy 1M|not specified|Prolonged QT interval	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	11	19206570	11	19185023	163009	175694
NM_003476.4(CSRP3):c.93C>G (p.His31Gln)	CSRP3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Aug 6, 2015)	criteria provided, single submitter	11	19213903	11	19192356	217825	214487
NM_000280.4(PAX6):c.1032+6T>G	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31814980	11	31793432	431006	424513
NM_000280.4(PAX6):c.357C>G (p.Ser119Arg)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31823109	11	31801561	430991	424528
NM_000280.4(PAX6):c.164A>C (p.Lys55Thr)	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31823302	11	31801754	430983	424536
NM_000280.4(PAX6):c.151G>A (p.Gly51Arg)	PAX6	Aniridia 1|not provided	Pathogenic(Last reviewed: May 12, 2018)	criteria provided, single submitter	11	31823315	11	31801767	430982	424537
NM_001604.5(PAX6):c.192C>A (p.Asn64Lys)	PAX6	not provided|Anophthalmia - microphthalmia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2014)	criteria provided, conflicting interpretations	11	31823316	11	31801768	167417	177907
NM_000280.4(PAX6):c.140A>G (p.Gln47Arg)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31824253	11	31802705	430978	424542
NM_000280.4(PAX6):c.19G>C (p.Gly7Arg)	PAX6	Aniridia 1	Likely pathogenic	no assertion criteria provided	11	31824374	11	31802826	430973	424546
NM_000280.4(PAX6):c.3G>T (p.Met1Ile)	PAX6	Aniridia 1	Pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	11	31827957	11	31806409	492990	485946
NM_000280.4(PAX6):c.1A>C (p.Met1Leu)	PAX6	Aniridia 1|Irido-corneo-trabecular dysgenesis	Pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	11	31827959	11	31806411	430972	424548
NM_000280.4(PAX6):c.1A>G (p.Met1Val)	PAX6	Aniridia 1	Pathogenic	no assertion criteria provided	11	31827959	11	31806411	430971	424547
NM_024426.4(WT1):c.896C>T (p.Ser299Phe)	WT1	Frasier syndrome	Likely pathogenic(Last reviewed: Jul 18, 2018)	no assertion criteria provided	11	32439177	11	32417631	78338	89229
NM_000256.3(MYBPC3):c.3771C>A (p.Asn1257Lys)	MYBPC3	not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 10, 2017)	criteria provided, conflicting interpretations	11	47353666	11	47332115	181022	179175
NM_000256.3(MYBPC3):c.3742G>A (p.Gly1248Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 11, 2017)	criteria provided, multiple submitters, no conflicts	11	47353695	11	47332144	42739	51909
NM_000256.3(MYBPC3):c.3728C>G (p.Pro1243Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jul 27, 2015)	criteria provided, single submitter	11	47353709	11	47332158	217829	214488
NM_000256.3(MYBPC3):c.3682C>T (p.Arg1228Cys)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2018)	criteria provided, conflicting interpretations	11	47353755	11	47332204	161306	171133
NM_000256.3(MYBPC3):c.3642G>T (p.Trp1214Cys)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	11	47353795	11	47332244	492980	485933
NM_000256.3(MYBPC3):c.3599T>C (p.Leu1200Pro)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2017)	criteria provided, conflicting interpretations	11	47354145	11	47332594	42725	51895
NM_000256.3(MYBPC3):c.3413G>A (p.Arg1138His)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2017)	criteria provided, conflicting interpretations	11	47354442	11	47332891	177689	175146
NM_000256.3(MYBPC3):c.3412C>T (p.Arg1138Cys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Jun 28, 2011)	criteria provided, single submitter	11	47354443	11	47332892	161307	171134
NM_000256.3(MYBPC3):c.3137C>T (p.Thr1046Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2016)	criteria provided, conflicting interpretations	11	47355161	11	47333610	161301	171135
NM_000256.3(MYBPC3):c.3065G>C (p.Arg1022Pro)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	11	47355233	11	47333682	42682	51852
NM_000256.3(MYBPC3):c.3065G>A (p.Arg1022His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Sep 27, 2016)	criteria provided, multiple submitters, no conflicts	11	47355233	11	47333682	42681	51851
NM_000256.3(MYBPC3):c.3049G>A (p.Glu1017Lys)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 5, 2017)	criteria provided, conflicting interpretations	11	47355249	11	47333698	42679	51849
NM_000256.3(MYBPC3):c.2980C>T (p.Leu994Phe)	MYBPC3	not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	11	47355487	11	47333936	180992	179223
NM_000256.3(MYBPC3):c.2882C>T (p.Pro961Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	11	47356616	11	47335065	42665	51835
NM_000256.3(MYBPC3):c.2873C>T (p.Thr958Ile)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2018)	criteria provided, conflicting interpretations	11	47356625	11	47335074	42664	51834
NM_000256.3(MYBPC3):c.2870C>G (p.Thr957Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 16, 2018)	criteria provided, conflicting interpretations	11	47356628	11	47335077	36607	45269
NM_000256.3(MYBPC3):c.2783C>T (p.Ser928Leu)	MYBPC3	not specified|Prolonged QT interval	Uncertain significance(Last reviewed: Jun 27, 2017)	criteria provided, multiple submitters, no conflicts	11	47356715	11	47335164	427958	419284
NM_000256.3(MYBPC3):c.2686G>A (p.Val896Met)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Sep 22, 2017)	criteria provided, multiple submitters, no conflicts	11	47357479	11	47335928	42652	51822
NM_000256.3(MYBPC3):c.2618C>A (p.Pro873His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	11	47357547	11	47335996	30143	39099
NM_000256.3(MYBPC3):c.2552C>T (p.Ala851Val)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 19, 2017)	criteria provided, multiple submitters, no conflicts	11	47358992	11	47337441	217837	214490
NM_000256.3(MYBPC3):c.2497G>A (p.Ala833Thr)	MYBPC3	Primary dilated cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Paroxysmal atrial fibrillation|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	47359047	11	47337496	42626	51796
NM_000256.3(MYBPC3):c.2459G>A (p.Arg820Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	11	47359085	11	47337534	8617	23656
NM_000256.3(MYBPC3):c.2429G>A (p.Arg810His)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	11	47359115	11	47337564	42620	51790
NM_000256.3(MYBPC3):c.2374T>C (p.Trp792Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	11	47359280	11	47337729	36605	45267
NM_000256.3(MYBPC3):c.2320G>A (p.Ala774Thr)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, multiple submitters, no conflicts	11	47359334	11	47337783	42618	51788
NM_000256.3(MYBPC3):c.2311G>A (p.Val771Met)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	11	47359343	11	47337792	161308	171136
NM_000256.3(MYBPC3):c.2269G>A (p.Val757Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 21, 2017)	criteria provided, multiple submitters, no conflicts	11	47360110	11	47338559	161309	171137
NM_000256.3(MYBPC3):c.2234A>G (p.Asp745Gly)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|not specified	Uncertain significance(Last reviewed: Jul 2, 2015)	criteria provided, multiple submitters, no conflicts	11	47360145	11	47338594	30142	39098
NM_000256.3(MYBPC3):c.2035C>T (p.Pro679Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	47361234	11	47339683	161302	171138
NM_000256.3(MYBPC3):c.2003G>A (p.Arg668His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Sep 7, 2017)	criteria provided, conflicting interpretations	11	47361266	11	47339715	164090	175175
NM_000256.3(MYBPC3):c.1855G>A (p.Glu619Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	11	47362731	11	47341180	161303	171139
NM_000256.3(MYBPC3):c.1828G>A (p.Asp610Asn)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Feb 21, 2018)	criteria provided, multiple submitters, no conflicts	11	47362758	11	47341207	42575	51745
NM_000256.3(MYBPC3):c.1790G>A (p.Arg597Gln)	MYBPC3	not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	11	47363542	11	47341991	164098	175179
NM_000256.3(MYBPC3):c.1624G>C (p.Glu542Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Familial dilated cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	11	47364129	11	47342578	8608	23647
NM_000256.3(MYBPC3):c.1591G>C (p.Gly531Arg)	MYBPC3	not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	11	47364162	11	47342611	42550	51720
NM_000256.3(MYBPC3):c.1564G>A (p.Ala522Thr)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	11	47364189	11	47342638	42545	51715
NM_000256.3(MYBPC3):c.1519G>A (p.Gly507Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2017)	criteria provided, conflicting interpretations	11	47364234	11	47342683	42543	51713
NM_000256.3(MYBPC3):c.1505G>A (p.Arg502Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	11	47364248	11	47342697	42541	51711
NM_000256.3(MYBPC3):c.1504C>T (p.Arg502Trp)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jul 10, 2018)	criteria provided, conflicting interpretations	11	47364249	11	47342698	42540	51710
NM_000256.3(MYBPC3):c.1484G>A (p.Arg495Gln)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|MYBPC3-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47364269	11	47342718	164113	174776
NM_000256.3(MYBPC3):c.1483C>G (p.Arg495Gly)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	11	47364270	11	47342719	42537	51707
NM_000256.3(MYBPC3):c.1468G>A (p.Gly490Arg)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	11	47364285	11	47342734	42536	51706
NM_000256.3(MYBPC3):c.1456T>G (p.Trp486Gly)	MYBPC3	not specified	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	11	47364382	11	47342831	42531	51701
NM_000256.3(MYBPC3):c.1373G>A (p.Arg458His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified	Uncertain significance(Last reviewed: Sep 14, 2012)	criteria provided, single submitter	11	47364465	11	47342914	42527	51697
NM_000256.3(MYBPC3):c.1370C>T (p.Thr457Met)	MYBPC3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Likely benign(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	11	47364468	11	47342917	161314	171140
NM_000256.3(MYBPC3):c.1357C>T (p.Pro453Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4	Likely pathogenic	criteria provided, single submitter	11	47364481	11	47342930	217475	214117
NM_000256.3(MYBPC3):c.1321G>A (p.Glu441Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47364602	11	47343051	36601	45263
NM_000256.3(MYBPC3):c.1286C>T (p.Ala429Val)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	11	47364637	11	47343086	42518	51688
NM_000256.3(MYBPC3):c.1246G>A (p.Gly416Ser)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	11	47364677	11	47343126	42515	51685
NM_000256.3(MYBPC3):c.1153G>A (p.Val385Met)	MYBPC3	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	11	47365113	11	47343562	219403	222144
NM_000256.3(MYBPC3):c.961G>A (p.Val321Met)	MYBPC3	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	47367887	11	47346336	161310	171141
NM_000256.3(MYBPC3):c.841C>T (p.Arg281Trp)	MYBPC3	not specified|Catecholaminergic polymorphic ventricular tachycardia	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	11	47369212	11	47347661	181052	179359
NM_000256.3(MYBPC3):c.836G>C (p.Gly279Ala)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Nov 12, 2017)	criteria provided, multiple submitters, no conflicts	11	47369217	11	47347666	42798	51968
NM_000256.3(MYBPC3):c.833G>A (p.Gly278Glu)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Personal and/or Family History of Cardiomyopathy	Benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	11	47369220	11	47347669	42797	51967
NM_000256.3(MYBPC3):c.818G>A (p.Arg273His)	MYBPC3	Familial hypertrophic cardiomyopathy 1|Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	11	47369411	11	47347860	161312	171142
NM_000256.3(MYBPC3):c.787G>A (p.Gly263Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	11	47369442	11	47347891	161315	171143
NM_000256.3(MYBPC3):c.772G>A (p.Glu258Lys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2018)	criteria provided, multiple submitters, no conflicts	11	47369975	11	47348424	42792	51962
NM_000256.3(MYBPC3):c.710A>C (p.Tyr237Ser)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	11	47370037	11	47348486	42787	51957
NM_000256.3(MYBPC3):c.682G>A (p.Asp228Asn)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47370065	11	47348514	161304	171144
NM_000256.3(MYBPC3):c.655G>C (p.Val219Leu)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 4, 2018)	criteria provided, multiple submitters, no conflicts	11	47370092	11	47348541	42784	51954
NM_000256.3(MYBPC3):c.646G>A (p.Ala216Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	11	47371333	11	47349782	42779	51949
NM_000256.3(MYBPC3):c.640G>A (p.Asp214Asn)	MYBPC3	Familial hypertrophic cardiomyopathy 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 24, 2013)	criteria provided, conflicting interpretations	11	47371339	11	47349788	191705	189889
NM_000256.3(MYBPC3):c.624G>C (p.Gln208His)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 13, 2017)	criteria provided, multiple submitters, no conflicts	11	47371355	11	47349804	42775	51945
NM_000256.3(MYBPC3):c.530G>A (p.Arg177His)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 13, 2017)	criteria provided, multiple submitters, no conflicts	11	47371449	11	47349898	42767	51937
NM_000256.3(MYBPC3):c.529C>T (p.Arg177Cys)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Left ventricular noncompaction 10|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	11	47371450	11	47349899	36613	45275
NM_000256.3(MYBPC3):c.481C>A (p.Pro161Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Oct 12, 2017)	criteria provided, conflicting interpretations	11	47371589	11	47350038	42759	51929
NM_000256.3(MYBPC3):c.478C>T (p.Arg160Trp)	MYBPC3	Dilated cardiomyopathy 1A|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	11	47371592	11	47350041	161311	171145
NM_000256.3(MYBPC3):c.461T>C (p.Ile154Thr)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	11	47371609	11	47350058	42756	51926
NM_000256.3(MYBPC3):c.223G>A (p.Asp75Asn)	MYBPC3	Familial hypertrophic cardiomyopathy 4|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	11	47372859	11	47351308	161313	171146
NM_000256.3(MYBPC3):c.184A>C (p.Thr62Pro)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	11	47372898	11	47351347	42577	51747
NM_000256.3(MYBPC3):c.13G>T (p.Gly5Trp)	MYBPC3	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jul 3, 2015)	criteria provided, single submitter	11	47374186	11	47352635	217839	214493
NM_000256.3(MYBPC3):c.13G>C (p.Gly5Arg)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Left ventricular hypertrophy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	11	47374186	11	47352635	161305	171147
NM_000256.3(MYBPC3):c.3G>C (p.Met1Ile)	MYBPC3	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, multiple submitters, no conflicts	11	47374196	11	47352645	42747	51917
NM_003120.2(SPI1):c.43C>G (p.Pro15Ala)	SPI1	SPI1-related eosinophilia syndrome	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	11	47399862	11	47378311	522841	513439
NM_004183.3(BEST1):c.26T>G (p.Val9Gly)	BEST1	Vitelliform macular dystrophy type 2	Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	11	61719304	11	61951832	438579	432200
NM_004183.3(BEST1):c.324C>G (p.Ser108Arg)	BEST1	Vitelliform macular dystrophy type 2	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	11	61723266	11	61955794	544680	535225
NM_004183.3(BEST1):c.535A>G (p.Asn179Asp)	BEST1	Vitelliform macular dystrophy type 2	Likely pathogenic(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	11	61724369	11	61956897	438484	432105
NM_004183.3(BEST1):c.544T>C (p.Trp182Arg)	BEST1	Vitelliform macular dystrophy type 2	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	11	61724378	11	61956906	544679	535224
NM_004183.3(BEST1):c.874G>C (p.Glu292Gln)	BEST1	Vitelliform macular dystrophy type 2	Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, single submitter	11	61726976	11	61959504	544678	535223
NM_004183.3(BEST1):c.888C>G (p.Asn296Lys)	BEST1	Vitelliform macular dystrophy type 2	Pathogenic(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	11	61726990	11	61959518	559498	550222
NM_032667.6(BSCL2):c.269C>T (p.Ser90Leu)	BSCL2|HNRNPUL2-BSCL2	Distal hereditary motor neuronopathy type 5|Charcot-Marie-Tooth disease, type 2|Silver spastic paraplegia syndrome|Spastic paraplegia 17|not provided	Pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	11	62469965	11	62702493	4544	19583
NM_138732.2(NRXN2):c.3641G>T (p.Arg1214Leu)	NRXN2	not provided	Uncertain significance(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	11	64390547	11	64623075	129836	135282
NM_138732.2(NRXN2):c.1471C>T (p.Arg491Cys)	NRXN2	not provided	Uncertain significance(Last reviewed: Mar 13, 2014)	criteria provided, single submitter	11	64434956	11	64667484	129830	135276
NM_138732.2(NRXN2):c.1067G>A (p.Arg356Gln)	NRXN2	not provided	Uncertain significance(Last reviewed: Mar 17, 2014)	criteria provided, single submitter	11	64453131	11	64685659	129829	135275
NM_138732.2(NRXN2):c.242T>A (p.Leu81Gln)	NRXN2	not specified	Likely benign	no assertion criteria provided	11	64480930	11	64713458	129831	135277
NM_130799.2(MEN1):c.1621G>A (p.Ala541Thr)	MEN1	Primary hyperparathyroidism|Multiple endocrine neoplasia, type 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	11	64572018	11	64804546	41852	50291
NM_000244.3(MEN1):c.1277G>A (p.Cys426Tyr)	MEN1	Multiple endocrine neoplasia, type 1|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	11	64572594	11	64805122	36523	45185
NM_000244.3(MEN1):c.1267G>A (p.Asp423Asn)	MEN1	Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	11	64572604	11	64805132	16703	31742
NM_000244.3(MEN1):c.578C>T (p.Pro193Leu)	MEN1	Multiple endocrine neoplasia, type 1|not specified|Hereditary cancer-predisposing syndrome|Hyperparathyroidism	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	11	64575454	11	64807982	161295	171148
NM_130799.2(MEN1):c.512G>A (p.Arg171Gln)	MEN1	Multiple endocrine neoplasia, type 1|not specified|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2017)	criteria provided, conflicting interpretations	11	64575505	11	64808033	41854	50293
NM_000244.3(MEN1):c.526C>T (p.Arg176Trp)	MEN1	Multiple endocrine neoplasia, type 1|not specified|Hereditary cancer-predisposing syndrome|Hyperparathyroidism	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	11	64575506	11	64808034	161294	171149
NM_000244.3(MEN1):c.1A>G (p.Met1Val)	MEN1	Multiple endocrine neoplasia, type 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2017)	criteria provided, multiple submitters, no conflicts	11	64577581	11	64810109	36525	45187
NM_018026.3(PACS1):c.607C>T (p.Arg203Trp)	PACS1	Hypotelorism|Multiple congenital anomalies|Schuurs-hoeijmakers syndrome|not provided|Horseshoe kidney|Optic disc pallor|Mitral valve prolapse|Aortic root dilatation|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	11	65978677	11	66211206	39581	48180
NM_006946.3(SPTBN2):c.3101T>C (p.Val1034Ala)	SPTBN2	Spinocerebellar ataxia 5|not specified|not provided|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	11	66468469	11	66700998	130371	135818
NM_006946.3(SPTBN2):c.1877T>C (p.Leu626Pro)	SPTBN2	Spinocerebellar ataxia 5	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	11	66472870	11	66705399	488611	481479
NM_006019.3(TCIRG1):c.2206C>A (p.Arg736Ser)	TCIRG1	Severe congenital neutropenia autosomal dominant|not provided|Congenital neutropenia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2014)	no assertion criteria provided	11	67817691	11	68050224	127173	132671
NM_002335.3(LRP5):c.592A>T (p.Asn198Tyr)	LRP5	High bone mass	Likely pathogenic	no assertion criteria provided	11	68125221	11	68357753	438745	432371
NM_133266.4(SHANK2):c.1136A>G (p.Tyr379Cys)	SHANK2	not specified	Likely benign	no assertion criteria provided	11	70333498	11	70487393	130303	135750
NM_000260.3(MYO7A):c.652G>A (p.Asp218Asn)	MYO7A	Deafness, autosomal dominant 11|Usher syndrome, type 1	Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	11	76867967	11	77156921	29924	38879
NM_000260.3(MYO7A):c.689C>T (p.Ala230Val)	MYO7A	Deafness, autosomal dominant 11|Usher syndrome, type 1|not specified	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2016)	criteria provided, multiple submitters, no conflicts	11	76868004	11	77156958	178993	178258
NM_003797.4(EED):c.1097T>C (p.Met366Thr)	EED	Cohen-Gibson syndrome	Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	11	85988152	11	86277110	584435	575495
NM_000051.3(ATM):c.6116A>T (p.Glu2039Val)	ATM|C11orf65	Familial cancer of breast	Uncertain significance	no assertion criteria provided	11	108186758	11	108316031	417621	404599
NM_000051.3(ATM):c.6860G>C (p.Gly2287Ala)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	11	108196837	11	108326110	127428	132885
NM_000051.3(ATM):c.7271T>G (p.Val2424Gly)	ATM|C11orf65	Familial cancer of breast|Ataxia-telangiectasia syndrome|Ataxia-telangiectasia variant|Breast cancer, susceptibility to|T-cell prolymphocytic leukemia|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	108199929	11	108329202	3023	18062
NM_003002.3(SDHD):c.158C>T (p.Pro53Leu)	SDHD	Paraganglioma and gastric stromal sarcoma|Pheochromocytoma|Paragangliomas 1|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	11	111958686	11	112087962	161388	171127
NM_003002.3(SDHD):c.242C>T (p.Pro81Leu)	SDHD	Paraganglioma and gastric stromal sarcoma|Pheochromocytoma|Paragangliomas 1|Hereditary Paraganglioma-Pheochromocytoma Syndromes|Paragangliomas 1 with sensorineural hearing loss|not provided|Cowden syndrome 3|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	11	111959663	11	112088939	6896	21935
NM_004588.4(SCN2B):c.332C>T (p.Ser111Leu)	SCN2B	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	11	118038916	11	118168201	427979	419281
NM_001197104.1(KMT2A):c.89C>G (p.Ala30Gly)	KMT2A	not specified|not provided	Benign/Likely benign(Last reviewed: Jan 24, 2017)	criteria provided, multiple submitters, no conflicts	11	118307316	11	118436601	158711	168850
NM_001197104.1(KMT2A):c.1433G>A (p.Arg478Gln)	KMT2A	Wiedemann-Steiner syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	11	118343307	11	118472592	561043	552149
NM_001197104.1(KMT2A):c.1642A>G (p.Thr548Ala)	KMT2A	Wiedemann-Steiner syndrome	Likely benign	no assertion criteria provided	11	118343516	11	118472801	375628	362442
NM_001197104.1(KMT2A):c.4342T>C (p.Cys1448Arg)	KMT2A	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Feb 12, 2013)	criteria provided, single submitter	11	118359338	11	118488623	216962	213607
NM_001197104.1(KMT2A):c.4426T>A (p.Cys1476Ser)	KMT2A	Wiedemann-Steiner syndrome	Uncertain significance(Last reviewed: Apr 21, 2014)	criteria provided, single submitter	11	118359422	11	118488707	158703	168854
NM_001197104.1(KMT2A):c.5494C>A (p.Pro1832Thr)	KMT2A	Wiedemann-Steiner syndrome	Likely pathogenic(Last reviewed: Oct 11, 2013)	criteria provided, single submitter	11	118366545	11	118495830	209168	205767
NM_001197104.1(KMT2A):c.6080G>A (p.Gly2027Glu)	KMT2A	Wiedemann-Steiner syndrome	Likely pathogenic	no assertion criteria provided	11	118370550	11	118499835	375619	362433
NM_001197104.1(KMT2A):c.6572G>A (p.Arg2191Gln)	KMT2A	not specified	Likely benign(Last reviewed: Jan 3, 2014)	criteria provided, single submitter	11	118373179	11	118502464	158706	168856
NM_000190.4(HMBS):c.257A>T (p.Glu86Val)	HMBS	Acute intermittent porphyria	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	118959973	11	119089263	161252	171128
NM_000190.4(HMBS):c.500G>A (p.Arg167Gln)	HMBS	Acute intermittent porphyria|not provided	Pathogenic(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	11	118962124	11	119091414	1446	16485
NM_000190.4(HMBS):c.583C>T (p.Arg195Cys)	HMBS	Acute intermittent porphyria	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	118962207	11	119091497	161251	171129
NM_000190.4(HMBS):c.674G>A (p.Arg225Gln)	HMBS	Acute intermittent porphyria|not specified	Uncertain significance(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	11	118963136	11	119092426	161253	171130
NM_000190.4(HMBS):c.962G>A (p.Arg321His)	HMBS	Acute intermittent porphyria|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	11	118963869	11	119093159	161250	171131
NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn)	HMBS	Acute intermittent porphyria	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	11	118963982	11	119093272	161249	171132
NM_005188.3(CBL):c.1099C>A (p.Gln367Lys)	CBL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	Likely pathogenic(Last reviewed: Dec 14, 2015)	criteria provided, single submitter	11	119148879	11	119278169	178870	175344
NM_005188.3(CBL):c.1754G>T (p.Arg585Leu)	CBL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2013)	criteria provided, conflicting interpretations	11	119156089	11	119285379	179116	175068
NM_015645.4(C1QTNF5):c.489C>G (p.Ser163Arg)	MFRP|C1QTNF5	Late-onset retinal degeneration	Likely pathogenic(Last reviewed: Jun 12, 2012)	criteria provided, single submitter	11	119210284	11	119339574	2126	17165
NM_005422.2(TECTA):c.3107G>A (p.Cys1036Tyr)	TECTA	Sensorineural hearing loss	Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, single submitter	11	121008295	11	121137586	517663	508754
NM_005422.2(TECTA):c.4527C>G (p.Cys1509Trp)	TECTA	not specified	Uncertain significance(Last reviewed: Sep 18, 2013)	criteria provided, single submitter	11	121028771	11	121158062	165366	175087
NM_005422.2(TECTA):c.6155G>A (p.Cys2052Tyr)	TECTA	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	11	121058696	11	121187987	165373	175093
NM_152722.4(HEPACAM):c.592G>A (p.Asp198Asn)	HEPACAM	Megalencephalic leukoencephalopathy with subcortical cysts 2b, remitting, with or without mental retardation	Uncertain significance(Last reviewed: Mar 3, 2017)	criteria provided, single submitter	11	124793742	11	124923846	522820	513438
NM_032531.3(KIRREL3):c.1177G>A (p.Ala393Thr)	KIRREL3	not specified	Likely benign(Last reviewed: Sep 16, 2013)	criteria provided, single submitter	11	126314949	11	126445054	129421	134867
NM_032531.3(KIRREL3):c.655G>A (p.Val219Met)	KIRREL3	not provided	Uncertain significance(Last reviewed: Aug 28, 2013)	criteria provided, single submitter	11	126333139	11	126463244	129422	134868
NM_032531.3(KIRREL3):c.568A>G (p.Ile190Val)	KIRREL3	not specified	Likely benign	no assertion criteria provided	11	126343227	11	126473332	129428	134874
NM_032531.3(KIRREL3):c.103G>A (p.Ala35Thr)	KIRREL3	not provided	Uncertain significance(Last reviewed: Aug 29, 2013)	criteria provided, single submitter	11	126432760	11	126562865	129419	134865
NM_000890.3(KCNJ5):c.616G>A (p.Ala206Thr)	KCNJ5	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	11	128781784	11	128911889	427972	419282
NM_000719.6(CACNA1C):c.1468G>A (p.Gly490Arg)	CACNA1C	Timothy syndrome|Brugada syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	12	2659186	12	2550020	17634	32673
NM_000719.6(CACNA1C):c.1553G>A (p.Arg518His)	CACNA1C	Familial hypertrophic cardiomyopathy 1|Long QT syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	12	2675632	12	2566466	372313	360088
NM_000719.6(CACNA1C):c.1582T>G (p.Trp528Gly)	CACNA1C	Primary dilated cardiomyopathy|Sudden cardiac death|Dilated cardiomyopathy	Uncertain significance(Last reviewed: Mar 14, 2017)	criteria provided, single submitter	12	2675661	12	2566495	492985	485934
NM_000719.6(CACNA1C):c.3679G>A (p.Val1227Ile)	CACNA1C	Timothy syndrome|Long QT syndrome|not specified|not provided|Cardiovascular phenotype|Short QT Syndrome 4	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	12	2719827	12	2610661	234984	236794
NM_000719.6(CACNA1C):c.4087G>C (p.Val1363Leu)	CACNA1C	CACNA1C-related condition	Likely pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	12	2763013	12	2653847	522828	513443
NM_000719.6(CACNA1C):c.5150C>G (p.Ala1717Gly)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Cardiomyopathy, restrictive|Long QT syndrome|Brugada syndrome|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	12	2788668	12	2679502	93411	99318
NM_000719.6(CACNA1C):c.5593G>A (p.Glu1865Lys)	CACNA1C|CACNA1C-AS1	Timothy syndrome|Long QT syndrome|Brugada syndrome|not specified|not provided|Cardiovascular phenotype|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2018)	criteria provided, conflicting interpretations	12	2794921	12	2685755	191566	189341
NM_000719.6(CACNA1C):c.5639G>A (p.Arg1880Gln)	CACNA1C|CACNA1C-AS1	Long QT syndrome|Brugada syndrome|not specified|not provided|Brugada syndrome (shorter-than-normal QT interval)|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	12	2794967	12	2685801	67555	78451
NM_000719.6(CACNA1C):c.6040G>A (p.Val2014Ile)	CACNA1C|CACNA1C-AS1	Brugada syndrome 3|Long QT syndrome|Brugada syndrome|not specified|not provided|Brugada syndrome (shorter-than-normal QT interval)|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Mar 17, 2018)	criteria provided, conflicting interpretations	12	2797868	12	2688702	67556	78452
NM_020638.2(FGF23):c.536G>A (p.Arg179Gln)	FGF23	Autosomal dominant hypophosphatemic rickets	Pathogenic(Last reviewed: Dec 5, 2013)	criteria provided, multiple submitters, no conflicts	12	4479729	12	4370563	36135	44799
NM_020638.2(FGF23):c.535C>T (p.Arg179Trp)	FGF23	Autosomal dominant hypophosphatemic rickets|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, multiple submitters, no conflicts	12	4479730	12	4370564	5026	20065
NM_020638.2(FGF23):c.260G>A (p.Gly87Asp)	FGF23	Tumoral calcinosis, familial, hyperphosphatemic	Likely pathogenic(Last reviewed: Jul 1, 2014)	criteria provided, single submitter	12	4481815	12	4372649	216929	213620
NM_002234.3(KCNA5):c.1733G>A (p.Arg578Lys)	KCNA5	Atrial fibrillation, familial, 7|Brugada syndrome 1|not specified	Benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	12	5155046	12	5045880	191573	189357
NM_001065.3(TNFRSF1A):c.362G>A (p.Arg121Gln)	TNFRSF1A	TNF receptor-associated periodic fever syndrome (TRAPS)|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 28, 2018)	criteria provided, conflicting interpretations	12	6442643	12	6333477	217017	213624
NM_001733.7(C1R):c.890G>A (p.Gly297Asp)	C1R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	12	7241461	12	7088865	372129	359036
NM_001733.7(C1R):c.869A>G (p.Asp290Gly)	C1R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	12	7241482	12	7088886	267356	262524
NM_001733.7(C1R):c.149_150delTCinsAT (p.Val50Asp)	C1R	Ehlers-Danlos syndrome, type 8|Ehlers-Danlos syndrome, periodontal type, 2	Pathogenic(Last reviewed: Aug 23, 2016)	criteria provided, single submitter	12	7244129 - 7244130	12	7091533 - 7091534	372130	359037
NM_144670.5(A2ML1):c.3397A>C (p.Asn1133His)	A2ML1	Noonan syndrome 1	Uncertain significance(Last reviewed: Aug 3, 2018)	no assertion criteria provided	12	9013788	12	8861192	559445	550169
NM_002336.2(LRP6):c.4298C>T (p.Ser1433Leu)	LRP6	Tooth agenesis|Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12279639	12	12126705	225160	227047
NM_002336.2(LRP6):c.4136G>A (p.Gly1379Asp)	LRP6	Tooth agenesis|Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12279801	12	12126867	225159	227048
NM_002336.2(LRP6):c.3365A>C (p.Asp1122Ala)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12300332	12	12147398	225158	227051
NM_002336.2(LRP6):c.2995G>C (p.Gly999Arg)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12302087	12	12149153	225157	227052
NM_002336.2(LRP6):c.2058C>G (p.Ile686Met)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12315348	12	12162414	225156	227054
NM_002336.2(LRP6):c.1620G>T (p.Leu540Phe)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12318155	12	12165221	225155	227055
NM_002336.2(LRP6):c.1609G>A (p.Gly537Arg)	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12318166	12	12165232	225151	227056
NM_002336.2(LRP6):c.1406C>T (p.Pro469Leu)	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12332883	12	12179949	225150	227057
NM_002336.2(LRP6):c.1004G>T (p.Arg335Leu)	LRP6	Orofacial clefting	Uncertain significance(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12334346	12	12181412	225154	227058
NM_002336.2(LRP6):c.517C>G (p.Arg173Gly)	LRP6	Tooth agenesis	Likely pathogenic(Last reviewed: Mar 10, 2016)	criteria provided, single submitter	12	12356267	12	12203333	225149	227059
NM_004064.4(CDKN1B):c.397C>A (p.Pro133Thr)	CDKN1B	Multiple endocrine neoplasia, type 4|Primary hyperparathyroidism|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	12	12871170	12	12718236	217127	213772
NM_000834.4(GRIN2B):c.2471T>G (p.Met824Arg)	GRIN2B	Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13720086	12	13567152	561027	552155
NM_000834.4(GRIN2B):c.2450A>G (p.Asn817Ser)	GRIN2B	not provided|Epileptic encephalopathy, early infantile, 27	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	12	13720107	12	13567173	546556	536833
NM_000834.4(GRIN2B):c.2071A>G (p.Thr691Ala)	GRIN2B	Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13724838	12	13571904	561023	552157
NM_000834.3(GRIN2B):c.2044C>T (p.Arg682Cys)	GRIN2B	Mental retardation, autosomal dominant 6	Pathogenic(Last reviewed: Jan 21, 2014)	criteria provided, single submitter	12	13724865	12	13571931	29730	38685
NM_000834.4(GRIN2B):c.1937A>G (p.Tyr646Cys)	GRIN2B	Epileptic encephalopathy, early infantile, 27	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13761610	12	13608676	561025	552158
NM_000834.4(GRIN2B):c.1821G>C (p.Trp607Cys)	GRIN2B	Mental retardation, autosomal dominant 6	Likely pathogenic(Last reviewed: Mar 13, 2015)	no assertion criteria provided	12	13761726	12	13608792	374327	361203
NM_000834.4(GRIN2B):c.1306T>C (p.Cys436Arg)	GRIN2B	Mental retardation, autosomal dominant 6	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	13769411	12	13616477	561022	552160
NM_004963.3(GUCY2C):c.410T>C (p.Leu137Ser)	GUCY2C|C12orf60	Duodenal atresia|Asplenia|Duodenal atresia|Reduced number of intrahepatic bile ducts|Abnormal biliary tract morphology	Pathogenic	no assertion criteria provided	12	14836177	12	14683243	375380	362154
NM_005691.3(ABCC9):c.3347G>A (p.Arg1116His)	ABCC9	Hypertrichotic osteochondrodysplasia	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	21995374	12	21842440	35533	44204
NM_005691.3(ABCC9):c.2878G>C (p.Glu960Gln)	ABCC9	Prolonged QT interval	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	12	21998755	12	21845821	427957	419285
NM_005691.3(ABCC9):c.878T>C (p.Phe293Ser)	ABCC9	Hypertrichotic osteochondrodysplasia	Likely pathogenic(Last reviewed: Jun 3, 2015)	criteria provided, single submitter	12	22065939	12	21913005	369679	353904
NM_004985.4(KRAS):c.466T>G (p.Phe156Val)	KRAS	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	12	25362830	12	25209896	45127	54294
NM_004985.4(KRAS):c.458A>T (p.Asp153Val)	KRAS	Noonan syndrome 3|Noonan syndrome|not specified|not provided|Rasopathy|Cardiofaciocutaneous syndrome 2	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25362838	12	25209904	12587	27626
NM_004985.4(KRAS):c.214A>T (p.Met72Leu)	KRAS	Noonan syndrome	Pathogenic(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	12	25380244	12	25227310	179141	175714
NM_004985.4(KRAS):c.194G>T (p.Ser65Ile)	KRAS	Noonan syndrome 3|Rasopathy	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	25380264	12	25227330	438796	432423
NM_004985.4(KRAS):c.179G>T (p.Gly60Val)	KRAS	Non-small cell lung cancer|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	12	25380279	12	25227345	163766	175855
NM_004985.4(KRAS):c.178G>C (p.Gly60Arg)	KRAS	not provided|Rasopathy|Cardiofaciocutaneous syndrome 2|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25380280	12	25227346	12586	27625
NM_004985.4(KRAS):c.173C>T (p.Thr58Ile)	KRAS	Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25380285	12	25227351	12588	27627
NM_004985.4(KRAS):c.101C>T (p.Pro34Leu)	KRAS	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25398218	12	25245284	40454	48924
NM_004985.4(KRAS):c.101C>G (p.Pro34Arg)	KRAS	not provided|Rasopathy|Cardiofaciocutaneous syndrome 2	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	12	25398218	12	25245284	12590	27629
NM_004985.4(KRAS):c.65A>G (p.Gln22Arg)	KRAS	Noonan syndrome 3|Noonan syndrome|not specified|not provided|Rasopathy|Cardiofaciocutaneous syndrome 2	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25398254	12	25245320	40452	48922
NM_004985.4(KRAS):c.40G>A (p.Val14Ile)	KRAS	Endometrial carcinoma|Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	25398279	12	25245345	12589	27628
NM_012062.4(DNM1L):c.1048G>A (p.Gly350Arg)	DNM1L	Encephalopathy due to defective mitochondrial and peroxisomal fission 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	32875536	12	32722602	253267	247689
NM_012063.3(DNM1L):c.1135G>A (p.Glu379Lys)	DNM1L|YARS2	Encephalopathy due to defective mitochondrial and peroxisomal fission 1	Likely pathogenic(Last reviewed: Jun 23, 2014)	no assertion criteria provided	12	32884003	12	32731069	374321	361204
NM_012062.4(DNM1L):c.1207C>T (p.Arg403Cys)	DNM1L|YARS2	Encephalopathy due to defective mitochondrial and peroxisomal fission 1|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	12	32884296	12	32731362	214313	211619
NM_004572.3(PKP2):c.2431C>A (p.Arg811Ser)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2018)	criteria provided, conflicting interpretations	12	32949101	12	32796167	45068	54235
NM_001005242.2(PKP2):c.1930T>C (p.Ser644Pro)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	12	32974373	12	32821439	45055	54222
NM_004572.3(PKP2):c.1759G>A (p.Val587Ile)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	12	32977026	12	32824092	36681	45342
NM_004572.3(PKP2):c.1577C>T (p.Thr526Met)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	12	32994073	12	32841139	45033	54200
NM_004572.3(PKP2):c.1465G>A (p.Gly489Arg)	PKP2	Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	12	32996161	12	32843227	161331	171150
NM_004572.3(PKP2):c.505A>G (p.Ser169Gly)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2018)	criteria provided, conflicting interpretations	12	33031309	12	32878375	45081	54248
NM_004572.3(PKP2):c.419C>T (p.Ser140Phe)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	12	33031395	12	32878461	45077	54244
NM_001005242.2(PKP2):c.184C>A (p.Gln62Lys)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	12	33049482	12	32896548	161332	171151
NM_004572.3(PKP2):c.76G>A (p.Asp26Asn)	PKP2	Arrhythmogenic right ventricular cardiomyopathy, type 9|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Aug 21, 2017)	criteria provided, multiple submitters, no conflicts	12	33049590	12	32896656	45084	54251
NM_198578.3(LRRK2):c.4321C>A (p.Arg1441Ser)	LRRK2	Parkinson disease, late-onset	Pathogenic(Last reviewed: Apr 14, 2016)	no assertion criteria provided	12	40704236	12	40310434	225276	227175
NM_198578.3(LRRK2):c.6055G>A (p.Gly2019Ser)	LRRK2	Parkinson disease 8, autosomal dominant|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 17, 2018)	criteria provided, multiple submitters, no conflicts	12	40734202	12	40340400	1940	16979
NM_001844.4(COL2A1):c.4316C>T (p.Thr1439Met)	COL2A1	Spondyloperipheral dysplasia|Spondyloepiphyseal dysplasia	Likely pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	12	48367873	12	47974090	17385	32424
NM_001844.4(COL2A1):c.1979G>A (p.Gly660Glu)	COL2A1	Achondrogenesis, type II	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	12	48377482	12	47983699	488485	481353
NM_003482.3(KMT2D):c.16411A>T (p.Arg5471Trp)	KMT2D	Kabuki syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49416064	12	49022281	158741	168902
NM_003482.3(KMT2D):c.15671G>A (p.Arg5224His)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2017)	criteria provided, conflicting interpretations	12	49420078	12	49026295	134730	138469
NM_003482.3(KMT2D):c.15641G>C (p.Arg5214Pro)	KMT2D	Kabuki syndrome 1	Pathogenic	no assertion criteria provided	12	49420108	12	49026325	523665	514313
NM_003482.3(KMT2D):c.15361G>T (p.Ala5121Ser)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49420388	12	49026605	158737	168906
NM_003482.3(KMT2D):c.15245T>G (p.Val5082Gly)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49420504	12	49026721	158736	168907
NM_003482.3(KMT2D):c.14840C>A (p.Pro4947His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49420909	12	49027126	158733	168910
NM_003482.3(KMT2D):c.14080G>C (p.Glu4694Gln)	KMT2D	Kabuki syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2016)	criteria provided, conflicting interpretations	12	49423015	12	49029232	134726	138465
NM_003482.3(KMT2D):c.13045C>G (p.Pro4349Ala)	KMT2D	Kabuki syndrome 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)	criteria provided, conflicting interpretations	12	49425443	12	49031660	94165	100065
NM_003482.3(KMT2D):c.13001C>T (p.Ala4334Val)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: May 22, 2014)	criteria provided, single submitter	12	49425487	12	49031704	158727	168915
NM_003482.3(KMT2D):c.12913G>A (p.Val4305Ile)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	12	49425575	12	49031792	94162	100062
NM_003482.3(KMT2D):c.12028T>C (p.Ser4010Pro)	KMT2D	not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	12	49426460	12	49032677	94154	100054
NM_003482.3(KMT2D):c.11610G>A (p.Met3870Ile)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 18, 2017)	criteria provided, multiple submitters, no conflicts	12	49426878	12	49033095	134717	138456
NM_003482.3(KMT2D):c.11563G>C (p.Ala3855Pro)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49426925	12	49033142	158718	168924
NM_003482.3(KMT2D):c.10993C>G (p.Pro3665Ala)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 28, 2017)	criteria provided, conflicting interpretations	12	49427495	12	49033712	134711	138450
NM_003482.3(KMT2D):c.10444C>T (p.Arg3482Trp)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	12	49428256	12	49034473	158713	168929
NM_003482.3(KMT2D):c.10312G>A (p.Val3438Met)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49428638	12	49034855	158712	168930
NM_003482.3(KMT2D):c.10256A>G (p.Asp3419Gly)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	12	49428694	12	49034911	94136	100036
NM_003482.3(KMT2D):c.10192A>G (p.Met3398Val)	KMT2D	Kabuki syndrome 1|not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49430947	12	49037164	94135	100035
NM_003482.3(KMT2D):c.9491G>A (p.Arg3164Gln)	KMT2D	not specified	Likely benign(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	12	49431648	12	49037865	158791	168932
NM_003482.3(KMT2D):c.8360A>C (p.Asn2787Thr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49433011	12	49039228	158789	168934
NM_003482.3(KMT2D):c.7904G>A (p.Arg2635Gln)	KMT2D	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49433649	12	49039866	158786	168937
NM_003482.3(KMT2D):c.7841C>T (p.Ser2614Leu)	KMT2D	not specified	Likely benign(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	12	49433712	12	49039929	158785	168938
NM_003482.3(KMT2D):c.7670C>T (p.Pro2557Leu)	KMT2D	not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, multiple submitters, no conflicts	12	49433883	12	49040100	94250	100150
NM_003482.3(KMT2D):c.7198C>G (p.Pro2400Ala)	KMT2D	Kabuki syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2017)	criteria provided, conflicting interpretations	12	49434355	12	49040572	158784	168939
NM_003482.3(KMT2D):c.7144C>T (p.Pro2382Ser)	KMT2D	not specified|Kabuki syndrome	Benign(Last reviewed: Jul 23, 2016)	criteria provided, multiple submitters, no conflicts	12	49434409	12	49040626	94247	100147
NM_003482.3(KMT2D):c.6844C>T (p.Arg2282Trp)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Aug 16, 2013)	criteria provided, single submitter	12	49434709	12	49040926	158781	168942
NM_003482.3(KMT2D):c.6640G>A (p.Ala2214Thr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Jan 8, 2014)	criteria provided, single submitter	12	49434913	12	49041130	158777	168946
NM_003482.3(KMT2D):c.6020A>C (p.Glu2007Ala)	KMT2D	not specified	Likely benign(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	12	49435961	12	49042178	158774	168949
NM_003482.3(KMT2D):c.4421G>A (p.Cys1474Tyr)	KMT2D	Kabuki syndrome 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 24, 2016)	criteria provided, conflicting interpretations	12	49440205	12	49046422	158770	168953
NM_003482.3(KMT2D):c.4343G>A (p.Cys1448Tyr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49440467	12	49046684	158768	168955
NM_003482.3(KMT2D):c.4131G>C (p.Gln1377His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49442442	12	49048659	158766	168957
NM_003482.3(KMT2D):c.4083G>C (p.Gln1361His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49442490	12	49048707	158764	168959
NM_003482.3(KMT2D):c.3803A>C (p.Asp1268Ala)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49443568	12	49049785	158761	168961
NM_003482.3(KMT2D):c.2657C>T (p.Pro886Leu)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49444809	12	49051026	158756	168965
NM_003482.3(KMT2D):c.2438C>T (p.Pro813Leu)	KMT2D	not specified|not provided|Kabuki syndrome	Benign(Last reviewed: Aug 28, 2017)	criteria provided, multiple submitters, no conflicts	12	49445028	12	49051245	94202	100102
NM_003482.3(KMT2D):c.2389C>G (p.Leu797Val)	KMT2D	Kabuki syndrome 1	Likely pathogenic(Last reviewed: Dec 16, 2014)	no assertion criteria provided	12	49445077	12	49051294	374296	361205
NM_003482.3(KMT2D):c.2215G>A (p.Glu739Lys)	KMT2D	not specified	Likely benign(Last reviewed: May 9, 2014)	criteria provided, single submitter	12	49445251	12	49051468	158751	168969
NM_003482.3(KMT2D):c.2078C>A (p.Pro693His)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49445388	12	49051605	158750	168970
NM_003482.3(KMT2D):c.2074C>A (p.Pro692Thr)	KMT2D	not specified|not provided|Kabuki syndrome	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	49445392	12	49051609	134664	138403
NM_003482.3(KMT2D):c.2062C>T (p.Arg688Cys)	KMT2D	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49445404	12	49051621	158749	168971
NM_003482.3(KMT2D):c.1940C>A (p.Pro647Gln)	KMT2D	Kabuki syndrome 1|not specified|not provided|Kabuki syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2017)	criteria provided, conflicting interpretations	12	49445526	12	49051743	94196	100096
NM_003482.3(KMT2D):c.1426G>A (p.Ala476Thr)	KMT2D	not specified|Kabuki syndrome	Benign(Last reviewed: Jul 27, 2017)	criteria provided, multiple submitters, no conflicts	12	49446040	12	49052257	94174	100074
NM_003482.3(KMT2D):c.968G>A (p.Cys323Tyr)	KMT2D	Kabuki syndrome 1	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	12	49446842	12	49053059	158792	168976
NM_003482.3(KMT2D):c.248G>A (p.Arg83Gln)	KMT2D	not specified|Kabuki syndrome	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	12	49448463	12	49054680	94203	100103
NM_003482.3(KMT2D):c.125C>T (p.Ser42Phe)	KMT2D	Kabuki syndrome 1	Likely pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	12	49448734	12	49054951	438838	432470
NM_006009.3(TUBA1A):c.1274T>A (p.Met425Lys)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49578875	12	49185092	160148	168980
NM_006009.3(TUBA1A):c.1265G>A (p.Arg422His)	TUBA1A	Lissencephaly 3|not provided	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, multiple submitters, no conflicts	12	49578884	12	49185101	7077	22116
NM_006009.3(TUBA1A):c.1205G>T (p.Arg402Leu)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: Jan 17, 2014)	criteria provided, single submitter	12	49578944	12	49185161	160147	168981
NM_006009.3(TUBA1A):c.1205G>A (p.Arg402His)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: Jun 21, 2013)	criteria provided, single submitter	12	49578944	12	49185161	7071	22110
NM_006009.3(TUBA1A):c.1204C>T (p.Arg402Cys)	TUBA1A	Lissencephaly 3|Limb-girdle muscular dystrophy, type 2D|not provided	Pathogenic(Last reviewed: May 15, 2017)	criteria provided, multiple submitters, no conflicts	12	49578945	12	49185162	160146	168982
NM_006009.3(TUBA1A):c.1204C>A (p.Arg402Ser)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49578945	12	49185162	160145	168983
NM_001270399.1(TUBA1A):c.1169G>A (p.Arg390His)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	12	49578980	12	49185197	488628	481496
NM_006009.3(TUBA1A):c.1148C>T (p.Ala383Val)	TUBA1A	Lissencephaly 3|Abnormality of neuronal migration	Likely pathogenic(Last reviewed: Feb 28, 2013)	criteria provided, single submitter	12	49579001	12	49185218	160143	168985
NM_006009.3(TUBA1A):c.1129A>G (p.Met377Val)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579020	12	49185237	160142	168986
NM_006009.3(TUBA1A):c.995T>C (p.Ile332Thr)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579154	12	49185371	160169	168988
NM_006009.3(TUBA1A):c.991G>A (p.Ala331Thr)	TUBA1A	Lissencephaly 3	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579158	12	49185375	160168	168989
NM_001270399.1(TUBA1A):c.920C>T (p.Pro307Leu)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	12	49579229	12	49185446	438589	432218
NM_006009.3(TUBA1A):c.808G>T (p.Ala270Ser)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Mar 10, 2014)	criteria provided, single submitter	12	49579341	12	49185558	160164	168992
NM_006009.3(TUBA1A):c.791G>A (p.Arg264His)	TUBA1A	Lissencephaly 3|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2017)	criteria provided, conflicting interpretations	12	49579358	12	49185575	287392	271629
NM_006009.3(TUBA1A):c.790C>T (p.Arg264Cys)	TUBA1A	Lissencephaly 3|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, multiple submitters, no conflicts	12	49579359	12	49185576	7070	22109
NM_006009.3(TUBA1A):c.758C>G (p.Thr253Arg)	TUBA1A	Lissencephaly 3	Uncertain significance(Last reviewed: Mar 5, 2014)	criteria provided, single submitter	12	49579391	12	49185608	160163	168993
NM_006009.3(TUBA1A):c.698A>G (p.Gln233Arg)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49579451	12	49185668	160162	168994
NM_006009.3(TUBA1A):c.481T>G (p.Tyr161Asp)	TUBA1A	Lissencephaly 3	Pathogenic(Last reviewed: May 30, 2014)	criteria provided, single submitter	12	49579668	12	49185885	160158	168997
NM_006009.3(TUBA1A):c.352G>A (p.Val118Met)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: May 20, 2014)	criteria provided, single submitter	12	49580116	12	49186333	217023	213622
NM_006009.3(TUBA1A):c.162T>A (p.Ser54Arg)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Jun 28, 2013)	criteria provided, single submitter	12	49580458	12	49186675	160150	169004
NM_006009.3(TUBA1A):c.152C>T (p.Thr51Ile)	TUBA1A	Lissencephaly 3	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	12	49580468	12	49186685	160149	169005
NM_006009.3(TUBA1A):c.5G>A (p.Arg2His)	TUBA1A	Lissencephaly 3|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 3, 2015)	criteria provided, multiple submitters, no conflicts	12	49580615	12	49186832	160161	169007
NM_014191.3(SCN8A):c.647T>G (p.Val216Gly)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: Oct 3, 2014)	no assertion criteria provided	12	52082574	12	51688790	374298	361206
NM_014191.3(SCN8A):c.2549G>A (p.Arg850Gln)	SCN8A	Early infantile epileptic encephalopathy 13|not provided|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	12	52159459	12	51765675	135651	139369
NM_014191.3(SCN8A):c.3076C>T (p.Arg1026Cys)	SCN8A	not specified|Early infantile epileptic encephalopathy|Early Infantile Epileptic Encephalopathy, Autosomal Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Aug 10, 2017)	criteria provided, multiple submitters, no conflicts	12	52162823	12	51769039	130244	135691
NM_014191.3(SCN8A):c.3158T>G (p.Ile1053Ser)	SCN8A	not provided|Early Infantile Epileptic Encephalopathy, Autosomal Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	12	52162905	12	51769121	130245	135692
NM_014191.3(SCN8A):c.4403A>G (p.Asn1468Ser)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	12	52183186	12	51789402	374375	361207
NM_014191.3(SCN8A):c.4409A>C (p.Gln1470Pro)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	12	52183192	12	51789408	488588	481456
NM_014191.3(SCN8A):c.4748T>C (p.Ile1583Thr)	SCN8A	not specified|Early infantile epileptic encephalopathy 13|not provided|Early infantile epileptic encephalopathy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2018)	criteria provided, conflicting interpretations	12	52188378	12	51794594	130248	135695
NM_014191.3(SCN8A):c.4774G>C (p.Val1592Leu)	SCN8A	Early infantile epileptic encephalopathy 13	Likely pathogenic(Last reviewed: Oct 31, 2013)	criteria provided, single submitter	12	52188404	12	51794620	130249	135696
NM_014191.3(SCN8A):c.5630A>G (p.Asn1877Ser)	SCN8A	Early infantile epileptic encephalopathy 13|not provided|Focal epilepsy|Early infantile epileptic encephalopathy|Seizures, benign familial infantile, 5	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	12	52200900	12	51807116	130252	135699
NM_000020.2(ACVRL1):c.88C>T (p.Pro30Ser)	ACVRL1	Haemorrhagic telangiectasia 2	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	12	52306909	12	51913125	161202	171152
NM_000020.2(ACVRL1):c.578T>C (p.Leu193Pro)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2	Likely pathogenic(Last reviewed: Jun 28, 2018)	no assertion criteria provided	12	52307810	12	51914026	548119	538606
NM_000020.2(ACVRL1):c.890A>G (p.His297Arg)	ACVRL1	not specified|Haemorrhagic telangiectasia 2	Uncertain significance(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	12	52309126	12	51915342	161204	171153
NM_000020.2(ACVRL1):c.1031G>A (p.Cys344Tyr)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	12	52309267	12	51915483	8254	23293
NM_000020.2(ACVRL1):c.1157G>A (p.Arg386His)	ACVRL1	Haemorrhagic telangiectasia 2	Likely pathogenic(Last reviewed: Jun 1, 2014)	no assertion criteria provided	12	52309928	12	51916144	161203	171154
NM_000020.2(ACVRL1):c.1445C>T (p.Ala482Val)	ACVRL1	Hereditary hemorrhagic telangiectasia type 2|not specified|Haemorrhagic telangiectasia 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2017)	criteria provided, conflicting interpretations	12	52314610	12	51920826	161201	171155
NM_003276.2(TMPO):c.370C>T (p.Leu124Phe)	TMPO	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	12	98921754	12	98527976	427956	419286
NM_002465.3(MYBPC1):c.742G>A (p.Glu248Lys)	MYBPC1	not provided	Pathogenic(Last reviewed: May 6, 2016)	criteria provided, single submitter	12	102036273	12	101642495	225889	227702
NM_130466.3(UBE3B):c.2962G>A (p.Ala988Thr)	UBE3B	Optic nerve hypoplasia	Likely benign	criteria provided, single submitter	12	109971310	12	109533505	496688	488170
NM_021625.4(TRPV4):c.2389G>A (p.Glu797Lys)	TRPV4	Metatrophic dysplasia|Spondylometaphyseal dysplasia, Kozlowski type|Spondyloepiphyseal dysplasia Maroteaux type|Skeletal dysplasia|Neuromuscular Diseases	Pathogenic(Last reviewed: Apr 2, 2014)	no assertion criteria provided	12	110222190	12	109784385	18435	33474
NM_021625.4(TRPV4):c.1445T>C (p.Met482Thr)	TRPV4	Charcot-Marie-Tooth disease type 2C	Uncertain significance	no assertion criteria provided	12	110232180	12	109794375	590924	581868
NM_021625.4(TRPV4):c.1207T>A (p.Ser403Thr)	TRPV4	Metatrophic dysplasia	Pathogenic(Last reviewed: Dec 29, 2016)	no assertion criteria provided	12	110234455	12	109796650	370071	356978
NM_021625.4(TRPV4):c.943C>T (p.Arg315Trp)	TRPV4	Distal spinal muscular atrophy, congenital nonprogressive|Scapuloperoneal spinal muscular atrophy|Charcot-Marie-Tooth disease type 2C|Charcot-Marie-Tooth disease|not provided|Neuromuscular Diseases	Pathogenic(Last reviewed: Sep 30, 2017)	criteria provided, multiple submitters, no conflicts	12	110236628	12	109798823	4999	20038
NM_021625.4(TRPV4):c.806G>A (p.Arg269His)	TRPV4	Distal spinal muscular atrophy, congenital nonprogressive|Charcot-Marie-Tooth disease type 2C|Charcot-Marie-Tooth disease|not provided|Neuromuscular Diseases|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	12	110238470	12	109800665	5000	20039
NM_021625.4(TRPV4):c.694C>T (p.Arg232Cys)	TRPV4	Distal spinal muscular atrophy, congenital nonprogressive|Charcot-Marie-Tooth disease type 2C|Skeletal dysplasia|not provided|Neuromuscular Diseases	Pathogenic(Last reviewed: Jul 19, 2017)	criteria provided, multiple submitters, no conflicts	12	110240814	12	109803009	30472	39429
NM_000432.3(MYL2):c.488A>C (p.Glu163Ala)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	12	111348894	12	110911090	43480	52650
NM_000432.3(MYL2):c.485G>A (p.Gly162Glu)	MYL2	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	12	111348897	12	110911093	43479	52649
NM_000432.3(MYL2):c.275G>T (p.Gly92Val)	MYL2	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	12	111351128	12	110913324	164476	175389
NM_000432.3(MYL2):c.260G>C (p.Gly87Ala)	MYL2	Primary familial hypertrophic cardiomyopathy|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2017)	criteria provided, conflicting interpretations	12	111352004	12	110914200	43461	52631
NM_000432.3(MYL2):c.173G>A (p.Arg58Gln)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	12	111352091	12	110914287	14067	29106
NM_000432.3(MYL2):c.170G>A (p.Gly57Glu)	MYL2	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2017)	criteria provided, conflicting interpretations	12	111352094	12	110914290	43458	52628
NM_000432.3(MYL2):c.141C>A (p.Asn47Lys)	MYL2	Familial hypertrophic cardiomyopathy 10|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Death in infancy|Ventricular extrasystoles|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	12	111353547	12	110915743	31766	40426
NM_000432.3(MYL2):c.125G>A (p.Gly42Asp)	MYL2	Familial hypertrophic cardiomyopathy 10	Likely pathogenic	criteria provided, single submitter	12	111353563	12	110915759	217490	214121
NM_000432.3(MYL2):c.64G>A (p.Glu22Lys)	MYL2	Familial hypertrophic cardiomyopathy 10|Primary familial hypertrophic cardiomyopathy|not provided|Death in early adulthood	Pathogenic/Likely pathogenic(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	12	111356937	12	110919133	14065	29104
NM_000432.3(MYL2):c.37G>A (p.Ala13Thr)	MYL2	Familial hypertrophic cardiomyopathy 10|Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	12	111356964	12	110919160	14064	29103
NM_002973.3(ATXN2):c.319C>G (p.Leu107Val)	ATXN2	Spinocerebellar ataxia 2|not specified	Benign/Likely benign(Last reviewed: Feb 7, 2015)	criteria provided, single submitter	12	112037000	12	111599196	128507	133956
NM_002834.4(PTPN11):c.5C>T (p.Thr2Ile)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	12	112856920	12	112419116	13349	28388
NM_002834.4(PTPN11):c.155C>T (p.Thr52Ile)	PTPN11	Noonan syndrome|not provided	Likely pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112888139	12	112450335	40484	48954
NM_002834.4(PTPN11):c.172A>C (p.Asn58His)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	12	112888156	12	112450352	40486	48956
NM_002834.4(PTPN11):c.174C>G (p.Asn58Lys)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	12	112888158	12	112450354	40489	48959
NM_002834.4(PTPN11):c.178G>A (p.Gly60Ser)	PTPN11	Noonan syndrome|not provided	Pathogenic(Last reviewed: Jul 31, 2017)	criteria provided, multiple submitters, no conflicts	12	112888162	12	112450358	40490	48960
NM_002834.4(PTPN11):c.179G>T (p.Gly60Val)	PTPN11	Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Jan 26, 2017)	criteria provided, single submitter	12	112888163	12	112450359	55797	70453
NM_002834.4(PTPN11):c.182A>C (p.Asp61Ala)	PTPN11	Noonan syndrome	Likely pathogenic(Last reviewed: Aug 9, 2013)	criteria provided, single submitter	12	112888166	12	112450362	179221	175539
NM_002834.4(PTPN11):c.182A>G (p.Asp61Gly)	PTPN11	Noonan syndrome 1|Noonan syndrome|Short stature|Abnormality of cardiovascular system morphology|not provided|Rasopathy	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	12	112888166	12	112450362	13330	28369
NM_002834.4(PTPN11):c.184T>G (p.Tyr62Asp)	PTPN11	Noonan syndrome 1|Noonan syndrome|Failure to thrive|Secundum atrial septal defect|Tricuspid regurgitation|not provided|Rasopathy|Patent ductus arteriosus|Right ventricular hypertrophy|Dysplastic pulmonary valve|Patent ductus arteriosus	Pathogenic(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	12	112888168	12	112450364	13329	28368
NM_002834.4(PTPN11):c.188A>G (p.Tyr63Cys)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy|Lymphoma|B lymphoblastic leukemia lymphoma, no ICD-O subtype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112888172	12	112450368	13333	28372
NM_002834.4(PTPN11):c.205G>C (p.Glu69Gln)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jul 23, 2018)	criteria provided, multiple submitters, no conflicts	12	112888189	12	112450385	40498	48968
NM_002834.4(PTPN11):c.209A>G (p.Lys70Arg)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	12	112888193	12	112450389	44603	53770
NM_002834.4(PTPN11):c.211T>C (p.Phe71Leu)	PTPN11	Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	12	112888195	12	112450391	40499	48969
NM_002834.4(PTPN11):c.214G>A (p.Ala72Thr)	PTPN11	Chronic lymphocytic leukemia|Neuroblastoma|Acute myeloid leukemia|not provided|Rasopathy|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	12	112888198	12	112450394	177754	175540
NM_002834.4(PTPN11):c.214G>C (p.Ala72Pro)	PTPN11	Noonan syndrome 3|Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 30, 2017)	criteria provided, multiple submitters, no conflicts	12	112888198	12	112450394	40500	48970
NM_002834.4(PTPN11):c.214G>T (p.Ala72Ser)	PTPN11	Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Feb 22, 2018)	criteria provided, multiple submitters, no conflicts	12	112888198	12	112450394	13324	28363
NM_002834.4(PTPN11):c.215C>G (p.Ala72Gly)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, multiple submitters, no conflicts	12	112888199	12	112450395	13325	28364
NM_002834.4(PTPN11):c.218C>T (p.Thr73Ile)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	12	112888202	12	112450398	13334	28373
NM_002834.4(PTPN11):c.228G>T (p.Glu76Asp)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, multiple submitters, no conflicts	12	112888212	12	112450408	40502	48972
NM_002834.4(PTPN11):c.236A>G (p.Gln79Arg)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	12	112888220	12	112450416	13340	28379
NM_002834.4(PTPN11):c.317A>C (p.Asp106Ala)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	12	112888301	12	112450497	40506	48976
NM_002834.4(PTPN11):c.417G>C (p.Glu139Asp)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not specified|not provided|Rasopathy|Hypertrophic cardiomyopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112891083	12	112453279	40513	48983
NM_002834.4(PTPN11):c.417G>T (p.Glu139Asp)	PTPN11	not provided|Rasopathy	Pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	12	112891083	12	112453279	40512	48982
NM_002834.4(PTPN11):c.598A>T (p.Asn200Tyr)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, multiple submitters, no conflicts	12	112892440	12	112454636	164998	175541
NM_002834.4(PTPN11):c.767A>G (p.Gln256Arg)	PTPN11	Noonan syndrome 1|not specified|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	12	112910758	12	112472954	40518	48988
NM_002834.4(PTPN11):c.774G>T (p.Glu258Asp)	PTPN11	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2015)	criteria provided, multiple submitters, no conflicts	12	112910765	12	112472961	44613	53780
NM_002834.4(PTPN11):c.781C>T (p.Leu261Phe)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112910772	12	112472968	40520	48990
NM_002834.4(PTPN11):c.794G>A (p.Arg265Gln)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases|PTPN11-related disorder	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112910785	12	112472981	40522	48992
NM_002834.4(PTPN11):c.802G>A (p.Gly268Ser)	PTPN11	Noonan syndrome|not provided|Rasopathy	Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	12	112910793	12	112472989	44614	53781
NM_002834.4(PTPN11):c.802G>T (p.Gly268Cys)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	12	112910793	12	112472989	40523	48993
NM_002834.4(PTPN11):c.836A>G (p.Tyr279Cys)	PTPN11	Noonan syndrome 1|LEOPARD syndrome 1|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 18, 2018)	criteria provided, multiple submitters, no conflicts	12	112910827	12	112473023	13328	28367
NM_002834.4(PTPN11):c.844A>G (p.Ile282Val)	PTPN11	Noonan syndrome 1|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	12	112910835	12	112473031	40525	48995
NM_002834.4(PTPN11):c.846C>G (p.Ile282Met)	PTPN11	Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	12	112910837	12	112473033	40526	48996
NM_002834.4(PTPN11):c.922A>G (p.Asn308Asp)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112915523	12	112477719	13326	28365
NM_002834.4(PTPN11):c.923A>G (p.Asn308Ser)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 9, 2018)	criteria provided, multiple submitters, no conflicts	12	112915524	12	112477720	13327	28366
NM_002834.4(PTPN11):c.1381G>A (p.Ala461Thr)	PTPN11	Noonan syndrome 3|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	12	112926248	12	112488444	13342	28381
NM_002834.4(PTPN11):c.1391G>C (p.Gly464Ala)	PTPN11	LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	12	112926258	12	112488454	13343	28382
NM_002834.4(PTPN11):c.1403C>T (p.Thr468Met)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|Noonan syndrome|not specified|not provided|Rasopathy|Inborn genetic diseases|PTPN11-related disorder	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112926270	12	112488466	13331	28370
NM_002834.4(PTPN11):c.1471C>T (p.Pro491Ser)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Dec 21, 2017)	criteria provided, multiple submitters, no conflicts	12	112926851	12	112489047	40550	49020
NM_002834.4(PTPN11):c.1472C>A (p.Pro491His)	PTPN11	Noonan syndrome|not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	12	112926852	12	112489048	40551	49021
NM_002834.4(PTPN11):c.1493G>T (p.Arg498Leu)	PTPN11	Noonan syndrome 1|LEOPARD syndrome 1|Scoliosis|not provided|Rasopathy|Abnormal facial shape|Cafe-au-lait spot|Specific learning disability|Intellectual disability, mild	Pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	12	112926873	12	112489069	40554	49024
NM_002834.4(PTPN11):c.1502G>A (p.Arg501Lys)	PTPN11	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Aug 26, 2017)	criteria provided, multiple submitters, no conflicts	12	112926882	12	112489078	40555	49025
NM_002834.4(PTPN11):c.1504T>G (p.Ser502Ala)	PTPN11	not provided|Rasopathy	Pathogenic(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	12	112926884	12	112489080	40556	49026
NM_002834.4(PTPN11):c.1504T>A (p.Ser502Thr)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	12	112926884	12	112489080	13332	28371
NM_002834.4(PTPN11):c.1505C>T (p.Ser502Leu)	PTPN11	Noonan syndrome|not provided	Pathogenic(Last reviewed: Mar 8, 2018)	criteria provided, multiple submitters, no conflicts	12	112926885	12	112489081	40557	49027
NM_002834.4(PTPN11):c.1507G>A (p.Gly503Arg)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	12	112926887	12	112489083	40559	49029
NM_002834.4(PTPN11):c.1507G>C (p.Gly503Arg)	PTPN11	Noonan syndrome 1|Juvenile myelomonocytic leukemia|Metachondromatosis|LEOPARD syndrome 1|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	12	112926887	12	112489083	40558	49028
NM_002834.4(PTPN11):c.1510A>G (p.Met504Val)	PTPN11	Noonan syndrome 1|Noonan syndrome|not provided|Rasopathy|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112926890	12	112489086	40562	49032
NM_002834.4(PTPN11):c.1517A>C (p.Gln506Pro)	PTPN11	Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	12	112926897	12	112489093	40563	49033
NM_002834.4(PTPN11):c.1528C>G (p.Gln510Glu)	PTPN11	Noonan syndrome 3|Noonan syndrome 1|LEOPARD syndrome 1|not provided|Rasopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 4, 2018)	criteria provided, multiple submitters, no conflicts	12	112926908	12	112489104	40566	49036
NM_002834.4(PTPN11):c.1529A>C (p.Gln510Pro)	PTPN11	Noonan syndrome 3|Noonan syndrome with multiple lentigines|LEOPARD syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	12	112926909	12	112489105	13344	28383
NM_000192.3(TBX5):c.710G>A (p.Arg237Gln)	TBX5	Holt-Oram syndrome|Aortic valve disease 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	criteria provided, multiple submitters, no conflicts	12	114823326	12	114385521	7993	23032
NM_015335.4(MED13L):c.2600C>T (p.Thr867Ile)	MED13L	Mental retardation and distinctive facial features with or without cardiac defects	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	12	116435005	12	115997200	488544	481412
NM_000545.6(HNF1A):c.79A>C (p.Ile27Leu)	HNF1A	Maturity onset diabetes mellitus in young|Insulin resistance, susceptibility to|SERUM HDL CHOLESTEROL LEVEL, MODIFIER OF|not specified|not provided	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121416650	12	120978847	14937	29976
NM_000545.6(HNF1A):c.293C>T (p.Ala98Val)	HNF1A	Maturity onset diabetes mellitus in young|not specified|not provided|Monogenic diabetes	Benign/Likely benign(Last reviewed: Sep 29, 2017)	criteria provided, multiple submitters, no conflicts	12	121416864	12	120979061	129233	134679
NM_000545.5(HNF1A):c.598C>T (p.Arg200Trp)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121431394	12	120993591	36824	45485
NM_000545.6(HNF1A):c.608G>A (p.Arg203His)	HNF1A	Diabetes mellitus type 1|not provided	Likely pathogenic(Last reviewed: Jan 3, 2017)	criteria provided, multiple submitters, no conflicts	12	121431404	12	120993601	129235	134681
NM_000545.6(HNF1A):c.670C>T (p.Pro224Ser)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121431466	12	120993663	36826	45487
NM_000545.6(HNF1A):c.731G>T (p.Arg244Ile)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121431984	12	120994181	36828	45489
NM_000545.6(HNF1A):c.790G>T (p.Val264Phe)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121432043	12	120994240	36830	45491
NM_000545.6(HNF1A):c.803T>C (p.Phe268Ser)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121432056	12	120994253	36831	45492
NM_000545.6(HNF1A):c.827C>G (p.Ala276Gly)	HNF1A	Maturity-onset diabetes of the young, type 3|not provided	Likely pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, multiple submitters, no conflicts	12	121432080	12	120994277	36832	45493
NM_000545.6(HNF1A):c.1114G>A (p.Ala372Thr)	HNF1A	not provided	Uncertain significance(Last reviewed: Jan 17, 2013)	criteria provided, single submitter	12	121434350	12	120996547	129226	134672
NM_000545.6(HNF1A):c.1424C>T (p.Pro475Leu)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121435391	12	120997588	36801	45462
NM_000545.6(HNF1A):c.1460G>A (p.Ser487Asn)	HNF1A	Maturity onset diabetes mellitus in young|not specified|not provided	Benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	12	121435427	12	120997624	129230	134676
NM_000545.6(HNF1A):c.1624-15G>A	HNF1A	Maturity-onset diabetes of the young, type 3|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2016)	criteria provided, conflicting interpretations	12	121437271	12	120999468	36806	45467
NM_000545.6(HNF1A):c.1663C>T (p.Leu555Phe)	HNF1A	Maturity-onset diabetes of the young, type 3	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	12	121437325	12	120999522	36808	45469
NM_023012.5(RSRC2):c.425G>A (p.Arg142Gln)	RSRC2	Obesity|Global developmental delay|Autistic behavior|Seizures|Myopia|Strabismus|Myopia|Global developmental delay|Obesity	Likely pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	12	123001951	12	122517404	242899	243989
NM_012226.4(P2RX2):c.799A>T (p.Ile267Phe)	P2RX2	not specified	Uncertain significance(Last reviewed: Nov 17, 2016)	criteria provided, single submitter	12	133198079	12	132621493	505201	497632
NM_006231.3(POLE):c.3971G>A (p.Arg1324His)	POLE	not specified|not provided|Colorectal cancer, susceptibility to, 12|Colorectal cancer	Uncertain significance(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	12	133225926	12	132649340	240495	241375
NM_006231.3(POLE):c.3904C>T (p.Leu1302Phe)	POLE	Colorectal cancer, susceptibility to, 12	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	12	133225993	12	132649407	473632	462661
NM_006231.3(POLE):c.2214G>C (p.Lys738Asn)	POLE	Colorectal cancer, susceptibility to, 12|Colorectal cancer	Uncertain significance(Last reviewed: Sep 26, 2017)	criteria provided, multiple submitters, no conflicts	12	133244194	12	132667608	226044	227849
NM_006231.3(POLE):c.2089C>G (p.Pro697Ala)	POLE	not specified|Colorectal cancer, susceptibility to, 12|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	12	133245026	12	132668440	240421	241441
NM_006231.3(POLE):c.1420G>A (p.Val474Ile)	POLE	Colorectal cancer, susceptibility to, 12	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	12	133249803	12	132673217	235886	237521
NM_006231.3(POLE):c.861T>A (p.Asp287Glu)	POLE	Familial colorectal cancer|not specified|not provided|Colorectal cancer, susceptibility to, 12|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	12	133253180	12	132676594	221000	222238
NM_006231.3(POLE):c.664C>T (p.Arg222Cys)	POLE	Colorectal cancer, susceptibility to, 12	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	12	133254220	12	132677634	582662	566700
NM_006231.3(POLE):c.16G>C (p.Gly6Arg)	POLE	not specified|not provided|Colorectal cancer, susceptibility to, 12|Hereditary cancer-predisposing syndrome|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	12	133263886	12	132687300	218680	215445
NM_004004.5(GJB2):c.551G>A (p.Arg184Gln)	GJB2	Deafness, autosomal dominant 3a|Hearing impairment|not provided|Hearing loss	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	13	20763170	13	20189031	29662	38617
NM_004004.5(GJB2):c.426C>A (p.Phe142Leu)	GJB2	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 2, 2011)	criteria provided, single submitter	13	20763295	13	20189156	44750	53917
NM_004004.5(GJB2):c.224G>A (p.Arg75Gln)	GJB2	Deafness, autosomal recessive 1A|Keratoderma palmoplantar deafness|Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness|not provided	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	13	20763497	13	20189358	17027	32066
NM_004004.5(GJB2):c.223C>T (p.Arg75Trp)	GJB2	Deafness, autosomal dominant 3a|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Oct 27, 2014)	criteria provided, single submitter	13	20763498	13	20189359	17011	32050
NM_004004.5(GJB2):c.196G>T (p.Asp66Tyr)	GJB2	Sensorineural hearing loss	Likely pathogenic(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	13	20763525	13	20189386	586962	578007
NM_004004.5(GJB2):c.176G>A (p.Gly59Asp)	GJB2	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Mar 10, 2015)	criteria provided, single submitter	13	20763545	13	20189406	163520	175766
NM_004004.5(GJB2):c.66G>T (p.Lys22Asn)	GJB2	Keratoderma palmoplantar deafness	Pathogenic(Last reviewed: Apr 26, 2016)	no assertion criteria provided	13	20763655	13	20189516	242831	243935
NM_006783.4(GJB6):c.31G>A (p.Gly11Arg)	GJB6	Deafness, autosomal recessive 1A|Deafness, autosomal recessive 1b|Deafness, autosomal dominant 3b|Hidrotic ectodermal dysplasia syndrome|not provided	Pathogenic(Last reviewed: Aug 25, 2017)	criteria provided, multiple submitters, no conflicts	13	20797589	13	20223450	5544	20583
NM_000209.3(PDX1):c.97C>A (p.Pro33Thr)	PDX1	Maturity-onset diabetes of the young, type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2016)	criteria provided, conflicting interpretations	13	28494372	13	27920235	36414	45077
NM_000059.3(BRCA2):c.3G>A (p.Met1Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	13	32890600	13	32316463	51579	66247
NM_000059.3(BRCA2):c.53G>A (p.Arg18His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32890650	13	32316513	51855	66523
NM_000059.3(BRCA2):c.125A>G (p.Tyr42Cys)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32893271	13	32319134	37734	46290
NM_000059.3(BRCA2):c.223G>C (p.Ala75Pro)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32893369	13	32319232	51258	65926
NM_000059.3(BRCA2):c.440A>G (p.Gln147Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Conflicting interpretations of pathogenicity(Last reviewed: Dec 19, 2017)	criteria provided, conflicting interpretations	13	32900252	13	32326115	51644	66312
NM_000059.3(BRCA2):c.464G>A (p.Arg155Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, multiple submitters, no conflicts	13	32900276	13	32326139	253032	247439
NM_000059.3(BRCA2):c.695A>G (p.Tyr232Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2017)	criteria provided, conflicting interpretations	13	32905069	13	32330932	141345	151059
NM_000059.3(BRCA2):c.709G>A (p.Asp237Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	13	32905083	13	32330946	91470	96947
NM_000059.3(BRCA2):c.742G>A (p.Ala248Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2018)	criteria provided, conflicting interpretations	13	32905116	13	32330979	52326	66994
NM_000059.3(BRCA2):c.773A>G (p.Gln258Arg)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Mar 12, 2016)	criteria provided, single submitter	13	32905147	13	32331010	252421	246787
NM_000059.3(BRCA2):c.865A>C (p.Asn289His)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32906480	13	32332343	41567	50006
NM_000059.3(BRCA2):c.943T>A (p.Cys315Ser)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	13	32906558	13	32332421	38241	46797
NM_000059.3(BRCA2):c.956A>C (p.Asn319Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	13	32906571	13	32332434	38248	46804
NM_000059.3(BRCA2):c.964A>C (p.Lys322Gln)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32906579	13	32332442	38258	46814
NM_000059.3(BRCA2):c.971G>C (p.Arg324Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 7, 2018)	criteria provided, multiple submitters, no conflicts	13	32906586	13	32332449	38261	46817
NM_000059.3(BRCA2):c.978C>A (p.Ser326Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32906593	13	32332456	52898	67566
NM_000059.3(BRCA2):c.1002T>G (p.His334Gln)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 7, 2017)	criteria provided, multiple submitters, no conflicts	13	32906617	13	32332480	252405	246789
NM_000059.3(BRCA2):c.1114A>C (p.Asn372His)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Ductal breast carcinoma	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32906729	13	32332592	9329	24368
NM_000059.3(BRCA2):c.1123C>T (p.Pro375Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32906738	13	32332601	51066	65734
NM_000059.3(BRCA2):c.1129G>C (p.Glu377Gln)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 1, 2017)	no assertion criteria provided	13	32906744	13	32332607	417620	404598
NM_000059.3(BRCA2):c.1151C>T (p.Ser384Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32906766	13	32332629	41541	49980
NM_000059.3(BRCA2):c.1385A>G (p.Glu462Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32907000	13	32332863	37738	46294
NM_000059.3(BRCA2):c.1387A>G (p.Thr463Ala)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: May 5, 2016)	criteria provided, single submitter	13	32907002	13	32332865	252411	246790
NM_000059.3(BRCA2):c.1409A>C (p.Glu470Ala)	BRCA2	Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 28, 2018)	criteria provided, conflicting interpretations	13	32907024	13	32332887	233895	234650
NM_000059.3(BRCA2):c.1427C>G (p.Ser476Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 25, 2018)	criteria provided, multiple submitters, no conflicts	13	32907042	13	32332905	37739	46295
NM_000059.3(BRCA2):c.1453A>G (p.Lys485Glu)	BRCA2	Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	13	32907068	13	32332931	582393	567274
NM_000059.3(BRCA2):c.1460C>A (p.Ala487Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 11, 2018)	criteria provided, conflicting interpretations	13	32907075	13	32332938	37741	46297
NM_000059.3(BRCA2):c.1514T>C (p.Ile505Thr)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32907129	13	32332992	41542	49981
NM_000059.3(BRCA2):c.1550A>G (p.Asn517Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32907165	13	32333028	37745	46301
NM_000059.3(BRCA2):c.1568A>G (p.His523Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	13	32907183	13	32333046	96766	102669
NM_000059.3(BRCA2):c.1574C>G (p.Thr525Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 8, 2016)	criteria provided, multiple submitters, no conflicts	13	32907189	13	32333052	252415	246791
NM_000059.3(BRCA2):c.1662T>G (p.Cys554Trp)	BRCA2	Breast-ovarian cancer, familial 2|Carcinoma of male breast|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32907277	13	32333140	51169	65837
NM_000059.3(BRCA2):c.1763A>G (p.Asn588Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	13	32907378	13	32333241	51186	65854
NM_000059.3(BRCA2):c.1786G>C (p.Asp596His)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 20, 2017)	criteria provided, conflicting interpretations	13	32907401	13	32333264	51192	65860
NM_000059.3(BRCA2):c.1792A>G (p.Thr598Ala)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2018)	criteria provided, conflicting interpretations	13	32907407	13	32333270	41543	49982
NM_000059.3(BRCA2):c.1889C>T (p.Thr630Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32907504	13	32333367	37768	46324
NM_000059.3(BRCA2):c.1964C>G (p.Pro655Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32910456	13	32336319	37770	46326
NM_000059.3(BRCA2):c.1993A>G (p.Thr665Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	13	32910485	13	32336348	141539	151253
NM_000059.3(BRCA2):c.2026T>C (p.Cys676Arg)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 19, 2016)	criteria provided, single submitter	13	32910518	13	32336381	37772	46328
NM_000059.3(BRCA2):c.2138A>T (p.Gln713Leu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	13	32910630	13	32336493	51249	65917
NM_000059.3(BRCA2):c.2332G>A (p.Val778Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	13	32910824	13	32336687	89044	94587
NM_000059.3(BRCA2):c.2350A>G (p.Met784Val)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32910842	13	32336705	41544	49983
NM_000059.3(BRCA2):c.2416G>C (p.Asp806His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32910908	13	32336771	51278	65946
NM_000059.3(BRCA2):c.2558A>G (p.Gln853Arg)	BRCA2	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, multiple submitters, no conflicts	13	32911050	13	32336913	142112	151826
NM_000059.3(BRCA2):c.2680G>A (p.Val894Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911172	13	32337035	51326	65994
NM_000059.3(BRCA2):c.2786T>C (p.Leu929Ser)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911278	13	32337141	51343	66011
NM_000059.3(BRCA2):c.2803G>A (p.Asp935Asn)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	13	32911295	13	32337158	51349	66017
NM_000059.3(BRCA2):c.2813C>A (p.Ala938Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	13	32911305	13	32337168	51353	66021
NM_000059.3(BRCA2):c.2848G>A (p.Val950Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	13	32911340	13	32337203	231995	234718
NM_000059.3(BRCA2):c.2892A>T (p.Lys964Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	13	32911384	13	32337247	133728	137467
NM_000059.3(BRCA2):c.2918C>T (p.Ser973Leu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	13	32911410	13	32337273	37807	46363
NM_000059.3(BRCA2):c.2960A>T (p.Asn987Ile)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911452	13	32337315	51379	66047
NM_000059.3(BRCA2):c.2971A>G (p.Asn991Asp)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32911463	13	32337326	41545	49984
NM_000059.3(BRCA2):c.3032C>G (p.Thr1011Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	13	32911524	13	32337387	37815	46371
NM_000059.3(BRCA2):c.3055C>G (p.Leu1019Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32911547	13	32337410	37817	46373
NM_000059.3(BRCA2):c.3245A>G (p.Lys1082Arg)	BRCA2	Breast-ovarian cancer, familial 2|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	13	32911737	13	32337600	51431	66099
NM_000059.3(BRCA2):c.3445A>G (p.Met1149Val)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Carcinoma of esophagus	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	13	32911937	13	32337800	51465	66133
NM_000059.3(BRCA2):c.3515C>T (p.Ser1172Leu)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912007	13	32337870	41546	49985
NM_000059.3(BRCA2):c.3682A>G (p.Asn1228Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912174	13	32338037	37852	46408
NM_000059.3(BRCA2):c.3697G>A (p.Ala1233Thr)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 15, 2016)	criteria provided, single submitter	13	32912189	13	32338052	51507	66175
NM_000059.3(BRCA2):c.3831T>G (p.Asn1277Lys)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	13	32912323	13	32338186	252413	246793
NM_000059.3(BRCA2):c.3869G>A (p.Cys1290Tyr)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32912361	13	32338224	37863	46419
NM_000059.3(BRCA2):c.4061C>T (p.Thr1354Met)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912553	13	32338416	51588	66256
NM_000059.3(BRCA2):c.4067T>C (p.Leu1356Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	13	32912559	13	32338422	234278	231871
NM_000059.3(BRCA2):c.4090A>C (p.Ile1364Leu)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32912582	13	32338445	51592	66260
NM_000059.3(BRCA2):c.4187A>G (p.Gln1396Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912679	13	32338542	37886	46442
NM_000059.3(BRCA2):c.4241C>T (p.Thr1414Met)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32912733	13	32338596	51616	66284
NM_000059.3(BRCA2):c.4258G>T (p.Asp1420Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32912750	13	32338613	41549	49988
NM_000059.3(BRCA2):c.4425G>A (p.Met1475Ile)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: May 18, 2016)	criteria provided, single submitter	13	32912917	13	32338780	252410	246795
NM_000059.3(BRCA2):c.4527A>C (p.Gln1509His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	13	32913019	13	32338882	220561	222309
NM_000059.3(BRCA2):c.4585G>A (p.Gly1529Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913077	13	32338940	37910	46466
NM_000059.3(BRCA2):c.4681C>A (p.His1561Asn)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	13	32913173	13	32339036	51695	66363
NM_000059.3(BRCA2):c.4741G>A (p.Glu1581Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	13	32913233	13	32339096	37920	46476
NM_000059.3(BRCA2):c.5070A>C (p.Lys1690Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913562	13	32339425	37942	46498
NM_000059.3(BRCA2):c.5171T>C (p.Ile1724Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	13	32913663	13	32339526	51803	66471
NM_000059.3(BRCA2):c.5191C>T (p.His1731Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 7, 2018)	criteria provided, multiple submitters, no conflicts	13	32913683	13	32339546	252409	246797
NM_000059.3(BRCA2):c.5198C>T (p.Ser1733Phe)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913690	13	32339553	37950	46506
NM_000059.3(BRCA2):c.5312G>A (p.Gly1771Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32913804	13	32339667	37958	46514
NM_000059.3(BRCA2):c.5414A>G (p.Asn1805Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2018)	criteria provided, conflicting interpretations	13	32913906	13	32339769	51858	66526
NM_000059.3(BRCA2):c.5635G>A (p.Glu1879Lys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 23, 2017)	criteria provided, conflicting interpretations	13	32914127	13	32339990	51895	66563
NM_000059.3(BRCA2):c.5640T>G (p.Asn1880Lys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	13	32914132	13	32339995	51896	66564
NM_000059.3(BRCA2):c.5704G>A (p.Asp1902Asn)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32914196	13	32340059	51912	66580
NM_000059.3(BRCA2):c.5710C>G (p.Leu1904Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914202	13	32340065	37990	46546
NM_000059.3(BRCA2):c.5744C>T (p.Thr1915Met)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32914236	13	32340099	41556	49995
NM_000059.3(BRCA2):c.5752C>T (p.His1918Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914244	13	32340107	51927	66595
NM_000059.3(BRCA2):c.5782G>A (p.Glu1928Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	13	32914274	13	32340137	51936	66604
NM_000059.3(BRCA2):c.5785A>G (p.Ile1929Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914277	13	32340140	37997	46553
NM_000059.3(BRCA2):c.5962G>A (p.Val1988Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	13	32914454	13	32340317	91430	96907
NM_000059.3(BRCA2):c.6100C>T (p.Arg2034Cys)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914592	13	32340455	41558	49997
NM_000059.3(BRCA2):c.6131G>T (p.Gly2044Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	13	32914623	13	32340486	38021	46577
NM_000059.3(BRCA2):c.6176G>A (p.Ser2059Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, multiple submitters, no conflicts	13	32914668	13	32340531	135808	139520
NM_000059.3(BRCA2):c.6295A>G (p.Arg2099Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, multiple submitters, no conflicts	13	32914787	13	32340650	91442	96919
NM_000059.3(BRCA2):c.6322C>T (p.Arg2108Cys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2017)	criteria provided, conflicting interpretations	13	32914814	13	32340677	41559	49998
NM_000059.3(BRCA2):c.6323G>A (p.Arg2108His)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914815	13	32340678	38037	46593
NM_000059.3(BRCA2):c.6338A>G (p.Asn2113Ser)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32914830	13	32340693	38039	46595
NM_000059.3(BRCA2):c.6347A>G (p.His2116Arg)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	13	32914839	13	32340702	41561	50000
NM_000059.3(BRCA2):c.6412G>T (p.Val2138Phe)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2018)	criteria provided, conflicting interpretations	13	32914904	13	32340767	52087	66755
NM_000059.3(BRCA2):c.6443C>A (p.Ser2148Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	13	32914935	13	32340798	52096	66764
NM_000059.3(BRCA2):c.6792G>C (p.Leu2264Phe)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	13	32915284	13	32341147	252417	246798
NM_000059.3(BRCA2):c.6821G>T (p.Gly2274Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 25, 2017)	criteria provided, conflicting interpretations	13	32915313	13	32341176	52199	66867
NM_000059.3(BRCA2):c.6853A>G (p.Ile2285Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32918706	13	32344569	38070	46626
NM_000059.3(BRCA2):c.6966G>T (p.Met2322Ile)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 17, 2017)	criteria provided, multiple submitters, no conflicts	13	32920992	13	32346855	52229	66897
NM_000059.3(BRCA2):c.6991A>G (p.Thr2331Ala)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	13	32921017	13	32346880	52233	66901
NM_000059.3(BRCA2):c.7007G>C (p.Arg2336Pro)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	13	32921033	13	32346896	52241	66909
NM_000059.3(BRCA2):c.7007G>A (p.Arg2336His)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	13	32921033	13	32346896	38077	46633
NM_000059.3(BRCA2):c.7017G>C (p.Lys2339Asn)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32929007	13	32354870	52249	66917
NM_000059.3(BRCA2):c.7093C>T (p.His2365Tyr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	13	32929083	13	32354946	232713	234919
NM_000059.3(BRCA2):c.7150C>A (p.Gln2384Lys)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32929140	13	32355003	38086	46642
NM_000059.3(BRCA2):c.7232A>C (p.Lys2411Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	13	32929222	13	32355085	52294	66962
NM_000059.3(BRCA2):c.7319A>G (p.His2440Arg)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32929309	13	32355172	41562	50001
NM_000059.3(BRCA2):c.7397C>T (p.Ala2466Val)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32929387	13	32355250	52317	66985
NM_000059.3(BRCA2):c.7469T>C (p.Ile2490Thr)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	13	32930598	13	32356461	96852	102755
NM_000059.3(BRCA2):c.7504C>T (p.Arg2502Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32930633	13	32356496	41563	50002
NM_000059.3(BRCA2):c.7534C>T (p.Leu2512Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	13	32930663	13	32356526	52349	67017
NM_000059.3(BRCA2):c.7544C>T (p.Thr2515Ile)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32930673	13	32356536	38102	46658
NM_000059.3(BRCA2):c.7601C>T (p.Ala2534Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	13	32930730	13	32356593	38109	46665
NM_000059.3(BRCA2):c.7786G>A (p.Gly2596Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	13	32932047	13	32357910	91492	96969
NM_000059.3(BRCA2):c.7822C>G (p.Pro2608Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	13	32936676	13	32362539	252423	246802
NM_000059.3(BRCA2):c.7857G>C (p.Trp2619Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	13	32936711	13	32362574	438744	432370
NM_000059.3(BRCA2):c.7878G>C (p.Trp2626Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32936732	13	32362595	38125	46681
NM_000059.3(BRCA2):c.7879A>T (p.Ile2627Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32936733	13	32362596	52430	67098
NM_000059.3(BRCA2):c.7975A>G (p.Arg2659Gly)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	13	32936829	13	32362692	38130	46686
NM_000059.3(BRCA2):c.7985C>A (p.Thr2662Lys)	BRCA2	Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 30, 2018)	criteria provided, conflicting interpretations	13	32937324	13	32363187	96864	102767
NM_000059.3(BRCA2):c.7994A>G (p.Asp2665Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32937333	13	32363196	38134	46690
NM_000059.3(BRCA2):c.8009C>T (p.Ser2670Leu)	BRCA2	Breast-ovarian cancer, familial 2|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 11, 2018)	criteria provided, conflicting interpretations	13	32937348	13	32363211	52471	67139
NM_000059.3(BRCA2):c.8042C>G (p.Thr2681Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	13	32937381	13	32363244	142520	152234
NM_000059.3(BRCA2):c.8111C>T (p.Ser2704Phe)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2018)	criteria provided, conflicting interpretations	13	32937450	13	32363313	52507	67175
NM_000059.3(BRCA2):c.8125A>G (p.Ser2709Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	13	32937464	13	32363327	91501	96978
NM_000059.3(BRCA2):c.8149G>T (p.Ala2717Ser)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32937488	13	32363351	41564	50003
NM_000059.3(BRCA2):c.8182G>A (p.Val2728Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 9, 2018)	criteria provided, multiple submitters, no conflicts	13	32937521	13	32363384	41565	50004
NM_000059.3(BRCA2):c.8187G>T (p.Lys2729Asn)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32937526	13	32363389	38142	46698
NM_000059.3(BRCA2):c.8243G>A (p.Gly2748Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32937582	13	32363445	52535	67203
NM_000059.3(BRCA2):c.8351G>A (p.Arg2784Gln)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	13	32944558	13	32370421	52559	67227
NM_000059.3(BRCA2):c.8447G>C (p.Gly2816Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	13	32944654	13	32370517	225280	227195
NM_000059.3(BRCA2):c.8503T>C (p.Ser2835Pro)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign/Likely benign(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	13	32945108	13	32370971	52606	67274
NM_000059.3(BRCA2):c.8567A>C (p.Glu2856Ala)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2018)	criteria provided, conflicting interpretations	13	32945172	13	32371035	38168	46724
NM_000059.3(BRCA2):c.8573A>G (p.Gln2858Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2018)	criteria provided, conflicting interpretations	13	32945178	13	32371041	52625	67293
NM_000059.3(BRCA2):c.8702G>T (p.Gly2901Val)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	13	32950876	13	32376739	252416	246803
NM_000059.3(BRCA2):c.8723T>G (p.Val2908Gly)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Dec 2, 2017)	criteria provided, multiple submitters, no conflicts	13	32950897	13	32376760	52662	67330
NM_000059.3(BRCA2):c.8739C>G (p.Asp2913Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	13	32950913	13	32376776	185201	184047
NM_000059.3(BRCA2):c.8830A>T (p.Ile2944Phe)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32953529	13	32379392	41569	50008
NM_000059.3(BRCA2):c.8850G>T (p.Lys2950Asn)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32953549	13	32379412	52692	67360
NM_000059.3(BRCA2):c.8851G>A (p.Ala2951Thr)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Sep 28, 2016)	reviewed by expert panel	13	32953550	13	32379413	41570	50009
NM_000059.3(BRCA2):c.8905G>A (p.Val2969Met)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32953604	13	32379467	52697	67365
NM_000059.3(BRCA2):c.8917C>T (p.Arg2973Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32953616	13	32379479	38193	46749
NM_000059.3(BRCA2):c.9004G>A (p.Glu3002Lys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	13	32953937	13	32379800	38201	46757
NM_000059.3(BRCA2):c.9006A>T (p.Glu3002Asp)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	13	32953939	13	32379802	52725	67393
NM_000059.3(BRCA2):c.9038C>T (p.Thr3013Ile)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2018)	criteria provided, conflicting interpretations	13	32953971	13	32379834	38205	46761
NM_000059.3(BRCA2):c.9227G>A (p.Gly3076Glu)	BRCA2	Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	13	32954253	13	32380116	52780	67448
NM_000059.3(BRCA2):c.9235G>A (p.Val3079Ile)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32954261	13	32380124	38220	46776
NM_000059.3(BRCA2):c.9275A>G (p.Tyr3092Cys)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	13	32968844	13	32394707	52800	67468
NM_000059.3(BRCA2):c.9292T>C (p.Tyr3098His)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32968861	13	32394724	38227	46783
NM_000059.3(BRCA2):c.9311A>G (p.Lys3104Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 24, 2016)	criteria provided, single submitter	13	32968880	13	32394743	417626	404604
NM_000059.3(BRCA2):c.9353T>C (p.Met3118Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	13	32968922	13	32394785	38232	46788
NM_000059.3(BRCA2):c.9364G>A (p.Ala3122Thr)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2018)	criteria provided, conflicting interpretations	13	32968933	13	32394796	142215	151929
NM_000059.3(BRCA2):c.9501G>C (p.Glu3167Asp)	BRCA2	Breast-ovarian cancer, familial 2|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 6, 2017)	criteria provided, multiple submitters, no conflicts	13	32969070	13	32394933	234895	231906
NM_000059.3(BRCA2):c.9583A>G (p.Thr3195Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	13	32971116	13	32396979	52872	67540
NM_000059.3(BRCA2):c.9586A>G (p.Lys3196Glu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2017)	criteria provided, conflicting interpretations	13	32971119	13	32396982	38251	46807
NM_000059.3(BRCA2):c.9634G>C (p.Gly3212Arg)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	13	32971167	13	32397030	38257	46813
NM_000059.3(BRCA2):c.9728C>T (p.Pro3243Leu)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jun 10, 2018)	criteria provided, conflicting interpretations	13	32972378	13	32398241	38262	46818
NM_000059.3(BRCA2):c.9730G>A (p.Val3244Ile)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32972380	13	32398243	41572	50011
NM_000059.3(BRCA2):c.9776T>C (p.Ile3259Thr)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Mar 26, 2016)	criteria provided, single submitter	13	32972426	13	32398289	252418	246806
NM_000059.3(BRCA2):c.9875C>T (p.Pro3292Leu)	BRCA2	Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	13	32972525	13	32398388	52910	67578
NM_000059.3(BRCA2):c.9920A>C (p.Lys3307Thr)	BRCA2	Breast-ovarian cancer, familial 2	Uncertain significance(Last reviewed: Apr 18, 2016)	criteria provided, single submitter	13	32972570	13	32398433	252414	246807
NM_000059.3(BRCA2):c.10045A>G (p.Thr3349Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	13	32972695	13	32398558	37719	46275
NM_000059.3(BRCA2):c.10089A>G (p.Ile3363Met)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	13	32972739	13	32398602	51039	65707
NM_000059.3(BRCA2):c.10111A>G (p.Thr3371Ala)	BRCA2	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	13	32972761	13	32398624	37720	46276
NM_000059.3(BRCA2):c.10234A>G (p.Ile3412Val)	BRCA2	Familial cancer of breast|Breast-ovarian cancer, familial 2|Fanconi anemia|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Jan 12, 2015)	reviewed by expert panel	13	32972884	13	32398747	41540	49979
NM_014832.4(TBC1D4):c.3824T>C (p.Val1275Ala)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75861001	13	75286865	130861	136305
NM_014832.4(TBC1D4):c.3762A>T (p.Glu1254Asp)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75861063	13	75286927	130860	136304
NM_014832.4(TBC1D4):c.3617A>G (p.Asn1206Ser)	TBC1D4	not specified	Benign(Last reviewed: Sep 5, 2013)	criteria provided, single submitter	13	75863116	13	75288980	130553	135999
NM_014832.4(TBC1D4):c.3440C>T (p.Thr1147Met)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75866284	13	75292148	130552	135998
NM_014832.4(TBC1D4):c.3356T>C (p.Val1119Ala)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75866368	13	75292232	130544	135990
NM_014832.4(TBC1D4):c.2455G>A (p.Val819Ile)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75884216	13	75310080	130549	135995
NM_014832.4(TBC1D4):c.2254A>G (p.Thr752Ala)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75887003	13	75312867	130547	135993
NM_014832.4(TBC1D4):c.2050C>G (p.Arg684Gly)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	75898521	13	75324385	130546	135992
NM_014832.4(TBC1D4):c.1810T>G (p.Tyr604Asp)	TBC1D4	not provided	Uncertain significance(Last reviewed: Nov 4, 2013)	criteria provided, single submitter	13	75900556	13	75326420	130543	135989
NM_014832.4(TBC1D4):c.302C>T (p.Ala101Val)	TBC1D4	not specified	Likely benign	no assertion criteria provided	13	76055602	13	75481466	130551	135997
NM_000115.4(EDNRB):c.914G>A (p.Ser305Asn)	EDNRB|EDNRB-AS1	Hirschsprung disease 2|Waardenburg syndrome type 2A|Waardenburg syndrome type 4A|not specified|Hirschsprung Disease, Recessive	Benign/Likely benign, risk factor(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	13	78475230	13	77901095	16638	31677
NM_052867.3(NALCN):c.1639A>G (p.Met547Val)	NALCN	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic	no assertion criteria provided	13	101844393	13	101192042	375369	362155
NM_052867.3(NALCN):c.985A>G (p.Arg329Gly)	NALCN	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Likely pathogenic(Last reviewed: Jul 21, 2015)	criteria provided, single submitter	13	101944403	13	101292052	369675	353906
NM_052867.3(NALCN):c.965T>C (p.Ile322Thr)	NALCN	Congenital contractures of the limbs and face, hypotonia, and developmental delay	Pathogenic	no assertion criteria provided	13	101944423	13	101292072	375370	362156
NM_001845.5(COL4A1):c.3353G>A (p.Gly1118Asp)	COL4A1	Porencephaly 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	13	110826846	13	110174499	560984	552166
NM_001845.5(COL4A1):c.2842G>A (p.Gly948Ser)	COL4A1	Optic nerve hypoplasia	Pathogenic(Last reviewed: Feb 14, 2018)	criteria provided, single submitter	13	110829259	13	110176912	496641	488126
NM_001845.5(COL4A1):c.2662G>A (p.Gly888Arg)	COL4A1	Brain small vessel disease with hemorrhage|Porencephaly 1	Likely pathogenic(Last reviewed: Sep 12, 2013)	criteria provided, single submitter	13	110830243	13	110177896	209141	205773
NM_001845.5(COL4A1):c.1450C>A (p.Pro484Thr)	COL4A1	Optic nerve hypoplasia	Uncertain significance	criteria provided, single submitter	13	110845192	13	110192845	496637	488122
NM_001845.5(COL4A1):c.161C>T (p.Pro54Leu)	COL4A1	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps|Brain small vessel disease with hemorrhage|Porencephalic cyst|not specified|Optic nerve hypoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	13	110866346	13	110213999	196327	193488
NM_001846.3(COL4A2):c.1948C>T (p.Pro650Ser)	COL4A2	Porencephalic cyst|Optic nerve hypoplasia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	13	111117923	13	110465576	311138	333616
NM_001846.3(COL4A2):c.2185G>A (p.Gly729Arg)	COL4A2	Optic nerve hypoplasia	Uncertain significance	criteria provided, single submitter	13	111121653	13	110469306	496734	488180
NM_001170629.1(CHD8):c.4762A>T (p.Arg1588Trp)	CHD8	Autism, susceptibility to, 18	Likely benign	no assertion criteria provided	14	21868195	14	21400036	375626	362440
NM_001170629.1(CHD8):c.2434C>T (p.Arg812Trp)	CHD8	Autism, susceptibility to, 18	Likely pathogenic(Last reviewed: Feb 17, 2015)	no assertion criteria provided	14	21876915	14	21408756	374259	361212
NM_001170629.1(CHD8):c.161G>T (p.Gly54Val)	CHD8	Autism, susceptibility to, 18	Likely benign	no assertion criteria provided	14	21899642	14	21431483	375627	362441
NM_002471.3(MYH6):c.4241C>T (p.Ser1414Phe)	MYH6	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Jul 14, 2015)	criteria provided, single submitter	14	23857482	14	23388273	217830	214494
NM_002471.3(MYH6):c.3220G>A (p.Asp1074Asn)	MYH6	not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, multiple submitters, no conflicts	14	23862152	14	23392943	179023	175568
NM_000257.3(MYH7):c.5740G>A (p.Glu1914Lys)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23883018	14	23413809	43088	52258
NM_000257.3(MYH7):c.5726G>C (p.Arg1909Pro)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23883032	14	23413823	43085	52255
NM_000257.3(MYH7):c.5717C>G (p.Ala1906Gly)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 6, 2014)	criteria provided, single submitter	14	23883041	14	23413832	43083	52253
NM_000257.3(MYH7):c.5561C>T (p.Thr1854Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2017)	criteria provided, conflicting interpretations	14	23883310	14	23414101	161320	171157
NM_000257.3(MYH7):c.5536C>T (p.Arg1846Cys)	MYH7	Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	14	23884227	14	23415018	161321	171158
NM_000257.3(MYH7):c.5494C>T (p.Arg1832Cys)	MYH7	Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Dilated cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	14	23884269	14	23415060	161322	171159
NM_000257.3(MYH7):c.5471A>G (p.Asn1824Ser)	MYH7	Prolonged QT interval	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	14	23884292	14	23415083	427959	419287
NM_000257.3(MYH7):c.5452C>T (p.Arg1818Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2016)	criteria provided, conflicting interpretations	14	23884311	14	23415102	217826	214496
NM_000257.3(MYH7):c.5422G>A (p.Gly1808Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	14	23884341	14	23415132	217468	214122
NM_000257.3(MYH7):c.5401G>A (p.Glu1801Lys)	MYH7	Primary dilated cardiomyopathy|Myopathy, distal, 1|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23884362	14	23415153	43069	52239
NM_000257.3(MYH7):c.5305C>A (p.Leu1769Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	14	23884458	14	23415249	161323	171160
NM_000257.3(MYH7):c.5287G>A (p.Ala1763Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	14	23884476	14	23415267	177846	175588
NM_000257.3(MYH7):c.5135G>A (p.Arg1712Gln)	MYH7|MHRT	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23884860	14	23415651	36642	45304
NM_000257.3(MYH7):c.4992C>A (p.Asn1664Lys)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2017)	criteria provided, conflicting interpretations	14	23885003	14	23415794	217461	214123
NM_000257.3(MYH7):c.4985G>C (p.Arg1662Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885010	14	23415801	143215	152933
NM_000257.3(MYH7):c.4985G>A (p.Arg1662His)	MYH7|MHRT	Primary dilated cardiomyopathy|not specified	Uncertain significance(Last reviewed: May 25, 2017)	criteria provided, single submitter	14	23885010	14	23415801	43049	52219
NM_000257.3(MYH7):c.4954G>T (p.Asp1652Tyr)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2018)	criteria provided, conflicting interpretations	14	23885041	14	23415832	43047	52217
NM_000257.3(MYH7):c.4937T>C (p.Leu1646Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885229	14	23416020	143214	152932
NM_000257.3(MYH7):c.4909G>A (p.Ala1637Thr)	MYH7|MHRT	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23885257	14	23416048	43044	52214
NM_000257.3(MYH7):c.4823G>C (p.Arg1608Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885343	14	23416134	143212	152930
NM_000257.3(MYH7):c.4817G>A (p.Arg1606His)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2018)	criteria provided, conflicting interpretations	14	23885349	14	23416140	43039	52209
NM_000257.3(MYH7):c.4795A>C (p.Thr1599Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23885371	14	23416162	143211	152929
NM_000257.3(MYH7):c.4622A>C (p.Gln1541Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23886099	14	23416890	143210	152928
NM_000257.3(MYH7):c.4571A>G (p.His1524Arg)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23886150	14	23416941	217469	214124
NM_000257.3(MYH7):c.4498C>T (p.Arg1500Trp)	MYH7|MHRT	Primary dilated cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	14	23886383	14	23417174	164284	175594
NM_000257.3(MYH7):c.4442T>C (p.Leu1481Pro)	MYH7|MHRT	Myopathy, distal, 1	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	14	23886439	14	23417230	143209	152927
NM_000257.3(MYH7):c.4388C>T (p.Ser1463Leu)	MYH7|MHRT	not specified	Uncertain significance(Last reviewed: Apr 7, 2017)	criteria provided, single submitter	14	23886493	14	23417284	517346	497663
NM_000257.3(MYH7):c.4377G>T (p.Lys1459Asn)	MYH7|MHRT	Familial hypertrophic cardiomyopathy 1|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23886504	14	23417295	43012	52182
NM_000257.3(MYH7):c.4321G>T (p.Ala1441Ser)	MYH7|MHRT	Myosin storage myopathy|Myopathy, distal, 1|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Sudden unexplained death|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	23886744	14	23417535	191728	189951
NM_000257.3(MYH7):c.4258C>T (p.Arg1420Trp)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23886807	14	23417598	43003	52173
NM_000257.3(MYH7):c.4135G>A (p.Ala1379Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	14	23887453	14	23418244	42993	52163
NM_000257.3(MYH7):c.4130C>T (p.Thr1377Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23887458	14	23418249	42992	52162
NM_000257.3(MYH7):c.4124A>G (p.Tyr1375Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	14	23887464	14	23418255	164293	175453
NM_000257.3(MYH7):c.4075C>T (p.Arg1359Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1S|not specified|not provided	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	14	23887513	14	23418304	178082	175599
NM_000257.3(MYH7):c.4066G>A (p.Glu1356Lys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23887522	14	23418313	164294	175600
NM_000257.3(MYH7):c.4052C>T (p.Thr1351Met)	MYH7	Primary familial hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	14	23887536	14	23418327	161324	171161
NM_000257.3(MYH7):c.4031G>A (p.Arg1344Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2016)	criteria provided, conflicting interpretations	14	23887557	14	23418348	208597	205175
NM_000257.3(MYH7):c.3981C>A (p.Asn1327Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23887607	14	23418398	36641	45303
NM_000257.3(MYH7):c.3748C>T (p.Arg1250Trp)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Aug 1, 2014)	criteria provided, single submitter	14	23888797	14	23419588	164299	175457
NM_000257.3(MYH7):c.3645G>C (p.Gln1215His)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 31, 2017)	criteria provided, conflicting interpretations	14	23889135	14	23419926	217463	214125
NM_000257.3(MYH7):c.3578G>A (p.Arg1193His)	MYH7	Primary dilated cardiomyopathy|not specified|not provided|Familial dilated cardiomyopathy	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23889202	14	23419993	42965	52135
NM_000257.3(MYH7):c.3358G>A (p.Glu1120Lys)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23889422	14	23420213	217465	214126
NM_000257.3(MYH7):c.3346G>A (p.Glu1116Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2014)	criteria provided, multiple submitters, no conflicts	14	23889434	14	23420225	177676	175459
NM_000257.3(MYH7):c.3325A>G (p.Lys1109Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	14	23890178	14	23420969	492984	485935
NM_000257.3(MYH7):c.3301G>A (p.Gly1101Ser)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	14	23890202	14	23420993	161325	171162
NM_000257.3(MYH7):c.3286G>T (p.Asp1096Tyr)	MYH7	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1S|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Dilated cardiomyopathy	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23890217	14	23421008	42953	52123
NM_000257.3(MYH7):c.3236G>A (p.Arg1079Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	14	23891398	14	23422189	177826	175460
NM_000257.3(MYH7):c.3170G>A (p.Gly1057Asp)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	14	23891464	14	23422255	492982	485936
NM_000257.3(MYH7):c.3169G>A (p.Gly1057Ser)	MYH7	not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23891465	14	23422256	42950	52120
NM_000257.3(MYH7):c.3158G>A (p.Arg1053Gln)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23891476	14	23422267	155814	165566
NM_000257.3(MYH7):c.3133C>T (p.Arg1045Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23891501	14	23422292	177753	175462
NM_000257.3(MYH7):c.2945T>C (p.Met982Thr)	MYH7	Myosin storage myopathy|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Increased left ventricular wall thickness|Inborn genetic diseases|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23892910	14	23423701	42941	52111
NM_000257.3(MYH7):c.2893G>A (p.Glu965Lys)	MYH7	Familial hypertrophic cardiomyopathy 1|not provided	Likely pathogenic(Last reviewed: Aug 6, 2015)	criteria provided, multiple submitters, no conflicts	14	23893145	14	23423936	217467	214127
NM_000257.3(MYH7):c.2846A>T (p.Glu949Val)	MYH7	not specified|not provided	Uncertain significance(Last reviewed: May 4, 2018)	criteria provided, multiple submitters, no conflicts	14	23893192	14	23423983	42937	52107
NM_000257.3(MYH7):c.2788G>C (p.Glu930Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: May 29, 2018)	criteria provided, multiple submitters, no conflicts	14	23893250	14	23424041	164312	175610
NM_000257.3(MYH7):c.2788G>A (p.Glu930Lys)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	14	23893250	14	23424041	42933	52103
NM_000257.3(MYH7):c.2782G>A (p.Asp928Asn)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	14	23893256	14	23424047	164313	175611
NM_000257.3(MYH7):c.2770G>A (p.Glu924Lys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	14	23893268	14	23424059	14092	29131
NM_000257.3(MYH7):c.2744T>C (p.Leu915Pro)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Apr 11, 2014)	criteria provided, single submitter	14	23893294	14	23424085	42927	52097
NM_000257.3(MYH7):c.2722C>G (p.Leu908Val)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893316	14	23424107	14097	29136
NM_000257.3(MYH7):c.2717A>G (p.Asp906Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893321	14	23424112	14125	29164
NM_000257.3(MYH7):c.2710C>T (p.Arg904Cys)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2018)	criteria provided, conflicting interpretations	14	23893328	14	23424119	164316	175612
NM_000257.3(MYH7):c.2681A>G (p.Glu894Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893357	14	23424148	42922	52092
NM_000257.3(MYH7):c.2678C>T (p.Ala893Val)	MYH7	Primary dilated cardiomyopathy|not specified	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23893979	14	23424770	177763	175468
NM_000257.3(MYH7):c.2655T>A (p.Asn885Lys)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894002	14	23424793	217462	214128
NM_000257.3(MYH7):c.2644C>G (p.Gln882Glu)	MYH7	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 6, 2017)	criteria provided, multiple submitters, no conflicts	14	23894013	14	23424804	42921	52091
NM_000257.3(MYH7):c.2631G>T (p.Met877Ile)	MYH7	Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 18, 2017)	no assertion criteria provided	14	23894026	14	23424817	417718	404619
NM_000257.3(MYH7):c.2609G>A (p.Arg870His)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Chest pain	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894048	14	23424839	14120	29159
NM_000257.3(MYH7):c.2608C>T (p.Arg870Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894049	14	23424840	161326	171163
NM_000257.3(MYH7):c.2578A>G (p.Lys860Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Feb 25, 2015)	criteria provided, single submitter	14	23894079	14	23424870	192312	190102
NM_000257.3(MYH7):c.2572C>T (p.Arg858Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Muscular Diseases|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	14	23894085	14	23424876	164324	175617
NM_000257.3(MYH7):c.2555T>C (p.Met852Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	14	23894102	14	23424893	42916	52086
NM_000257.3(MYH7):c.2546T>C (p.Met849Thr)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Apr 1, 2015)	criteria provided, single submitter	14	23894111	14	23424902	42914	52084
NM_000257.3(MYH7):c.2539A>G (p.Lys847Glu)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894118	14	23424909	177757	175619
NM_000257.3(MYH7):c.2524A>G (p.Ser842Gly)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894133	14	23424924	217474	214130
NM_000257.3(MYH7):c.2513C>A (p.Pro838Gln)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	14	23894144	14	23424935	164329	175620
NM_000257.3(MYH7):c.2513C>T (p.Pro838Leu)	MYH7	Familial hypertrophic cardiomyopathy 1|Familial restrictive cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894144	14	23424935	42910	52080
NM_000257.3(MYH7):c.2470G>C (p.Val824Leu)	MYH7	not specified	Uncertain significance(Last reviewed: Oct 24, 2012)	criteria provided, single submitter	14	23894187	14	23424978	42906	52076
NM_000257.3(MYH7):c.2420G>A (p.Arg807His)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, multiple submitters, no conflicts	14	23894494	14	23425285	391904	373042
NM_000257.3(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Wolff-Parkinson-White pattern|Severe combined immunodeficiency disease|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Immunodeficiency|Hypertrophic cardiomyopathy|Lymphopenia|Abnormality of cellular immune system|Abnormality of T cell physiology|Combined immunodeficiency|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	14	23894525	14	23425316	42901	52071
NM_000257.3(MYH7):c.2360G>A (p.Arg787His)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Uncertain significance(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894554	14	23425345	42900	52070
NM_000257.3(MYH7):c.2359C>T (p.Arg787Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	14	23894555	14	23425346	161327	171164
NM_000257.3(MYH7):c.2334C>G (p.Asp778Glu)	MYH7	not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 24, 2017)	criteria provided, multiple submitters, no conflicts	14	23894580	14	23425371	265252	260053
NM_000257.3(MYH7):c.2302G>A (p.Gly768Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	14	23894612	14	23425403	164337	175624
NM_000257.3(MYH7):c.2291T>A (p.Phe764Tyr)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894623	14	23425414	217473	214131
NM_000257.3(MYH7):c.2225C>A (p.Ala742Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	14	23894965	14	23425756	192310	190103
NM_000257.3(MYH7):c.2221G>T (p.Gly741Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894969	14	23425760	177665	175480
NM_000257.3(MYH7):c.2221G>A (p.Gly741Arg)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	14	23894969	14	23425760	42890	52060
NM_000257.3(MYH7):c.2221G>C (p.Gly741Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894969	14	23425760	14098	29137
NM_000257.3(MYH7):c.2207T>C (p.Ile736Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23894983	14	23425774	164342	175481
NM_000257.3(MYH7):c.2201A>C (p.Gln734Pro)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23894989	14	23425780	217464	214132
NM_000257.3(MYH7):c.2198G>A (p.Gly733Glu)	MYH7	Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	14	23894992	14	23425783	177628	175482
NM_000257.3(MYH7):c.2191C>T (p.Pro731Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 11, 2012)	criteria provided, multiple submitters, no conflicts	14	23894999	14	23425790	181176	179623
NM_000257.3(MYH7):c.2183C>T (p.Ala728Val)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	14	23895007	14	23425798	14111	29150
NM_000257.3(MYH7):c.2171T>A (p.Ile724Asn)	MYH7	not specified	Uncertain significance(Last reviewed: Jan 19, 2014)	criteria provided, single submitter	14	23895019	14	23425810	42887	52057
NM_000257.3(MYH7):c.2167C>G (p.Arg723Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895023	14	23425814	42885	52055
NM_000257.3(MYH7):c.2167C>T (p.Arg723Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895023	14	23425814	14095	29134
NM_000257.3(MYH7):c.2156G>C (p.Arg719Pro)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Likely pathogenic	criteria provided, single submitter	14	23895179	14	23425970	217460	214133
NM_000257.3(MYH7):c.2156G>A (p.Arg719Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895179	14	23425970	14107	29146
NM_000257.3(MYH7):c.2155C>T (p.Arg719Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895180	14	23425971	14104	29143
NM_000257.3(MYH7):c.2146G>A (p.Gly716Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23895189	14	23425980	14105	29144
NM_000257.3(MYH7):c.2123G>C (p.Gly708Ala)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Jun 6, 2017)	criteria provided, multiple submitters, no conflicts	14	23895212	14	23426003	42882	52052
NM_000257.3(MYH7):c.2105T>A (p.Ile702Asn)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	14	23895230	14	23426021	42880	52050
NM_000257.3(MYH7):c.2104A>G (p.Ile702Val)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23895231	14	23426022	217470	214134
NM_000257.3(MYH7):c.2093T>C (p.Val698Ala)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2014)	criteria provided, conflicting interpretations	14	23895242	14	23426033	42878	52048
NM_000257.3(MYH7):c.2087A>G (p.Asn696Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Uncertain significance(Last reviewed: May 25, 2017)	criteria provided, multiple submitters, no conflicts	14	23895248	14	23426039	181173	179628
NM_000257.3(MYH7):c.2080C>T (p.Arg694Cys)	MYH7	Myopathy, distal, 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	14	23895255	14	23426046	177627	175630
NM_000257.3(MYH7):c.1988G>A (p.Arg663His)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23896042	14	23426833	42875	52045
NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	14	23896043	14	23426834	42874	52044
NM_000257.3(MYH7):c.1969A>C (p.Lys657Gln)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Nov 15, 2013)	criteria provided, single submitter	14	23896061	14	23426852	164351	175486
NM_000257.3(MYH7):c.1954A>G (p.Arg652Gly)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2017)	criteria provided, multiple submitters, no conflicts	14	23896451	14	23427242	177626	175632
NM_000257.3(MYH7):c.1816G>A (p.Val606Met)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	14	23896866	14	23427657	14091	29130
NM_000257.3(MYH7):c.1757T>C (p.Val586Ala)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	14	23896925	14	23427716	42865	52035
NM_000257.3(MYH7):c.1750G>A (p.Gly584Ser)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Feb 8, 2018)	criteria provided, multiple submitters, no conflicts	14	23896932	14	23427723	42862	52032
NM_000257.3(MYH7):c.1750G>C (p.Gly584Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23896932	14	23427723	14090	29129
NM_000257.3(MYH7):c.1727A>G (p.His576Arg)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2018)	criteria provided, conflicting interpretations	14	23896955	14	23427746	177625	175490
NM_000257.3(MYH7):c.1608G>T (p.Glu536Asp)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jan 28, 2013)	no assertion criteria provided	14	23897074	14	23427865	177671	175636
NM_000257.3(MYH7):c.1594T>C (p.Ser532Pro)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23897088	14	23427879	14108	29147
NM_000257.3(MYH7):c.1584G>A (p.Met528Ile)	MYH7	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Jan 29, 2015)	criteria provided, single submitter	14	23897098	14	23427889	164361	175491
NM_000257.3(MYH7):c.1573G>A (p.Glu525Lys)	MYH7	Dilated cardiomyopathy 1S|Cardiomyopathy|Familial cardiomyopathy|Hypertrophic cardiomyopathy|Left ventricular noncompaction cardiomyopathy	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	14	23897714	14	23428505	132925	136674
NM_000257.3(MYH7):c.1544T>C (p.Met515Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Dilated cardiomyopathy 1S|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related	Likely pathogenic(Last reviewed: Dec 4, 2012)	criteria provided, single submitter	14	23897743	14	23428534	216968	213631
NM_000257.3(MYH7):c.1532T>C (p.Ile511Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2016)	criteria provided, conflicting interpretations	14	23897755	14	23428546	42848	52018
NM_000257.3(MYH7):c.1491G>T (p.Glu497Asp)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	14	23897796	14	23428587	14124	29163
NM_000257.3(MYH7):c.1479G>C (p.Met493Ile)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23897808	14	23428599	217471	214135
NM_000257.3(MYH7):c.1478T>A (p.Met493Lys)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Dec 17, 2016)	criteria provided, single submitter	14	23897809	14	23428600	192308	190104
NM_000257.3(MYH7):c.1436A>G (p.Asn479Ser)	MYH7	not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	14	23897851	14	23428642	177623	175641
NM_000257.3(MYH7):c.1358G>A (p.Arg453His)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898213	14	23429004	42838	52008
NM_000257.3(MYH7):c.1357C>T (p.Arg453Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898214	14	23429005	14089	29128
NM_000257.3(MYH7):c.1324C>T (p.Arg442Cys)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2018)	criteria provided, conflicting interpretations	14	23898247	14	23429038	177897	175497
NM_000257.3(MYH7):c.1318G>A (p.Val440Met)	MYH7	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 13, 2018)	criteria provided, conflicting interpretations	14	23898253	14	23429044	42835	52005
NM_000257.3(MYH7):c.1208G>A (p.Arg403Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898487	14	23429278	14087	29126
NM_000257.3(MYH7):c.1207C>T (p.Arg403Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Congenital myopathy with fiber type disproportion|Dilated cardiomyopathy 1S|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|Scapuloperoneal myopathy, MYH7-related|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898488	14	23429279	14102	29141
NM_000257.3(MYH7):c.1189A>G (p.Lys397Glu)	MYH7	Familial hypertrophic cardiomyopathy 1|Dilated cardiomyopathy 1S	Likely pathogenic(Last reviewed: Sep 30, 2018)	criteria provided, single submitter	14	23898506	14	23429297	585010	576065
NM_000257.3(MYH7):c.1157A>G (p.Tyr386Cys)	MYH7	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23898538	14	23429329	164378	175645
NM_000257.3(MYH7):c.1128C>A (p.Asp376Glu)	MYH7	Primary dilated cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2017)	criteria provided, conflicting interpretations	14	23898994	14	23429785	181170	179662
NM_000257.3(MYH7):c.1106G>A (p.Arg369Gln)	MYH7	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1S|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23899016	14	23429807	42822	51992
NM_000257.3(MYH7):c.1013T>A (p.Val338Glu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	14	23899109	14	23429900	492983	485937
NM_000257.3(MYH7):c.1013T>C (p.Val338Ala)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2015)	criteria provided, conflicting interpretations	14	23899109	14	23429900	42818	51988
NM_000257.3(MYH7):c.1012G>A (p.Val338Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 20, 2014)	criteria provided, multiple submitters, no conflicts	14	23899110	14	23429901	164381	175502
NM_000257.3(MYH7):c.1003G>T (p.Ala335Ser)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 11, 2013)	criteria provided, single submitter	14	23899119	14	23429910	164382	175648
NM_000257.3(MYH7):c.976G>C (p.Ala326Pro)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	14	23899792	14	23430583	43117	52287
NM_000257.3(MYH7):c.958G>A (p.Val320Met)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2018)	criteria provided, conflicting interpretations	14	23899810	14	23430601	161328	171165
NM_000257.3(MYH7):c.925G>A (p.Asp309Asn)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, multiple submitters, no conflicts	14	23899843	14	23430634	181402	179672
NM_000257.3(MYH7):c.872C>T (p.Ser291Phe)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2014)	criteria provided, conflicting interpretations	14	23900133	14	23430924	43110	52280
NM_000257.3(MYH7):c.842G>C (p.Arg281Thr)	MYH7	Primary dilated cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 23, 2017)	criteria provided, multiple submitters, no conflicts	14	23900163	14	23430954	181327	179675
NM_000257.3(MYH7):c.799C>G (p.Leu267Val)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 15, 2013)	criteria provided, single submitter	14	23900206	14	23430997	177935	175506
NM_000257.3(MYH7):c.788T>C (p.Ile263Thr)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23900635	14	23431426	43106	52276
NM_000257.3(MYH7):c.755T>G (p.Phe252Cys)	MYH7	Familial hypertrophic cardiomyopathy 1	Likely pathogenic	criteria provided, single submitter	14	23900668	14	23431459	217472	214136
NM_000257.3(MYH7):c.746G>A (p.Arg249Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	14	23900677	14	23431468	14088	29127
NM_000257.3(MYH7):c.715G>A (p.Asp239Asn)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	14	23900811	14	23431602	43100	52270
NM_000257.3(MYH7):c.709C>T (p.Arg237Trp)	MYH7	Primary dilated cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2018)	criteria provided, conflicting interpretations	14	23900817	14	23431608	43098	52268
NM_000257.3(MYH7):c.611G>T (p.Arg204Leu)	MYH7	Cardiomyopathy|not specified|not provided|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2018)	criteria provided, conflicting interpretations	14	23900998	14	23431789	177869	175656
NM_000257.3(MYH7):c.602T>C (p.Ile201Thr)	MYH7	Primary dilated cardiomyopathy|not provided|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Apr 19, 2017)	criteria provided, multiple submitters, no conflicts	14	23901007	14	23431798	43093	52263
NM_000257.3(MYH7):c.596C>T (p.Ala199Val)	MYH7	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	14	23901013	14	23431804	177692	175511
NM_000257.3(MYH7):c.560A>G (p.Asn187Ser)	MYH7	not specified	Uncertain significance(Last reviewed: Jan 9, 2014)	criteria provided, single submitter	14	23901049	14	23431840	43077	52247
NM_000257.3(MYH7):c.556G>C (p.Val186Leu)	MYH7	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 20, 2015)	criteria provided, single submitter	14	23901053	14	23431844	192309	190105
NM_000257.3(MYH7):c.507A>T (p.Arg169Ser)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	14	23901711	14	23432502	43055	52225
NM_000257.3(MYH7):c.506G>A (p.Arg169Lys)	MYH7	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2017)	criteria provided, single submitter	14	23901712	14	23432503	43054	52224
NM_000257.3(MYH7):c.438G>T (p.Lys146Asn)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2013)	criteria provided, multiple submitters, no conflicts	14	23901912	14	23432703	43013	52183
NM_000257.3(MYH7):c.428G>A (p.Arg143Gln)	MYH7	Familial hypertrophic cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23901922	14	23432713	43006	52176
NM_000257.3(MYH7):c.427C>T (p.Arg143Trp)	MYH7	Familial hypertrophic cardiomyopathy 1|not specified|not provided|Hypertrophic cardiomyopathy|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2017)	criteria provided, conflicting interpretations	14	23901923	14	23432714	164401	175658
NM_000257.3(MYH7):c.115G>A (p.Val39Met)	MYH7	Primary familial hypertrophic cardiomyopathy|not specified|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2017)	criteria provided, conflicting interpretations	14	23902827	14	23433618	42827	51997
NM_000257.3(MYH7):c.77C>T (p.Ala26Val)	MYH7	Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|Primary familial hypertrophic cardiomyopathy|Myopathy, distal, 1|not specified|not provided|Hypertrophic cardiomyopathy|Scapuloperoneal myopathy|Left ventricular noncompaction cardiomyopathy|Cardiovascular phenotype|Dilated Cardiomyopathy, Dominant	Benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	14	23902865	14	23433656	37375	45929
NM_005249.4(FOXG1):c.209A>C (p.Gln70Pro)	FOXG1	Rett syndrome, congenital variant|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2017)	criteria provided, conflicting interpretations	14	29236694	14	28767488	158591	169050
NM_005249.4(FOXG1):c.543G>T (p.Lys181Asn)	FOXG1	Rett syndrome, congenital variant	Likely pathogenic(Last reviewed: Sep 2, 2015)	criteria provided, single submitter	14	29237028	14	28767822	369681	353907
NM_005249.4(FOXG1):c.563C>G (p.Ala188Gly)	FOXG1	Rett syndrome, congenital variant	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29237048	14	28767842	158596	169055
NM_005249.4(FOXG1):c.755G>T (p.Gly252Val)	FOXG1	Rett syndrome, congenital variant|not provided	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29237240	14	28768034	158598	169057
NM_005249.4(FOXG1):c.757A>G (p.Asn253Asp)	FOXG1	Rett syndrome, congenital variant	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	14	29237242	14	28768036	158599	169058
NM_005249.4(FOXG1):c.799G>A (p.Gly267Ser)	FOXG1	Rett syndrome, congenital variant|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	14	29237284	14	28768078	158602	169061
NM_005249.4(FOXG1):c.1397G>A (p.Gly466Glu)	FOXG1	Rett syndrome, congenital variant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	29237882	14	28768676	561012	552174
NM_004086.2(COCH):c.151C>T (p.Pro51Ser)	COCH|LOC100506071	Deafness, autosomal dominant 9|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Sep 19, 2018)	reviewed by expert panel	14	31346846	14	30877640	6611	21650
NM_004086.2(COCH):c.355G>A (p.Ala119Thr)	COCH|LOC100506071	Deafness, autosomal dominant 9|Nonsyndromic hearing loss and deafness	Uncertain significance(Last reviewed: Sep 17, 2018)	reviewed by expert panel	14	31348132	14	30878926	6613	21652
NM_004086.2(COCH):c.1625G>T (p.Cys542Phe)	COCH|LOC100506071	Deafness, autosomal dominant 9|Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Nov 24, 2015)	criteria provided, single submitter	14	31358969	14	30889763	6614	21653
NM_006194.3(PAX9):c.3G>A (p.Met1Ile)	PAX9	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jun 24, 2017)	no assertion criteria provided	14	37131297	14	36662092	430692	424223
NM_006194.3(PAX9):c.59C>T (p.Pro20Leu)	PAX9	Tooth agenesis, selective, 3	Pathogenic(Last reviewed: Jan 18, 2017)	no assertion criteria provided	14	37132156	14	36662951	375454	362221
NM_015915.4(ATL1):c.1206C>A (p.Phe402Leu)	ATL1	Spastic paraplegia 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	51094835	14	50628117	560958	552176
NM_015915.4(ATL1):c.1222A>T (p.Met408Leu)	ATL1	Spastic paraplegia 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	51094851	14	50628133	560959	552177
NM_000161.2(GCH1):c.610G>A (p.Val204Ile)	GCH1	not provided|Dystonia, dopa-responsive	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2017)	criteria provided, conflicting interpretations	14	55312502	14	54845784	161248	171166
NM_000161.2(GCH1):c.206C>T (p.Pro69Leu)	GCH1	Dystonia 5, Dopa-responsive type|GTP cyclohydrolase I deficiency|Hyperphenylalaninemia due to tetrahydrobiopterin deficiency|not provided|Dystonia, dopa-responsive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	14	55369176	14	54902458	161247	171167
NM_005982.3(SIX1):c.746C>A (p.Pro249Gln)	SIX1	not specified	Uncertain significance(Last reviewed: Sep 12, 2017)	criteria provided, single submitter	14	61113110	14	60646392	517597	497038
NM_005982.3(SIX1):c.386A>G (p.Tyr129Cys)	SIX1	Branchiootic syndrome 3|Deafness, autosomal dominant 23|Melnick-Fraser syndrome|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	14	61115522	14	60648804	8308	23347
NM_182914.2(SYNE2):c.1296C>A (p.Ser432Arg)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	14	64444625	14	63977907	130469	135915
NM_182914.2(SYNE2):c.1721T>C (p.Ile574Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64447776	14	63981058	130486	135932
NM_182914.2(SYNE2):c.2026A>G (p.Lys676Glu)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	14	64450479	14	63983761	130491	135937
NM_182914.2(SYNE2):c.3559A>C (p.Ile1187Leu)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Dec 18, 2017)	criteria provided, multiple submitters, no conflicts	14	64467358	14	64000640	130495	135941
NM_182914.2(SYNE2):c.4177C>T (p.Arg1393Trp)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64469828	14	64003110	130497	135943
NM_182914.2(SYNE2):c.5517A>T (p.Leu1839Phe)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	14	64488739	14	64022021	130500	135946
NM_182914.2(SYNE2):c.5906T>C (p.Met1969Thr)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64491695	14	64024977	130501	135947
NM_182914.2(SYNE2):c.6851C>T (p.Ala2284Val)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64496749	14	64030031	130504	135950
NM_182914.2(SYNE2):c.7040C>A (p.Ala2347Glu)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	14	64497894	14	64031176	130506	135952
NM_182914.2(SYNE2):c.7075A>G (p.Ser2359Gly)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	14	64497929	14	64031211	130507	135953
NM_182914.2(SYNE2):c.7076G>A (p.Ser2359Asn)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64497930	14	64031212	130508	135954
NM_182914.2(SYNE2):c.7124T>C (p.Leu2375Pro)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	14	64497978	14	64031260	130509	135955
NM_182914.2(SYNE2):c.7183G>A (p.Ala2395Thr)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64498037	14	64031319	130511	135957
NM_182914.2(SYNE2):c.7690A>G (p.Ile2564Val)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64518321	14	64051603	130512	135958
NM_182914.2(SYNE2):c.8404A>G (p.Ser2802Gly)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64519035	14	64052317	130513	135959
NM_182914.2(SYNE2):c.8597C>T (p.Thr2866Met)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	14	64519228	14	64052510	130515	135961
NM_182914.2(SYNE2):c.8824A>G (p.Ile2942Val)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64519455	14	64052737	130516	135962
NM_182914.2(SYNE2):c.9023T>C (p.Ile3008Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	14	64519654	14	64052936	130517	135963
NM_182914.2(SYNE2):c.9078A>T (p.Glu3026Asp)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64519709	14	64052991	130518	135964
NM_182914.2(SYNE2):c.9389A>G (p.Asn3130Ser)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	14	64520020	14	64053302	130519	135965
NM_182914.2(SYNE2):c.9757G>C (p.Asp3253His)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64522674	14	64055956	130520	135966
NM_182914.2(SYNE2):c.9926A>G (p.His3309Arg)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64522843	14	64056125	130521	135967
NM_182914.2(SYNE2):c.10567A>C (p.Lys3523Gln)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	14	64537498	14	64070780	130456	135902
NM_182914.2(SYNE2):c.10835A>G (p.Gln3612Arg)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	14	64540823	14	64074105	130457	135903
NM_182914.2(SYNE2):c.11935C>G (p.Leu3979Val)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	14	64557725	14	64091007	130460	135906
NM_182914.2(SYNE2):c.11944A>C (p.Asn3982His)	SYNE2	Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64557734	14	64091016	130461	135907
NM_182914.2(SYNE2):c.12001T>C (p.Trp4001Arg)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	14	64560091	14	64093373	130462	135908
NM_182914.2(SYNE2):c.12043T>C (p.Tyr4015His)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	14	64560133	14	64093415	130464	135910
NM_182914.2(SYNE2):c.12122G>A (p.Arg4041His)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	14	64564680	14	64097962	130465	135911
NM_182914.2(SYNE2):c.12626T>C (p.Ile4209Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	14	64580075	14	64113357	130467	135913
NM_182914.2(SYNE2):c.13254C>A (p.Asn4418Lys)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, multiple submitters, no conflicts	14	64588825	14	64122107	130470	135916
NM_182914.2(SYNE2):c.14734C>G (p.Pro4912Ala)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	14	64604592	14	64137874	130475	135921
NM_182914.2(SYNE2):c.14737G>A (p.Glu4913Lys)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	14	64604595	14	64137877	130476	135922
NM_182914.2(SYNE2):c.15556C>A (p.Leu5186Met)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	14	64612858	14	64146140	130480	135926
NM_182914.2(SYNE2):c.15794T>C (p.Val5265Ala)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	14	64625344	14	64158626	130481	135927
NM_182914.2(SYNE2):c.16522T>A (p.Ser5508Thr)	SYNE2	Emery-Dreifuss muscular dystrophy 5, autosomal dominant|Emery-Dreifuss muscular dystrophy|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	14	64632045	14	64165327	130483	135929
NM_000021.3(PSEN1):c.1141C>T (p.Leu381Phe)	PSEN1	Alzheimer disease, type 3|Alzheimer disease familial 3, with spastic paraparesis	Likely pathogenic(Last reviewed: Nov 17, 2017)	criteria provided, single submitter	14	73683845	14	73217137	120170	125778
NM_000021.3(PSEN1):c.1141C>G (p.Leu381Val)	PSEN1	Alzheimer disease, type 3|not provided	Pathogenic(Last reviewed: Nov 19, 2013)	criteria provided, single submitter	14	73683845	14	73217137	98101	103993
NM_001040108.1(MLH3):c.4180G>A (p.Ala1394Thr)	MLH3	Colorectal cancer, non-polyposis|MLH3-Related Lynch Syndrome	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	14	75485594	14	75018891	161297	171168
NM_001040108.1(MLH3):c.2941G>A (p.Gly981Ser)	MLH3	Colorectal cancer, non-polyposis	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	14	75513418	14	75046715	161298	171169
NM_001040108.1(MLH3):c.2449A>G (p.Ser817Gly)	MLH3	Colorectal cancer, non-polyposis|MLH3-Related Lynch Syndrome	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	14	75513910	14	75047207	161296	171170
NM_001040108.1(MLH3):c.713A>G (p.Tyr238Cys)	MLH3	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	14	75515646	14	75048943	375855	362739
NM_003239.4(TGFB3):c.787G>C (p.Asp263His)	TGFB3	Loeys-Dietz syndrome 5|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	14	76429798	14	75963455	203492	199892
NM_024496.3(IRF2BPL):c.1259T>C (p.Phe420Ser)	IRF2BPL	IRF2BPL-related condition	Likely pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	14	77492877	14	77026534	584438	575500
NM_004993.5(ATXN3):c.916G>C (p.Gly306Arg)	ATXN3	Azorean disease|not specified	Benign/Likely benign(Last reviewed: Sep 24, 2015)	no assertion criteria provided	14	92537354	14	92071010	128515	133964
NM_004993.5(ATXN3):c.883A>C (p.Lys295Gln)	ATXN3|LOC108663987	not specified	Likely benign	no assertion criteria provided	14	92537387	14	92071043	128513	133962
NM_004993.5(ATXN3):c.882A>G (p.Gln294=)	ATXN3|LOC108663987	not specified	Likely benign	no assertion criteria provided	14	92537388	14	92071044	128512	133961
NM_004993.5(ATXN3):c.634G>A (p.Val212Met)	ATXN3	not specified	Likely benign	no assertion criteria provided	14	92548785	14	92082441	128511	133960
NM_001376.4(DYNC1H1):c.791G>T (p.Arg264Leu)	DYNC1H1	Spinal muscular atrophy|SMA: Spinal muscular atrophy	Pathogenic(Last reviewed: Jun 21, 2013)	criteria provided, single submitter	14	102446717	14	101980380	162033	171752
NM_001376.4(DYNC1H1):c.1544C>T (p.Ala515Val)	DYNC1H1	Mental retardation, autosomal dominant 13	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102452106	14	101985769	560993	552168
NM_001376.5(DYNC1H1):c.1792C>T (p.Arg598Cys)	DYNC1H1	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|Charcot-Marie-Tooth disease, axonal, type 2O|not provided|Hereditary motor and sensory neuropathy|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	14	102452354	14	101986017	139652	143271
NM_001376.4(DYNC1H1):c.1817C>T (p.Thr606Ile)	DYNC1H1	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102452379	14	101986042	560994	552169
NM_001376.4(DYNC1H1):c.2327C>T (p.Pro776Leu)	DYNC1H1	Spinal muscular atrophy, lower extremity predominant 1, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 20, 2017)	criteria provided, conflicting interpretations	14	102452889	14	101986552	372934	360017
NM_001376.4(DYNC1H1):c.4700G>T (p.Arg1567Leu)	DYNC1H1	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	14	102469031	14	102002694	216921	213627
NM_001376.4(DYNC1H1):c.4808G>C (p.Arg1603Thr)	DYNC1H1	Mental retardation, autosomal dominant 13	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102469227	14	102002890	560995	552170
NM_001376.4(DYNC1H1):c.4868G>A (p.Arg1623Gln)	DYNC1H1	Mental retardation, autosomal dominant 13|not provided	Likely pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, multiple submitters, no conflicts	14	102469287	14	102002950	424046	409059
NM_001376.4(DYNC1H1):c.10172C>T (p.Pro3391Leu)	DYNC1H1	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	14	102499494	14	102033157	438584	432219
NM_001376.4(DYNC1H1):c.10280A>C (p.Gln3427Pro)	DYNC1H1	Mental retardation, autosomal dominant 13	Likely pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	14	102499688	14	102033351	488494	481362
NM_001376.4(DYNC1H1):c.12087C>A (p.His4029Gln)	DYNC1H1	Charcot-Marie-Tooth disease, type 2|not specified|not provided|Spinocerebellar Ataxia, Dominant|Intellectual Disability, Dominant|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	14	102508056	14	102041719	128928	134375
NM_019066.4(MAGEL2):c.3151C>A (p.Leu1051Ile)	MAGEL2	not specified	Benign/Likely benign(Last reviewed: Aug 18, 2015)	criteria provided, multiple submitters, no conflicts	15	23889739	15	23644592	158812	169073
NM_019066.4(MAGEL2):c.2612C>T (p.Ala871Val)	MAGEL2	not specified|not provided	Benign/Likely benign(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	15	23890278	15	23645131	158811	169074
NM_019066.4(MAGEL2):c.2611G>T (p.Ala871Ser)	MAGEL2	not specified|not provided	Benign/Likely benign(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	15	23890279	15	23645132	158810	169075
NM_019066.4(MAGEL2):c.383T>C (p.Leu128Pro)	MAGEL2	not specified	Benign/Likely benign(Last reviewed: Oct 5, 2015)	criteria provided, multiple submitters, no conflicts	15	23892507	15	23647360	158814	169076
NM_130838.1(UBE3A):c.2549G>A (p.Gly850Asp)	UBE3A|SNHG14	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, multiple submitters, no conflicts	15	25584294	15	25339147	160221	169077
NM_130838.1(UBE3A):c.2503C>T (p.Leu835Phe)	UBE3A|SNHG14	Angelman syndrome|not provided	Likely pathogenic(Last reviewed: Feb 27, 2014)	criteria provided, multiple submitters, no conflicts	15	25584340	15	25339193	156620	166474
NM_130838.1(UBE3A):c.2485T>C (p.Tyr829His)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25584358	15	25339211	160219	169079
NM_130838.1(UBE3A):c.2071G>A (p.Val691Ile)	UBE3A|SNHG14	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25599824	15	25354677	160217	169081
NM_130838.1(UBE3A):c.2026A>G (p.Asn676Asp)	UBE3A|SNHG14	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25601077	15	25355930	160216	169082
NM_130838.1(UBE3A):c.1805A>G (p.Asn602Ser)	UBE3A|SNHG14	Angelman syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2016)	criteria provided, conflicting interpretations	15	25601932	15	25356785	160214	169084
NM_130838.1(UBE3A):c.1763A>G (p.Gln588Arg)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25601974	15	25356827	160212	169086
NM_130838.1(UBE3A):c.1688A>G (p.Asp563Gly)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25605535	15	25360388	160209	169089
NM_130838.1(UBE3A):c.1682A>G (p.Asn561Ser)	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	15	25605541	15	25360394	160208	169090
NM_130838.1(UBE3A):c.1634G>A (p.Gly545Glu)	UBE3A|SNHG14	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25605589	15	25360442	160207	169091
NM_130838.1(UBE3A):c.1132A>C (p.Ile378Leu)	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	15	25616129	15	25370982	160201	169096
NM_130838.1(UBE3A):c.1116A>T (p.Glu372Asp)	UBE3A|SNHG14	Angelman syndrome|not specified	Uncertain significance(Last reviewed: Oct 30, 2015)	criteria provided, multiple submitters, no conflicts	15	25616145	15	25370998	160200	169097
NM_130838.1(UBE3A):c.755A>G (p.Asn252Ser)	UBE3A|SNHG14	Angelman syndrome|not specified	Uncertain significance(Last reviewed: Sep 20, 2017)	criteria provided, multiple submitters, no conflicts	15	25616506	15	25371359	156141	165941
NM_130838.1(UBE3A):c.398T>G (p.Val133Gly)	UBE3A|SNHG14	Angelman syndrome	Uncertain significance(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	15	25616863	15	25371716	156131	165931
NM_130838.1(UBE3A):c.317C>A (p.Thr106Lys)	UBE3A|SNHG14	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25616944	15	25371797	155994	165798
NM_130838.1(UBE3A):c.268A>G (p.Met90Val)	UBE3A|SNHG14	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25620645	15	25375498	160222	169106
NM_130838.1(UBE3A):c.116G>A (p.Arg39His)	UBE3A|SNHG14	not specified	Benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	15	25620797	15	25375650	160202	169107
NM_000814.5(GABRB3):c.695G>C (p.Arg232Pro)	GABRB3	Epilepsy, childhood absence 5	Likely pathogenic(Last reviewed: Apr 14, 2014)	criteria provided, single submitter	15	26812868	15	26567721	209156	205778
NM_013372.6(GREM1):c.169A>C (p.Asn57His)	GREM1	Hereditary mixed polyposis syndrome	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	15	33023060	15	32730859	375861	362740
NM_005159.4(ACTC1):c.793C>G (p.Gln265Glu)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|Primary familial hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 26, 2018)	criteria provided, conflicting interpretations	15	35084306	15	34792105	177786	175955
NM_005159.4(ACTC1):c.301G>A (p.Glu101Lys)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11|Dilated cardiomyopathy 1R|Atrial septal defect 5|Primary familial hypertrophic cardiomyopathy|Left ventricular noncompaction 4|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	15	35085599	15	34793398	18331	33370
NM_005159.4(ACTC1):c.281A>G (p.Asn94Ser)	ACTC1|LOC101928174	Familial hypertrophic cardiomyopathy 11	Likely pathogenic	criteria provided, single submitter	15	35085619	15	34793418	217487	214137
NM_002875.4(RAD51):c.772G>A (p.Glu258Lys)	RAD51	Fanconi anemia, complementation group R	Likely pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	15	41021830	15	40729632	522859	513451
NM_173500.3(TTBK2):c.23T>C (p.Leu8Pro)	TTBK2	not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	43170793	15	42878595	130646	136092
NM_000138.4(FBN1):c.8494A>G (p.Ser2832Gly)	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	15	48703309	15	48411112	161236	171171
NM_000138.4(FBN1):c.8176C>T (p.Arg2726Trp)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Inborn genetic diseases|Geleophysic dysplasia|Ectopia lentis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	15	48704816	15	48412619	16445	31484
NM_000138.4(FBN1):c.8081G>A (p.Arg2694Gln)	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	15	48704911	15	48412714	161240	171172
NM_000138.4(FBN1):c.7906G>A (p.Gly2636Ser)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	15	48707878	15	48415681	393275	373456
NM_000138.4(FBN1):c.7846A>G (p.Ile2616Val)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, multiple submitters, no conflicts	15	48707938	15	48415741	161237	171173
NM_000138.4(FBN1):c.7754T>C (p.Ile2585Thr)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not specified|Dilatation of ascending aorta|Scoliosis|Tall stature|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Aortic aneurysm|Joint hypermobility|Severe Myopia|Aortic aneurysm|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype|Marfan lipodystrophy syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	15	48712949	15	48420752	163462	175979
NM_000138.4(FBN1):c.7702G>A (p.Val2568Met)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Mar 9, 2014)	criteria provided, single submitter	15	48713001	15	48420804	161238	171174
NM_000138.4(FBN1):c.7660C>T (p.Arg2554Trp)	FBN1	not specified|Marfan syndrome, incomplete	Uncertain significance(Last reviewed: May 10, 2016)	criteria provided, single submitter	15	48713794	15	48421597	161241	171175
NM_000138.4(FBN1):c.7649G>A (p.Cys2550Tyr)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	15	48713805	15	48421608	590852	581791
NM_000138.4(FBN1):c.7580A>C (p.Glu2527Ala)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Feb 29, 2016)	criteria provided, single submitter	15	48713874	15	48421677	42428	51598
NM_000138.4(FBN1):c.7379A>G (p.Lys2460Arg)	FBN1	Marfan syndrome|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 15, 2017)	criteria provided, multiple submitters, no conflicts	15	48717640	15	48425443	161239	171176
NM_000138.4(FBN1):c.7241G>A (p.Arg2414Gln)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Uncertain significance(Last reviewed: May 11, 2017)	criteria provided, multiple submitters, no conflicts	15	48718025	15	48425828	161234	171177
NM_000138.4(FBN1):c.7168T>C (p.Cys2390Arg)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Nov 20, 2015)	criteria provided, single submitter	15	48719800	15	48427603	42421	51591
NM_000138.4(FBN1):c.7094G>A (p.Cys2365Tyr)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	15	48719874	15	48427677	42419	51589
NM_000138.4(FBN1):c.6806T>C (p.Ile2269Thr)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections|Cardiovascular phenotype|Marfan lipodystrophy syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2018)	criteria provided, conflicting interpretations	15	48722933	15	48430736	36107	44771
NM_000138.4(FBN1):c.6700G>A (p.Val2234Met)	FBN1	Marfan syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	15	48725102	15	48432905	36104	44768
NM_000138.4(FBN1):c.6354C>G (p.Ile2118Met)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Likely pathogenic(Last reviewed: Apr 20, 2018)	criteria provided, multiple submitters, no conflicts	15	48729544	15	48437347	180039	175982
NM_000138.4(FBN1):c.5588G>A (p.Gly1863Glu)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Jul 14, 2016)	criteria provided, single submitter	15	48741048	15	48448851	42388	51558
NM_000138.4(FBN1):c.5099A>G (p.Tyr1700Cys)	FBN1	Acromicric dysplasia|not provided	Pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	15	48755404	15	48463207	29701	38656
NM_000138.4(FBN1):c.4588C>T (p.Arg1530Cys)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Marfan lipodystrophy syndrome|Aortic aneurysm, ascending, and dissection	Pathogenic/Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	15	48760294	15	48468097	36078	44742
NM_000138.4(FBN1):c.4444G>A (p.Gly1482Ser)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Nov 18, 2016)	criteria provided, single submitter	15	48762846	15	48470649	373256	360178
NM_000138.4(FBN1):c.4441A>G (p.Ser1481Gly)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Marfan lipodystrophy syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	15	48762849	15	48470652	36074	44738
NM_000138.4(FBN1):c.4406G>C (p.Arg1469Pro)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection	Likely pathogenic(Last reviewed: Oct 13, 2011)	criteria provided, single submitter	15	48762884	15	48470687	42361	51531
NM_000138.4(FBN1):c.4270C>G (p.Pro1424Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Acute aortic dissections|Familial thoracic aortic aneurysms	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	15	48764814	15	48472617	42355	51525
NM_000138.4(FBN1):c.4222T>C (p.Cys1408Arg)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	15	48764862	15	48472665	42351	51521
NM_000138.4(FBN1):c.3886T>C (p.Cys1296Arg)	FBN1	Marfan syndrome|not provided	Likely pathogenic(Last reviewed: Jan 18, 2014)	criteria provided, multiple submitters, no conflicts	15	48773930	15	48481733	42344	51514
NM_000138.4(FBN1):c.3797A>T (p.Tyr1266Phe)	FBN1	Marfan syndrome|not provided|Cardiovascular phenotype|Acute aortic dissections|Familial thoracic aortic aneurysms	Uncertain significance(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	15	48776056	15	48483859	161235	171178
NM_000138.4(FBN1):c.3589G>C (p.Asp1197His)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Sep 24, 2013)	criteria provided, single submitter	15	48779272	15	48487075	179244	176129
NM_000138.4(FBN1):c.3589G>A (p.Asp1197Asn)	FBN1	not specified	Uncertain significance(Last reviewed: Sep 30, 2011)	criteria provided, single submitter	15	48779272	15	48487075	42339	51509
NM_000138.4(FBN1):c.3509G>A (p.Arg1170His)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfanoid habitus|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	15	48779352	15	48487155	16451	31490
NM_000138.4(FBN1):c.3442C>G (p.Pro1148Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|FNB1 POLYMORPHISM|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype	Benign(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	15	48779530	15	48487333	36065	44729
NM_000138.4(FBN1):c.3392A>G (p.Asn1131Ser)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: May 18, 2017)	criteria provided, single submitter	15	48779580	15	48487383	42332	51502
NM_000138.4(FBN1):c.3058A>G (p.Thr1020Ala)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2018)	criteria provided, conflicting interpretations	15	48782072	15	48489875	42325	51495
NM_000138.4(FBN1):c.3037G>A (p.Gly1013Arg)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, multiple submitters, no conflicts	15	48782093	15	48489896	177648	175987
NM_000138.4(FBN1):c.2956G>A (p.Ala986Thr)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	15	48782174	15	48489977	36060	44724
NM_000138.4(FBN1):c.2942G>C (p.Cys981Ser)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	15	48782188	15	48489991	179765	176131
NM_000138.4(FBN1):c.2927G>A (p.Arg976His)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Conflicting interpretations of pathogenicity(Last reviewed: Mar 27, 2017)	criteria provided, conflicting interpretations	15	48782203	15	48490006	42321	51491
NM_000138.4(FBN1):c.2489G>C (p.Cys830Ser)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	15	48787716	15	48495519	42310	51480
NM_000138.4(FBN1):c.2448C>G (p.Cys816Trp)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: May 5, 2017)	criteria provided, single submitter	15	48787757	15	48495560	42306	51476
NM_000138.4(FBN1):c.2056G>A (p.Ala686Thr)	FBN1	Marfan syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	15	48796041	15	48503844	161242	171179
NM_000138.4(FBN1):c.1879C>T (p.Arg627Cys)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|Thoracic aortic Aneurysm and dissection (TAAD)	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	15	48797303	15	48505106	163480	175988
NM_000138.4(FBN1):c.1643A>T (p.Asn548Ile)	FBN1	Marfan syndrome	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48802312	15	48510115	16432	31471
NM_000138.4(FBN1):c.1345G>A (p.Val449Ile)	FBN1	Marfan syndrome|not specified	Uncertain significance(Last reviewed: Apr 25, 2016)	criteria provided, multiple submitters, no conflicts	15	48807707	15	48515510	161243	171180
NM_000138.4(FBN1):c.1027G>A (p.Gly343Arg)	FBN1	Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome|Acromicric dysplasia|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Cardiovascular phenotype|Geleophysic dysplasia|Ectopia lentis|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 24, 2018)	criteria provided, conflicting interpretations	15	48812976	15	48520779	161244	171181
NM_000138.4(FBN1):c.718C>T (p.Arg240Cys)	FBN1	Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|MASS syndrome|Stiff skin syndrome|Weill-Marchesani syndrome 2|Acromicric dysplasia|Geleophysic dysplasia 2|Thoracic aortic aneurysm and aortic dissection|not provided|Thoracic aortic Aneurysm and dissection (TAAD)|Marfan lipodystrophy syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	15	48829826	15	48537629	16461	31500
NM_000138.4(FBN1):c.649T>G (p.Trp217Gly)	FBN1	Marfan syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	15	48829895	15	48537698	36101	44765
NM_000138.4(FBN1):c.364C>T (p.Arg122Cys)	FBN1	Marfan syndrome|Marfan syndrome, atypical|High palate|not provided|Arachnodactyly|Lens subluxation|Aortic dissection|Cardiovascular phenotype	Pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	15	48892414	15	48600217	16440	31479
NM_000138.4(FBN1):c.59A>G (p.Tyr20Cys)	FBN1	Marfan syndrome|Thoracic aortic aneurysm and aortic dissection|not specified|not provided|Thoracic aortic Aneurysm and dissection (TAAD)	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	15	48936908	15	48644711	161245	171182
NM_001018005.1(TPM1):c.46G>C (p.Glu16Gln)	TPM1	Primary familial hypertrophic cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Nov 7, 2012)	criteria provided, single submitter	15	63335074	15	63042875	177702	176135
NM_001018005.1(TPM1):c.62G>T (p.Arg21Leu)	TPM1	Familial hypertrophic cardiomyopathy 3|not specified|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2018)	criteria provided, conflicting interpretations	15	63335090	15	63042891	181678	179749
NM_001018005.1(TPM1):c.284T>C (p.Val95Ala)	TPM1	Familial hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	15	63349227	15	63057028	12457	27496
NM_001018005.1(TPM1):c.337C>G (p.Leu113Val)	TPM1	Primary dilated cardiomyopathy|not provided|Left ventricular noncompaction 9	Likely pathogenic(Last reviewed: Dec 9, 2016)	criteria provided, multiple submitters, no conflicts	15	63349280	15	63057081	43414	52584
NM_001018005.1(TPM1):c.388A>G (p.Ile130Val)	TPM1	Pulmonary atresia with intact ventricular septum	Likely pathogenic	no assertion criteria provided	15	63351775	15	63059576	370041	354281
NM_001018005.1(TPM1):c.457C>G (p.His153Asp)	TPM1	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 21, 2017)	criteria provided, conflicting interpretations	15	63351844	15	63059645	43419	52589
NM_001018005.1(TPM1):c.475G>A (p.Asp159Asn)	TPM1	Primary dilated cardiomyopathy|Dilated cardiomyopathy 1Y|not specified|not provided|Left ventricular noncompaction 9|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2019)	criteria provided, conflicting interpretations	15	63351862	15	63059663	43420	52590
NM_001018005.1(TPM1):c.515T>C (p.Ile172Thr)	TPM1	Primary familial hypertrophic cardiomyopathy|not specified|not provided	Uncertain significance(Last reviewed: Mar 21, 2017)	criteria provided, multiple submitters, no conflicts	15	63353090	15	63060891	31879	40539
NM_001018005.1(TPM1):c.523G>A (p.Asp175Asn)	TPM1	Familial hypertrophic cardiomyopathy 3|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	15	63353098	15	63060899	12456	27495
NM_000366.5(TPM1):c.559G>C (p.Glu187Gln)	TPM1	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Feb 8, 2013)	no assertion criteria provided	15	63353134	15	63060935	177659	176139
NM_001018005.1(TPM1):c.635A>T (p.Glu212Val)	TPM1	Familial hypertrophic cardiomyopathy 1	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	15	63353983	15	63061784	492989	485938
NM_001018005.1(TPM1):c.686C>T (p.Ser229Phe)	TPM1	Atrial septal defect 1	Likely pathogenic	no assertion criteria provided	15	63354460	15	63062261	370040	354280
NM_001018005.1(TPM1):c.688G>A (p.Asp230Asn)	TPM1	Primary dilated cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	15	63354462	15	63062263	31884	40544
NM_001018005.1(TPM1):c.851T>C (p.Ile284Thr)	TPM1	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	15	63356341	15	63064142	188708	186532
NM_001101362.2(KBTBD13):c.242C>T (p.Ala81Val)	KBTBD13	not specified|Nemaline Myopathy, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	15	65369395	15	65077057	129308	134754
NM_001101362.2(KBTBD13):c.794G>A (p.Gly265Asp)	KBTBD13	Nemaline myopathy 6|not specified|Nemaline Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jul 25, 2017)	criteria provided, multiple submitters, no conflicts	15	65369947	15	65077609	129310	134756
NM_002755.3(MAP2K1):c.169A>C (p.Lys57Gln)	MAP2K1	Rasopathy|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66727453	15	66435115	40779	49249
NM_002755.3(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	Non-small cell lung cancer|Autism spectrum disorder|not provided|Rasopathy|Cardiofaciocutaneous syndrome 3|Cutaneous melanoma|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66727483	15	66435145	40781	49251
NM_002755.3(MAP2K1):c.364A>G (p.Asn122Asp)	MAP2K1	Rasopathy	Likely pathogenic(Last reviewed: Jul 28, 2015)	criteria provided, single submitter	15	66729156	15	66436818	228273	230599
NM_002755.3(MAP2K1):c.370C>A (p.Pro124Thr)	MAP2K1	Cardiofaciocutaneous syndrome 3	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	66729162	15	66436824	40742	49212
NM_002755.3(MAP2K1):c.388T>C (p.Tyr130His)	MAP2K1	Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66729180	15	66436842	40747	49217
NM_002755.3(MAP2K1):c.389A>G (p.Tyr130Cys)	MAP2K1	not provided|Rasopathy|Cardiofaciocutaneous syndrome 3|Inborn genetic diseases|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	15	66729181	15	66436843	13351	28390
NM_005902.3(SMAD3):c.803G>A (p.Arg268His)	SMAD3	Thoracic aortic aneurysm and aortic dissection|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 3, 2018)	criteria provided, conflicting interpretations	15	67473723	15	67181385	213766	210283
NM_014249.3(NR2E3):c.166G>A (p.Gly56Arg)	NR2E3	Retinitis pigmentosa 37|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, multiple submitters, no conflicts	15	72103870	15	71811530	5533	20572
NM_005477.2(HCN4):c.1928T>G (p.Leu643Arg)	HCN4	Sudden cardiac death|Sudden cardiac death|Sinus bradycardia	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	15	73617346	15	73325005	427950	419289
NM_005477.2(HCN4):c.724C>T (p.Arg242Cys)	HCN4	Brugada syndrome 8|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	15	73659888	15	73367547	240173	242115
NM_005477.2(HCN4):c.520C>T (p.Pro174Ser)	HCN4	Brugada syndrome 8|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	15	73660092	15	73367751	190787	188642
NM_013227.3(ACAN):c.7244A>T (p.Asp2415Val)	ACAN	Osteochondritis dissecans	Uncertain significance(Last reviewed: Jun 7, 2016)	no assertion criteria provided	15	89416167	15	88872936	252934	247337
NM_002666.4(PLIN1):c.1139C>T (p.Ala380Val)	PLIN1	not provided|Monogenic diabetes	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2016)	criteria provided, conflicting interpretations	15	90210237	15	89667006	129967	135413
NM_002666.4(PLIN1):c.1043C>T (p.Ser348Leu)	PLIN1	not specified|Monogenic diabetes	Benign(Last reviewed: Aug 16, 2016)	criteria provided, multiple submitters, no conflicts	15	90210333	15	89667102	129969	135415
NM_002666.4(PLIN1):c.812C>T (p.Ala271Val)	PLIN1	not specified|Monogenic diabetes	Benign(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	15	90210984	15	89667753	129974	135420
NM_002666.4(PLIN1):c.580C>G (p.Pro194Ala)	PLIN1	not specified	Likely benign	no assertion criteria provided	15	90213229	15	89669998	129973	135419
NM_002168.3(IDH2):c.1304C>T (p.Thr435Met)	IDH2	not specified|not provided	Likely benign(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	15	90627553	15	90084321	158664	169178
NM_002168.3(IDH2):c.419G>A (p.Arg140Gln)	IDH2	Multiple myeloma|Squamous cell carcinoma of the head and neck|Acute myeloid leukemia|D-2-hydroxyglutaric aciduria 2|Myelodysplastic syndrome|not provided|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	15	90631934	15	90088702	14716	29755
NM_001271.3(CHD2):c.1937G>A (p.Gly646Glu)	CHD2	Epileptic encephalopathy, childhood-onset	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	93499816	15	92956586	560972	552186
NM_001271.3(CHD2):c.2699G>A (p.Arg900Gln)	CHD2	Epileptic encephalopathy, childhood-onset	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	15	93521585	15	92978355	560973	552187
NM_001031737.2(CCDC78):c.966C>A (p.Asn322Lys)	CCDC78	Myopathy, centronuclear, 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 10, 2017)	criteria provided, conflicting interpretations	16	774193	16	724193	128634	134083
NM_001031737.2(CCDC78):c.803C>T (p.Thr268Met)	CCDC78	not specified|Myopathy, centronuclear, 4	Benign(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	16	774472	16	724472	128632	134081
NM_001031737.2(CCDC78):c.754T>C (p.Trp252Arg)	CCDC78	not specified	Benign(Last reviewed: Aug 15, 2013)	criteria provided, multiple submitters, no conflicts	16	774692	16	724692	128631	134080
NM_021098.2(CACNA1H):c.4645A>G (p.Met1549Val)	CACNA1H	Primary hyperaldosteronism|Hyperaldosteronism, familial, type IV	Pathogenic(Last reviewed: Apr 24, 2015)	no assertion criteria provided	16	1262024	16	1212024	189779	187648
NM_000548.4(TSC2):c.167A>G (p.Asn56Ser)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2017)	criteria provided, conflicting interpretations	16	2100429	16	2050428	161398	171186
NM_000548.4(TSC2):c.223G>A (p.Glu75Lys)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2018)	criteria provided, conflicting interpretations	16	2100485	16	2050484	161399	171187
NM_000548.4(TSC2):c.292C>T (p.Arg98Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	16	2103409	16	2053408	65223	76155
NM_000548.4(TSC2):c.736A>G (p.Thr246Ala)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified	Uncertain significance(Last reviewed: Mar 8, 2017)	criteria provided, multiple submitters, no conflicts	16	2106732	16	2056731	49384	58546
NM_000548.3(TSC2):c.1100G>A (p.Arg367Gln)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	16	2110795	16	2060794	41725	50164
NM_000548.4(TSC2):c.1229T>G (p.Leu410Arg)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Likely pathogenic(Last reviewed: Aug 27, 2015)	criteria provided, single submitter	16	2111981	16	2061980	49680	58842
NM_000548.4(TSC2):c.1255C>T (p.Pro419Ser)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic(Last reviewed: Dec 17, 2012)	criteria provided, single submitter	16	2112007	16	2062006	50176	59338
NM_000548.4(TSC2):c.1378G>A (p.Ala460Thr)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	16	2112989	16	2062988	49660	58822
NM_000548.4(TSC2):c.1574A>G (p.Asn525Ser)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	16	2114403	16	2064402	49681	58843
NM_000548.4(TSC2):c.1678G>A (p.Val560Met)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	16	2115598	16	2065597	65075	76006
NM_000548.4(TSC2):c.1832G>A (p.Arg611Gln)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	16	2120572	16	2070571	12397	27436
NM_000548.4(TSC2):c.1939G>A (p.Asp647Asn)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2018)	criteria provided, conflicting interpretations	16	2121610	16	2071609	41731	50170
NM_000548.4(TSC2):c.2074G>A (p.Val692Ile)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Uncertain significance(Last reviewed: Jan 26, 2018)	criteria provided, multiple submitters, no conflicts	16	2121912	16	2071911	226045	227853
NM_000548.4(TSC2):c.2410T>C (p.Cys804Arg)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2015)	criteria provided, multiple submitters, no conflicts	16	2124255	16	2074254	49725	58887
NM_000548.4(TSC2):c.2476C>A (p.Leu826Met)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 9, 2018)	criteria provided, conflicting interpretations	16	2124321	16	2074320	41732	50171
NM_000548.4(TSC2):c.2521G>A (p.Val841Ile)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2016)	criteria provided, conflicting interpretations	16	2124366	16	2074365	237994	242259
NM_000548.4(TSC2):c.2666C>T (p.Ala889Val)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2017)	criteria provided, conflicting interpretations	16	2126095	16	2076094	49586	58748
NM_000548.4(TSC2):c.2713C>T (p.Arg905Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, multiple submitters, no conflicts	16	2126142	16	2076141	12404	27443
NM_000548.4(TSC2):c.3095G>C (p.Arg1032Pro)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	16	2129161	16	2079160	49241	58403
NM_000548.4(TSC2):c.3421G>A (p.Ala1141Thr)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	16	2130189	16	2080188	49258	58420
NM_000548.4(TSC2):c.3430G>A (p.Val1144Met)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	16	2130198	16	2080197	41733	50172
NM_000548.4(TSC2):c.3598C>T (p.Arg1200Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Feb 6, 2018)	criteria provided, multiple submitters, no conflicts	16	2130366	16	2080365	49770	58932
NM_000548.4(TSC2):c.3611G>A (p.Gly1204Glu)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Likely pathogenic(Last reviewed: Mar 24, 2016)	criteria provided, multiple submitters, no conflicts	16	2131596	16	2081595	50148	59310
NM_000548.4(TSC2):c.3914C>T (p.Pro1305Leu)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	16	2133726	16	2083725	41737	50176
NM_000548.4(TSC2):c.3986G>A (p.Arg1329His)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	16	2133798	16	2083797	41738	50177
NM_000548.4(TSC2):c.5138G>C (p.Arg1713Pro)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome	Likely pathogenic(Last reviewed: Jun 10, 2015)	criteria provided, single submitter	16	2138118	16	2088117	49931	59093
NM_000548.4(TSC2):c.5227C>T (p.Arg1743Trp)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	16	2138294	16	2088293	49471	58633
NM_000548.3(TSC2):c.5228G>A (p.Arg1743Gln)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not provided	Pathogenic(Last reviewed: Jun 9, 2018)	criteria provided, multiple submitters, no conflicts	16	2138295	16	2088294	49960	59122
NM_000548.4(TSC2):c.5321G>C (p.Ser1774Thr)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	16	2138508	16	2088507	41745	50184
NM_000548.4(TSC2):c.5359G>A (p.Gly1787Ser)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	16	2138546	16	2088545	41746	50185
NM_000548.4(TSC2):c.5378G>A (p.Arg1793Gln)	TSC2	Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2018)	criteria provided, conflicting interpretations	16	2138565	16	2088564	49941	59103
NM_000548.3(TSC2):c.5383C>T (p.Arg1795Cys)	TSC2	Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Tuberous sclerosis and lymphangiomyomatosis	Conflicting interpretations of pathogenicity(Last reviewed: Mar 7, 2018)	criteria provided, conflicting interpretations	16	2138570	16	2088569	41748	50187
NM_001009944.2(PKD1):c.7268C>A (p.Ser2423Tyr)	PKD1	Polycystic kidney disease, adult type	Likely pathogenic	no assertion criteria provided	16	2156620	16	2106619	496638	488123
NM_001009944.2(PKD1):c.7226C>T (p.Thr2409Met)	PKD1	Polycystic kidney disease, adult type	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	16	2156662	16	2106661	584459	575501
NM_001009944.2(PKD1):c.5986G>A (p.Val1996Met)	PKD1	Polycystic kidney disease, adult type	Uncertain significance	no assertion criteria provided	16	2159182	16	2109181	427735	417437
NM_001009944.2(PKD1):c.696T>G (p.Cys232Trp)	PKD1	Polycystic kidney disease, adult type	Likely pathogenic	no assertion criteria provided	16	2168297	16	2118296	427736	417438
NM_001009944.2(PKD1):c.127C>G (p.Pro43Ala)	PKD1	Polycystic kidney disease, adult type	Uncertain significance	no assertion criteria provided	16	2185564	16	2135563	427740	417442
NM_032271.2(TRAF7):c.1964G>A (p.Arg655Gln)	TRAF7	CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY|TRAF7-related developmental delay, congenital anomalies, and dysmorphic features	Pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	16	2226351	16	2176350	587685	578643
NM_001199107.1(TBC1D24):c.404C>T (p.Pro135Leu)	TBC1D24	Parkinsonism|Autosomal dominant epilepsy	Pathogenic(Last reviewed: Jan 10, 2017)	no assertion criteria provided	16	2546553	16	2496552	375708	362597
NM_000243.2(MEFV):c.2082G>A (p.Met694Ile)	MEFV	Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not provided	Pathogenic(Last reviewed: Oct 10, 2017)	criteria provided, multiple submitters, no conflicts	16	3293405	16	3243405	2539	17578
NM_004380.2(CREBBP):c.7040C>T (p.Ala2347Val)	CREBBP	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3778008	16	3728007	158399	169205
NM_004380.2(CREBBP):c.6624A>C (p.Gln2208His)	CREBBP	not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	16	3778424	16	3728423	158398	169206
NM_004380.2(CREBBP):c.6449C>T (p.Pro2150Leu)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3778599	16	3728598	158397	169207
NM_004380.2(CREBBP):c.5933A>G (p.Asn1978Ser)	CREBBP	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 8, 2017)	criteria provided, multiple submitters, no conflicts	16	3779115	16	3729114	95057	100957
NM_004380.2(CREBBP):c.5800T>C (p.Ser1934Pro)	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Uncertain significance(Last reviewed: Apr 1, 2015)	criteria provided, multiple submitters, no conflicts	16	3779248	16	3729247	158387	169216
NM_004380.2(CREBBP):c.5719G>A (p.Ala1907Thr)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 10, 2018)	criteria provided, conflicting interpretations	16	3779329	16	3729328	95056	100956
NM_004380.2(CREBBP):c.5614A>G (p.Met1872Val)	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	16	3779434	16	3729433	209145	205780
NM_004380.2(CREBBP):c.5050T>C (p.Ser1684Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3781315	16	3731314	158385	169218
NM_004380.2(CREBBP):c.4894T>C (p.Phe1632Leu)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Apr 15, 2013)	criteria provided, single submitter	16	3781471	16	3731470	158383	169220
NM_004380.2(CREBBP):c.4508A>G (p.Tyr1503Cys)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786703	16	3736702	158377	169226
NM_004380.2(CREBBP):c.4445A>G (p.Tyr1482Cys)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3786766	16	3736765	158376	169227
NM_004380.2(CREBBP):c.4444T>G (p.Tyr1482Asp)	CREBBP	Rubinstein-Taybi syndrome 1	Pathogenic(Last reviewed: Oct 10, 2013)	criteria provided, single submitter	16	3786767	16	3736766	158375	169228
NM_004380.2(CREBBP):c.4376A>G (p.Glu1459Gly)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3788578	16	3738577	158373	169230
NM_004380.2(CREBBP):c.4226T>C (p.Phe1409Ser)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3789633	16	3739632	158370	169233
NM_004380.2(CREBBP):c.4022G>C (p.Arg1341Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3790511	16	3740510	158366	169237
NM_004380.2(CREBBP):c.3989A>G (p.Gln1330Arg)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	16	3790544	16	3740543	158365	169238
NM_004380.2(CREBBP):c.3832G>A (p.Glu1278Lys)	CREBBP	Rubinstein-Taybi syndrome 1|not provided	Pathogenic(Last reviewed: Mar 15, 2016)	criteria provided, multiple submitters, no conflicts	16	3799632	16	3749631	9433	24472
NM_004380.2(CREBBP):c.3500A>G (p.Tyr1167Cys)	CREBBP	Rubinstein-Taybi syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: May 8, 2018)	criteria provided, conflicting interpretations	16	3807919	16	3757918	158357	169245
NM_004380.2(CREBBP):c.2974G>A (p.Val992Ile)	CREBBP	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 18, 2016)	criteria provided, multiple submitters, no conflicts	16	3819261	16	3769260	95040	100940
NM_004380.2(CREBBP):c.2941G>A (p.Ala981Thr)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 17, 2016)	criteria provided, multiple submitters, no conflicts	16	3819294	16	3769293	95037	100937
NM_004380.2(CREBBP):c.2728A>G (p.Thr910Ala)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 17, 2017)	criteria provided, conflicting interpretations	16	3820723	16	3770722	30042	38997
NM_004380.2(CREBBP):c.2606T>C (p.Leu869Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3820845	16	3770844	158347	169252
NM_004380.2(CREBBP):c.1955A>C (p.His652Pro)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2013)	criteria provided, single submitter	16	3828170	16	3778169	158343	169256
NM_004380.2(CREBBP):c.1651C>A (p.Leu551Ile)	CREBBP	Rubinstein-Taybi syndrome 1|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2018)	criteria provided, conflicting interpretations	16	3831230	16	3781229	95026	100926
NM_004380.2(CREBBP):c.1211G>C (p.Cys404Ser)	CREBBP	not specified	Likely benign(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3843392	16	3793391	158336	169262
NM_004380.2(CREBBP):c.383C>G (p.Ser128Cys)	CREBBP	not specified|not provided	Likely benign(Last reviewed: Mar 3, 2017)	criteria provided, multiple submitters, no conflicts	16	3900713	16	3850712	133930	137669
NM_004380.2(CREBBP):c.164A>G (p.Asn55Ser)	CREBBP	Rubinstein-Taybi syndrome 1	Uncertain significance(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	16	3900932	16	3850931	158340	169270
NM_004380.2(CREBBP):c.37A>G (p.Lys13Glu)	CREBBP	Rubinstein-Taybi syndrome 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	16	3929881	16	3879880	158360	169272
NM_000833.4(GRIN2A):c.3785C>T (p.Thr1262Ile)	GRIN2A	not provided	Uncertain significance(Last reviewed: Jun 11, 2013)	criteria provided, single submitter	16	9857616	16	9763759	129187	134633
NM_000833.4(GRIN2A):c.3619T>C (p.Tyr1207His)	GRIN2A	not provided	Uncertain significance(Last reviewed: Oct 31, 2017)	criteria provided, multiple submitters, no conflicts	16	9857782	16	9763925	129198	134644
NM_000833.4(GRIN2A):c.3553A>G (p.Lys1185Glu)	GRIN2A	not specified	Likely benign(Last reviewed: Jan 29, 2014)	criteria provided, single submitter	16	9857848	16	9763991	129197	134643
NM_000833.4(GRIN2A):c.2899G>C (p.Val967Leu)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, multiple submitters, no conflicts	16	9858502	16	9764645	129195	134641
NM_000833.4(GRIN2A):c.2453C>A (p.Ala818Glu)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	16	9862850	16	9768993	495226	486724
NM_000833.4(GRIN2A):c.2452G>A (p.Ala818Thr)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2018)	criteria provided, conflicting interpretations	16	9862851	16	9768994	522855	513463
NM_000833.4(GRIN2A):c.1936A>G (p.Thr646Ala)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Likely pathogenic(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	16	9923351	16	9829494	488524	481392
NM_000833.4(GRIN2A):c.1913C>T (p.Ala638Val)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	9923374	16	9829517	561021	552198
NM_000833.4(GRIN2A):c.1667C>T (p.Ser556Phe)	GRIN2A	not specified	Likely benign(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	16	9928072	16	9834215	129184	134630
NM_000833.4(GRIN2A):c.662A>G (p.Lys221Arg)	GRIN2A	Epilepsy, focal, with speech disorder and with or without mental retardation|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	16	10032161	16	9938304	129199	134645
NM_000833.4(GRIN2A):c.547T>A (p.Phe183Ile)	GRIN2A	not specified|not provided|Rolandic epilepsy|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2017)	criteria provided, conflicting interpretations	16	10032276	16	9938419	129189	134635
NM_002474.2(MYH11):c.5800A>T (p.Thr1934Ser)	MYH11|NDE1	Aortic aneurysm, familial thoracic 6|Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not specified|Cardiovascular phenotype|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	16	15797967	16	15704110	201044	197832
NM_001040113.1(MYH11):c.5294G>A (p.Arg1765Gln)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Thoracic aortic aneurysm and aortic dissection|not provided	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, multiple submitters, no conflicts	16	15812194	16	15718337	161316	29170
NM_001040113.1(MYH11):c.5197G>A (p.Ala1733Thr)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Familial thoracic aortic aneurysm	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	16	15812291	16	15718434	375862	362741
NM_001040113.1(MYH11):c.4963C>T (p.Arg1655Cys)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Aortic aneurysm	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	16	15814019	16	15720162	161318	171183
NM_001040113.1(MYH11):c.4417A>C (p.Lys1473Gln)	MYH11|NDE1	Aortic aneurysm, familial thoracic 4|Cardiovascular phenotype|Familial thoracic aortic aneurysm	Uncertain significance(Last reviewed: Jul 5, 2017)	criteria provided, multiple submitters, no conflicts	16	15815461	16	15721604	375854	362742
NM_001040113.1(MYH11):c.2026C>T (p.Arg676Cys)	MYH11	Aortic aneurysm, familial thoracic 4|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2018)	criteria provided, conflicting interpretations	16	15844048	16	15750191	161319	171184
NM_001040113.1(MYH11):c.760C>T (p.Arg254Cys)	MYH11	Aortic aneurysm, familial thoracic 4|Loeys-Dietz syndrome|not specified|Altered myosin contractile function|Inborn genetic diseases|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2017)	criteria provided, conflicting interpretations	16	15872688	16	15778831	161317	171185
NM_001008389.2(UMOD):c.949T>G (p.Cys317Gly)	UMOD	Familial juvenile gout	Likely pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	16	20359569	16	20348247	446167	439514
NM_003361.3(UMOD):c.358T>G (p.Cys120Gly)	UMOD	Familial juvenile gout	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	16	20360265	16	20348943	488632	481500
NM_024675.3(PALB2):c.1001A>G (p.Tyr334Cys)	PALB2	Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome|Hereditary cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2018)	criteria provided, conflicting interpretations	16	23646866	16	23635545	126581	132091
NM_024675.3(PALB2):c.155T>C (p.Val52Ala)	PALB2	Familial cancer of breast|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	16	23649227	16	23637906	246458	244978
NM_145239.2(PRRT2):c.67G>A (p.Glu23Lys)	PRRT2	Dystonia 10|not specified|not provided|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 2, 2018)	criteria provided, conflicting interpretations	16	29824442	16	29813121	130039	135485
NM_145239.2(PRRT2):c.412C>G (p.Pro138Ala)	PRRT2	Dystonia 10|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 1, 2017)	criteria provided, multiple submitters, no conflicts	16	29824787	16	29813466	130038	135484
NM_001256442.1(PRRT2):c.959C>T (p.Ala320Val)	PRRT2	Seizures, benign familial infantile, 2|Dystonia 10	Pathogenic	criteria provided, single submitter	16	29825733	16	29814412	440911	434539
NM_006662.2(SRCAP):c.5303T>C (p.Leu1768Pro)	SRCAP	not specified	Likely benign(Last reviewed: Sep 3, 2013)	criteria provided, single submitter	16	30736048	16	30724727	160036	169199
NM_006662.2(SRCAP):c.8755C>T (p.Leu2919Phe)	SRCAP	Floating-Harbor syndrome|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	30750116	16	30738795	160039	169202
NM_002968.2(SALL1):c.130G>A (p.Val44Ile)	SALL1	Townes-Brocks syndrome 1	Uncertain significance	criteria provided, single submitter	16	51176003	16	51142092	224342	226089
NM_138736.2(GNAO1):c.133G>C (p.Gly45Arg)	GNAO1	Inborn genetic diseases	Pathogenic	criteria provided, single submitter	16	56226500	16	56192588	225047	226954
NM_020988.2(GNAO1):c.607G>A (p.Gly203Arg)	GNAO1	not provided|Early infantile epileptic encephalopathy 17|Early infantile epileptic encephalopathy	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	16	56370656	16	56336744	66115	77012
NM_138736.2(GNAO1):c.626G>T (p.Arg209Leu)	GNAO1	Early infantile epileptic encephalopathy 17|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	16	56370675	16	56336763	431699	425224
NM_020988.2(GNAO1):c.662C>A (p.Ala221Asp)	GNAO1	Neurodevelopmental disorder with involuntary movements	Likely pathogenic(Last reviewed: Dec 1, 2016)	criteria provided, single submitter	16	56370711	16	56336799	522843	513460
NM_138736.2(GNAO1):c.692A>G (p.Tyr231Cys)	GNAO1	not provided|Early infantile epileptic encephalopathy 17	Pathogenic(Last reviewed: May 18, 2018)	criteria provided, single submitter	16	56370741	16	56336829	374381	361222
NM_001129727.2(PLEKHG4):c.1235C>T (p.Thr412Ile)	PLEKHG4	not specified	Likely benign	no assertion criteria provided	16	67316234	16	67282331	129964	135410
NM_001129727.2(PLEKHG4):c.1574A>G (p.Asp525Gly)	PLEKHG4	not specified	Likely benign	no assertion criteria provided	16	67318242	16	67284339	129965	135411
NM_001129727.2(PLEKHG4):c.2489G>A (p.Arg830His)	PLEKHG4	not specified	Likely benign	no assertion criteria provided	16	67320223	16	67286320	129966	135412
NM_004360.5(CDH1):c.3G>A (p.Met1Ile)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68771321	16	68737418	239906	242448
NM_004360.5(CDH1):c.79C>T (p.Pro27Ser)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68772230	16	68738327	239913	242450
NM_004360.5(CDH1):c.88C>A (p.Pro30Thr)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Orofacial clefting	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68772239	16	68738336	127933	133390
NM_004360.5(CDH1):c.188G>A (p.Arg63Gln)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68835597	16	68801694	127919	133376
NM_004360.5(CDH1):c.286A>G (p.Ile96Val)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68835695	16	68801792	220611	222499
NM_004360.5(CDH1):c.535A>G (p.Lys179Glu)	CDH1	Hereditary diffuse gastric cancer|not provided	Uncertain significance(Last reviewed: Nov 22, 2018)	reviewed by expert panel	16	68842599	16	68808696	496233	487892
NM_004360.5(CDH1):c.604G>A (p.Val202Ile)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68842668	16	68808765	133853	137592
NM_004360.5(CDH1):c.635G>T (p.Gly212Val)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68842699	16	68808796	479488	477773
NM_004360.5(CDH1):c.670C>T (p.Arg224Cys)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome|Anophthalmia - microphthalmia	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68842734	16	68808831	127932	133389
NM_004360.5(CDH1):c.892G>A (p.Ala298Thr)	CDH1	Hereditary diffuse gastric cancer|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome|Colon cancer	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68845646	16	68811743	41787	50226
NM_004360.5(CDH1):c.1008G>T (p.Glu336Asp)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68845762	16	68811859	18453	33492
NM_004360.5(CDH1):c.1018A>G (p.Thr340Ala)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome|Adenocarcinoma of stomach	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68846047	16	68812144	12245	27284
NM_004360.5(CDH1):c.1118C>T (p.Pro373Leu)	CDH1	Hereditary diffuse gastric cancer|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68846147	16	68812244	142285	151999
NM_004360.5(CDH1):c.1162G>A (p.Glu388Lys)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847240	16	68813337	127906	133363
NM_004360.5(CDH1):c.1225T>C (p.Trp409Arg)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847303	16	68813400	133855	137594
NM_004360.5(CDH1):c.1297G>A (p.Asp433Asn)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847375	16	68813472	127910	133367
NM_004360.5(CDH1):c.1298A>G (p.Asp433Gly)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68847376	16	68813473	141810	151524
NM_004360.5(CDH1):c.1409C>T (p.Thr470Ile)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68849506	16	68815603	127913	133370
NM_004360.4(CDH1):c.1633C>T (p.Arg545Trp)	CDH1	Familial cancer of breast|Hereditary diffuse gastric cancer	Uncertain significance(Last reviewed: Sep 11, 2017)	criteria provided, single submitter	16	68853250	16	68819347	446218	439582
NM_004360.5(CDH1):c.1679C>G (p.Thr560Arg)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68853296	16	68819393	234554	231976
NM_004360.5(CDH1):c.1774G>A (p.Ala592Thr)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68855966	16	68822063	41783	50222
NM_004360.5(CDH1):c.1849G>A (p.Ala617Thr)	CDH1	Endometrial carcinoma|Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68856041	16	68822138	12232	27271
NM_004360.5(CDH1):c.1888C>G (p.Leu630Val)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68856080	16	68822177	133846	137585
NM_004360.5(CDH1):c.2104G>A (p.Glu702Lys)	CDH1	Hereditary diffuse gastric cancer|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68857469	16	68823566	127921	133378
NM_004360.5(CDH1):c.2195G>A (p.Arg732Gln)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68862107	16	68828204	406663	402094
NM_004360.5(CDH1):c.2245C>T (p.Arg749Trp)	CDH1	Hereditary diffuse gastric cancer|not provided	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68862157	16	68828254	418841	409709
NM_004360.5(CDH1):c.2396C>G (p.Pro799Arg)	CDH1	Hereditary diffuse gastric cancer|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68863657	16	68829754	140871	150585
NM_004360.5(CDH1):c.2413G>A (p.Asp805Asn)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68863674	16	68829771	127925	133382
NM_004360.5(CDH1):c.2494G>A (p.Val832Met)	CDH1	Hereditary diffuse gastric cancer|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867247	16	68833344	12246	27285
NM_004360.5(CDH1):c.2512A>G (p.Ser838Gly)	CDH1	Hereditary diffuse gastric cancer|Neoplasm of ovary|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867265	16	68833362	12233	27272
NM_004360.5(CDH1):c.2635G>A (p.Gly879Ser)	CDH1	Hereditary diffuse gastric cancer|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	reviewed by expert panel	16	68867388	16	68833485	127928	133385
NM_001605.2(AARS):c.986G>A (p.Arg329His)	AARS	Charcot-Marie-Tooth disease, type 2N|Charcot-Marie-Tooth disease, type 2|Charcot-Marie-Tooth disease	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, multiple submitters, no conflicts	16	70302259	16	70268356	8466	23505
NM_015386.2(COG4):c.1546G>A (p.Gly516Arg)	COG4	not specified|COG4 related congenital disorder of glycosylation, autosomal dominant|SAUL-WILSON SYNDROME	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2018)	criteria provided, conflicting interpretations	16	70530270	16	70496367	449730	445607
NM_001361.4(DHODH):c.19A>C (p.Lys7Gln)	DHODH	Miller syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	72042682	16	72008783	128895	134342
NM_001361.4(DHODH):c.1022C>T (p.Ala341Val)	DHODH	Miller syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	16	72057421	16	72023522	128894	134341
NM_004933.2(CDH15):c.109G>T (p.Ala37Ser)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89245890	16	89179482	128642	134091
NM_004933.2(CDH15):c.227G>A (p.Gly76Asp)	CDH15	not provided	Uncertain significance(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	16	89246633	16	89180225	128640	134089
NM_004933.2(CDH15):c.598G>A (p.Glu200Lys)	CDH15	not provided	Uncertain significance(Last reviewed: Oct 16, 2013)	criteria provided, single submitter	16	89251676	16	89185268	128653	134102
NM_004933.2(CDH15):c.671C>T (p.Ala224Val)	CDH15	not provided	Uncertain significance(Last reviewed: Feb 18, 2014)	criteria provided, single submitter	16	89253844	16	89187436	128655	134104
NM_004933.2(CDH15):c.782C>A (p.Thr261Asn)	CDH15	not provided	Uncertain significance(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	16	89253955	16	89187547	128657	134106
NM_004933.2(CDH15):c.788A>G (p.Asp263Gly)	CDH15	not provided	Uncertain significance(Last reviewed: Feb 11, 2014)	criteria provided, single submitter	16	89253961	16	89187553	128658	134107
NM_004933.2(CDH15):c.1750A>C (p.Lys584Gln)	CDH15	not specified	Benign(Last reviewed: Oct 24, 2013)	criteria provided, single submitter	16	89258747	16	89192339	128646	134095
NM_004933.2(CDH15):c.2353G>A (p.Gly785Arg)	CDH15	not specified	Likely benign	no assertion criteria provided	16	89261471	16	89195063	128649	134098
NM_001256182.1(ANKRD11):c.7751C>A (p.Ala2584Asp)	ANKRD11	KBG syndrome	Likely pathogenic	no assertion criteria provided	16	89337280	16	89270872	375576	362386
NM_003119.2(SPG7):c.1529C>T	SPG7	Spastic paraplegia 7|Hereditary spastic paraplegia|Optic nerve hypoplasia|Dysarthria|not provided|Gait ataxia|Cerebral cortical atrophy|Spastic paraparesis|Inborn genetic diseases|Spastic Paraplegia, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2018)	criteria provided, conflicting interpretations	16	89613145	16	89546737	42016	51184
NM_006086.3(TUBB3):c.136C>T (p.Arg46Trp)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	16	89999057	16	89932649	438582	432220
NM_006086.3(TUBB3):c.292G>A (p.Gly98Ser)	TUBB3	Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement|Cortical dysplasia, complex, with other brain malformations 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 18, 2016)	criteria provided, conflicting interpretations	16	90001151	16	89934743	160191	169307
NM_006086.3(TUBB3):c.728C>T (p.Pro243Leu)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Uncertain significance(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	16	90001587	16	89935179	160195	169309
NM_006086.3(TUBB3):c.740A>G (p.Asn247Ser)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Uncertain significance(Last reviewed: May 29, 2013)	criteria provided, single submitter	16	90001599	16	89935191	160196	169310
NM_006086.3(TUBB3):c.982G>A (p.Glu328Lys)	TUBB3	Cortical dysplasia, complex, with other brain malformations 1	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	16	90001841	16	89935433	374309	361225
NM_006086.3(TUBB3):c.1331C>T (p.Ser444Leu)	TUBB3	not specified	Likely benign(Last reviewed: Jun 4, 2014)	criteria provided, single submitter	16	90002190	16	89935782	160189	169313
NM_000430.3(PAFAH1B1):c.3G>A (p.Met1Ile)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2541585	17	2638291	159520	169332
NM_000430.3(PAFAH1B1):c.56T>G (p.Leu19Arg)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2568689	17	2665395	159529	169335
NM_000430.3(PAFAH1B1):c.121G>A (p.Glu41Lys)	PAFAH1B1	Lissencephaly 1|not provided	Likely pathogenic(Last reviewed: Feb 27, 2017)	criteria provided, multiple submitters, no conflicts	17	2569313	17	2666019	159503	169338
NM_000430.3(PAFAH1B1):c.163T>A (p.Trp55Arg)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569355	17	2666061	159507	169341
NM_000430.3(PAFAH1B1):c.192G>C (p.Lys64Asn)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2569384	17	2666090	159511	169342
NM_000430.3(PAFAH1B1):c.371T>A (p.Val124Asp)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2570464	17	2667170	159515	169348
NM_000430.3(PAFAH1B1):c.386A>T (p.Asp129Val)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2570479	17	2667185	159517	169349
NM_000430.3(PAFAH1B1):c.484G>A (p.Gly162Ser)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573541	17	2670247	8079	23118
NM_000430.3(PAFAH1B1):c.503G>A (p.Cys168Tyr)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2573560	17	2670266	159525	169356
NM_000430.3(PAFAH1B1):c.671G>A (p.Gly224Asp)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2576051	17	2672757	159538	169366
NM_000430.3(PAFAH1B1):c.751A>C (p.Ser251Arg)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577433	17	2674139	159545	169374
NM_000430.3(PAFAH1B1):c.841T>C (p.Cys281Arg)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2577523	17	2674229	159546	169375
NM_000430.3(PAFAH1B1):c.938C>T (p.Ser313Phe)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2579836	17	2676542	159552	169380
NM_000430.3(PAFAH1B1):c.965T>G (p.Met322Arg)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2579863	17	2676569	159553	169381
NM_000430.3(PAFAH1B1):c.1009C>T (p.His337Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583464	17	2680170	159489	169385
NM_000430.3(PAFAH1B1):c.1009C>G (p.His337Asp)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: May 1, 2013)	criteria provided, single submitter	17	2583464	17	2680170	159488	169384
NM_000430.3(PAFAH1B1):c.1064G>A (p.Ser355Asn)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583519	17	2680225	159492	169388
NM_000430.3(PAFAH1B1):c.1135C>T (p.His379Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583590	17	2680296	159495	169391
NM_000430.3(PAFAH1B1):c.1159G>T (p.Asp387Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2583614	17	2680320	159497	169392
NM_000430.3(PAFAH1B1):c.1165C>T (p.His389Tyr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585028	17	2681734	159498	169394
NM_000430.3(PAFAH1B1):c.1193G>A (p.Gly398Asp)	PAFAH1B1	Lissencephaly 1	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585056	17	2681762	159500	169396
NM_000430.3(PAFAH1B1):c.1196G>C (p.Ser399Thr)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585059	17	2681765	159501	169397
NM_000430.3(PAFAH1B1):c.1201G>C (p.Asp401His)	PAFAH1B1	Lissencephaly 1	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	17	2585064	17	2681770	159502	169398
NM_000546.5(TP53):c.917G>A (p.Arg306Gln)	TP53	Familial cancer of breast|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 8, 2018)	criteria provided, conflicting interpretations	17	7577021	17	7673703	458574	469117
NM_000546.5(TP53):c.869G>A (p.Arg290His)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	7577069	17	7673751	127825	133282
NM_000546.5(TP53):c.848G>A (p.Arg283His)	TP53	Li-Fraumeni syndrome|not specified|not provided|Astrocytoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	17	7577090	17	7673772	142324	152038
NM_000546.5(TP53):c.847C>T (p.Arg283Cys)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm of stomach|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	7577091	17	7673773	127824	133281
NM_000546.5(TP53):c.844C>T (p.Arg282Trp)	TP53	Liver cancer|Non-Hodgkin lymphoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Astrocytoma, anaplastic|Li-Fraumeni-like syndrome|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Pleomorphic xanthoastrocytoma	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	7577094	17	7673776	12364	27403
NM_000546.5(TP53):c.747G>T (p.Arg249Ser)	TP53	Carcinoma of cervix|Liver cancer|Li-Fraumeni syndrome|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	17	7577534	17	7674216	12352	27391
NM_000546.5(TP53):c.743G>A (p.Arg248Gln)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Sarcoma|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant Colorectal Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	7577538	17	7674220	12356	27395
NM_000546.5(TP53):c.742C>T (p.Arg248Trp)	TP53	Liver cancer|Chronic lymphocytic leukemia|Medulloblastoma|Malignant melanoma of skin|Multiple myeloma|Pectus excavatum|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Small cell lung cancer|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Acute myeloid leukemia|Myelodysplastic syndrome|Short stature|Cognitive impairment|Webbed neck|not provided|Pancytopenia|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Abnormality of the tongue|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Carcinoma of esophagus|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7577539	17	7674221	12347	27386
NM_000546.5(TP53):c.733G>A (p.Gly245Ser)	TP53	Liver cancer|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Astrocytoma, anaplastic|Li-Fraumeni-like syndrome|Li-Fraumeni syndrome|Squamous cell lung carcinoma|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Adenocarcinoma|Carcinoma of esophagus|Neoplasm|Colorectal Neoplasms|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Atypical teratoid/rhabdoid tumor	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	7577548	17	7674230	12365	27404
NM_000546.5(TP53):c.704A>G (p.Asn235Ser)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Rhabdomyosarcoma	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	17	7577577	17	7674259	127821	133278
NM_000546.5(TP53):c.665C>T (p.Pro222Leu)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	7578184	17	7674866	161397	171191
NM_000546.5(TP53):c.638G>A (p.Arg213Gln)	TP53	Liver cancer|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell lung carcinoma|Renal cell carcinoma, papillary, 1|not specified|not provided|Neoplasm of brain|Neoplasm of the breast|Glioblastoma|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Adenoid cystic carcinoma|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Uterine Carcinosarcoma|PARP Inhibitor response	Pathogenic(Last reviewed: Jun 17, 2018)	criteria provided, multiple submitters, no conflicts	17	7578211	17	7674893	135359	139098
NM_000546.5(TP53):c.542G>A (p.Arg181His)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	17	7578388	17	7675070	142320	152034
NM_000546.5(TP53):c.524G>A (p.Arg175His)	TP53	Malignant tumor of esophagus|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Neoplasm	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	17	7578406	17	7675088	12374	27413
NM_000546.5(TP53):c.473G>A (p.Arg158His)	TP53	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	17	7578457	17	7675139	141963	151677
NM_000546.5(TP53):c.470T>C (p.Val157Ala)	TP53	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma	Likely pathogenic(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	17	7578460	17	7675142	428887	420661
NM_000546.5(TP53):c.467G>A (p.Arg156His)	TP53	Li-Fraumeni syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	7578463	17	7675145	127811	133268
NM_000546.5(TP53):c.455C>T (p.Pro152Leu)	TP53	Familial cancer of breast|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Nov 21, 2018)	criteria provided, multiple submitters, no conflicts	17	7578475	17	7675157	142766	152480
NM_000180.3(GUCY2D):c.2513G>A (p.Arg838His)	GUCY2D	Cone-rod dystrophy 6|not provided|Retinal dystrophy	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	17	7918019	17	8014701	9357	24396
NM_002472.2(MYH8):c.5074T>C (p.Trp1692Arg)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10297658	17	10394341	129678	135124
NM_002472.2(MYH8):c.1907C>T (p.Ala636Val)	MYH8|MYHAS	Hecht syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10312472	17	10409155	129671	135117
NM_017534.5(MYH2):c.1160C>T (p.Ala387Val)	MYH2|MYHAS	Inclusion body myopathy 3	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	17	10442867	17	10539550	374380	361226
NM_002470.3(MYH3):c.5254G>A (p.Ala1752Thr)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10534960	17	10631643	129664	135110
NM_002470.3(MYH3):c.3938C>T (p.Thr1313Ile)	MYH3	Freeman-Sheldon syndrome|not specified|not provided|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10539089	17	10635772	129660	135106
NM_002470.3(MYH3):c.3574G>A (p.Ala1192Thr)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10541515	17	10638198	129658	135104
NM_002470.3(MYH3):c.3008C>T (p.Ala1003Val)	MYH3	Freeman-Sheldon syndrome|not specified|Arthrogryposis multiplex congenita	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	17	10542709	17	10639392	129654	135100
NM_000304.3(PMP22):c.449G>T (p.Gly150Val)	PMP22	Charcot-Marie-Tooth disease and deafness|Dejerine-Sottas disease	Pathogenic	no assertion criteria provided	17	15134268	17	15230951	433198	426772
NM_000304.3(PMP22):c.353C>T (p.Thr118Met)	PMP22	Hereditary liability to pressure palsies|Charcot-Marie-Tooth disease, type IA|Charcot-Marie-Tooth disease, type 1a, autosomal recessive|Charcot-Marie-Tooth disease, type I|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 4, 2018)	criteria provided, conflicting interpretations	17	15134364	17	15231047	8431	23470
NM_000304.3(PMP22):c.235T>A (p.Ser79Thr)	PMP22	Charcot-Marie-Tooth disease, type IA	Likely pathogenic(Last reviewed: Aug 14, 2015)	criteria provided, single submitter	17	15142872	17	15239555	217236	213837
NM_012452.2(TNFRSF13B):c.310T>C (p.Cys104Arg)	TNFRSF13B	Talipes equinovarus|Common variable immunodeficiency 2|Immunoglobulin A deficiency 2|Skeletal dysplasia|not specified|Micrognathia|Hemivertebrae|not provided|Preaxial foot polydactyly|Respiratory failure|Short femur|Vertebral segmentation defect|Pseudoarthrosis|Chronic lung disease|Interstitial pulmonary abnormality|Coat hanger sign of ribs|Vertebral hypoplasia|Absent epiphyses|Cleft palate|Patent ductus arteriosus|Common Variable Immune Deficiency, Dominant	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	17	16852187	17	16948873	5302	20341
NM_144997.6(FLCN):c.1523A>G (p.Lys508Arg)	FLCN	Multiple fibrofolliculomas|not specified|not provided|Hereditary cancer-predisposing syndrome|Birt-Hogg-Dub syndrome	Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, multiple submitters, no conflicts	17	17118314	17	17215000	41856	50295
NM_144606.5(FLCN):c.833C>T (p.Pro278Leu)	FLCN	Multiple fibrofolliculomas	Uncertain significance(Last reviewed: Dec 1, 2015)	criteria provided, single submitter	17	17124889	17	17221575	225284	227196
NM_144606.6(FLCN):c.715C>T (p.Arg239Cys)	FLCN	Multiple fibrofolliculomas|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	17	17125879	17	17222565	134427	138166
NM_030665.3(RAI1):c.269G>C (p.Gly90Ala)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 5, 2017)	criteria provided, multiple submitters, no conflicts	17	17696531	17	17793217	96183	102077
NM_030665.3(RAI1):c.493C>A (p.Pro165Thr)	RAI1	Smith-Magenis syndrome|not specified|History of neurodevelopmental disorder	Benign(Last reviewed: May 3, 2017)	criteria provided, multiple submitters, no conflicts	17	17696755	17	17793441	96194	102088
NM_030665.3(RAI1):c.610C>T (p.Pro204Ser)	RAI1	not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 17, 2016)	criteria provided, multiple submitters, no conflicts	17	17696872	17	17793558	130083	135529
NM_030665.3(RAI1):c.725C>T (p.Pro242Leu)	RAI1	not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jun 16, 2017)	criteria provided, multiple submitters, no conflicts	17	17696987	17	17793673	96196	102090
NM_030665.3(RAI1):c.1748G>A (p.Ser583Asn)	RAI1	Smith-Magenis syndrome	Uncertain significance(Last reviewed: Dec 31, 2016)	criteria provided, single submitter	17	17698010	17	17794696	375265	361967
NM_030665.3(RAI1):c.3791A>G (p.Glu1264Gly)	RAI1	not specified|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 16, 2016)	criteria provided, multiple submitters, no conflicts	17	17700053	17	17796739	130087	135533
NM_002749.3(MAPK7):c.886G>A (p.Ala296Thr)	MAPK7	Scoliosis, isolated, susceptibility to, 1	Pathogenic	no assertion criteria provided	17	19284408	17	19381095	427639	417075
NM_002749.3(MAPK7):c.1760C>T (p.Pro587Leu)	MAPK7	Scoliosis, isolated, susceptibility to, 1	Pathogenic	no assertion criteria provided	17	19285376	17	19382063	427640	417076
NM_002749.3(MAPK7):c.1943C>T (p.Pro648Leu)	MAPK7	Scoliosis, isolated, susceptibility to, 1	Pathogenic	no assertion criteria provided	17	19285559	17	19382246	427641	417077
NM_001042492.2(NF1):c.2288T>C (p.Leu763Pro)	NF1	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Apr 28, 2017)	criteria provided, multiple submitters, no conflicts	17	29554272	17	31227254	68312	79203
NM_001042492.2(NF1):c.3827G>A (p.Arg1276Gln)	NF1	Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	17	29562747	17	31235729	68341	79232
NM_000267.3(NF1):c.4168C>T (p.Leu1390Phe)	NF1	Neurofibromatosis, type 1|Neurofibromatosis-Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	17	29585419	17	31258401	30992	39949
NM_000267.3(NF1):c.4267A>G (p.Lys1423Glu)	NF1	Multiple cafe-au-lait spots|Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome|Axillary freckling|Neurofibromas|Optic nerve glioma	Pathogenic(Last reviewed: May 17, 2018)	criteria provided, multiple submitters, no conflicts	17	29585518	17	31258500	336	15375
NM_001042492.2(NF1):c.4465A>G (p.Ser1489Gly)	NF1	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	17	29587421	17	31260403	68351	79242
NM_000267.3(NF1):c.5648A>G (p.Asn1883Ser)	NF1	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	17	29657415	17	31330397	220757	222619
NM_000267.3(NF1):c.6277G>T (p.Gly2093Cys)	NF1	Neurofibromatosis, type 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	29663845	17	31336827	561056	552201
NM_001042492.2(NF1):c.6818A>G (p.Lys2273Arg)	NF1	Neurofibromatosis, type 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 9, 2014)	criteria provided, single submitter	17	29665156	17	31338138	428947	420824
NM_015355.4(SUZ12):c.1797A>C (p.Gln599His)	SUZ12	Weaver syndrome	Uncertain significance(Last reviewed: Feb 12, 2018)	criteria provided, single submitter	17	30323819	17	31996800	590939	581883
NM_002878.3(RAD51D):c.394G>A (p.Val132Ile)	RAD51D|RAD51L3-RFFL	Breast-ovarian cancer, familial 4|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	33434093	17	35107074	185178	184833
NM_003673.3(TCAP):c.259C>T (p.Arg87Trp)	TCAP	Primary dilated cardiomyopathy	Likely benign(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	17	37822117	17	39665864	202102	198475
NM_000223.3(KRT12):c.404G>C (p.Arg135Thr)	KRT12	Meesman's corneal dystrophy|not provided	Pathogenic(Last reviewed: Jan 1, 2000)	no assertion criteria provided	17	39023035	17	40866783	7921	22960
NM_005557.3(KRT16):c.379C>T (p.Arg127Cys)	KRT16	Pachyonychia congenita 1|Palmoplantar keratoderma, nonepidermolytic, focal|not provided	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, multiple submitters, no conflicts	17	39768562	17	41612310	14601	29640
NM_005557.3(KRT16):c.365A>G (p.Gln122Arg)	KRT16	Pachyonychia congenita 1	Likely pathogenic(Last reviewed: Apr 8, 2014)	criteria provided, single submitter	17	39768576	17	41612324	216955	213644
NM_012448.3(STAT5B):c.1433C>T (p.Ala478Val)	STAT5B	Growth hormone insensitivity with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	17	40368072	17	42216054	517661	508752
NM_012448.3(STAT5B):c.1421A>G (p.Gln474Arg)	STAT5B	Growth hormone insensitivity with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	17	40368084	17	42216066	492931	485862
NM_012448.3(STAT5B):c.530A>C (p.Gln177Pro)	STAT5B	Growth hormone insensitivity with immunodeficiency	Pathogenic(Last reviewed: Aug 2, 2017)	no assertion criteria provided	17	40375420	17	42223402	522611	513224
NM_139276.2(STAT3):c.2147C>T (p.Thr716Met)	STAT3	Hyperimmunoglobulin E syndrome|not provided|Autoimmune disease, multisystem, infantile-onset, 1|STAT3 gain of function	Pathogenic/Likely pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, multiple submitters, no conflicts	17	40468917	17	42316899	224848	226683
NM_139276.2(STAT3):c.2134T>C (p.Cys712Arg)	STAT3	Hyperimmunoglobulin E syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	40469210	17	42317192	36791	45452
NM_139276.2(STAT3):c.2107G>A (p.Ala703Thr)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40469237	17	42317219	224850	226684
NM_139276.2(STAT3):c.1988C>T (p.Thr663Ile)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40474413	17	42322395	224845	226685
NM_139276.2(STAT3):c.1970A>G (p.Tyr657Cys)	STAT3	Hyperimmunoglobulin E syndrome	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	40474431	17	42322413	36790	45451
NM_139276.2(STAT3):c.1261G>A (p.Gly421Arg)	STAT3	not provided|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	17	40481448	17	42329430	224844	226686
NM_139276.2(STAT3):c.1260T>G (p.Asn420Lys)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40481449	17	42329431	224849	226687
NM_139276.2(STAT3):c.1243G>A (p.Glu415Lys)	STAT3	Hyperimmunoglobulin E syndrome|Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, multiple submitters, no conflicts	17	40481466	17	42329448	36784	45445
NM_139276.2(STAT3):c.1057G>T (p.Val353Phe)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40483542	17	42331524	224847	226688
NM_139276.2(STAT3):c.1032G>C (p.Gln344His)	STAT3	Autoimmune disease, multisystem, infantile-onset, 1	Pathogenic(Last reviewed: Oct 30, 2014)	criteria provided, single submitter	17	40485708	17	42333690	224843	226689
NM_139276.2(STAT3):c.1003C>T (p.Arg335Trp)	STAT3	Hyperimmunoglobulin E syndrome|not provided|STAT3 gain of function	Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, multiple submitters, no conflicts	17	40485737	17	42333719	36783	45444
NM_139276.2(STAT3):c.454C>T (p.Arg152Trp)	STAT3	Hyperimmunoglobulin E syndrome|Autoimmune disease, multisystem, infantile-onset, 1|STAT3 gain of function	Pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	17	40491346	17	42339328	224846	226690
NM_007294.3(BRCA1):c.5558A>G (p.Tyr1853Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, multiple submitters, no conflicts	17	41197729	17	43045712	55627	70294
NM_007294.3(BRCA1):c.5497G>A (p.Val1833Met)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	17	41197790	17	43045773	55598	70265
NM_007294.3(BRCA1):c.5431C>T (p.Gln1811Ter)	BRCA1	Breast-ovarian cancer, familial 1|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	17	41199696	17	43047679	55577	70244
NM_007294.3(BRCA1):c.5411T>A (p.Val1804Asp)	BRCA1	Breast-ovarian cancer, familial 1|Ovarian cancer|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41199716	17	43047699	55568	70235
NM_007294.3(BRCA1):c.5359_5363delTGTGGinsAGTGA (p.Cys1787_Gly1788delinsSerAsp)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	17	41201181 - 41201185	17	43049164 - 43049168	187349	184875
NM_007294.3(BRCA1):c.5363G>T (p.Gly1788Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41201181	17	43049164	37660	46216
NM_007294.3(BRCA1):c.5339T>C (p.Leu1780Pro)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2018)	criteria provided, conflicting interpretations	17	41201205	17	43049188	55541	70208
NM_007294.3(BRCA1):c.5329A>T (p.Thr1777Ser)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Jun 10, 2016)	criteria provided, single submitter	17	41203083	17	43051066	252402	246809
NM_007294.3(BRCA1):c.5252G>A (p.Arg1751Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41209094	17	43057077	55481	70148
NM_007294.3(BRCA1):c.5225A>G (p.Asn1742Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	17	41209121	17	43057104	219464	222650
NM_007294.3(BRCA1):c.5123C>A (p.Ala1708Glu)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215920	17	43063903	55407	70074
NM_007294.3(BRCA1):c.5123C>T (p.Ala1708Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	17	41215920	17	43063903	37640	46196
NM_007294.3(BRCA1):c.5117G>C (p.Gly1706Ala)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215926	17	43063909	55406	70073
NM_007294.3(BRCA1):c.5117G>A (p.Gly1706Glu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215926	17	43063909	37638	46194
NM_007294.3(BRCA1):c.5116G>A (p.Gly1706Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2017)	criteria provided, conflicting interpretations	17	41215927	17	43063910	267221	262101
NM_007294.3(BRCA1):c.5096G>A (p.Arg1699Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41215947	17	43063930	37636	46192
NM_007294.3(BRCA1):c.5095C>T (p.Arg1699Trp)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Fanconi anemia, complementation group A|Ovarian cancer|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and colorectal cancer|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41215948	17	43063931	55396	70063
NM_007294.3(BRCA1):c.5072C>T (p.Thr1691Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Apr 19, 2018)	criteria provided, multiple submitters, no conflicts	17	41219627	17	43067610	37628	46184
NM_007294.3(BRCA1):c.5066T>G (p.Met1689Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	17	41219633	17	43067616	37625	46181
NM_007294.3(BRCA1):c.5024C>T (p.Thr1675Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2017)	criteria provided, conflicting interpretations	17	41219675	17	43067658	240811	242767
NM_007294.3(BRCA1):c.5005G>T (p.Ala1669Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast carcinoma|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	17	41219694	17	43067677	41831	50270
NM_007294.3(BRCA1):c.4988T>A (p.Met1663Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41219711	17	43067694	55349	70016
NM_007294.3(BRCA1):c.4956G>A (p.Met1652Ile)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41222975	17	43070958	41830	50269
NM_007294.3(BRCA1):c.4955T>C (p.Met1652Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41222976	17	43070959	37615	46171
NM_007294.3(BRCA1):c.4883T>C (p.Met1628Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41223048	17	43071031	41828	50267
NM_007294.3(BRCA1):c.4882A>G (p.Met1628Val)	BRCA1	Breast-ovarian cancer, familial 1|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	17	41223049	17	43071032	55306	69973
NM_007294.3(BRCA1):c.4868C>G (p.Ala1623Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 3, 2018)	criteria provided, conflicting interpretations	17	41223063	17	43071046	37614	46170
NM_007294.3(BRCA1):c.4837A>G (p.Ser1613Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41223094	17	43071077	41827	50266
NM_007294.3(BRCA1):c.4766G>A (p.Arg1589His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 19, 2018)	criteria provided, conflicting interpretations	17	41223165	17	43071148	55284	69951
NM_007294.3(BRCA1):c.4691T>C (p.Leu1564Pro)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41223240	17	43071223	55262	69929
NM_007294.3(BRCA1):c.4682C>T (p.Thr1561Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2018)	criteria provided, conflicting interpretations	17	41223249	17	43071232	55259	69926
NM_007294.3(BRCA1):c.4675G>C (p.Glu1559Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 19, 2016)	criteria provided, multiple submitters, no conflicts	17	41226348	17	43074331	37605	46161
NM_007294.3(BRCA1):c.4649C>T (p.Thr1550Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, multiple submitters, no conflicts	17	41226374	17	43074357	55251	69918
NM_007294.3(BRCA1):c.4636G>A (p.Asp1546Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41226387	17	43074370	55245	69912
NM_007294.3(BRCA1):c.4625C>G (p.Ser1542Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2018)	criteria provided, conflicting interpretations	17	41226398	17	43074381	55242	69909
NM_007294.3(BRCA1):c.4600G>A (p.Val1534Met)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41226423	17	43074406	55235	69902
NM_007294.3(BRCA1):c.4535G>T (p.Ser1512Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41226488	17	43074471	41826	50265
NM_007294.3(BRCA1):c.4484G>T (p.Arg1495Met)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41228505	17	43076488	37598	46154
NM_007294.3(BRCA1):c.4458T>G (p.Ser1486Arg)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Mar 16, 2016)	criteria provided, single submitter	17	41228531	17	43076514	252387	246816
NM_007294.3(BRCA1):c.4327C>G (p.Arg1443Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	17	41234451	17	43082434	17676	32715
NM_007294.3(BRCA1):c.4273C>G (p.Pro1425Ala)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: May 17, 2016)	criteria provided, single submitter	17	41234505	17	43082488	252398	246818
NM_007294.3(BRCA1):c.4204C>T (p.His1402Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41234574	17	43082557	55140	69807
NM_007294.3(BRCA1):c.4039A>G (p.Arg1347Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243509	17	43091492	41821	50260
NM_007294.3(BRCA1):c.3845A>T (p.Glu1282Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2017)	criteria provided, conflicting interpretations	17	41243703	17	43091686	55027	69694
NM_007294.3(BRCA1):c.3815A>G (p.Asn1272Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	17	41243733	17	43091716	232792	235998
NM_007294.3(BRCA1):c.3797G>C (p.Ser1266Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243751	17	43091734	55009	69676
NM_007294.3(BRCA1):c.3776A>C (p.Asn1259Thr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2017)	criteria provided, conflicting interpretations	17	41243772	17	43091755	125651	131189
NM_007294.3(BRCA1):c.3748G>A (p.Glu1250Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243800	17	43091783	54987	69654
NM_007294.3(BRCA1):c.3713C>T (p.Pro1238Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41243835	17	43091818	37543	46099
NM_007294.3(BRCA1):c.3708T>G (p.Asn1236Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41243840	17	43091823	54970	69637
NM_007294.3(BRCA1):c.3691T>C (p.Phe1231Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41243857	17	43091840	37541	46097
NM_007294.3(BRCA1):c.3657G>C (p.Glu1219Asp)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	17	41243891	17	43091874	37537	46093
NM_007294.3(BRCA1):c.3600G>C (p.Gln1200His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	17	41243948	17	43091931	54930	69597
NM_007294.3(BRCA1):c.3587C>T (p.Thr1196Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	17	41243961	17	43091944	54926	69593
NM_007294.3(BRCA1):c.3548A>G (p.Lys1183Arg)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244000	17	43091983	41818	50257
NM_007294.3(BRCA1):c.3454G>A (p.Asp1152Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	17	41244094	17	43092077	54890	69557
NM_007294.3(BRCA1):c.3418A>G (p.Ser1140Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244130	17	43092113	41817	50256
NM_007294.3(BRCA1):c.3302G>A (p.Ser1101Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244246	17	43092229	54830	69497
NM_007294.3(BRCA1):c.3292C>T (p.Leu1098Phe)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Apr 13, 2016)	criteria provided, single submitter	17	41244256	17	43092239	252394	246819
NM_007294.3(BRCA1):c.3119G>A (p.Ser1040Asn)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244429	17	43092412	17670	32709
NM_007294.3(BRCA1):c.3113A>G (p.Glu1038Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Pancreatic cancer 4|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|FANCONI ANEMIA, COMPLEMENTATION GROUP S	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244435	17	43092418	41815	50254
NM_007294.3(BRCA1):c.3083G>A (p.Arg1028His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244465	17	43092448	37507	46063
NM_007294.3(BRCA1):c.3024G>A (p.Met1008Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244524	17	43092507	41814	50253
NM_007294.3(BRCA1):c.3022A>G (p.Met1008Val)	BRCA1	Breast-ovarian cancer, familial 1|Malignant tumor of prostate|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244526	17	43092509	54755	69422
NM_007294.3(BRCA1):c.2789C>T (p.Pro930Leu)	BRCA1	Breast-ovarian cancer, familial 1|not specified	Uncertain significance(Last reviewed: Jun 7, 2016)	criteria provided, multiple submitters, no conflicts	17	41244759	17	43092742	54680	69347
NM_007294.3(BRCA1):c.2773A>C (p.Ile925Leu)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244775	17	43092758	37489	46045
NM_007294.3(BRCA1):c.2612C>T (p.Pro871Leu)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244936	17	43092919	41812	50251
NM_007294.3(BRCA1):c.2596C>T (p.Arg866Cys)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244952	17	43092935	41811	50250
NM_007294.3(BRCA1):c.2566T>C (p.Tyr856His)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41244982	17	43092965	54604	69271
NM_007294.3(BRCA1):c.2554C>G (p.Leu852Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Aug 7, 2015)	criteria provided, multiple submitters, no conflicts	17	41244994	17	43092977	216656	213323
NM_007294.3(BRCA1):c.2521C>T (p.Arg841Trp)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245027	17	43093010	17681	32720
NM_007294.3(BRCA1):c.2477C>A (p.Thr826Lys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245071	17	43093054	37473	46029
NM_007294.3(BRCA1):c.2458A>G (p.Lys820Glu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245090	17	43093073	41810	50249
NM_007294.3(BRCA1):c.2428A>T (p.Asn810Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245120	17	43093103	54567	69234
NM_007294.3(BRCA1):c.2412G>C (p.Gln804His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245136	17	43093119	54561	69228
NM_007294.3(BRCA1):c.2347A>G (p.Ile783Val)	BRCA1	Breast-ovarian cancer, familial 1|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2018)	criteria provided, conflicting interpretations	17	41245201	17	43093184	54541	69208
NM_007294.3(BRCA1):c.2315T>C (p.Val772Ala)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245233	17	43093216	41809	50248
NM_007294.3(BRCA1):c.2312T>C (p.Leu771Ser)	BRCA1	Breast-ovarian cancer, familial 1|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Feb 14, 2017)	criteria provided, multiple submitters, no conflicts	17	41245236	17	43093219	182145	180861
NM_007294.3(BRCA1):c.2225A>G (p.Asn742Ser)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Nov 4, 2016)	no assertion criteria provided	17	41245323	17	43093306	403717	390694
NM_007294.3(BRCA1):c.2167A>G (p.Asn723Asp)	BRCA1	Breast-ovarian cancer, familial 1|Malignant tumor of prostate|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245381	17	43093364	37454	46010
NM_007294.3(BRCA1):c.2077G>A (p.Asp693Asn)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245471	17	43093454	41808	50247
NM_007294.3(BRCA1):c.2002C>T (p.Leu668Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245546	17	43093529	37441	45997
NM_007294.3(BRCA1):c.1907G>A (p.Cys636Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 19, 2018)	criteria provided, conflicting interpretations	17	41245641	17	43093624	91570	97047
NM_007294.3(BRCA1):c.1865C>T (p.Ala622Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245683	17	43093666	54371	69038
NM_007294.3(BRCA1):c.1842G>T (p.Lys614Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, multiple submitters, no conflicts	17	41245706	17	43093689	252401	246822
NM_007294.3(BRCA1):c.1709C>A (p.Pro570Gln)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified	Uncertain significance(Last reviewed: May 10, 2018)	criteria provided, multiple submitters, no conflicts	17	41245839	17	43093822	245965	245047
NM_007294.3(BRCA1):c.1648A>C (p.Asn550His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41245900	17	43093883	37423	45979
NM_007294.3(BRCA1):c.1534C>T (p.Leu512Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 21, 2018)	criteria provided, conflicting interpretations	17	41246014	17	43093997	37420	45976
NM_007294.3(BRCA1):c.1511G>A (p.Arg504His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246037	17	43094020	54278	68945
NM_007294.3(BRCA1):c.1487G>A (p.Arg496His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246061	17	43094044	41805	50244
NM_007294.3(BRCA1):c.1486C>T (p.Arg496Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246062	17	43094045	37416	45972
NM_007294.3(BRCA1):c.1456T>C (p.Phe486Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246092	17	43094075	54258	68925
NM_007294.3(BRCA1):c.1427A>G (p.His476Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2018)	criteria provided, conflicting interpretations	17	41246121	17	43094104	54251	68918
NM_007294.3(BRCA1):c.1384G>A (p.Gly462Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41246164	17	43094147	54230	68897
NM_007294.3(BRCA1):c.1381T>C (p.Phe461Leu)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	17	41246167	17	43094150	54227	68894
NM_007294.3(BRCA1):c.1342C>T (p.His448Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	17	41246206	17	43094189	187241	185067
NM_007294.3(BRCA1):c.1155G>T (p.Trp385Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 25, 2018)	criteria provided, multiple submitters, no conflicts	17	41246393	17	43094376	240771	242800
NM_007294.3(BRCA1):c.1137T>G (p.Ile379Met)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	17	41246411	17	43094394	54143	68810
NM_007294.3(BRCA1):c.1075C>T (p.Pro359Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	17	41246473	17	43094456	252384	246823
NM_007294.3(BRCA1):c.1067A>G (p.Gln356Arg)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Ductal breast carcinoma	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246481	17	43094464	41803	50242
NM_007294.3(BRCA1):c.1016A>G (p.Lys339Arg)	BRCA1	Hereditary breast and ovarian cancer syndrome	Likely benign(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	17	41246532	17	43094515	549761	540531
NM_007294.3(BRCA1):c.891G>A (p.Met297Ile)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246657	17	43094640	55743	70410
NM_007294.3(BRCA1):c.812T>G (p.Val271Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 22, 2016)	criteria provided, multiple submitters, no conflicts	17	41246736	17	43094719	252383	246824
NM_007294.3(BRCA1):c.811G>A (p.Val271Met)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|Cancer of the pancreas	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	17	41246737	17	43094720	55720	70387
NM_007294.3(BRCA1):c.742A>C (p.Thr248Pro)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 4, 2017)	criteria provided, multiple submitters, no conflicts	17	41246806	17	43094789	252390	246825
NM_007294.3(BRCA1):c.736T>G (p.Leu246Val)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41246812	17	43094795	41835	50274
NM_007294.3(BRCA1):c.694G>A (p.Asp232Asn)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2018)	criteria provided, conflicting interpretations	17	41246854	17	43094837	55672	70339
NM_007294.3(BRCA1):c.557C>A (p.Ser186Tyr)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41249297	17	43097280	55635	70302
NM_007294.3(BRCA1):c.536A>G (p.Tyr179Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41251803	17	43099786	37661	46217
NM_007294.3(BRCA1):c.535T>C (p.Tyr179His)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	17	41251804	17	43099787	141458	151172
NM_007294.3(BRCA1):c.478G>A (p.Gly160Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, multiple submitters, no conflicts	17	41251861	17	43099844	233928	236161
NM_007294.3(BRCA1):c.470C>G (p.Ser157Cys)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	17	41251869	17	43099852	55266	69933
NM_007294.3(BRCA1):c.332A>C (p.Glu111Ala)	BRCA1	Breast-ovarian cancer, familial 1|not specified	Uncertain significance(Last reviewed: Feb 16, 2017)	criteria provided, single submitter	17	41256248	17	43104231	54844	69511
NM_007294.3(BRCA1):c.314A>G (p.Tyr105Cys)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Neoplasm of the breast|Hereditary cancer-predisposing syndrome	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41256266	17	43104249	54780	69447
NM_007294.3(BRCA1):c.211A>G (p.Arg71Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41258474	17	43106457	17693	32732
NM_007294.3(BRCA1):c.199G>T (p.Asp67Tyr)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41258486	17	43106469	54431	69098
NM_007294.3(BRCA1):c.190T>G (p.Cys64Gly)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2017)	criteria provided, multiple submitters, no conflicts	17	41258495	17	43106478	17660	32699
NM_007294.3(BRCA1):c.181T>G (p.Cys61Gly)	BRCA1	Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Breast carcinoma	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41258504	17	43106487	17661	32700
NM_007294.3(BRCA1):c.172C>T (p.Pro58Ser)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	17	41258513	17	43106496	252393	246829
NM_007294.3(BRCA1):c.169G>C (p.Gly57Arg)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jan 19, 2017)	criteria provided, multiple submitters, no conflicts	17	41258516	17	43106499	252391	246830
NM_007294.3(BRCA1):c.140G>T (p.Cys47Phe)	BRCA1	Breast-ovarian cancer, familial 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2016)	criteria provided, conflicting interpretations	17	41258545	17	43106528	54247	68914
NM_007294.3(BRCA1):c.131G>T (p.Cys44Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Apr 18, 2018)	criteria provided, multiple submitters, no conflicts	17	41267746	17	43115729	54200	68867
NM_007294.3(BRCA1):c.130T>A (p.Cys44Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41267747	17	43115730	54191	68858
NM_007294.3(BRCA1):c.122A>T (p.His41Leu)	BRCA1	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2017)	criteria provided, conflicting interpretations	17	41267755	17	43115738	230862	236179
NM_007294.3(BRCA1):c.118G>A (p.Asp40Asn)	BRCA1	Breast-ovarian cancer, familial 1	Uncertain significance(Last reviewed: Mar 23, 2016)	criteria provided, single submitter	17	41267759	17	43115742	252392	246831
NM_007294.3(BRCA1):c.103G>T (p.Val35Phe)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	17	41267774	17	43115757	252386	246832
NM_007294.3(BRCA1):c.65T>C (p.Leu22Ser)	BRCA1	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	17	41276049	17	43124032	55656	70323
NM_014233.3(UBTF):c.628G>A (p.Glu210Lys)	UBTF	UBTF E210K Neuroregression Syndrome|Infantile or childhood onset neurodegenerative disease, global developmental delay, and intellectual disability|NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	17	42290219	17	44212851	437909	431537
NM_000342.3(SLC4A1):c.118G>A (p.Glu40Lys)	SLC4A1	Spherocytosis type 4|Pseudohyperkalemia Cardiff|Hemolytic anemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	17	42338993	17	44261625	17756	32795
NM_004247.3(EFTUD2):c.2438G>A (p.Arg813Lys)	EFTUD2	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	42930913	17	44853545	560998	552204
NM_002055.4(GFAP):c.1246C>T (p.Arg416Trp)	GFAP	Alexander Disease|not provided	Pathogenic(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	17	42985443	17	44908075	16169	31208
NM_002055.4(GFAP):c.989G>C (p.Arg330Pro)	GFAP	Alexander Disease	Uncertain significance(Last reviewed: Apr 4, 2016)	criteria provided, single submitter	17	42988742	17	44911374	522797	513469
NM_002055.4(GFAP):c.215A>G (p.Glu72Gly)	GFAP	Alexander Disease	Likely pathogenic(Last reviewed: Apr 30, 2015)	no assertion criteria provided	17	42992640	17	44915272	374303	361227
NM_002055.4(GFAP):c.208C>T (p.Arg70Trp)	GFAP	Alexander Disease|not provided	Pathogenic(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	17	42992647	17	44915279	66460	77357
NM_001002841.1(MYL4):c.31G>A (p.Glu11Lys)	MYL4	Familial atrial fibrillation|Atrial fibrillation, familial, 18	Pathogenic(Last reviewed: Dec 28, 2016)	no assertion criteria provided	17	45286819	17	47209453	224067	225795
NM_005220.2(DLX3):c.476G>T (p.Arg159Leu)	DLX3	Amelogenesis imperfecta, type IV|Tricho-dento-osseous syndrome	Pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	48070804	17	49993440	430609	423257
NM_000088.3(COL1A1):c.2932C>T (p.Pro978Ser)	COL1A1	Osteogenesis imperfecta type I|Osteogenesis imperfecta|Thoracic aortic aneurysm and aortic dissection|not specified|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	17	48266534	17	50189173	35918	44582
NM_000088.3(COL1A1):c.2866G>A (p.Gly956Arg)	COL1A1	Osteogenesis imperfecta type I	Likely pathogenic(Last reviewed: Feb 4, 2014)	criteria provided, single submitter	17	48266600	17	50189239	209140	205787
NM_000088.3(COL1A1):c.2641G>A (p.Gly881Ser)	COL1A1	Osteogenesis imperfecta type I	Pathogenic	no assertion criteria provided	17	48267066	17	50189705	430640	424020
NM_000088.3(COL1A1):c.994G>A (p.Gly332Arg)	COL1A1	Osteogenesis imperfecta with normal sclerae, dominant form|Osteogenesis imperfecta type III|Osteogenesis imperfecta type I|Osteogenesis imperfecta|not provided	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	17	48273524	17	50196163	17312	32351
NM_000088.3(COL1A1):c.805G>A (p.Gly269Ser)	COL1A1	Osteogenesis imperfecta	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	17	48274031	17	50196670	35929	44593
NM_000088.3(COL1A1):c.613C>G (p.Pro205Ala)	COL1A1	Osteogenesis imperfecta type I|Osteogenesis imperfecta|not specified|not provided|Connective tissue disorder	Conflicting interpretations of pathogenicity(Last reviewed: Apr 12, 2018)	criteria provided, conflicting interpretations	17	48275339	17	50197978	218424	215539
NM_058216.2(RAD51C):c.307T>G (p.Phe103Val)	RAD51C	Hereditary breast and ovarian cancer syndrome	Uncertain significance(Last reviewed: Jun 13, 2017)	no assertion criteria provided	17	56772453	17	58695092	427903	418977
NM_058216.2(RAD51C):c.790G>A (p.Gly264Ser)	RAD51C	Breast-ovarian cancer, familial 3|Fanconi anemia, complementation group O|Hereditary breast and ovarian cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2018)	criteria provided, conflicting interpretations	17	56787304	17	58709943	128211	133668
NM_005994.3(TBX2):c.59G>A (p.Arg20Gln)	TBX2	TBX2-related condition|VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION	Pathogenic(Last reviewed: Feb 24, 2016)	criteria provided, single submitter	17	59477596	17	61400235	522826	513470
NM_032043.2(BRIP1):c.790C>T (p.Arg264Trp)	BRIP1	Familial cancer of breast|Fanconi anemia, complementation group J|Neoplasm of ovary|not specified|not provided|Hereditary cancer-predisposing syndrome	Likely benign(Last reviewed: Mar 28, 2018)	criteria provided, multiple submitters, no conflicts	17	59885956	17	61808595	128195	133652
NM_032043.2(BRIP1):c.689C>T (p.Ser230Leu)	BRIP1	Familial cancer of breast|Fanconi anemia, complementation group J|Neoplasm of ovary|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	17	59886057	17	61808696	186643	185297
NM_032043.2(BRIP1):c.139C>G (p.Pro47Ala)	BRIP1	Familial cancer of breast|Fanconi anemia, complementation group J|Neoplasm of ovary|Breast cancer, early-onset|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, multiple submitters, no conflicts	17	59937223	17	61859862	4736	19775
NM_004655.3(AXIN2):c.2272G>A (p.Ala758Thr)	AXIN2	Oligodontia-colorectal cancer syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome|Oligodontia|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Feb 23, 2018)	criteria provided, conflicting interpretations	17	63530163	17	65534045	127943	133400
NM_004655.3(AXIN2):c.1168A>G (p.Ser390Gly)	AXIN2	Oligodontia-colorectal cancer syndrome|not specified|not provided|Oligodontia|Colorectal cancer	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2018)	criteria provided, conflicting interpretations	17	63534353	17	65538235	127934	133391
NM_004459.6(BPTF):c.5770G>A (p.Ala1924Thr)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly	Likely pathogenic(Last reviewed: Jul 3, 2017)	no assertion criteria provided	17	65914918	17	67918802	431070	424593
NM_004459.6(BPTF):c.8558T>G (p.Met2853Arg)	BPTF	Global developmental delay|Expressive language delay|Global developmental delay|Postnatal microcephaly|NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2017)	no assertion criteria provided	17	65971957	17	67975841	431071	424594
NM_002734.4(PRKAR1A):c.220C>T (p.Arg74Cys)	PRKAR1A	Carney complex, type 1|Carney complex	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	17	66518939	17	68522798	12674	27713
NM_000891.2(KCNJ2):c.277G>A (p.Val93Ile)	KCNJ2	Andersen Tawil syndrome|Short QT syndrome 3|Atrial fibrillation|Atrial fibrillation, familial, 9|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	17	68171457	17	70175316	30121	39077
NM_000891.2(KCNJ2):c.953A>G (p.Asn318Ser)	KCNJ2	Andersen Tawil syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 6, 2015)	no assertion criteria provided	17	68172133	17	70175992	161257	171189
NM_000891.2(KCNJ2):c.1199C>T (p.Thr400Met)	KCNJ2	Long QT syndrome|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Aug 4, 2017)	criteria provided, multiple submitters, no conflicts	17	68172379	17	70176238	161258	171190
NM_000346.3(SOX9):c.515A>G (p.Tyr172Cys)	SOX9	Camptomelic dysplasia	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	17	70118943	17	72122802	488603	481471
NM_000346.3(SOX9):c.1427T>C (p.Met476Thr)	SOX9	Camptomelic dysplasia	Likely pathogenic(Last reviewed: May 1, 2016)	no assertion criteria provided	17	70120425	17	72124284	374384	361229
NM_004252.4(SLC9A3R1):c.657C>G (p.Ile219Met)	SLC9A3R1	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	17	72759559	17	74763420	561111	552206
NM_004035.6(ACOX1):c.710A>G (p.Asn237Ser)	ACOX1	ACOX1-related condition	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	17	73951711	17	75955630	584427	575503
NM_001256071.2(RNF213):c.12553A>G (p.Lys4185Glu)	RNF213|LOC100294362	Moyamoya disease 2	Likely pathogenic(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	17	78346336	17	80372536	585198	576249
NM_001256071.2(RNF213):c.12562G>A (p.Ala4188Thr)	RNF213|LOC100294362	Moyamoya disease 2	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	17	78346345	17	80372545	585199	576250
NM_001614.4(ACTG1):c.721G>A (p.Glu241Lys)	ACTG1	Deafness, autosomal dominant 20|Nonsyndromic hearing loss and deafness|not provided	Likely pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	17	79478295	17	81511269	18322	33361
NM_001614.4(ACTG1):c.617G>A (p.Arg206Gln)	ACTG1	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Aug 10, 2017)	criteria provided, single submitter	17	79478399	17	81511373	517300	508742
NM_001199954.2(ACTG1):c.118C>T (p.His40Tyr)	ACTG1	Baraitser-Winter Syndrome 2	Likely pathogenic(Last reviewed: Sep 24, 2014)	no assertion criteria provided	17	79479263	17	81512237	374385	361230
NM_005052.2(RAC3):c.86C>T (p.Pro29Leu)	RAC3	Intellectual disability|Abnormality of brain morphology	association	no assertion criteria provided	17	79990313	17	82032437	585004	576060
NM_005052.2(RAC3):c.182A>T (p.Gln61Leu)	RAC3	Intellectual disability|Abnormality of brain morphology	association	no assertion criteria provided	17	79990661	17	82032785	585005	576061
NM_173208.2(TGIF1):c.337C>T (p.Arg113Cys)	TGIF1	Holoprosencephaly 4	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	18	3457456	18	3457458	545574	536083
NM_006796.2(AFG3L2):c.2011G>A (p.Gly671Arg)	AFG3L2	Spinocerebellar ataxia 28	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	18	12337504	18	12337505	30425	39382
NM_001142966.2(GREB1L):c.4368G>T (p.Gln1456His)	GREB1L	Inner ear Malformation	Pathogenic(Last reviewed: Nov 25, 2017)	no assertion criteria provided	18	19085910	18	21505949	446527	440045
NM_005257.5(GATA6):c.43G>C (p.Gly15Arg)	GATA6	not specified|Atrioventricular septal defect 5|Monogenic diabetes	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	18	19751148	18	22171187	129134	134580
NM_005257.5(GATA6):c.851C>G (p.Ala284Gly)	GATA6	not specified|Atrioventricular septal defect 5|Monogenic diabetes	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	18	19751956	18	22171995	129135	134581
NM_024422.4(DSC2):c.2603C>T (p.Ser868Phe)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|not specified|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	18	28648084	18	31068118	427964	419290
NM_004949.4(DSC2):c.2471C>T (p.Ser824Leu)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy	Uncertain significance(Last reviewed: May 22, 2016)	criteria provided, multiple submitters, no conflicts	18	28648897	18	31068931	161223	171192
NM_004949.4(DSC2):c.2194T>G (p.Leu732Val)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not specified|Arrhythmogenic right ventricular dysplasia/cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2017)	criteria provided, conflicting interpretations	18	28650748	18	31070782	36005	44669
NM_004949.4(DSC2):c.1073C>T (p.Thr358Ile)	DSC2	Arrhythmogenic right ventricular cardiomyopathy, type 11|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiac arrest|Cardiovascular phenotype	Likely benign(Last reviewed: Mar 23, 2018)	criteria provided, multiple submitters, no conflicts	18	28662896	18	31082930	46160	55325
NM_004949.4(DSC2):c.1018A>G (p.Thr340Ala)	DSC2	Arrhythmogenic right ventricular dysplasia/cardiomyopathy	Likely benign(Last reviewed: Jun 1, 2014)	no assertion criteria provided	18	28662951	18	31082985	161222	171193
NM_001943.4(DSG2):c.137G>A (p.Arg46Gln)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	18	29099821	18	31519858	16812	31851
NM_001943.4(DSG2):c.146G>A (p.Arg49His)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	18	29099830	18	31519867	16810	31849
NM_001943.4(DSG2):c.166G>A (p.Val56Met)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Catecholaminergic polymorphic ventricular tachycardia type 1|Arrhythmogenic right ventricular cardiomyopathy|Dilated cardiomyopathy 1BB|Primary familial hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	18	29099850	18	31519887	16818	31857
NM_001943.3(DSG2):c.473T>G (p.Val158Gly)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular dysplasia, familial 1|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	18	29101156	18	31521193	44319	53486
NM_001943.4(DSG2):c.1174G>A (p.Val392Ile)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 15, 2017)	criteria provided, conflicting interpretations	18	29111109	18	31531146	36009	44673
NM_001943.4(DSG2):c.1912G>A (p.Gly638Arg)	DSG2	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not specified|Cardiovascular phenotype	Uncertain significance(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	18	29121188	18	31541225	161224	171194
NM_001943.4(DSG2):c.2434G>T (p.Gly812Cys)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|Cardiovascular phenotype	Likely pathogenic(Last reviewed: Mar 6, 2017)	criteria provided, single submitter	18	29125783	18	31545820	16814	31853
NM_001943.4(DSG2):c.2759T>G (p.Val920Gly)	DSG2|DSG2-AS1	Arrhythmogenic right ventricular cardiomyopathy, type 10|Arrhythmogenic right ventricular cardiomyopathy|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	18	29126108	18	31546145	44307	53474
NM_000371.3(TTR):c.148G>A (p.Val50Met)	TTR	Amyloidogenic transthyretin amyloidosis|not provided	Pathogenic(Last reviewed: Jun 20, 2018)	criteria provided, multiple submitters, no conflicts	18	29172937	18	31592974	13417	28456
NM_000371.3(TTR):c.208A>C (p.Ser70Arg)	TTR	Amyloidogenic transthyretin amyloidosis	Likely pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	18	29175090	18	31595127	36889	45550
NM_000371.3(TTR):c.238A>G (p.Thr80Ala)	TTR	Amyloidogenic transthyretin amyloidosis|not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	18	29175120	18	31595157	13421	28460
NM_000371.3(TTR):c.424G>A (p.Val142Ile)	TTR	Carpal tunnel syndrome|Dystransthyretinemic euthyroidal hyperthyroxinemia|Amyloidogenic transthyretin amyloidosis|Amyloid Cardiomyopathy, Transthyretin-related|Cardiomyopathy|Anemia|not provided|Pancytopenia|Pneumonia|Bone marrow hypocellularity|Cardiovascular phenotype	Pathogenic(Last reviewed: Sep 16, 2018)	criteria provided, multiple submitters, no conflicts	18	29178618	18	31598655	13426	28465
NM_015559.3(SETBP1):c.46G>A (p.Glu16Lys)	SETBP1	Schinzel-Giedion syndrome	Uncertain significance(Last reviewed: May 5, 2014)	criteria provided, single submitter	18	42281357	18	44701392	159883	169418
NM_015559.3(SETBP1):c.540+7405G>A	SETBP1	not specified	Likely benign	no assertion criteria provided	18	42456653	18	44876688	159884	169419
NM_015559.3(SETBP1):c.691G>C (p.Val231Leu)	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign(Last reviewed: May 7, 2018)	criteria provided, multiple submitters, no conflicts	18	42529996	18	44950031	159885	169420
NM_015559.3(SETBP1):c.1223C>G (p.Ala408Gly)	SETBP1	Schinzel-Giedion syndrome	Uncertain significance(Last reviewed: May 14, 2014)	criteria provided, single submitter	18	42530528	18	44950563	159868	169422
NM_015559.3(SETBP1):c.2602G>C (p.Asp868His)	SETBP1	Schinzel-Giedion syndrome	Likely pathogenic(Last reviewed: May 7, 2014)	criteria provided, single submitter	18	42531907	18	44951942	159871	169425
NM_015559.3(SETBP1):c.2602G>A (p.Asp868Asn)	SETBP1	Schinzel-Giedion syndrome|not provided	Pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	18	42531907	18	44951942	1032	16071
NM_015559.3(SETBP1):c.2608G>A (p.Gly870Ser)	SETBP1	Chronic myelogenous leukemia|Schinzel-Giedion syndrome	Pathogenic(Last reviewed: Sep 19, 2013)	criteria provided, single submitter	18	42531913	18	44951948	1035	16074
NM_015559.3(SETBP1):c.2612T>C (p.Ile871Thr)	SETBP1	Schinzel-Giedion syndrome|not provided	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	18	42531917	18	44951952	1031	16070
NM_015559.3(SETBP1):c.3301G>A (p.Val1101Ile)	SETBP1	Schinzel-Giedion syndrome|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	42532606	18	44952641	159872	169426
NM_015559.3(SETBP1):c.3388C>A (p.Pro1130Thr)	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	18	42532693	18	44952728	159873	169427
NM_015559.3(SETBP1):c.4129G>C (p.Val1377Leu)	SETBP1	Schinzel-Giedion syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	42618578	18	45038613	159878	169432
NM_015559.3(SETBP1):c.4398G>T (p.Glu1466Asp)	SETBP1	Schinzel-Giedion syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	18	42643270	18	45063305	159880	169434
NM_015559.3(SETBP1):c.4640C>A (p.Thr1547Asn)	SETBP1	Schinzel-Giedion syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 28, 2016)	criteria provided, multiple submitters, no conflicts	18	42643512	18	45063547	159882	169436
NM_005359.5(SMAD4):c.209A>G (p.Lys70Arg)	SMAD4	Myhre syndrome	Uncertain significance(Last reviewed: Jun 29, 2017)	criteria provided, single submitter	18	48573625	18	51047255	438836	432469
NM_005359.5(SMAD4):c.970T>C (p.Cys324Arg)	SMAD4	Juvenile polyposis syndrome|not specified	Uncertain significance(Last reviewed: Dec 2, 2015)	criteria provided, single submitter	18	48591807	18	51065437	24819	36160
NM_005359.5(SMAD4):c.989A>G (p.Glu330Gly)	SMAD4	Juvenile polyposis syndrome|not provided|Hereditary cancer-predisposing syndrome	Likely pathogenic(Last reviewed: Feb 24, 2014)	criteria provided, single submitter	18	48591826	18	51065456	24824	36165
NM_005359.5(SMAD4):c.1058A>C (p.Tyr353Ser)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591895	18	51065525	24829	36170
NM_005359.5(SMAD4):c.1081C>A (p.Arg361Ser)	SMAD4	Juvenile polyposis syndrome|Neoplasm of the large intestine|Colorectal Neoplasms	Pathogenic(Last reviewed: Oct 2, 2014)	no assertion criteria provided	18	48591918	18	51065548	24822	36163
NM_005359.5(SMAD4):c.1081C>T (p.Arg361Cys)	SMAD4	Juvenile polyposis syndrome|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|JP, JP/HHT, and HHT|not provided|Neoplasm of the breast|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Colorectal Neoplasms|Uterine cervical neoplasms|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	18	48591918	18	51065548	8543	23582
NM_005359.5(SMAD4):c.1087T>C (p.Cys363Arg)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48591924	18	51065554	24834	36175
NM_005359.5(SMAD4):c.1139G>A (p.Arg380Lys)	SMAD4	Juvenile polyposis syndrome	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	18	48591976	18	51065606	38283	46838
NM_005359.5(SMAD4):c.1168G>A (p.Glu390Lys)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48593417	18	51067047	24843	36184
NM_005359.5(SMAD4):c.1472G>T (p.Gly491Val)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604650	18	51078280	24857	36198
NM_005359.5(SMAD4):c.1478A>C (p.Asp493Ala)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604656	18	51078286	24858	36199
NM_005359.5(SMAD4):c.1499T>C (p.Ile500Thr)	SMAD4	Myhre syndrome|not provided	Pathogenic(Last reviewed: Oct 26, 2017)	criteria provided, multiple submitters, no conflicts	18	48604677	18	51078307	30149	39105
NM_005359.5(SMAD4):c.1523G>A (p.Gly508Asp)	SMAD4	Juvenile polyposis syndrome	Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, single submitter	18	48604701	18	51078331	549766	540532
NM_005359.5(SMAD4):c.1525T>A (p.Trp509Arg)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604703	18	51078333	24859	36200
NM_005359.5(SMAD4):c.1529G>T (p.Gly510Val)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604707	18	51078337	24861	36202
NM_005359.5(SMAD4):c.1571G>T (p.Trp524Leu)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604749	18	51078379	24866	36207
NM_005359.5(SMAD4):c.1573A>G (p.Ile525Val)	SMAD4	Myhre syndrome|Juvenile polyposis syndrome|Osler hemorrhagic telangiectasia syndrome|not specified|not provided|Gastrointestinal polyposis|Cardiovascular phenotype|Juvenile Polyposis	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2017)	criteria provided, conflicting interpretations	18	48604751	18	51078381	41788	50227
NM_005359.5(SMAD4):c.1597C>G (p.Leu533Val)	SMAD4	Juvenile polyposis syndrome	Pathogenic(Last reviewed: Dec 4, 2012)	no assertion criteria provided	18	48604775	18	51078405	24873	36214
NM_005215.3(DCC):c.3872G>A (p.Arg1291Gln)	DCC	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	18	51013302	18	53486932	375864	362743
NM_005215.3(DCC):c.4028G>A (p.Arg1343His)	DCC	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	18	51025797	18	53499427	375859	362744
NM_001083962.1(TCF4):c.1840G>C (p.Ala614Pro)	TCF4	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52896117	18	55228886	160081	169438
NM_001083962.1(TCF4):c.1741G>T (p.Val581Phe)	TCF4	Pitt-Hopkins syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 27, 2018)	criteria provided, conflicting interpretations	18	52896216	18	55228985	160079	169440
NM_001083962.1(TCF4):c.1739G>A (p.Arg580Gln)	TCF4	Pitt-Hopkins syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	18	52896218	18	55228987	7371	22410
NM_001083962.1(TCF4):c.1733G>C (p.Arg578Pro)	TCF4	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52896224	18	55228993	7374	22413
NM_001083962.1(TCF4):c.1350G>A (p.Met450Ile)	TCF4	Pitt-Hopkins syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	18	52921728	18	55254497	160077	169442
NM_001083962.1(TCF4):c.944C>T (p.Ala315Val)	TCF4	Pitt-Hopkins syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	18	52928743	18	55261512	160091	169446
NM_001083962.1(TCF4):c.550-2A>G	TCF4	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Feb 21, 2012)	criteria provided, single submitter	18	52946889	18	55279658	217015	213650
NM_001083962.1(TCF4):c.305-165C>T	TCF4	not specified	Likely benign	no assertion criteria provided	18	53070914	18	55403683	160083	169454
NM_001083962.1(TCF4):c.223A>G (p.Thr75Ala)	TCF4|TCF4-AS1	not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	18	53128331	18	55461100	160082	169455
NM_005912.2(MC4R):c.914G>A (p.Arg305Gln)	MC4R	Obesity	Uncertain significance(Last reviewed: Apr 6, 2018)	criteria provided, single submitter	18	58038669	18	60371436	524206	514853
NM_005912.2(MC4R):c.896C>A (p.Pro299His)	MC4R	Obesity	Pathogenic(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	18	58038687	18	60371454	36488	45150
NM_005912.2(MC4R):c.806T>A (p.Ile269Asn)	MC4R	Obesity|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2017)	criteria provided, conflicting interpretations	18	58038777	18	60371544	36486	45148
NM_005912.2(MC4R):c.677T>C (p.Ile226Thr)	MC4R	Obesity	Uncertain significance(Last reviewed: Aug 18, 2011)	criteria provided, single submitter	18	58038906	18	60371673	36485	45147
NM_005912.2(MC4R):c.606C>A (p.Phe202Leu)	MC4R	Obesity|not specified|Monogenic diabetes	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2017)	criteria provided, conflicting interpretations	18	58038977	18	60371744	36484	45146
NM_017757.2(ZNF407):c.181A>G (p.Ser61Gly)	ZNF407	not specified	Benign(Last reviewed: Feb 16, 2015)	criteria provided, single submitter	18	72343156	18	74631200	130817	136262
NM_017757.2(ZNF407):c.206A>G (p.Asn69Ser)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72343181	18	74631225	130818	136263
NM_017757.2(ZNF407):c.1534G>A (p.Gly512Arg)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72344509	18	74632553	130815	136260
NM_017757.2(ZNF407):c.2915A>C (p.Asn972Thr)	ZNF407	not specified	Likely benign	no assertion criteria provided	18	72345890	18	74633934	130819	136264
NM_017757.2(ZNF407):c.4939A>G (p.Met1647Val)	ZNF407	not provided	Uncertain significance(Last reviewed: Mar 21, 2014)	criteria provided, single submitter	18	72589214	18	74877258	130824	136269
NM_000455.4(STK11):c.464G>A (p.Gly155Glu)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	19	1219412	19	1219413	492532	485458
NM_000455.4(STK11):c.542A>G (p.Asn181Ser)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	19	1220449	19	1220450	254654	249194
NM_000455.4(STK11):c.894C>A (p.Phe298Leu)	STK11	Peutz-Jeghers syndrome|not specified|not provided|Hereditary cancer-predisposing syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	19	1221979	19	1221980	127707	133164
NM_000455.4(STK11):c.971C>T (p.Pro324Leu)	STK11	Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	1223034	19	1223035	135931	139643
NM_000455.4(STK11):c.1254C>G (p.Cys418Trp)	STK11	Peutz-Jeghers syndrome|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	19	1226598	19	1226599	135918	139630
NM_030662.3(MAP2K2):c.937C>T (p.Arg313Trp)	MAP2K2	not provided|Cardiofaciocutaneous syndrome 4	Uncertain significance(Last reviewed: Jun 30, 2016)	criteria provided, single submitter	19	4097324	19	4097326	280685	264952
NM_030662.3(MAP2K2):c.619G>A (p.Glu207Lys)	MAP2K2	not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Likely pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	19	4101103	19	4101105	40813	49283
NM_030662.3(MAP2K2):c.181A>G (p.Lys61Glu)	MAP2K2	Cardiofaciocutaneous syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	19	4117539	19	4117541	40769	49239
NM_006087.3(TUBB4A):c.1228G>A (p.Glu410Lys)	TUBB4A	Leukodystrophy, hypomyelinating, 6	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	19	6495282	19	6495271	135658	139376
NM_006087.3(TUBB4A):c.1164G>C (p.Met388Ile)	TUBB4A	Leukodystrophy, hypomyelinating, 6	Likely pathogenic(Last reviewed: Nov 5, 2014)	criteria provided, single submitter	19	6495346	19	6495335	209201	205792
NM_006087.3(TUBB4A):c.1062C>G (p.Cys354Trp)	TUBB4A	Leukodystrophy, hypomyelinating, 6	Likely pathogenic(Last reviewed: Apr 18, 2016)	no assertion criteria provided	19	6495448	19	6495437	453295	446894
NM_006087.3(TUBB4A):c.763G>A (p.Val255Ile)	TUBB4A	Leukodystrophy, hypomyelinating, 6|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	6495747	19	6495736	217025	213656
NM_006087.3(TUBB4A):c.745G>A (p.Asp249Asn)	TUBB4A	Leukodystrophy, hypomyelinating, 6|not provided	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	19	6495765	19	6495754	50985	65656
NM_012335.3(MYO1F):c.1781G>A (p.Arg594Gln)	MYO1F	Bilateral sensorineural hearing impairment	Uncertain significance(Last reviewed: May 22, 2014)	no assertion criteria provided	19	8601851	19	8536967	374265	361233
NM_001130823.2(DNMT1):c.1532A>G (p.Tyr511Cys)	DNMT1	Hereditary sensory neuropathy type IE|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2016)	criteria provided, multiple submitters, no conflicts	19	10265693	19	10155017	29682	38637
NM_001130823.2(DNMT1):c.406C>T (p.Arg136Cys)	DNMT1	Beckwith-Wiedemann syndrome|Hereditary sensory neuropathy type IE|not specified|Dementia, Deafness, and Sensory Neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: May 25, 2018)	criteria provided, conflicting interpretations	19	10291065	19	10180389	234461	232066
NM_001005360.2(DNM2):c.190G>A (p.Val64Ile)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|Peripheral neuropathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2017)	criteria provided, conflicting interpretations	19	10870442	19	10759766	133978	137717
NM_001005360.2(DNM2):c.238C>T (p.His80Tyr)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|not specified|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	10883157	19	10772481	137130	140833
NM_001005360.2(DNM2):c.958G>A (p.Asp320Asn)	DNM2	not specified|not provided|Centronuclear Myopathy, Dominant|Charcot-Marie-Tooth, Intermediate	Conflicting interpretations of pathogenicity(Last reviewed: Jan 16, 2018)	criteria provided, conflicting interpretations	19	10897348	19	10786672	158529	169459
NM_001190716.1(DNM2):c.1021G>A (p.Glu341Lys)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B	Likely pathogenic(Last reviewed: Sep 25, 2014)	criteria provided, single submitter	19	10904424	19	10793748	218920	215729
NM_001190716.1(DNM2):c.1072G>A (p.Gly358Arg)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Charcot-Marie-Tooth disease, type 2M|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	19	10904475	19	10793799	7287	22326
NM_001005360.2(DNM2):c.1090C>T (p.Arg364Cys)	DNM2	Myopathy, centronuclear, 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	19	10904493	19	10793817	560989	552214
NM_001005360.2(DNM2):c.1102G>A (p.Glu368Lys)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Muscular Diseases|not provided|Myopathy, centronuclear	Pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	19	10904505	19	10793829	7282	22321
NM_001005360.2(DNM2):c.1105C>T (p.Arg369Trp)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Myopathy, centronuclear	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	19	10904508	19	10793832	7280	22319
NM_001005360.2(DNM2):c.1106G>A (p.Arg369Gln)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Myopathy, centronuclear	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	19	10904509	19	10793833	7279	22318
NM_001005360.2(DNM2):c.1124T>A (p.Val375Glu)	DNM2	Myopathy, centronuclear	Likely pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	19	10904527	19	10793851	158513	169460
NM_001005360.2(DNM2):c.1393C>T (p.Arg465Trp)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|not provided|Myopathy, centronuclear	Pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	19	10909219	19	10798543	7281	22320
NM_001005360.2(DNM2):c.1565G>A (p.Arg522His)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|not provided|Myopathy, centronuclear	Pathogenic(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	19	10922947	19	10812271	158514	169461
NM_001005360.2(DNM2):c.1567A>G (p.Arg523Gly)	DNM2	not provided	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	10922949	19	10812273	158515	169462
NM_001005360.2(DNM2):c.1856C>T (p.Ser619Leu)	DNM2	Charcot-Marie-Tooth disease, dominant intermediate B|Myopathy, centronuclear, 1|Severe X-linked myotubular myopathy|not provided|Myopathy, centronuclear	Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2018)	criteria provided, multiple submitters, no conflicts	19	10934538	19	10823862	7285	22324
NM_001005360.2(DNM2):c.1862T>C (p.Leu621Pro)	DNM2	Myopathy, centronuclear	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	19	10934544	19	10823868	158519	169466
NM_001005360.2(DNM2):c.1880C>G (p.Pro627Arg)	DNM2	not provided|Myopathy, centronuclear	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2016)	criteria provided, multiple submitters, no conflicts	19	10934562	19	10823886	158520	169467
NM_001128849.1(SMARCA4):c.1114T>C (p.Tyr372His)	SMARCA4	Rhabdoid tumor predisposition syndrome 2|not specified|Hereditary cancer-predisposing syndrome|Coffin-Siris syndrome	Benign/Likely benign(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	19	11098596	19	10987920	126355	131887
NM_003072.3(SMARCA4):c.2653C>T (p.Arg885Cys)	SMARCA4	Mental retardation, autosomal dominant 16|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Sep 7, 2017)	criteria provided, multiple submitters, no conflicts	19	11132437	19	11021761	30344	39300
NM_001128849.1(SMARCA4):c.3608G>A (p.Arg1203His)	SMARCA4	Mental retardation, autosomal dominant 16|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	19	11144027	19	11033351	449452	446024
NM_000527.4(LDLR):c.1A>T (p.Met1Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200225	19	11089549	250968	245334
NM_000527.4(LDLR):c.1A>G (p.Met1Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200225	19	11089549	250967	245333
NM_000527.4(LDLR):c.1A>C (p.Met1Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200225	19	11089549	250966	245332
NM_000527.4(LDLR):c.3G>T (p.Met1Ile)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11200227	19	11089551	250969	245335
NM_000527.4(LDLR):c.28T>C (p.Trp10Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11200252	19	11089576	250976	245341
NM_000527.4(LDLR):c.28T>A (p.Trp10Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11200252	19	11089576	250975	245340
NM_000527.4(LDLR):c.44T>A (p.Leu15His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11200268	19	11089592	250980	245346
NM_000527.4(LDLR):c.47T>C (p.Leu16Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11200271	19	11089595	250982	245348
NM_000527.4(LDLR):c.58G>A (p.Gly20Arg)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	19	11200282	19	11089606	161272	171195
NM_000527.4(LDLR):c.81C>G (p.Cys27Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11210912	19	11100236	226304	228117
NM_000527.4(LDLR):c.82G>A (p.Glu28Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11210913	19	11100237	430745	424291
NM_000527.4(LDLR):c.91G>A (p.Glu31Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210922	19	11100246	251013	245368
NM_000527.4(LDLR):c.95T>G (p.Phe32Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210926	19	11100250	251016	245371
NM_000527.4(LDLR):c.100T>G (p.Cys34Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11210931	19	11100255	251018	245373
NM_000527.4(LDLR):c.101G>C (p.Cys34Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210932	19	11100256	251019	245374
NM_000527.4(LDLR):c.108C>A (p.Asp36Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210939	19	11100263	251022	245377
NM_000527.4(LDLR):c.116G>T (p.Cys39Phe)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, single submitter	19	11210947	19	11100271	430746	424292
NM_000527.4(LDLR):c.136T>G (p.Cys46Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11210967	19	11100291	251030	245385
NM_000527.4(LDLR):c.137G>A (p.Cys46Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11210968	19	11100292	251031	245386
NM_000527.4(LDLR):c.137G>C (p.Cys46Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11210968	19	11100292	3742	18781
NM_000527.4(LDLR):c.139G>A (p.Asp47Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11210970	19	11100294	251034	245388
NM_000527.4(LDLR):c.148G>T (p.Ala50Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2017)	criteria provided, conflicting interpretations	19	11210979	19	11100303	68099	78990
NM_000527.4(LDLR):c.155G>A (p.Cys52Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11210986	19	11100310	251038	245393
NM_000527.4(LDLR):c.166T>C (p.Ser56Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	19	11210997	19	11100321	237864	243267
NM_000527.4(LDLR):c.169G>A (p.Asp57Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211000	19	11100324	251040	245395
NM_000527.4(LDLR):c.172G>A (p.Glu58Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211003	19	11100327	251043	245397
NM_000527.4(LDLR):c.173A>G (p.Glu58Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11211004	19	11100328	251044	245399
NM_000527.4(LDLR):c.185C>T (p.Thr62Met)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 25, 2018)	criteria provided, conflicting interpretations	19	11211016	19	11100340	161273	171196
NM_000527.4(LDLR):c.187T>C (p.Cys63Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11211018	19	11100342	251046	245401
NM_000527.4(LDLR):c.188G>A (p.Cys63Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11211019	19	11100343	251047	245402
NM_000527.4(LDLR):c.223T>A (p.Cys75Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	11213372	19	11102696	251079	245422
NM_000527.4(LDLR):c.224G>A (p.Cys75Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213373	19	11102697	226308	228121
NM_000527.4(LDLR):c.225T>G (p.Cys75Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213374	19	11102698	251080	245423
NM_000527.4(LDLR):c.232C>T (p.Arg78Cys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213381	19	11102705	161289	171197
NM_000527.4(LDLR):c.233G>A (p.Arg78His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11213382	19	11102706	251085	245428
NM_000527.4(LDLR):c.240C>A (p.Asn80Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213389	19	11102713	251087	245430
NM_000527.4(LDLR):c.241C>A (p.Arg81Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213390	19	11102714	251088	245431
NM_000527.4(LDLR):c.241C>T (p.Arg81Cys)	LDLR	Familial hypercholesterolemia|not provided|Early-onset coronary artery disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11213390	19	11102714	183083	181222
NM_000527.4(LDLR):c.244T>G (p.Cys82Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213393	19	11102717	251091	245433
NM_000527.4(LDLR):c.245G>T (p.Cys82Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 12, 2018)	criteria provided, multiple submitters, no conflicts	19	11213394	19	11102718	251093	245436
NM_000527.4(LDLR):c.245G>A (p.Cys82Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213394	19	11102718	251092	245435
NM_000527.4(LDLR):c.251C>G (p.Pro84Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213400	19	11102724	251095	245438
NM_000527.4(LDLR):c.251C>T (p.Pro84Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213400	19	11102724	226310	228123
NM_000527.4(LDLR):c.259T>G (p.Trp87Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11213408	19	11102732	3685	18724
NM_000527.4(LDLR):c.265T>G (p.Cys89Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213414	19	11102738	251103	245446
NM_000527.4(LDLR):c.265T>C (p.Cys89Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213414	19	11102738	251102	245445
NM_000527.4(LDLR):c.266G>A (p.Cys89Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 26, 2017)	criteria provided, multiple submitters, no conflicts	19	11213415	19	11102739	226312	228125
NM_000527.4(LDLR):c.267C>G (p.Cys89Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11213416	19	11102740	251104	245447
NM_000527.4(LDLR):c.268G>T (p.Asp90Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11213417	19	11102741	251106	245449
NM_000527.4(LDLR):c.268G>A (p.Asp90Asn)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 15, 2018)	criteria provided, conflicting interpretations	19	11213417	19	11102741	251105	245448
NM_000527.4(LDLR):c.269A>G (p.Asp90Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11213418	19	11102742	226313	228126
NM_000527.4(LDLR):c.270T>A (p.Asp90Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213419	19	11102743	251107	245450
NM_000527.4(LDLR):c.280G>T (p.Asp94Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213429	19	11102753	251109	245452
NM_000527.4(LDLR):c.283T>G (p.Cys95Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2017)	criteria provided, conflicting interpretations	19	11213432	19	11102756	251112	245455
NM_000527.4(LDLR):c.283T>C (p.Cys95Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213432	19	11102756	251111	245454
NM_000527.4(LDLR):c.283T>A (p.Cys95Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213432	19	11102756	251110	245453
NM_000527.4(LDLR):c.284G>T (p.Cys95Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 17, 2018)	criteria provided, multiple submitters, no conflicts	19	11213433	19	11102757	251114	245457
NM_000527.4(LDLR):c.284G>A (p.Cys95Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213433	19	11102757	251113	245456
NM_000527.4(LDLR):c.291C>G (p.Asn97Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213440	19	11102764	251116	245459
NM_000527.4(LDLR):c.292G>C (p.Gly98Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213441	19	11102765	251119	245462
NM_000527.4(LDLR):c.292G>A (p.Gly98Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213441	19	11102765	251118	245461
NM_000527.4(LDLR):c.298G>A (p.Asp100Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11213447	19	11102771	251121	245464
NM_000527.4(LDLR):c.299A>T (p.Asp100Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11213448	19	11102772	369854	354080
NM_000527.4(LDLR):c.299A>G (p.Asp100Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213448	19	11102772	251122	245465
NM_000527.4(LDLR):c.300C>A (p.Asp100Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11213449	19	11102773	403629	390609
NM_000527.4(LDLR):c.301G>A (p.Glu101Lys)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 3, 2017)	criteria provided, multiple submitters, no conflicts	19	11213450	19	11102774	161266	171199
NM_000527.4(LDLR):c.310T>C (p.Cys104Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213459	19	11102783	251129	245471
NM_000527.4(LDLR):c.311G>T (p.Cys104Phe)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11213460	19	11102784	251130	245473
NM_000527.4(LDLR):c.311G>A (p.Cys104Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11213460	19	11102784	226315	228128
NM_000527.4(LDLR):c.312T>G (p.Cys104Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11213461	19	11102785	251131	245474
NM_000527.4(LDLR):c.324_325delGTinsTC (p.Cys109Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215906 - 11215907	19	11105230 - 11105231	251154	245492
NM_000527.4(LDLR):c.325T>C (p.Cys109Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215907	19	11105231	251156	245493
NM_000527.4(LDLR):c.326G>T (p.Cys109Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215908	19	11105232	251157	245495
NM_000527.4(LDLR):c.326G>A (p.Cys109Tyr)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	19	11215908	19	11105232	226319	228132
NM_000527.4(LDLR):c.326G>C (p.Cys109Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215908	19	11105232	3743	18782
NM_000527.4(LDLR):c.337G>A (p.Glu113Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 8, 2018)	criteria provided, conflicting interpretations	19	11215919	19	11105243	237872	243268
NM_000527.4(LDLR):c.343C>T (p.Arg115Cys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11215925	19	11105249	251162	245500
NM_000527.4(LDLR):c.344G>A (p.Arg115His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11215926	19	11105250	225402	227401
NM_000527.4(LDLR):c.346T>C (p.Cys116Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 13, 2018)	criteria provided, multiple submitters, no conflicts	19	11215928	19	11105252	251163	245501
NM_000527.4(LDLR):c.347G>T (p.Cys116Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215929	19	11105253	251166	245502
NM_000527.4(LDLR):c.352G>T (p.Asp118Tyr)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11215934	19	11105258	183085	181224
NM_000527.4(LDLR):c.361T>G (p.Cys121Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215943	19	11105267	251175	245513
NM_000527.4(LDLR):c.361T>C (p.Cys121Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215943	19	11105267	251174	245512
NM_000527.4(LDLR):c.361T>A (p.Cys121Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215943	19	11105267	251173	245511
NM_000527.4(LDLR):c.362G>T (p.Cys121Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215944	19	11105268	251177	245515
NM_000527.4(LDLR):c.362G>C (p.Cys121Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215944	19	11105268	251176	245514
NM_000527.4(LDLR):c.362G>A (p.Cys121Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215944	19	11105268	36463	45126
NM_000527.4(LDLR):c.364A>T (p.Ile122Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215946	19	11105270	251178	245516
NM_000527.4(LDLR):c.370C>T (p.Arg124Trp)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2016)	criteria provided, conflicting interpretations	19	11215952	19	11105276	251185	245523
NM_000527.4(LDLR):c.376T>C (p.Phe126Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215958	19	11105282	251189	245527
NM_000527.4(LDLR):c.377T>A (p.Phe126Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215959	19	11105283	251190	245528
NM_000527.4(LDLR):c.380T>A (p.Val127Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215962	19	11105286	251191	245529
NM_000527.4(LDLR):c.382T>C (p.Cys128Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215964	19	11105288	251193	245530
NM_000527.4(LDLR):c.383G>C (p.Cys128Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11215965	19	11105289	403630	390610
NM_000527.4(LDLR):c.383G>T (p.Cys128Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215965	19	11105289	251194	245532
NM_000527.4(LDLR):c.386A>G (p.Asp129Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215968	19	11105292	251195	245533
NM_000527.4(LDLR):c.388T>C (p.Ser130Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11215970	19	11105294	251197	245535
NM_000527.4(LDLR):c.391G>C (p.Asp131His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215973	19	11105297	251200	245538
NM_000527.4(LDLR):c.397G>A (p.Asp133Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215979	19	11105303	251202	245539
NM_000527.4(LDLR):c.400T>C (p.Cys134Arg)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2017)	criteria provided, multiple submitters, no conflicts	19	11215982	19	11105306	226322	228135
NM_000527.4(LDLR):c.401G>T (p.Cys134Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215983	19	11105307	251204	245542
NM_000527.4(LDLR):c.401G>A (p.Cys134Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215983	19	11105307	251203	245541
NM_000527.4(LDLR):c.402C>G (p.Cys134Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215984	19	11105308	251205	245543
NM_000527.4(LDLR):c.407A>T (p.Asp136Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215989	19	11105313	251206	245544
NM_000527.4(LDLR):c.409G>T (p.Gly137Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11215991	19	11105315	251207	245545
NM_000527.4(LDLR):c.409G>A (p.Gly137Ser)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11215991	19	11105315	183087	181226
NM_000527.4(LDLR):c.415G>C (p.Asp139His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215997	19	11105321	251210	245548
NM_000527.4(LDLR):c.415G>A (p.Asp139Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11215997	19	11105321	251209	245547
NM_000527.4(LDLR):c.416A>T (p.Asp139Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215998	19	11105322	251212	245550
NM_000527.4(LDLR):c.416A>G (p.Asp139Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11215998	19	11105322	251211	245549
NM_000527.4(LDLR):c.417C>G (p.Asp139Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11215999	19	11105323	226323	228136
NM_000527.4(LDLR):c.418G>A (p.Glu140Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216000	19	11105324	251213	245551
NM_000527.4(LDLR):c.419A>G (p.Glu140Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216001	19	11105325	251215	245553
NM_000527.4(LDLR):c.420G>T (p.Glu140Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216002	19	11105326	251217	245555
NM_000527.4(LDLR):c.420G>C (p.Glu140Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11216002	19	11105326	251216	245554
NM_000527.4(LDLR):c.427T>C (p.Cys143Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216009	19	11105333	251219	245557
NM_000527.4(LDLR):c.427T>G (p.Cys143Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216009	19	11105333	226324	228137
NM_000527.4(LDLR):c.428G>T (p.Cys143Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216010	19	11105334	523723	514377
NM_000527.4(LDLR):c.428G>C (p.Cys143Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216010	19	11105334	369851	354083
NM_000527.4(LDLR):c.428G>A (p.Cys143Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216010	19	11105334	251220	245558
NM_000527.4(LDLR):c.440C>T (p.Thr147Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216022	19	11105346	251223	245561
NM_000527.4(LDLR):c.442T>C (p.Cys148Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216024	19	11105348	251224	245562
NM_000527.4(LDLR):c.443G>C (p.Cys148Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216025	19	11105349	251227	245564
NM_000527.4(LDLR):c.443G>A (p.Cys148Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216025	19	11105349	251225	245563
NM_000527.4(LDLR):c.444T>G (p.Cys148Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216026	19	11105350	251228	245565
NM_000527.4(LDLR):c.445G>T (p.Gly149Cys)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216027	19	11105351	251229	245566
NM_000527.4(LDLR):c.457T>G (p.Phe153Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11216039	19	11105363	251235	245572
NM_000527.4(LDLR):c.458T>G (p.Phe153Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216040	19	11105364	251236	245573
NM_000527.4(LDLR):c.463T>G (p.Cys155Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11216045	19	11105369	251239	245576
NM_000527.4(LDLR):c.463T>C (p.Cys155Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216045	19	11105369	251238	245575
NM_000527.4(LDLR):c.464G>T (p.Cys155Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216046	19	11105370	251241	245578
NM_000527.4(LDLR):c.464G>A (p.Cys155Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216046	19	11105370	251240	245577
NM_000527.4(LDLR):c.470G>A (p.Ser157Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216052	19	11105376	441186	434824
NM_000527.4(LDLR):c.473C>G (p.Ser158Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216055	19	11105379	251245	245582
NM_000527.4(LDLR):c.478T>G (p.Cys160Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216060	19	11105384	251248	245585
NM_000527.4(LDLR):c.478T>C (p.Cys160Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216060	19	11105384	251247	245584
NM_000527.4(LDLR):c.479G>T (p.Cys160Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216061	19	11105385	441187	434825
NM_000527.4(LDLR):c.479_480delGCinsTT (p.Cys160Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216061 - 11216062	19	11105385 - 11105386	431510	425026
NM_000527.4(LDLR):c.479G>A (p.Cys160Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	19	11216061	19	11105385	251249	245586
NM_000527.4(LDLR):c.485C>T (p.Pro162Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216067	19	11105391	251251	245588
NM_000527.4(LDLR):c.491T>C (p.Leu164Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216073	19	11105397	251252	245589
NM_000527.4(LDLR):c.493T>G (p.Trp165Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216075	19	11105399	251253	245590
NM_000527.4(LDLR):c.499T>C (p.Cys167Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216081	19	11105405	251255	245592
NM_000527.4(LDLR):c.500G>A (p.Cys167Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216082	19	11105406	251256	245593
NM_000527.4(LDLR):c.501C>G (p.Cys167Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216083	19	11105407	251257	245594
NM_000527.4(LDLR):c.502G>T (p.Asp168Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216084	19	11105408	251259	245596
NM_000527.4(LDLR):c.502G>C (p.Asp168His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216084	19	11105408	251258	245595
NM_000527.4(LDLR):c.502G>A (p.Asp168Asn)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	19	11216084	19	11105408	183136	181228
NM_000527.4(LDLR):c.503A>C (p.Asp168Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216085	19	11105409	375785	362677
NM_000527.4(LDLR):c.503A>G (p.Asp168Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216085	19	11105409	251260	245597
NM_000527.4(LDLR):c.504C>A (p.Asp168Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216086	19	11105410	251261	245598
NM_000527.4(LDLR):c.506A>T (p.Asn169Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216088	19	11105412	251262	245599
NM_000527.4(LDLR):c.510C>A (p.Asp170Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	19	11216092	19	11105416	403662	390611
NM_000527.4(LDLR):c.514G>T (p.Asp172Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216096	19	11105420	251268	245605
NM_000527.4(LDLR):c.514G>C (p.Asp172His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216096	19	11105420	251267	245604
NM_000527.4(LDLR):c.514G>A (p.Asp172Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216096	19	11105420	251266	245603
NM_000527.4(LDLR):c.515A>G (p.Asp172Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216097	19	11105421	251269	245606
NM_000527.4(LDLR):c.516C>G (p.Asp172Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216098	19	11105422	251271	245607
NM_000527.4(LDLR):c.517T>G (p.Cys173Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216099	19	11105423	251273	245610
NM_000527.4(LDLR):c.517T>C (p.Cys173Arg)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Apr 24, 2017)	criteria provided, multiple submitters, no conflicts	19	11216099	19	11105423	251272	245609
NM_000527.4(LDLR):c.518G>A (p.Cys173Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216100	19	11105424	251275	245611
NM_000527.4(LDLR):c.519C>G (p.Cys173Trp)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11216101	19	11105425	251277	245614
NM_000527.4(LDLR):c.523G>T (p.Asp175Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216105	19	11105429	251278	245615
NM_000527.4(LDLR):c.523G>A (p.Asp175Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11216105	19	11105429	3726	18765
NM_000527.4(LDLR):c.527G>T (p.Gly176Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216109	19	11105433	251281	245618
NM_000527.4(LDLR):c.529T>C (p.Ser177Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11216111	19	11105435	403631	390612
NM_000527.4(LDLR):c.530C>T (p.Ser177Leu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11216112	19	11105436	3686	18725
NM_000527.4(LDLR):c.532G>T (p.Asp178Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216114	19	11105438	251285	245621
NM_000527.4(LDLR):c.532G>C (p.Asp178His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216114	19	11105438	251284	245620
NM_000527.4(LDLR):c.532G>A (p.Asp178Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216114	19	11105438	251283	245619
NM_000527.4(LDLR):c.533A>G (p.Asp178Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216115	19	11105439	251286	245623
NM_000527.4(LDLR):c.533A>T (p.Asp178Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216115	19	11105439	226326	228139
NM_000527.4(LDLR):c.534T>G (p.Asp178Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11216116	19	11105440	251287	245624
NM_000527.4(LDLR):c.535G>A (p.Glu179Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216117	19	11105441	251288	245625
NM_000527.4(LDLR):c.536A>G (p.Glu179Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216118	19	11105442	251290	245627
NM_000527.4(LDLR):c.542C>T (p.Pro181Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216124	19	11105448	431512	425028
NM_000527.4(LDLR):c.542C>G (p.Pro181Arg)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2018)	criteria provided, conflicting interpretations	19	11216124	19	11105448	183089	181229
NM_000527.4(LDLR):c.550T>C (p.Cys184Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216132	19	11105456	251294	245630
NM_000527.4(LDLR):c.551G>A (p.Cys184Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	19	11216133	19	11105457	3739	18778
NM_000527.4(LDLR):c.552T>G (p.Cys184Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216134	19	11105458	251293	245631
NM_000527.4(LDLR):c.589T>G (p.Cys197Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2018)	criteria provided, multiple submitters, no conflicts	19	11216171	19	11105495	251308	245645
NM_000527.4(LDLR):c.589T>C (p.Cys197Arg)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216171	19	11105495	183091	181231
NM_000527.4(LDLR):c.590G>T (p.Cys197Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216172	19	11105496	251309	245646
NM_000527.4(LDLR):c.590G>A (p.Cys197Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, multiple submitters, no conflicts	19	11216172	19	11105496	200919	198012
NM_000527.4(LDLR):c.591C>G (p.Cys197Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216173	19	11105497	251311	245648
NM_000527.4(LDLR):c.601G>A (p.Glu201Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216183	19	11105507	251317	245654
NM_000527.4(LDLR):c.605T>C (p.Phe202Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216187	19	11105511	251318	245655
NM_000527.4(LDLR):c.611G>T (p.Cys204Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216193	19	11105517	251322	245659
NM_000527.4(LDLR):c.611G>C (p.Cys204Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216193	19	11105517	251321	245658
NM_000527.4(LDLR):c.611G>A (p.Cys204Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216193	19	11105517	251320	245657
NM_000527.4(LDLR):c.618T>G (p.Ser206Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216200	19	11105524	251325	245662
NM_000527.4(LDLR):c.622G>A (p.Glu208Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 13, 2017)	criteria provided, multiple submitters, no conflicts	19	11216204	19	11105528	251328	245665
NM_000527.4(LDLR):c.626G>A (p.Cys209Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216208	19	11105532	251332	245669
NM_000527.4(LDLR):c.629T>A (p.Ile210Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216211	19	11105535	251333	245670
NM_000527.4(LDLR):c.631C>T (p.His211Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11216213	19	11105537	251335	245672
NM_000527.4(LDLR):c.631C>G (p.His211Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11216213	19	11105537	251334	245671
NM_000527.4(LDLR):c.632A>T (p.His211Leu)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2017)	criteria provided, conflicting interpretations	19	11216214	19	11105538	251337	245673
NM_000527.4(LDLR):c.641G>C (p.Trp214Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216223	19	11105547	251339	245676
NM_000527.4(LDLR):c.643C>A (p.Arg215Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216225	19	11105549	251342	245678
NM_000527.4(LDLR):c.646T>C (p.Cys216Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216228	19	11105552	251345	245681
NM_000527.4(LDLR):c.647G>T (p.Cys216Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216229	19	11105553	251347	245684
NM_000527.4(LDLR):c.647G>A (p.Cys216Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11216229	19	11105553	251346	245683
NM_000527.4(LDLR):c.661G>T (p.Asp221Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216243	19	11105567	251356	245694
NM_000527.4(LDLR):c.661G>A (p.Asp221Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 4, 2018)	criteria provided, multiple submitters, no conflicts	19	11216243	19	11105567	226331	228144
NM_000527.4(LDLR):c.662A>T (p.Asp221Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216244	19	11105568	251357	245697
NM_000527.4(LDLR):c.662A>G (p.Asp221Gly)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, multiple submitters, no conflicts	19	11216244	19	11105568	183092	181233
NM_000527.4(LDLR):c.664T>G (p.Cys222Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216246	19	11105570	251361	245699
NM_000527.4(LDLR):c.664T>C (p.Cys222Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11216246	19	11105570	226332	228145
NM_000527.4(LDLR):c.665G>T (p.Cys222Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216247	19	11105571	251362	245701
NM_000527.4(LDLR):c.665G>A (p.Cys222Tyr)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216247	19	11105571	183093	181234
NM_000527.4(LDLR):c.666C>G (p.Cys222Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216248	19	11105572	251365	245703
NM_000527.4(LDLR):c.669G>C (p.Lys223Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216251	19	11105575	251370	245707
NM_000527.4(LDLR):c.670G>A (p.Asp224Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216252	19	11105576	3706	18745
NM_000527.4(LDLR):c.671A>T (p.Asp224Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216253	19	11105577	251375	245714
NM_000527.4(LDLR):c.671A>G (p.Asp224Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216253	19	11105577	251374	245713
NM_000527.4(LDLR):c.671A>C (p.Asp224Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216253	19	11105577	251373	245712
NM_000527.4(LDLR):c.676T>C (p.Ser226Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216258	19	11105582	251384	245722
NM_000527.4(LDLR):c.677C>G (p.Ser226Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216259	19	11105583	251385	245724
NM_000527.4(LDLR):c.680A>T (p.Asp227Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216262	19	11105586	251388	245725
NM_000527.4(LDLR):c.681C>A (p.Asp227Glu)	LDLR	Familial hypercholesterolemia	Pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11216263	19	11105587	403632	390613
NM_000527.4(LDLR):c.681C>G (p.Asp227Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11216263	19	11105587	3690	18729
NM_000527.4(LDLR):c.682G>C (p.Glu228Gln)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2017)	criteria provided, multiple submitters, no conflicts	19	11216264	19	11105588	251393	245730
NM_000527.4(LDLR):c.682G>A (p.Glu228Lys)	LDLR	Familial hypercholesterolemia|not provided|Aortic dissection|Carotid artery dissection|Internal carotid artery dissection|Carotid artery occlusion|Stroke	Pathogenic/Likely pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	19	11216264	19	11105588	3691	18730
NM_000527.4(LDLR):c.683A>C (p.Glu228Ala)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216265	19	11105589	251394	245733
NM_000527.4(LDLR):c.684G>C (p.Glu228Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11216266	19	11105590	523724	514378
NM_000527.4(LDLR):c.691T>G (p.Cys231Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11216273	19	11105597	251397	245736
NM_000527.4(LDLR):c.691T>C (p.Cys231Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11216273	19	11105597	251396	245735
NM_000527.4(LDLR):c.692G>A (p.Cys231Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11216274	19	11105598	251398	245737
NM_000527.4(LDLR):c.693C>G (p.Cys231Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11216275	19	11105599	251400	245738
NM_000527.4(LDLR):c.706T>C (p.Cys236Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217252	19	11106576	251419	245755
NM_000527.4(LDLR):c.709C>T (p.Arg237Cys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	19	11217255	19	11106579	251421	245757
NM_000527.4(LDLR):c.718G>A (p.Glu240Lys)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11217264	19	11106588	200920	198013
NM_000527.4(LDLR):c.722T>C (p.Phe241Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217268	19	11106592	251423	245759
NM_000527.4(LDLR):c.727T>C (p.Cys243Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217273	19	11106597	251425	245761
NM_000527.4(LDLR):c.737G>A (p.Gly246Glu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217283	19	11106607	251427	245762
NM_000527.4(LDLR):c.742T>G (p.Cys248Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217288	19	11106612	251428	245764
NM_000527.4(LDLR):c.743G>T (p.Cys248Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11217289	19	11106613	251430	245766
NM_000527.4(LDLR):c.743G>A (p.Cys248Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217289	19	11106613	251429	245765
NM_000527.4(LDLR):c.746T>C (p.Ile249Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217292	19	11106616	251432	245768
NM_000527.4(LDLR):c.757C>T (p.Arg253Trp)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11217303	19	11106627	161261	171200
NM_000527.4(LDLR):c.758G>C (p.Arg253Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217304	19	11106628	251435	245771
NM_000527.4(LDLR):c.761A>C (p.Gln254Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2017)	criteria provided, multiple submitters, no conflicts	19	11217307	19	11106631	251437	245773
NM_000527.4(LDLR):c.762G>T (p.Gln254His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217308	19	11106632	251439	245774
NM_000527.4(LDLR):c.762_763invGT (p.Cys255Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217308 - 11217309	19	11106632 - 11106633	251438	245775
NM_000527.4(LDLR):c.763T>G (p.Cys255Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217309	19	11106633	251442	245778
NM_000527.4(LDLR):c.763T>C (p.Cys255Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217309	19	11106633	251441	245777
NM_000527.4(LDLR):c.763T>A (p.Cys255Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217309	19	11106633	251440	245776
NM_000527.4(LDLR):c.764G>A (p.Cys255Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217310	19	11106634	251443	245779
NM_000527.4(LDLR):c.767A>G (p.Asp256Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11217313	19	11106637	251444	245780
NM_000527.4(LDLR):c.768C>A (p.Asp256Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11217314	19	11106638	438322	431953
NM_000527.4(LDLR):c.768C>G (p.Asp256Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217314	19	11106638	251445	245781
NM_000527.4(LDLR):c.769C>T (p.Arg257Trp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2018)	criteria provided, conflicting interpretations	19	11217315	19	11106639	251446	245782
NM_000527.4(LDLR):c.782G>T (p.Cys261Phe)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	19	11217328	19	11106652	3740	18779
NM_000527.4(LDLR):c.793A>T (p.Ser265Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217339	19	11106663	251454	245790
NM_000527.4(LDLR):c.796G>T (p.Asp266Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217342	19	11106666	251456	245791
NM_000527.4(LDLR):c.796G>A (p.Asp266Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11217342	19	11106666	226334	228147
NM_000527.4(LDLR):c.797A>T (p.Asp266Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217343	19	11106667	251458	245794
NM_000527.4(LDLR):c.797A>G (p.Asp266Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217343	19	11106667	251457	245793
NM_000527.4(LDLR):c.798T>A (p.Asp266Glu)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 17, 2018)	criteria provided, conflicting interpretations	19	11217344	19	11106668	161287	171201
NM_000527.4(LDLR):c.799G>A (p.Glu267Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217345	19	11106669	251459	245795
NM_000527.4(LDLR):c.800A>C (p.Glu267Ala)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11217346	19	11106670	251460	245796
NM_000527.4(LDLR):c.801A>T (p.Glu267Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217347	19	11106671	251461	245797
NM_000527.4(LDLR):c.806G>A (p.Gly269Asp)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2017)	criteria provided, conflicting interpretations	19	11217352	19	11106676	161279	171202
NM_000527.4(LDLR):c.808T>C (p.Cys270Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11217354	19	11106678	251463	245799
NM_000527.4(LDLR):c.808T>A (p.Cys270Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217354	19	11106678	251462	245798
NM_000527.4(LDLR):c.809G>A (p.Cys270Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11217355	19	11106679	251464	245800
NM_000527.4(LDLR):c.811G>A (p.Val271Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11217357	19	11106681	189297	187194
NM_000527.4(LDLR):c.815A>C (p.Asn272Thr)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11217361	19	11106685	251468	245804
NM_000527.4(LDLR):c.826T>G (p.Cys276Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218076	19	11107400	251480	245813
NM_000527.4(LDLR):c.826T>C (p.Cys276Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218076	19	11107400	251479	245812
NM_000527.4(LDLR):c.827G>A (p.Cys276Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218077	19	11107401	251481	245814
NM_000527.4(LDLR):c.828C>G (p.Cys276Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218078	19	11107402	251482	245815
NM_000527.4(LDLR):c.829G>A (p.Glu277Lys)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2017)	criteria provided, conflicting interpretations	19	11218079	19	11107403	183097	181238
NM_000527.4(LDLR):c.846C>A (p.Phe282Leu)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11218096	19	11107420	183098	181239
NM_000527.4(LDLR):c.850T>G (p.Cys284Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218100	19	11107424	251485	245818
NM_000527.4(LDLR):c.850T>C (p.Cys284Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218100	19	11107424	251484	245817
NM_000527.4(LDLR):c.858C>A (p.Ser286Arg)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	19	11218108	19	11107432	251488	245821
NM_000527.4(LDLR):c.859G>T (p.Gly287Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218109	19	11107433	251489	245822
NM_000527.4(LDLR):c.859G>A (p.Gly287Ser)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218109	19	11107433	161280	171203
NM_000527.4(LDLR):c.862G>A (p.Glu288Lys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)	criteria provided, conflicting interpretations	19	11218112	19	11107436	161268	171204
NM_000527.4(LDLR):c.865T>C (p.Cys289Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218115	19	11107439	251492	245824
NM_000527.4(LDLR):c.869T>G (p.Ile290Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218119	19	11107443	251494	245826
NM_000527.4(LDLR):c.880A>G (p.Lys294Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218130	19	11107454	251498	245831
NM_000527.4(LDLR):c.887G>C (p.Cys296Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218137	19	11107461	251503	245835
NM_000527.4(LDLR):c.887G>A (p.Cys296Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218137	19	11107461	251502	245834
NM_000527.4(LDLR):c.895G>T (p.Ala299Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218145	19	11107469	251508	245841
NM_000527.4(LDLR):c.895G>A (p.Ala299Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218145	19	11107469	251507	245840
NM_000527.4(LDLR):c.898A>G (p.Arg300Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11218148	19	11107472	251510	245843
NM_000527.4(LDLR):c.901G>T (p.Asp301Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218151	19	11107475	251512	245845
NM_000527.4(LDLR):c.902A>G (p.Asp301Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218152	19	11107476	251514	245847
NM_000527.4(LDLR):c.902A>C (p.Asp301Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218152	19	11107476	251513	245846
NM_000527.4(LDLR):c.905G>A (p.Cys302Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218155	19	11107479	251515	245848
NM_000527.4(LDLR):c.906C>G (p.Cys302Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218156	19	11107480	251516	245849
NM_000527.4(LDLR):c.907C>T (p.Arg303Trp)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2018)	criteria provided, conflicting interpretations	19	11218157	19	11107481	161281	171205
NM_000527.4(LDLR):c.910G>C (p.Asp304His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11218160	19	11107484	440612	434263
NM_000527.4(LDLR):c.910G>T (p.Asp304Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218160	19	11107484	251517	245850
NM_000527.4(LDLR):c.910G>A (p.Asp304Asn)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	11218160	19	11107484	3692	18731
NM_000527.4(LDLR):c.912C>G (p.Asp304Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11218162	19	11107486	226336	228149
NM_000527.4(LDLR):c.915G>C (p.Trp305Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218165	19	11107489	251521	245854
NM_000527.4(LDLR):c.917C>T (p.Ser306Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11218167	19	11107491	226337	228150
NM_000527.4(LDLR):c.919G>C (p.Asp307His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218169	19	11107493	251526	245859
NM_000527.4(LDLR):c.919G>A (p.Asp307Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11218169	19	11107493	251525	245858
NM_000527.4(LDLR):c.920A>G (p.Asp307Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11218170	19	11107494	523725	514379
NM_000527.4(LDLR):c.921T>G (p.Asp307Glu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11218171	19	11107495	251527	245860
NM_000527.4(LDLR):c.922G>A (p.Glu308Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218172	19	11107496	251528	245861
NM_000527.4(LDLR):c.932A>C (p.Lys311Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218182	19	11107506	251531	245863
NM_000527.4(LDLR):c.937T>G (p.Cys313Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11218187	19	11107511	251538	245871
NM_000527.4(LDLR):c.937T>C (p.Cys313Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11218187	19	11107511	251537	245870
NM_000527.4(LDLR):c.938G>A (p.Cys313Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11218188	19	11107512	226339	228151
NM_000527.4(LDLR):c.938_939delGCinsAT (p.Cys313Tyr)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11218188 - 11218189	19	11107512 - 11107513	226338	228152
NM_000527.4(LDLR):c.939C>G (p.Cys313Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11218189	19	11107513	251540	245873
NM_000527.4(LDLR):c.947A>C (p.Asn316Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221334	19	11110658	251566	245890
NM_000527.4(LDLR):c.947A>G (p.Asn316Ser)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221334	19	11110658	183103	181244
NM_000527.4(LDLR):c.949G>A (p.Glu317Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221336	19	11110660	251567	245891
NM_000527.4(LDLR):c.952T>C (p.Cys318Arg)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, multiple submitters, no conflicts	19	11221339	19	11110663	251570	245894
NM_000527.4(LDLR):c.953G>T (p.Cys318Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221340	19	11110664	251572	245896
NM_000527.4(LDLR):c.953G>A (p.Cys318Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221340	19	11110664	251571	245895
NM_000527.4(LDLR):c.965A>T (p.Asn322Ile)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221352	19	11110676	251575	245899
NM_000527.4(LDLR):c.967G>A (p.Gly323Ser)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221354	19	11110678	161282	171206
NM_000527.4(LDLR):c.970G>A (p.Gly324Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2017)	criteria provided, conflicting interpretations	19	11221357	19	11110681	161263	171207
NM_000527.4(LDLR):c.974G>A (p.Cys325Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Likely pathogenic(Last reviewed: May 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221361	19	11110685	251580	245904
NM_000527.4(LDLR):c.977C>T (p.Ser326Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221364	19	11110688	251582	245906
NM_000527.4(LDLR):c.977C>G (p.Ser326Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11221364	19	11110688	251581	245905
NM_000527.4(LDLR):c.979C>T (p.His327Tyr)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11221366	19	11110690	251583	245907
NM_000527.4(LDLR):c.981C>A (p.His327Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	19	11221368	19	11110692	403665	390615
NM_000527.4(LDLR):c.985T>G (p.Cys329Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221372	19	11110696	251585	245909
NM_000527.4(LDLR):c.986G>T (p.Cys329Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221373	19	11110697	251586	245910
NM_000527.4(LDLR):c.986G>A (p.Cys329Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11221373	19	11110697	226344	228154
NM_000527.4(LDLR):c.987C>G (p.Cys329Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221374	19	11110698	441207	434839
NM_000527.4(LDLR):c.1003G>A (p.Gly335Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 13, 2018)	criteria provided, conflicting interpretations	19	11221390	19	11110714	183105	181246
NM_000527.4(LDLR):c.1004G>T (p.Gly335Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221391	19	11110715	251587	245911
NM_000527.4(LDLR):c.1007A>G (p.Tyr336Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221394	19	11110718	251588	245912
NM_000527.4(LDLR):c.1012T>G (p.Cys338Gly)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, multiple submitters, no conflicts	19	11221399	19	11110723	251594	245918
NM_000527.4(LDLR):c.1012T>C (p.Cys338Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221399	19	11110723	251593	245917
NM_000527.4(LDLR):c.1012T>A (p.Cys338Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221399	19	11110723	251592	245916
NM_000527.4(LDLR):c.1013G>T (p.Cys338Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11221400	19	11110724	441208	434840
NM_000527.4(LDLR):c.1013G>A (p.Cys338Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	19	11221400	19	11110724	251595	245919
NM_000527.4(LDLR):c.1016T>C (p.Leu339Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221403	19	11110727	251597	245921
NM_000527.4(LDLR):c.1019G>A (p.Cys340Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11221406	19	11110730	251600	245923
NM_000527.4(LDLR):c.1019_1020delGCinsTG (p.Cys340Leu)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11221406 - 11221407	19	11110730 - 11110731	251599	245924
NM_000527.4(LDLR):c.1020C>G (p.Cys340Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221407	19	11110731	251601	245925
NM_000527.4(LDLR):c.1024G>T (p.Asp342Tyr)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11221411	19	11110735	251603	245927
NM_000527.4(LDLR):c.1024G>A (p.Asp342Asn)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2017)	criteria provided, conflicting interpretations	19	11221411	19	11110735	161274	171208
NM_000527.4(LDLR):c.1027G>T (p.Gly343Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221414	19	11110738	251605	245929
NM_000527.4(LDLR):c.1027G>A (p.Gly343Ser)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	19	11221414	19	11110738	183106	181247
NM_000527.4(LDLR):c.1028G>A (p.Gly343Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11221415	19	11110739	251606	245930
NM_000527.4(LDLR):c.1049G>C (p.Arg350Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2017)	criteria provided, conflicting interpretations	19	11221436	19	11110760	226343	228157
NM_000527.4(LDLR):c.1054T>C (p.Cys352Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221441	19	11110765	251618	245941
NM_000527.4(LDLR):c.1054T>A (p.Cys352Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11221441	19	11110765	251617	245940
NM_000527.4(LDLR):c.1055G>T (p.Cys352Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11221442	19	11110766	251619	245943
NM_000527.4(LDLR):c.1055G>A (p.Cys352Tyr)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, multiple submitters, no conflicts	19	11221442	19	11110766	36450	45113
NM_000527.4(LDLR):c.1056C>G (p.Cys352Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2017)	criteria provided, multiple submitters, no conflicts	19	11221443	19	11110767	251622	245945
NM_000527.4(LDLR):c.1057G>A (p.Glu353Lys)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11221444	19	11110768	161275	171209
NM_000527.4(LDLR):c.1061A>T (p.Asp354Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11222190	19	11111514	251640	245961
NM_000527.4(LDLR):c.1061A>G (p.Asp354Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222190	19	11111514	251639	245960
NM_000527.4(LDLR):c.1061A>C (p.Asp354Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222190	19	11111514	251638	245959
NM_000527.4(LDLR):c.1065C>G (p.Ile355Met)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11222194	19	11111518	403634	390616
NM_000527.4(LDLR):c.1066G>C (p.Asp356His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11222195	19	11111519	251644	245967
NM_000527.4(LDLR):c.1066G>T (p.Asp356Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222195	19	11111519	226345	228158
NM_000527.4(LDLR):c.1067A>C (p.Asp356Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222196	19	11111520	251645	245968
NM_000527.4(LDLR):c.1069G>A (p.Glu357Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11222198	19	11111522	251649	245971
NM_000527.4(LDLR):c.1070A>G (p.Glu357Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222199	19	11111523	251651	245973
NM_000527.4(LDLR):c.1072T>C (p.Cys358Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222201	19	11111525	251652	245975
NM_000527.4(LDLR):c.1073G>A (p.Cys358Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222202	19	11111526	226346	228159
NM_000527.4(LDLR):c.1085A>C (p.Asp362Ala)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222214	19	11111538	36452	45115
NM_000527.4(LDLR):c.1088C>A (p.Thr363Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222217	19	11111541	251656	245979
NM_000527.4(LDLR):c.1090T>C (p.Cys364Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	19	11222219	19	11111543	251657	245980
NM_000527.4(LDLR):c.1091G>A (p.Cys364Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222220	19	11111544	369852	354092
NM_000527.4(LDLR):c.1091G>T (p.Cys364Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222220	19	11111544	251659	245982
NM_000527.4(LDLR):c.1091G>C (p.Cys364Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222220	19	11111544	251658	245981
NM_000527.4(LDLR):c.1097A>G (p.Gln366Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222226	19	11111550	251662	245985
NM_000527.4(LDLR):c.1097A>C (p.Gln366Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222226	19	11111550	251661	245984
NM_000527.4(LDLR):c.1102T>C (p.Cys368Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	11222231	19	11111555	369848	354093
NM_000527.4(LDLR):c.1102T>G (p.Cys368Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222231	19	11111555	251664	245987
NM_000527.4(LDLR):c.1103G>C (p.Cys368Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11222232	19	11111556	251666	245989
NM_000527.4(LDLR):c.1103G>A (p.Cys368Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2018)	criteria provided, conflicting interpretations	19	11222232	19	11111556	251665	245988
NM_000527.4(LDLR):c.1109A>C (p.Asn370Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222238	19	11111562	251668	245991
NM_000527.4(LDLR):c.1110C>G (p.Asn370Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222239	19	11111563	251669	245992
NM_000527.4(LDLR):c.1112T>C (p.Leu371Pro)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11222241	19	11111565	403635	390617
NM_000527.4(LDLR):c.1117G>T (p.Gly373Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11222246	19	11111570	251672	245995
NM_000527.4(LDLR):c.1118G>T (p.Gly373Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222247	19	11111571	251674	245997
NM_000527.4(LDLR):c.1118G>A (p.Gly373Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 9, 2018)	criteria provided, multiple submitters, no conflicts	19	11222247	19	11111571	251673	245996
NM_000527.4(LDLR):c.1124A>G (p.Tyr375Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222253	19	11111577	251679	246002
NM_000527.4(LDLR):c.1124A>C (p.Tyr375Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222253	19	11111577	251678	246001
NM_000527.4(LDLR):c.1129T>G (p.Cys377Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222258	19	11111582	251680	246003
NM_000527.4(LDLR):c.1130G>T (p.Cys377Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11222259	19	11111583	438323	431954
NM_000527.4(LDLR):c.1130G>C (p.Cys377Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222259	19	11111583	251682	246005
NM_000527.4(LDLR):c.1130G>A (p.Cys377Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222259	19	11111583	251681	246004
NM_000527.4(LDLR):c.1133A>C (p.Gln378Pro)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11222262	19	11111586	183108	181249
NM_000527.4(LDLR):c.1135T>C (p.Cys379Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2016)	criteria provided, multiple submitters, no conflicts	19	11222264	19	11111588	251685	246008
NM_000527.4(LDLR):c.1136G>A (p.Cys379Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222265	19	11111589	251686	246009
NM_000527.4(LDLR):c.1145G>T (p.Gly382Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222274	19	11111598	251687	246010
NM_000527.4(LDLR):c.1151A>C (p.Gln384Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11222280	19	11111604	251690	246012
NM_000527.4(LDLR):c.1154T>G (p.Leu385Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222283	19	11111607	251692	246015
NM_000527.4(LDLR):c.1166C>T (p.Thr389Met)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11222295	19	11111619	161283	171210
NM_000527.4(LDLR):c.1171G>A (p.Ala391Thr)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2017)	criteria provided, conflicting interpretations	19	11222300	19	11111624	183138	181250
NM_000527.4(LDLR):c.1174T>C (p.Cys392Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11222303	19	11111627	251697	246019
NM_000527.4(LDLR):c.1177A>C (p.Lys393Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11222306	19	11111630	403636	390618
NM_000527.4(LDLR):c.1179G>C (p.Lys393Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11222308	19	11111632	251700	246023
NM_000527.4(LDLR):c.1186G>A (p.Gly396Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11222315	19	11111639	251704	246026
NM_000527.4(LDLR):c.1195G>A (p.Ala399Thr)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223962	19	11113286	183109	181251
NM_000527.4(LDLR):c.1196C>A (p.Ala399Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223963	19	11113287	226350	228163
NM_000527.4(LDLR):c.1201C>G (p.Leu401Val)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2018)	criteria provided, conflicting interpretations	19	11223968	19	11113292	161267	171211
NM_000527.4(LDLR):c.1202T>A (p.Leu401His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223969	19	11113293	3735	18774
NM_000527.4(LDLR):c.1207T>C (p.Phe403Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223974	19	11113298	251732	246045
NM_000527.4(LDLR):c.1210A>T (p.Thr404Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11223977	19	11113301	431523	425037
NM_000527.4(LDLR):c.1210A>C (p.Thr404Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11223977	19	11113301	251735	246049
NM_000527.4(LDLR):c.1211C>T (p.Thr404Ile)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11223978	19	11113302	251736	246050
NM_000527.4(LDLR):c.1215C>G (p.Asn405Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 10, 2018)	criteria provided, multiple submitters, no conflicts	19	11223982	19	11113306	251738	246052
NM_000527.4(LDLR):c.1216C>T (p.Arg406Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11223983	19	11113307	226351	228164
NM_000527.4(LDLR):c.1217G>A (p.Arg406Gln)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11223984	19	11113308	228798	230981
NM_000527.4(LDLR):c.1217G>C (p.Arg406Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11223984	19	11113308	226352	228165
NM_000527.4(LDLR):c.1222G>A (p.Glu408Lys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	19	11223989	19	11113313	36453	45116
NM_000527.4(LDLR):c.1223A>T (p.Glu408Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11223990	19	11113314	251740	246054
NM_000527.4(LDLR):c.1223A>C (p.Glu408Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11223990	19	11113314	251739	246053
NM_000527.4(LDLR):c.1230G>T (p.Arg410Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11223997	19	11113321	251742	246056
NM_000527.4(LDLR):c.1230G>C (p.Arg410Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11223997	19	11113321	251741	246055
NM_000527.4(LDLR):c.1231A>G (p.Lys411Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11223998	19	11113322	251743	246057
NM_000527.4(LDLR):c.1235T>C (p.Met412Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224002	19	11113326	251745	246059
NM_000527.4(LDLR):c.1238C>T (p.Thr413Met)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2017)	criteria provided, conflicting interpretations	19	11224005	19	11113329	161276	171212
NM_000527.4(LDLR):c.1241T>G (p.Leu414Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224008	19	11113332	251747	246061
NM_000527.4(LDLR):c.1243G>C (p.Asp415His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224010	19	11113334	251748	246062
NM_000527.4(LDLR):c.1246C>T (p.Arg416Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, multiple submitters, no conflicts	19	11224013	19	11113337	183110	181252
NM_000527.4(LDLR):c.1247G>T (p.Arg416Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224014	19	11113338	251754	246068
NM_000527.4(LDLR):c.1247G>C (p.Arg416Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224014	19	11113338	251753	246067
NM_000527.4(LDLR):c.1247G>A (p.Arg416Gln)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 13, 2016)	criteria provided, multiple submitters, no conflicts	19	11224014	19	11113338	251752	246066
NM_000527.4(LDLR):c.1252G>A (p.Glu418Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224019	19	11113343	225182	227097
NM_000527.4(LDLR):c.1255T>G (p.Tyr419Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224022	19	11113346	369853	354094
NM_000527.4(LDLR):c.1255T>C (p.Tyr419His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224022	19	11113346	251756	246070
NM_000527.4(LDLR):c.1265T>C (p.Leu422Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224032	19	11113356	251759	246073
NM_000527.4(LDLR):c.1268T>C (p.Ile423Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224035	19	11113359	251760	246074
NM_000527.4(LDLR):c.1269C>G (p.Ile423Met)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11224036	19	11113360	431525	425039
NM_000527.4(LDLR):c.1274A>T (p.Asn425Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224041	19	11113365	251762	246076
NM_000527.4(LDLR):c.1285G>T (p.Val429Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11224052	19	11113376	251767	246081
NM_000527.4(LDLR):c.1285G>C (p.Val429Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224052	19	11113376	226353	228166
NM_000527.4(LDLR):c.1285G>A (p.Val429Met)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Apr 6, 2018)	criteria provided, multiple submitters, no conflicts	19	11224052	19	11113376	3694	18733
NM_000527.4(LDLR):c.1291G>A (p.Ala431Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224058	19	11113382	3695	18734
NM_000527.4(LDLR):c.1294C>G (p.Leu432Val)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 6, 2016)	criteria provided, conflicting interpretations	19	11224061	19	11113385	183111	181253
NM_000527.4(LDLR):c.1295T>C (p.Leu432Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224062	19	11113386	251770	246084
NM_000527.4(LDLR):c.1297G>T (p.Asp433Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224064	19	11113388	251772	246086
NM_000527.4(LDLR):c.1297G>C (p.Asp433His)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224064	19	11113388	3732	18771
NM_000527.4(LDLR):c.1301C>T (p.Thr434Met)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224068	19	11113392	251775	246089
NM_000527.4(LDLR):c.1301C>G (p.Thr434Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11224068	19	11113392	251774	246088
NM_000527.4(LDLR):c.1301C>A (p.Thr434Lys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224068	19	11113392	251773	246087
NM_000527.4(LDLR):c.1322T>C (p.Ile441Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224089	19	11113413	251783	246097
NM_000527.4(LDLR):c.1322T>A (p.Ile441Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224089	19	11113413	251782	246096
NM_000527.4(LDLR):c.1323C>G (p.Ile441Met)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224090	19	11113414	251784	246098
NM_000527.4(LDLR):c.1324T>C (p.Tyr442His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224091	19	11113415	251786	246100
NM_000527.4(LDLR):c.1324T>A (p.Tyr442Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224091	19	11113415	251785	246099
NM_000527.4(LDLR):c.1325A>G (p.Tyr442Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224092	19	11113416	251787	246101
NM_000527.4(LDLR):c.1328G>C (p.Trp443Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11224095	19	11113419	251790	246104
NM_000527.4(LDLR):c.1329G>T (p.Trp443Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224096	19	11113420	251793	246107
NM_000527.4(LDLR):c.1329G>C (p.Trp443Cys)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	19	11224096	19	11113420	251792	246106
NM_000527.4(LDLR):c.1330T>C (p.Ser444Pro)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, multiple submitters, no conflicts	19	11224097	19	11113421	226354	228167
NM_000527.4(LDLR):c.1335C>A (p.Asp445Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224102	19	11113426	251794	246108
NM_000527.4(LDLR):c.1339T>C (p.Ser447Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224106	19	11113430	251796	246110
NM_000527.4(LDLR):c.1340C>G (p.Ser447Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224107	19	11113431	251797	246111
NM_000527.4(LDLR):c.1351A>T (p.Ile451Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224118	19	11113442	251800	246114
NM_000527.4(LDLR):c.1352T>C (p.Ile451Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224119	19	11113443	251801	246115
NM_000527.4(LDLR):c.1361C>A (p.Thr454Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224213	19	11113537	251812	246126
NM_000527.4(LDLR):c.1367T>A (p.Leu456His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224219	19	11113543	251817	246130
NM_000527.4(LDLR):c.1394A>G (p.Tyr465Cys)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11224246	19	11113570	251826	246140
NM_000527.4(LDLR):c.1403T>A (p.Val468Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224255	19	11113579	251828	246142
NM_000527.4(LDLR):c.1408A>G (p.Ser470Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11224260	19	11113584	369856	354096
NM_000527.4(LDLR):c.1414G>T (p.Asp472Tyr)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2017)	criteria provided, conflicting interpretations	19	11224266	19	11113590	183116	181258
NM_000527.4(LDLR):c.1418T>G (p.Ile473Ser)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11224270	19	11113594	548075	538572
NM_000527.4(LDLR):c.1424C>T (p.Ala475Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224276	19	11113600	251836	246150
NM_000527.4(LDLR):c.1426C>T (p.Pro476Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224278	19	11113602	251837	246151
NM_000527.4(LDLR):c.1429G>A (p.Asp477Asn)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11224281	19	11113605	251838	246152
NM_000527.4(LDLR):c.1432G>T (p.Gly478Trp)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11224284	19	11113608	548076	538573
NM_000527.4(LDLR):c.1432G>A (p.Gly478Arg)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2018)	criteria provided, conflicting interpretations	19	11224284	19	11113608	161277	171213
NM_000527.4(LDLR):c.1436T>C (p.Leu479Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224288	19	11113612	251840	246154
NM_000527.4(LDLR):c.1438G>C (p.Ala480Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224290	19	11113614	251841	246155
NM_000527.4(LDLR):c.1441G>A (p.Val481Met)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224293	19	11113617	251843	246157
NM_000527.4(LDLR):c.1444G>T (p.Asp482Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224296	19	11113620	251845	246159
NM_000527.4(LDLR):c.1444G>C (p.Asp482His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224296	19	11113620	251844	246158
NM_000527.4(LDLR):c.1444G>A (p.Asp482Asn)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2017)	criteria provided, conflicting interpretations	19	11224296	19	11113620	161284	171214
NM_000527.4(LDLR):c.1445A>G (p.Asp482Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224297	19	11113621	251846	246160
NM_000527.4(LDLR):c.1447T>C (p.Trp483Arg)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 15, 2017)	criteria provided, multiple submitters, no conflicts	19	11224299	19	11113623	251847	246161
NM_000527.4(LDLR):c.1454A>G (p.His485Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224306	19	11113630	251848	246164
NM_000527.4(LDLR):c.1455C>G (p.His485Gln)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224307	19	11113631	251851	246165
NM_000527.4(LDLR):c.1463T>G (p.Ile488Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224315	19	11113639	251858	246172
NM_000527.4(LDLR):c.1463T>C (p.Ile488Thr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 14, 2018)	criteria provided, conflicting interpretations	19	11224315	19	11113639	251857	246171
NM_000527.4(LDLR):c.1463T>A (p.Ile488Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224315	19	11113639	251856	246170
NM_000527.4(LDLR):c.1466A>G (p.Tyr489Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224318	19	11113642	251859	246173
NM_000527.4(LDLR):c.1468T>G (p.Trp490Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224320	19	11113644	251860	246174
NM_000527.4(LDLR):c.1468T>C (p.Trp490Arg)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2017)	criteria provided, conflicting interpretations	19	11224320	19	11113644	180402	178734
NM_000527.4(LDLR):c.1472C>A (p.Thr491Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224324	19	11113648	251863	246177
NM_000527.4(LDLR):c.1474G>C (p.Asp492His)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	19	11224326	19	11113650	251864	246178
NM_000527.4(LDLR):c.1474G>A (p.Asp492Asn)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11224326	19	11113650	161285	171216
NM_000527.4(LDLR):c.1475A>G (p.Asp492Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224327	19	11113651	251865	246179
NM_000527.4(LDLR):c.1487G>T (p.Gly496Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224339	19	11113663	251867	246181
NM_000527.4(LDLR):c.1489A>C (p.Thr497Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224341	19	11113665	251868	246182
NM_000527.4(LDLR):c.1502C>T (p.Ala501Val)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2017)	criteria provided, conflicting interpretations	19	11224354	19	11113678	251874	246188
NM_000527.4(LDLR):c.1502C>A (p.Ala501Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224354	19	11113678	251873	246187
NM_000527.4(LDLR):c.1514G>A (p.Gly505Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224366	19	11113690	251879	246193
NM_000527.4(LDLR):c.1520A>C (p.Lys507Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224372	19	11113696	251883	246197
NM_000527.4(LDLR):c.1525A>G (p.Lys509Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224377	19	11113701	251885	246199
NM_000527.4(LDLR):c.1529C>T (p.Thr510Met)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224381	19	11113705	251886	246200
NM_000527.4(LDLR):c.1532T>C (p.Leu511Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224384	19	11113708	251887	246201
NM_000527.4(LDLR):c.1538G>A (p.Arg513Lys)	LDLR	Familial hypercholesterolemia	Likely benign(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11224390	19	11113714	251890	246204
NM_000527.4(LDLR):c.1546G>A (p.Gly516Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11224398	19	11113722	226359	228172
NM_000527.4(LDLR):c.1552A>G (p.Lys518Glu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11224404	19	11113728	251894	246208
NM_000527.4(LDLR):c.1555C>T (p.Pro519Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11224407	19	11113731	251896	246210
NM_000527.4(LDLR):c.1558A>G (p.Arg520Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224410	19	11113734	251897	246211
NM_000527.4(LDLR):c.1567G>T (p.Val523Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224419	19	11113743	251900	246213
NM_000527.4(LDLR):c.1567G>A (p.Val523Met)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11224419	19	11113743	3696	18735
NM_000527.4(LDLR):c.1570G>A (p.Val524Met)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11224422	19	11113746	183119	181261
NM_000527.4(LDLR):c.1571T>G (p.Val524Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224423	19	11113747	251901	246215
NM_000527.4(LDLR):c.1574A>T (p.Asp525Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224426	19	11113750	251902	246216
NM_000527.4(LDLR):c.1576C>A (p.Pro526Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224428	19	11113752	251903	246217
NM_000527.4(LDLR):c.1576C>T (p.Pro526Ser)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2017)	criteria provided, conflicting interpretations	19	11224428	19	11113752	183120	181262
NM_000527.4(LDLR):c.1577C>G (p.Pro526Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11224429	19	11113753	251904	246218
NM_000527.4(LDLR):c.1586G>A (p.Gly529Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11224438	19	11113762	237863	243273
NM_000527.4(LDLR):c.1592T>G (p.Met531Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11226775	19	11116099	226362	228175
NM_000527.4(LDLR):c.1595A>G (p.Tyr532Cys)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11226778	19	11116102	403641	390623
NM_000527.4(LDLR):c.1597T>C (p.Trp533Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226780	19	11116104	251925	246230
NM_000527.4(LDLR):c.1601C>A (p.Thr534Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226784	19	11116108	251929	246234
NM_000527.4(LDLR):c.1603G>T (p.Asp535Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226786	19	11116110	251930	246235
NM_000527.4(LDLR):c.1606T>G (p.Trp536Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226789	19	11116113	251931	246236
NM_000527.4(LDLR):c.1618G>A (p.Ala540Thr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226801	19	11116125	226363	228176
NM_000527.4(LDLR):c.1625T>G (p.Ile542Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226808	19	11116132	251939	246244
NM_000527.4(LDLR):c.1633G>T (p.Gly545Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226816	19	11116140	251944	246249
NM_000527.4(LDLR):c.1633G>C (p.Gly545Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226816	19	11116140	251943	246248
NM_000527.4(LDLR):c.1633G>A (p.Gly545Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226816	19	11116140	251942	246247
NM_000527.4(LDLR):c.1634G>A (p.Gly545Glu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226817	19	11116141	251945	246250
NM_000527.4(LDLR):c.1636G>C (p.Gly546Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226819	19	11116143	251946	246251
NM_000527.4(LDLR):c.1637G>T (p.Gly546Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226820	19	11116144	251947	246252
NM_000527.4(LDLR):c.1637G>A (p.Gly546Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226820	19	11116144	3697	18736
NM_000527.4(LDLR):c.1640T>C (p.Leu547Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Sep 19, 2017)	criteria provided, multiple submitters, no conflicts	19	11226823	19	11116147	251949	246253
NM_000527.4(LDLR):c.1644T>G (p.Asn548Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226827	19	11116151	251952	246256
NM_000527.4(LDLR):c.1644T>A (p.Asn548Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226827	19	11116151	251951	246255
NM_000527.4(LDLR):c.1646G>T (p.Gly549Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226829	19	11116153	251955	246259
NM_000527.4(LDLR):c.1646G>A (p.Gly549Asp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2018)	criteria provided, multiple submitters, no conflicts	19	11226829	19	11116153	3698	18737
NM_000527.4(LDLR):c.1664T>C (p.Leu555Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226847	19	11116171	251962	246267
NM_000527.4(LDLR):c.1687C>T (p.Pro563Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226870	19	11116194	251970	246275
NM_000527.4(LDLR):c.1688C>A (p.Pro563His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11226871	19	11116195	251971	246276
NM_000527.4(LDLR):c.1690A>G (p.Asn564Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226873	19	11116197	251973	246278
NM_000527.4(LDLR):c.1690A>C (p.Asn564His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 4, 2018)	criteria provided, conflicting interpretations	19	11226873	19	11116197	226365	18776
NM_000527.4(LDLR):c.1691A>G (p.Asn564Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Apr 24, 2018)	criteria provided, multiple submitters, no conflicts	19	11226874	19	11116198	224616	226401
NM_000527.4(LDLR):c.1694G>C (p.Gly565Ala)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226877	19	11116201	226366	228178
NM_000527.4(LDLR):c.1694G>T (p.Gly565Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	11226877	19	11116201	3688	18727
NM_000527.4(LDLR):c.1698_1704delCACCCTAinsGCCCAAT (p.Ile566_Leu568delinsMetProAsn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226881 - 11226887	19	11116205 - 11116211	251974	246279
NM_000527.4(LDLR):c.1702C>G (p.Leu568Val)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11226885	19	11116209	251976	246280
NM_000527.4(LDLR):c.1703T>C (p.Leu568Pro)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11226886	19	11116210	251977	246282
NM_000527.4(LDLR):c.1705G>T (p.Asp569Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11226888	19	11116212	251979	246283
NM_000527.4(LDLR):c.1715G>A (p.Ser572Asn)	LDLR	Familial hypercholesterolemia	Likely benign(Last reviewed: Mar 22, 2017)	criteria provided, multiple submitters, no conflicts	19	11227544	19	11116868	251994	246295
NM_000527.4(LDLR):c.1720C>T (p.Arg574Cys)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2017)	criteria provided, conflicting interpretations	19	11227549	19	11116873	183123	181265
NM_000527.4(LDLR):c.1721G>A (p.Arg574His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2018)	criteria provided, conflicting interpretations	19	11227550	19	11116874	251996	246297
NM_000527.4(LDLR):c.1721G>T (p.Arg574Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11227550	19	11116874	237867	243275
NM_000527.4(LDLR):c.1723C>T (p.Leu575Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11227552	19	11116876	438324	431955
NM_000527.4(LDLR):c.1727A>G (p.Tyr576Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227556	19	11116880	251999	246300
NM_000527.4(LDLR):c.1727A>C (p.Tyr576Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227556	19	11116880	251998	246299
NM_000527.4(LDLR):c.1729T>C (p.Trp577Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227558	19	11116882	252001	246301
NM_000527.4(LDLR):c.1729T>G (p.Trp577Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2017)	criteria provided, multiple submitters, no conflicts	19	11227558	19	11116882	252000	246302
NM_000527.4(LDLR):c.1730G>C (p.Trp577Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227559	19	11116883	252003	246303
NM_000527.4(LDLR):c.1731G>T (p.Trp577Cys)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11227560	19	11116884	252004	246305
NM_000527.4(LDLR):c.1735G>A (p.Asp579Asn)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, multiple submitters, no conflicts	19	11227564	19	11116888	252006	246306
NM_000527.4(LDLR):c.1735G>T (p.Asp579Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227564	19	11116888	226371	228183
NM_000527.4(LDLR):c.1736A>G (p.Asp579Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227565	19	11116889	252008	246309
NM_000527.4(LDLR):c.1736A>C (p.Asp579Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227565	19	11116889	252007	246308
NM_000527.4(LDLR):c.1737C>G (p.Asp579Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227566	19	11116890	252009	246310
NM_000527.4(LDLR):c.1739C>T (p.Ser580Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11227568	19	11116892	438325	431956
NM_000527.4(LDLR):c.1744C>G (p.Leu582Val)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11227573	19	11116897	548080	538577
NM_000527.4(LDLR):c.1744C>T (p.Leu582Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227573	19	11116897	430786	424330
NM_000527.4(LDLR):c.1745T>C (p.Leu582Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227574	19	11116898	226372	228184
NM_000527.4(LDLR):c.1747C>T (p.His583Tyr)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2018)	criteria provided, conflicting interpretations	19	11227576	19	11116900	200921	198015
NM_000527.4(LDLR):c.1747C>G (p.His583Asp)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227576	19	11116900	183124	181266
NM_000527.4(LDLR):c.1748A>G (p.His583Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11227577	19	11116901	252012	246313
NM_000527.4(LDLR):c.1749C>G (p.His583Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11227578	19	11116902	441220	434845
NM_000527.4(LDLR):c.1749C>A (p.His583Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227578	19	11116902	252014	246314
NM_000527.4(LDLR):c.1750T>C (p.Ser584Pro)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227579	19	11116903	252015	246316
NM_000527.4(LDLR):c.1754T>C (p.Ile585Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227583	19	11116907	252018	246319
NM_000527.4(LDLR):c.1754T>A (p.Ile585Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227583	19	11116907	252017	246318
NM_000527.4(LDLR):c.1765G>A (p.Asp589Asn)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	19	11227594	19	11116918	252022	246323
NM_000527.4(LDLR):c.1775G>A (p.Gly592Glu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	19	11227604	19	11116928	161271	171217
NM_000527.4(LDLR):c.1783C>T (p.Arg595Trp)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 24, 2017)	criteria provided, conflicting interpretations	19	11227612	19	11116936	161290	171218
NM_000527.4(LDLR):c.1784G>T (p.Arg595Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227613	19	11116937	252029	246329
NM_000527.4(LDLR):c.1784G>A (p.Arg595Gln)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2018)	criteria provided, conflicting interpretations	19	11227613	19	11116937	183126	181268
NM_000527.4(LDLR):c.1796T>G (p.Leu599Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227625	19	11116949	252036	246337
NM_000527.4(LDLR):c.1796T>C (p.Leu599Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11227625	19	11116949	252035	246336
NM_000527.4(LDLR):c.1800G>C (p.Glu600Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2018)	criteria provided, conflicting interpretations	19	11227629	19	11116953	431535	425049
NM_000527.4(LDLR):c.1801G>T (p.Asp601Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227630	19	11116954	252039	246340
NM_000527.4(LDLR):c.1801G>C (p.Asp601His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227630	19	11116954	252038	246339
NM_000527.4(LDLR):c.1802A>T (p.Asp601Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227631	19	11116955	252040	246341
NM_000527.4(LDLR):c.1814T>C (p.Leu605Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227643	19	11116967	226374	228186
NM_000527.4(LDLR):c.1816G>A (p.Ala606Thr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2017)	criteria provided, conflicting interpretations	19	11227645	19	11116969	252046	246347
NM_000527.4(LDLR):c.1816G>T (p.Ala606Ser)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2017)	criteria provided, conflicting interpretations	19	11227645	19	11116969	161264	171219
NM_000527.4(LDLR):c.1820A>G (p.His607Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227649	19	11116973	252047	246348
NM_000527.4(LDLR):c.1822C>T (p.Pro608Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11227651	19	11116975	252049	246350
NM_000527.4(LDLR):c.1822C>A (p.Pro608Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227651	19	11116975	252048	246349
NM_000527.4(LDLR):c.1823C>T (p.Pro608Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227652	19	11116976	252051	246352
NM_000527.4(LDLR):c.1823C>G (p.Pro608Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227652	19	11116976	252050	246351
NM_000527.4(LDLR):c.1829C>T (p.Ser610Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11227658	19	11116982	252055	246355
NM_000527.4(LDLR):c.1829C>G (p.Ser610Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11227658	19	11116982	252054	246354
NM_000527.4(LDLR):c.1833G>T (p.Leu611Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11227662	19	11116986	252059	246359
NM_000527.4(LDLR):c.1833G>C (p.Leu611Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11227662	19	11116986	252058	246358
NM_000527.4(LDLR):c.1837G>A (p.Val613Ile)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227666	19	11116990	161288	171220
NM_000527.4(LDLR):c.1840T>A (p.Phe614Ile)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11227669	19	11116993	252061	246362
NM_000527.4(LDLR):c.1843G>A (p.Glu615Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227672	19	11116996	252063	246364
NM_000527.4(LDLR):c.1844A>T (p.Glu615Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11227673	19	11116997	252064	246365
NM_000527.4(LDLR):c.1853T>G (p.Val618Gly)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11230775	19	11120099	375824	362716
NM_000527.4(LDLR):c.1855T>C (p.Phe619Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11230777	19	11120101	252083	246378
NM_000527.4(LDLR):c.1856T>G (p.Phe619Cys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230778	19	11120102	252085	246381
NM_000527.4(LDLR):c.1856T>C (p.Phe619Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230778	19	11120102	252084	246380
NM_000527.4(LDLR):c.1858T>C (p.Trp620Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230780	19	11120104	252086	246382
NM_000527.4(LDLR):c.1860G>C (p.Trp620Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11230782	19	11120106	252090	246385
NM_000527.4(LDLR):c.1860G>T (p.Trp620Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230782	19	11120106	226376	228189
NM_000527.4(LDLR):c.1862C>G (p.Thr621Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230784	19	11120108	252091	246387
NM_000527.4(LDLR):c.1864G>A (p.Asp622Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11230786	19	11120110	252092	246388
NM_000527.4(LDLR):c.1865A>G (p.Asp622Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2016)	criteria provided, conflicting interpretations	19	11230787	19	11120111	252094	246390
NM_000527.4(LDLR):c.1865A>C (p.Asp622Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230787	19	11120111	252093	246389
NM_000527.4(LDLR):c.1867A>G (p.Ile623Val)	LDLR	Familial hypercholesterolemia|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2018)	criteria provided, conflicting interpretations	19	11230789	19	11120113	252096	246391
NM_000527.4(LDLR):c.1868T>C (p.Ile623Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic	criteria provided, single submitter	19	11230790	19	11120114	369855	354097
NM_000527.4(LDLR):c.1879G>A (p.Ala627Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230801	19	11120125	252101	246397
NM_000527.4(LDLR):c.1880C>T (p.Ala627Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230802	19	11120126	252102	246398
NM_000527.4(LDLR):c.1880C>A (p.Ala627Asp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11230802	19	11120126	226377	228190
NM_000527.4(LDLR):c.1883T>C (p.Ile628Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230805	19	11120129	252103	246399
NM_000527.4(LDLR):c.1886T>G (p.Phe629Cys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230808	19	11120132	252105	246400
NM_000527.4(LDLR):c.1892C>A (p.Ala631Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230814	19	11120138	252106	246402
NM_000527.4(LDLR):c.1897C>T (p.Arg633Cys)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2018)	criteria provided, multiple submitters, no conflicts	19	11230819	19	11120143	226379	228192
NM_000527.4(LDLR):c.1898G>T (p.Arg633Leu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230820	19	11120144	252107	246403
NM_000527.4(LDLR):c.1898G>A (p.Arg633His)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 28, 2017)	criteria provided, conflicting interpretations	19	11230820	19	11120144	226380	228193
NM_000527.4(LDLR):c.1900C>T (p.Leu634Phe)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11230822	19	11120146	548081	538578
NM_000527.4(LDLR):c.1904C>T (p.Thr635Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230826	19	11120150	252108	246404
NM_000527.4(LDLR):c.1906G>A (p.Gly636Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230828	19	11120152	252109	246405
NM_000527.4(LDLR):c.1907G>T (p.Gly636Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11230829	19	11120153	438327	431958
NM_000527.4(LDLR):c.1916T>G (p.Val639Gly)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230838	19	11120162	252112	246408
NM_000527.4(LDLR):c.1925T>C (p.Leu642Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230847	19	11120171	252113	246409
NM_000527.4(LDLR):c.1936C>A (p.Leu646Ile)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230858	19	11120182	252118	246414
NM_000527.4(LDLR):c.1942T>G (p.Ser648Ala)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11230864	19	11120188	431538	425052
NM_000527.4(LDLR):c.1942T>C (p.Ser648Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11230864	19	11120188	252120	246416
NM_000527.4(LDLR):c.1945C>T (p.Pro649Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230867	19	11120191	252121	246417
NM_000527.4(LDLR):c.1951G>T (p.Asp651Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230873	19	11120197	252127	246423
NM_000527.4(LDLR):c.1951G>A (p.Asp651Asn)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11230873	19	11120197	183128	181270
NM_000527.4(LDLR):c.1952A>T (p.Asp651Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230874	19	11120198	252128	246424
NM_000527.4(LDLR):c.1957G>T (p.Val653Phe)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 2, 2018)	criteria provided, conflicting interpretations	19	11230879	19	11120203	252129	246425
NM_000527.4(LDLR):c.1960C>T (p.Leu654Phe)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11230882	19	11120206	252132	246428
NM_000527.4(LDLR):c.1965C>G (p.Phe655Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11230887	19	11120211	252135	246431
NM_000527.4(LDLR):c.1966C>A (p.His656Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 16, 2016)	criteria provided, conflicting interpretations	19	11230888	19	11120212	252136	246432
NM_000527.4(LDLR):c.1968C>G (p.His656Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230890	19	11120214	252137	246433
NM_000527.4(LDLR):c.1973T>C (p.Leu658Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11230895	19	11120219	252138	246434
NM_000527.4(LDLR):c.1978C>A (p.Gln660Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230900	19	11120224	252143	246439
NM_000527.4(LDLR):c.1979A>G (p.Gln660Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11230901	19	11120225	252144	246440
NM_000527.4(LDLR):c.1988G>A (p.Gly663Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231046	19	11120370	252155	246450
NM_000527.4(LDLR):c.1999T>C (p.Cys667Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231057	19	11120381	252163	246458
NM_000527.4(LDLR):c.1999T>A (p.Cys667Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231057	19	11120381	252162	246457
NM_000527.4(LDLR):c.2000G>T (p.Cys667Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231058	19	11120382	252165	246459
NM_000527.4(LDLR):c.2000G>A (p.Cys667Tyr)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2017)	criteria provided, multiple submitters, no conflicts	19	11231058	19	11120382	3689	18728
NM_000527.4(LDLR):c.2001T>G (p.Cys667Trp)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11231059	19	11120383	252168	246462
NM_000527.4(LDLR):c.2023G>A (p.Gly675Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231081	19	11120405	252173	246468
NM_000527.4(LDLR):c.2026G>C (p.Gly676Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231084	19	11120408	252176	246471
NM_000527.4(LDLR):c.2026G>A (p.Gly676Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231084	19	11120408	252175	246470
NM_000527.4(LDLR):c.2029T>C (p.Cys677Arg)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11231087	19	11120411	226384	228197
NM_000527.4(LDLR):c.2030G>A (p.Cys677Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231088	19	11120412	252178	246472
NM_000527.4(LDLR):c.2030G>T (p.Cys677Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231088	19	11120412	226385	228198
NM_000527.4(LDLR):c.2041T>G (p.Cys681Gly)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 13, 2016)	criteria provided, conflicting interpretations	19	11231099	19	11120423	252185	246480
NM_000527.4(LDLR):c.2041T>A (p.Cys681Ser)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231099	19	11120423	252184	246479
NM_000527.4(LDLR):c.2042G>C (p.Cys681Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231100	19	11120424	252187	246482
NM_000527.4(LDLR):c.2042G>A (p.Cys681Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Jun 8, 2018)	criteria provided, multiple submitters, no conflicts	19	11231100	19	11120424	252186	246481
NM_000527.4(LDLR):c.2043C>G (p.Cys681Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231101	19	11120425	252188	246483
NM_000527.4(LDLR):c.2045T>C (p.Leu682Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231103	19	11120427	252189	246484
NM_000527.4(LDLR):c.2050G>A (p.Ala684Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Dec 16, 2016)	criteria provided, multiple submitters, no conflicts	19	11231108	19	11120432	252192	246486
NM_000527.4(LDLR):c.2053C>T (p.Pro685Ser)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231111	19	11120435	252194	246489
NM_000527.4(LDLR):c.2053C>A (p.Pro685Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231111	19	11120435	252193	246488
NM_000527.4(LDLR):c.2054C>A (p.Pro685Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 1, 2016)	criteria provided, single submitter	19	11231112	19	11120436	441227	434850
NM_000527.4(LDLR):c.2054C>T (p.Pro685Leu)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 15, 2018)	criteria provided, multiple submitters, no conflicts	19	11231112	19	11120436	3702	18741
NM_000527.4(LDLR):c.2059A>T (p.Ile687Phe)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	19	11231117	19	11120441	403664	390626
NM_000527.4(LDLR):c.2072C>T (p.Ser691Leu)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11231130	19	11120454	403644	390627
NM_000527.4(LDLR):c.2080T>G (p.Phe694Val)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231138	19	11120462	252208	246503
NM_000527.4(LDLR):c.2087G>A (p.Cys696Tyr)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11231145	19	11120469	252210	246505
NM_000527.4(LDLR):c.2088C>G (p.Cys696Trp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11231146	19	11120470	252212	246507
NM_000527.4(LDLR):c.2089G>C (p.Ala697Pro)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231147	19	11120471	252213	246508
NM_000527.4(LDLR):c.2092T>G (p.Cys698Gly)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	19	11231150	19	11120474	548083	538580
NM_000527.4(LDLR):c.2093G>T (p.Cys698Phe)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231151	19	11120475	252216	246511
NM_000527.4(LDLR):c.2093G>A (p.Cys698Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231151	19	11120475	252215	246510
NM_000527.4(LDLR):c.2096C>T (p.Pro699Leu)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2017)	criteria provided, conflicting interpretations	19	11231154	19	11120478	252219	246513
NM_000527.4(LDLR):c.2099A>G (p.Asp700Gly)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231157	19	11120481	252220	246515
NM_000527.4(LDLR):c.2100C>G (p.Asp700Glu)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231158	19	11120482	252221	246516
NM_000527.4(LDLR):c.2101G>A (p.Gly701Ser)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2017)	criteria provided, conflicting interpretations	19	11231159	19	11120483	183130	181272
NM_000527.4(LDLR):c.2119G>T (p.Asp707Tyr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11231177	19	11120501	252226	246521
NM_000527.4(LDLR):c.2119G>A (p.Asp707Asn)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231177	19	11120501	252225	246520
NM_000527.4(LDLR):c.2120A>T (p.Asp707Val)	LDLR	Familial hypercholesterolemia|not provided	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	19	11231178	19	11120502	252227	246522
NM_000527.4(LDLR):c.2131T>A (p.Cys711Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231189	19	11120513	252228	246523
NM_000527.4(LDLR):c.2132G>T (p.Cys711Phe)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231190	19	11120514	252231	246526
NM_000527.4(LDLR):c.2132G>C (p.Cys711Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231190	19	11120514	252230	246525
NM_000527.4(LDLR):c.2132G>A (p.Cys711Tyr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11231190	19	11120514	252229	246524
NM_000527.4(LDLR):c.2140G>A (p.Glu714Lys)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231198	19	11120522	252233	246528
NM_000527.4(LDLR):c.2140G>C (p.Glu714Gln)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11231198	19	11120522	226386	228199
NM_000527.4(LDLR):c.2177C>T (p.Thr726Ile)	LDLR	Familial hypercholesterolemia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2018)	criteria provided, conflicting interpretations	19	11233886	19	11123210	36461	45124
NM_000527.4(LDLR):c.2231G>A (p.Arg744Gln)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2017)	criteria provided, conflicting interpretations	19	11233940	19	11123264	68104	78995
NM_000527.4(LDLR):c.2242G>A (p.Asp748Asn)	LDLR	Familial hypercholesterolemia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	11233951	19	11123275	183133	181275
NM_000527.4(LDLR):c.2252G>A (p.Arg751Gln)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11233961	19	11123285	161286	171221
NM_000527.4(LDLR):c.2282C>T (p.Thr761Met)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11233991	19	11123315	161262	171222
NM_000527.4(LDLR):c.2320G>A (p.Asp774Asn)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	19	11238692	19	11128016	403663	390630
NM_000527.4(LDLR):c.2343G>T (p.Glu781Asp)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11238715	19	11128039	252290	246576
NM_000527.4(LDLR):c.2375T>C (p.Ile792Thr)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 25, 2016)	criteria provided, conflicting interpretations	19	11238747	19	11128071	252295	246582
NM_000527.4(LDLR):c.2389G>T (p.Val797Leu)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2017)	criteria provided, conflicting interpretations	19	11238761	19	11128085	252298	246585
NM_000527.4(LDLR):c.2389G>A (p.Val797Met)	LDLR	Familial hypercholesterolemia|Familial hypercholesterolemias|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	19	11238761	19	11128085	226393	228206
NM_000527.4(LDLR):c.2396T>G (p.Leu799Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, multiple submitters, no conflicts	19	11240195	19	11129519	252320	246605
NM_000527.4(LDLR):c.2407T>C (p.Cys803Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Nov 5, 2016)	criteria provided, single submitter	19	11240206	19	11129530	403648	390631
NM_000527.4(LDLR):c.2413G>A (p.Gly805Arg)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240212	19	11129536	252328	246613
NM_000527.4(LDLR):c.2441G>A (p.Arg814Gln)	LDLR	Familial hypercholesterolemia|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2017)	criteria provided, conflicting interpretations	19	11240240	19	11129564	161278	171223
NM_000527.4(LDLR):c.2448G>C (p.Lys816Asn)	LDLR	Familial hypercholesterolemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2016)	criteria provided, conflicting interpretations	19	11240247	19	11129571	440698	434349
NM_000527.4(LDLR):c.2473A>G (p.Asn825Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240272	19	11129596	252340	246625
NM_000527.4(LDLR):c.2475C>A (p.Asn825Lys)	LDLR	Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240274	19	11129598	252341	246626
NM_000527.4(LDLR):c.2475C>G (p.Asn825Lys)	LDLR	Familial hypercholesterolemia|Hypercholesterolaemia	Pathogenic/Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240274	19	11129598	161265	171224
NM_000527.4(LDLR):c.2476C>A (p.Pro826Thr)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	19	11240275	19	11129599	252343	246627
NM_000527.4(LDLR):c.2479G>A (p.Val827Ile)	LDLR	Familial hypercholesterolemia|not specified|not provided|Hypercholesterolaemia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2017)	criteria provided, conflicting interpretations	19	11240278	19	11129602	36462	45125
NM_000527.4(LDLR):c.2482T>C (p.Tyr828His)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240281	19	11129605	252345	246630
NM_000527.4(LDLR):c.2483A>C (p.Tyr828Ser)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240282	19	11129606	226395	228207
NM_000527.4(LDLR):c.2483A>G (p.Tyr828Cys)	LDLR	Familial hypercholesterolemia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, multiple submitters, no conflicts	19	11240282	19	11129606	3704	18743
NM_000527.4(LDLR):c.2531G>A (p.Gly844Asp)	LDLR	Familial hypercholesterolemia	Likely pathogenic(Last reviewed: Mar 25, 2016)	criteria provided, single submitter	19	11240330	19	11129654	3734	18773
NM_000527.4(LDLR):c.2579C>T (p.Ala860Val)	LDLR	Familial hypercholesterolemia	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, multiple submitters, no conflicts	19	11241988	19	11131312	374957	361885
NM_006563.4(KLF1):c.954G>C (p.Trp318Cys)	KLF1	BLOOD GROUP--LUTHERAN INHIBITOR	Affects(Last reviewed: Aug 9, 2016)	no assertion criteria provided	19	12995834	19	12885020	253309	247752
NM_001271043.2(NFIX):c.440G>A (p.Gly147Glu)	NFIX	Marshall-Smith syndrome	Pathogenic(Last reviewed: Mar 20, 2017)	criteria provided, single submitter	19	13136223	19	13025409	487523	480574
NM_052876.3(NACC1):c.892C>T (p.Arg298Trp)	NACC1	not provided|Inborn genetic diseases|Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	19	13246913	19	13136099	417784	404685
NM_001127221.1(CACNA1A):c.5035C>T (p.Arg1679Cys)	CACNA1A	Episodic ataxia type 2	Pathogenic(Last reviewed: Feb 11, 2019)	no assertion criteria provided	19	13346463	19	13235649	68434	79325
NM_001127222.1(CACNA1A):c.5015G>C (p.Arg1672Pro)	CACNA1A	Cerebellar ataxia|Intellectual disability|Cerebellar atrophy	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2015)	no assertion criteria provided	19	13346480	19	13235666	375366	362161
NM_001127221.1(CACNA1A):c.4991G>A (p.Arg1664Gln)	CACNA1A	Episodic ataxia type 2|Spinocerebellar ataxia 6|Global developmental delay|not provided|Global developmental delay|Enlarged cisterna magna|Chronic and progressive ataxia|Ataxia _ Neurologic (child onset)|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder|Non-progressive congenital cerebellar ataxia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2019)	criteria provided, conflicting interpretations	19	13346507	19	13235693	68432	79323
NM_001127221.1(CACNA1A):c.4177G>A (p.Val1393Met)	CACNA1A	Episodic ataxia type 2|Spinocerebellar ataxia 6|Migraine|Familial hemiplegic migraine type 1|not provided|Inborn genetic diseases|Epileptic encephalopathy, early infantile, 42	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2018)	criteria provided, conflicting interpretations	19	13372340	19	13261526	195935	193096
NM_001127221.1(CACNA1A):c.4058C>T (p.Pro1353Leu)	CACNA1A	Episodic ataxia type 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	19	13373582	19	13262768	420945	410512
NM_001127221.1(CACNA1A):c.4055G>T (p.Arg1352Leu)	CACNA1A	not provided|CACNA1A-related condition	Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, multiple submitters, no conflicts	19	13373585	19	13262771	450236	446050
NM_001127221.1(CACNA1A):c.3313G>A (p.Gly1105Ser)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	19	13397560	19	13286746	68428	79319
NM_001127221.1(CACNA1A):c.3031C>G (p.Pro1011Ala)	CACNA1A	Episodic ataxia type 2|not specified|not provided|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	19	13409419	19	13298605	128550	133999
NM_001127221.1(CACNA1A):c.2978A>T (p.Glu993Val)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13409472	19	13298658	68427	79318
NM_001127221.1(CACNA1A):c.2754G>C (p.Glu918Asp)	CACNA1A	Episodic ataxia type 2|Familial hemiplegic migraine type 1|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Apr 30, 2017)	criteria provided, multiple submitters, no conflicts	19	13409696	19	13298882	68426	79317
NM_001127221.1(CACNA1A):c.2740C>T (p.Pro914Ser)	CACNA1A	Episodic ataxia type 2|not specified|not provided|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, multiple submitters, no conflicts	19	13409710	19	13298896	128548	133997
NM_001127221.1(CACNA1A):c.2195A>C (p.Glu732Ala)	CACNA1A	Episodic ataxia type 2|not specified|Epileptic encephalopathy, early infantile, 42|History of neurodevelopmental disorder	Benign(Last reviewed: Jan 27, 2018)	criteria provided, multiple submitters, no conflicts	19	13411451	19	13300637	128547	133996
NM_001127221.1(CACNA1A):c.2147A>C (p.Asn716Thr)	CACNA1A	Epileptic encephalopathy, early infantile, 42	Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	19	13414388	19	13303574	488475	481343
NM_001127221.1(CACNA1A):c.904G>A (p.Asp302Asn)	CACNA1A	Episodic ataxia type 2|Spinocerebellar ataxia 6	Likely pathogenic(Last reviewed: Sep 9, 2014)	criteria provided, single submitter	19	13470494	19	13359680	216896	213651
NM_023035.2(CACNA1A):c.835C>T (p.Arg279Cys)	CACNA1A	Episodic ataxia type 2|Gait ataxia|Epileptic encephalopathy	Pathogenic(Last reviewed: Jan 10, 2018)	no assertion criteria provided	19	13470563	19	13359749	545691	536183
NM_001127221.1(CACNA1A):c.689G>T (p.Gly230Val)	CACNA1A	Familial hemiplegic migraine type 1	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	19	13476226	19	13365412	560966	552215
NM_000435.2(NOTCH3):c.3691C>T (p.Arg1231Cys)	NOTCH3	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 26, 2018)	criteria provided, conflicting interpretations	19	15289863	19	15179052	216972	213652
NM_000095.2(COMP):c.1126G>T (p.Asp376Tyr)	COMP	Multiple epiphyseal dysplasia 1|Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome	Likely pathogenic(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	19	18898309	19	18787500	438839	432471
NM_004386.2(NCAN):c.3115G>A (p.Ala1039Thr)	NCAN	Developmental dyslexia	Uncertain significance(Last reviewed: Nov 22, 2016)	no assertion criteria provided	19	19344693	19	19233884	291298	275535
NM_004364.4(CEBPA):c.754G>T (p.Ala252Ser)	CEBPA	Acute myeloid leukemia	Benign(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33792567	19	33301661	21404	34256
NM_004364.4(CEBPA):c.713C>A (p.Ala238Glu)	CEBPA	Acute myeloid leukemia	Benign(Last reviewed: Oct 21, 2010)	no assertion criteria provided	19	33792608	19	33301702	21403	34255
NM_199037.4(SCN1B):c.308A>T (p.Asp103Val)	SCN1B	Cardiomyopathy	Pathogenic	no assertion criteria provided	19	35524503	19	35033599	375404	362162
NM_001037.4(SCN1B):c.363C>G (p.Cys121Trp)	SCN1B	Generalized epilepsy with febrile seizures plus, type 1|Brugada syndrome 5|Generalized epilepsy with febrile seizures plus|Seizures|not provided|Atrial fibrillation, familial, 13	Pathogenic/Likely pathogenic(Last reviewed: Apr 25, 2018)	criteria provided, multiple submitters, no conflicts	19	35524558	19	35033654	9252	24291
NM_001037.4(SCN1B):c.412G>A (p.Val138Ile)	SCN1B	Cardiac conduction defect, nonspecific|Brugada syndrome 5|Long QT syndrome|Generalized epilepsy with febrile seizures plus|Brugada syndrome|not specified|Seizures|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2017)	criteria provided, conflicting interpretations	19	35524607	19	35033703	180508	178737
NM_000540.2(RYR1):c.131G>A (p.Arg44His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2017)	criteria provided, conflicting interpretations	19	38931470	19	38440830	133046	136794
NM_000540.2(RYR1):c.1453A>G (p.Met485Val)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|Malignant hyperthermia|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 20, 2018)	criteria provided, conflicting interpretations	19	38945887	19	38455247	133076	136823
NM_000540.2(RYR1):c.1589G>A (p.Arg530His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, multiple submitters, no conflicts	19	38946103	19	38455463	133101	136848
NM_000540.2(RYR1):c.1598G>A (p.Arg533His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	19	38946112	19	38455472	133103	136850
NM_000540.2(RYR1):c.1840C>T (p.Arg614Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided|Inborn genetic diseases|RYR1-Related Disorders	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	19	38948185	19	38457545	12964	28003
NM_000540.2(RYR1):c.2119G>A (p.Gly707Ser)	RYR1	Multiminicore Disease	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	38948884	19	38458244	161368	171226
NM_000540.2(RYR1):c.2122G>A (p.Asp708Asn)	RYR1	Malignant hyperthermia, susceptibility to, 1|Congenital myopathy|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 17, 2018)	criteria provided, conflicting interpretations	19	38948887	19	38458247	159840	169548
NM_000540.2(RYR1):c.2275A>G (p.Asn759Asp)	RYR1	Malignant hyperthermia, susceptibility to, 1|not specified|not provided|Myopathy, RYR1-associated|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, multiple submitters, no conflicts	19	38949893	19	38459253	161369	171227
NM_000540.2(RYR1):c.2677G>A (p.Gly893Ser)	RYR1	Myopathy, Central Core|Congenital myopathy|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|RYR1-Related Disorders	Likely benign(Last reviewed: Dec 24, 2017)	criteria provided, multiple submitters, no conflicts	19	38954162	19	38463522	161362	171228
NM_000540.2(RYR1):c.2797G>A (p.Ala933Thr)	RYR1	Neuromuscular disease, congenital, with uniform type 1 fiber|not specified|not provided|Malignant hyperthermia and exertional rhabdomyolosis|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2018)	criteria provided, conflicting interpretations	19	38955289	19	38464649	161363	171229
NM_000540.2(RYR1):c.2956C>T (p.Arg986Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|Congenital myopathy|RYR1-Related Disorders	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	19	38956816	19	38466176	161367	171230
NM_000540.2(RYR1):c.3127C>T (p.Arg1043Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Oct 21, 2016)	criteria provided, multiple submitters, no conflicts	19	38956987	19	38466347	133124	136871
NM_000540.2(RYR1):c.3800C>G (p.Pro1267Arg)	RYR1	Multiminicore Disease|not provided	Uncertain significance(Last reviewed: Sep 1, 2015)	criteria provided, single submitter	19	38964051	19	38473411	161370	171231
NM_000540.2(RYR1):c.4055C>G (p.Ala1352Gly)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not specified|not provided|RYR1-Related Disorders	Benign/Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	38964306	19	38473666	159846	169554
NM_000540.2(RYR1):c.4178A>G (p.Lys1393Arg)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2018)	criteria provided, conflicting interpretations	19	38965975	19	38475335	93269	99176
NM_000540.2(RYR1):c.4400A>G (p.Lys1467Arg)	RYR1	Malignant hyperthermia equivocal with halotane	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	38968456	19	38477816	161371	171232
NM_000540.2(RYR1):c.4405C>T (p.Arg1469Trp)	RYR1	Congenital myopathy|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2018)	criteria provided, conflicting interpretations	19	38968461	19	38477821	161372	171233
NM_000540.2(RYR1):c.4424T>C (p.Met1475Thr)	RYR1	Malignant hyperthermia	Uncertain significance(Last reviewed: Mar 11, 2015)	criteria provided, single submitter	19	38968480	19	38477840	226046	227850
NM_000540.2(RYR1):c.4711A>G (p.Ile1571Val)	RYR1	Malignant hyperthermia, susceptibility to, 1|not specified|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	38973933	19	38483293	159851	169559
NM_000540.2(RYR1):c.5036G>A (p.Arg1679His)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|Malignant hyperthermia|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	19	38976331	19	38485691	161364	171234
NM_000540.2(RYR1):c.5120G>A (p.Arg1707His)	RYR1	not provided|Myopathy, RYR1-associated	Uncertain significance(Last reviewed: Sep 2, 2016)	criteria provided, multiple submitters, no conflicts	19	38976415	19	38485775	161373	171235
NM_000540.2(RYR1):c.5183C>T (p.Ser1728Phe)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 8, 2018)	criteria provided, multiple submitters, no conflicts	19	38976478	19	38485838	133144	136891
NM_000540.2(RYR1):c.6478G>A (p.Gly2160Ser)	RYR1	not specified|Malignant hyperthermia and exertional rhabdomyolosis|RYR1-Related Disorder	Uncertain significance(Last reviewed: Jan 30, 2017)	criteria provided, single submitter	19	38985195	19	38494555	161374	171236
NM_000540.2(RYR1):c.6617C>T (p.Thr2206Met)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|Ptosis|not provided|Sacral agenesis|History of neonatal hypotonia|RYR1-Related Disorders	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	19	38986923	19	38496283	12977	28016
NM_000540.2(RYR1):c.6640G>A (p.Val2214Ile)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jun 5, 2017)	criteria provided, multiple submitters, no conflicts	19	38986946	19	38496306	133168	136915
NM_000540.2(RYR1):c.6961A>G (p.Ile2321Val)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	19	38989817	19	38499177	133173	136920
NM_000540.2(RYR1):c.7025A>G (p.Asn2342Ser)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	19	38989881	19	38499241	133175	136922
NM_000540.2(RYR1):c.7048G>A (p.Ala2350Thr)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Pathogenic(Last reviewed: Aug 29, 2016)	criteria provided, single submitter	19	38990295	19	38499655	133182	136929
NM_000540.2(RYR1):c.7099G>A (p.Ala2367Thr)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Likely pathogenic(Last reviewed: Nov 21, 2013)	criteria provided, single submitter	19	38990346	19	38499706	133187	136934
NM_000540.2(RYR1):c.7210G>A (p.Glu2404Lys)	RYR1	Malignant hyperthermia, susceptibility to, 1	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	38990457	19	38499817	161379	171237
NM_000540.2(RYR1):c.7291G>A (p.Asp2431Asn)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Uncertain significance(Last reviewed: Jul 30, 2016)	criteria provided, single submitter	19	38990624	19	38499984	133194	136941
NM_000540.2(RYR1):c.7300G>A (p.Gly2434Arg)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided|RYR1-Related Disorders	Pathogenic(Last reviewed: Jun 2, 2018)	criteria provided, multiple submitters, no conflicts	19	38990633	19	38499993	12970	28009
NM_000540.2(RYR1):c.7360C>T (p.Arg2454Cys)	RYR1	Myopathy, Central Core|Malignant hyperthermia susceptibility|not provided|RYR1-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	19	38991282	19	38500642	133202	136949
NM_000540.2(RYR1):c.7372C>T (p.Arg2458Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Jan 17, 2017)	criteria provided, multiple submitters, no conflicts	19	38991294	19	38500654	12971	28010
NM_000540.2(RYR1):c.9356G>A (p.Arg3119His)	RYR1	Myopathy, Central Core|not specified|not provided	Uncertain significance(Last reviewed: Jul 22, 2017)	criteria provided, multiple submitters, no conflicts	19	39003007	19	38512367	133241	136986
NM_000540.2(RYR1):c.9713A>G (p.Glu3238Gly)	RYR1	Myopathy, Central Core|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|not specified|not provided|Axial myopathy, late-onset|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 16, 2017)	criteria provided, conflicting interpretations	19	39008026	19	38517386	161365	171238
NM_000540.2(RYR1):c.9758T>C (p.Ile3253Thr)	RYR1	Congenital myopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 15, 2017)	criteria provided, conflicting interpretations	19	39008071	19	38517431	159865	169570
NM_000540.2(RYR1):c.10097G>A (p.Arg3366His)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|Multiminicore/minicore/multicore disease|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	39009932	19	38519292	132990	136739
NM_000540.2(RYR1):c.10616G>A (p.Arg3539His)	RYR1	Myopathy, Central Core|Malignant hyperthermia, susceptibility to, 1|not specified|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2018)	criteria provided, conflicting interpretations	19	39016132	19	38525492	132997	136745
NM_000540.2(RYR1):c.10621G>A (p.Ala3541Thr)	RYR1	Axial myopathy, late-onset	Uncertain significance(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	39016137	19	38525497	161375	171239
NM_000540.2(RYR1):c.11518G>A (p.Val3840Ile)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Feb 2, 2017)	criteria provided, single submitter	19	39026638	19	38535998	133013	136761
NM_000540.2(RYR1):c.11557G>A (p.Glu3853Lys)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|Muscular dystrophy and arthrogryposis	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, multiple submitters, no conflicts	19	39026677	19	38536037	161376	171240
NM_000540.2(RYR1):c.11798A>G (p.Tyr3933Cys)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided|RYR1-Related Disorders	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	19	39034191	19	38543551	133021	136769
NM_000540.2(RYR1):c.12121C>T (p.Arg4041Trp)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Uncertain significance(Last reviewed: Apr 15, 2015)	criteria provided, single submitter	19	39038899	19	38548259	133032	136780
NM_000540.2(RYR1):c.13505A>G (p.Glu4502Gly)	RYR1	Myopathy, Central Core|Congenital myopathy|Neuromuscular disease, congenital, with uniform type 1 fiber|Malignant hyperthermia susceptibility|Multiminicore Disease|Malignant hypothermia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	19	39057618	19	38566978	161366	171242
NM_000540.2(RYR1):c.13513G>C (p.Asp4505His)	RYR1	Malignant hyperthermia, susceptibility to, 1|Congenital muscular dystrophy|Malignant hyperthermia susceptibility|not specified|Generalized muscle weakness|not provided|Congenital hip dislocation|Malignant hyperthermia|EMG: myopathic abnormalities|Congenital muscular dystrophy|Myopathy, progressive axial with cataracts|Dysplasia of acetabulum|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2018)	criteria provided, conflicting interpretations	19	39057626	19	38566986	93252	99159
NM_000540.2(RYR1):c.13673G>A (p.Arg4558Gln)	RYR1	Myopathy, Central Core|not provided|RYR1-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2018)	criteria provided, conflicting interpretations	19	39061260	19	38570620	65984	76892
NM_000540.2(RYR1):c.13760C>T (p.Pro4587Leu)	RYR1	Malignant hyperthermia, susceptibility to, 1|not provided	Uncertain significance(Last reviewed: Apr 23, 2015)	criteria provided, single submitter	19	39062672	19	38572032	161377	171243
NM_000540.2(RYR1):c.14468C>T (p.Thr4823Met)	RYR1	Congenital myopathy|not provided	Uncertain significance(Last reviewed: Oct 20, 2017)	criteria provided, single submitter	19	39070725	19	38580085	161378	171244
NM_000540.2(RYR1):c.14524G>A	RYR1	not provided|Myopathy, congenital with cores|RYR1-Related Disorders|Skeletal muscle disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 5, 2018)	criteria provided, conflicting interpretations	19	39071022	19	38580382	133075	38832
NM_000540.2(RYR1):c.14717C>T (p.Ala4906Val)	RYR1	Myopathy, Central Core|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2014)	no assertion criteria provided	19	39075653	19	38585013	65926	76834
NM_000540.2(RYR1):c.14918C>T (p.Pro4973Leu)	RYR1	Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility|not provided|RYR1-Related Disorders	Likely pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	19	39076780	19	38586140	133098	136845
NM_004924.5(ACTN4):c.719T>C (p.Met240Thr)	ACTN4	Focal segmental glomerulosclerosis 1	Uncertain significance	no assertion criteria provided	19	39200102	19	38709462	427769	417658
NM_152296.3(ATP1A3):c.2767G>A (p.Asp923Asn)	ATP1A3	Dystonia 12|Alternating hemiplegia of childhood 2	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, multiple submitters, no conflicts	19	42472989	19	41968837	12915	27954
NM_152296.5(ATP1A3):c.2401G>A (p.Asp801Asn)	ATP1A3	Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss|Dystonia 12|Alternating hemiplegia of childhood 2|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	19	42474557	19	41970405	37107	45777
NM_152296.4(ATP1A3):c.2267G>A (p.Arg756His)	ATP1A3	Dystonia 12|Alternating hemiplegia of childhood 2|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Sep 8, 2017)	criteria provided, multiple submitters, no conflicts	19	42474691	19	41970539	161134	170985
NM_152296.4(ATP1A3):c.974G>A (p.Gly325Asp)	ATP1A3	Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss	Likely pathogenic(Last reviewed: Jun 10, 2014)	criteria provided, single submitter	19	42489089	19	41984937	216891	213654
NM_001256214.1(ATP1A3):c.424G>A (p.Val142Met)	ATP1A3	Juvenile onset psychosis	Pathogenic(Last reviewed: Apr 11, 2016)	criteria provided, single submitter	19	42490354	19	41986202	267411	262636
NM_001039213.4(CEACAM16):c.1186A>G (p.Thr396Ala)	CEACAM16	Nonsyndromic hearing loss and deafness	Likely pathogenic(Last reviewed: Jul 6, 2016)	criteria provided, single submitter	19	45211378	19	44708106	228513	231041
NM_000041.3(APOE):c.[388T>C;478C>T]	APOE	Familial type 3 hyperlipoproteinemia	Pathogenic(Last reviewed: Feb 14, 2017)	no assertion criteria provided	19|19	45411941	19|19	44908684	440870	32903|38488
NM_025136.3(OPA3):c.313C>G (p.Gln105Glu)	OPA3	Optic atrophy and cataract, autosomal dominant	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	19	46056999	19	45553741	4241	19280
NM_025136.3(OPA3):c.277G>A (p.Gly93Ser)	OPA3	Optic atrophy and cataract, autosomal dominant	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	19	46057035	19	45553777	4240	19279
NM_175875.4(SIX5):c.1261G>A (p.Val421Ile)	SIX5	Branchiootorenal syndrome 2	Uncertain significance	criteria provided, single submitter	19	46269956	19	45766698	224344	226091
NM_000554.5(CRX):c.124G>A (p.Glu42Lys)	CRX	Leber congenital amaurosis 7	Likely pathogenic(Last reviewed: May 21, 2013)	criteria provided, single submitter	19	48339523	19	47836266	216914	213655
NM_017636.3(TRPM4):c.739A>T (p.Asn247Tyr)	TRPM4	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	19	49671936	19	49168679	427974	419291
NM_017636.3(TRPM4):c.1603G>A (p.Glu535Lys)	TRPM4	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	19	49686174	19	49182917	427975	419292
NM_001077186.1(MYH14):c.2822G>T (p.Arg941Leu)	MYH14	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	Pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	19	50771512	19	50268255	30739	39696
NM_001256849.1(POLD1):c.17G>A (p.Arg6Gln)	POLD1	Colorectal cancer 10|Hereditary cancer-predisposing syndrome|Colorectal cancer	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	19	50902125	19	50398868	226047	227854
NM_001256849.1(POLD1):c.208G>T (p.Val70Phe)	POLD1	Familial colorectal cancer|Colorectal cancer 10|Carcinoma of colon|not specified|not provided|Hereditary cancer-predisposing syndrome	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, multiple submitters, no conflicts	19	50902633	19	50399376	225288	227197
NM_002691.3(POLD1):c.433G>A (p.Ala145Thr)	POLD1	Colorectal cancer 10|not specified|not provided|Hereditary cancer-predisposing syndrome|Colon cancer	Benign/Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, multiple submitters, no conflicts	19	50905151	19	50401894	221138	222826
NM_002691.3(POLD1):c.589A>C (p.Ser197Arg)	POLD1	Familial colorectal cancer|Colorectal cancer 10	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	19	50905381	19	50402124	537130	533272
NM_001256849.1(POLD1):c.3035G>A (p.Cys1012Tyr)	POLD1	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	19	50919948	19	50416691	375857	362745
NM_001256849.1(POLD1):c.3041G>A (p.Gly1014Asp)	POLD1	Colorectal cancer	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	19	50919954	19	50416697	375858	362746
NM_014225.5(PPP2R1A):c.544C>T (p.Arg182Trp)	PPP2R1A	not provided|Mental retardation, autosomal dominant 36	Pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, multiple submitters, no conflicts	19	52715979	19	52212726	190312	188141
NM_000363.4(TNNI3):c.611G>A (p.Arg204His)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	19	55663224	19	55151856	177679	176208
NM_000363.4(TNNI3):c.586G>A (p.Asp196Asn)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	19	55663249	19	55151881	12422	27461
NM_000363.4(TNNI3):c.575G>A (p.Arg192His)	TNNI3	Familial restrictive cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 11, 2018)	criteria provided, multiple submitters, no conflicts	19	55663260	19	55151892	12424	27463
NM_000363.4(TNNI3):c.568G>T (p.Asp190Tyr)	TNNI3	Primary familial hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	19	55663267	19	55151899	165511	176212
NM_000363.4(TNNI3):c.557G>A (p.Arg186Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2018)	criteria provided, multiple submitters, no conflicts	19	55663278	19	55151910	43395	52565
NM_000363.4(TNNI3):c.550G>A (p.Glu184Lys)	TNNI3	Primary dilated cardiomyopathy	Likely pathogenic(Last reviewed: Sep 6, 2013)	no assertion criteria provided	19	55663285	19	55151917	43394	52564
NM_000363.4(TNNI3):c.544G>A (p.Glu182Lys)	TNNI3	Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy	Pathogenic(Last reviewed: Sep 10, 2014)	criteria provided, multiple submitters, no conflicts	19	55665403	19	55154035	43392	52562
NM_000363.4(TNNI3):c.508C>T (p.Arg170Trp)	TNNI3	Cardiomyopathy, restrictive|Familial restrictive cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	19	55665439	19	55154071	179285	176073
NM_000363.4(TNNI3):c.508C>G (p.Arg170Gly)	TNNI3	Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 1FF|Familial hypertrophic cardiomyopathy 7|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2013)	criteria provided, conflicting interpretations	19	55665439	19	55154071	165517	176215
NM_000363.4(TNNI3):c.485G>C (p.Arg162Pro)	TNNI3	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, multiple submitters, no conflicts	19	55665462	19	55154094	43390	52560
NM_000363.4(TNNI3):c.485G>A (p.Arg162Gln)	TNNI3	Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 1FF|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Jan 16, 2018)	criteria provided, multiple submitters, no conflicts	19	55665462	19	55154094	43389	52559
NM_000363.4(TNNI3):c.484C>T (p.Arg162Trp)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2018)	criteria provided, conflicting interpretations	19	55665463	19	55154095	161396	171245
NM_000363.4(TNNI3):c.470C>T (p.Ala157Val)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: May 14, 2018)	criteria provided, multiple submitters, no conflicts	19	55665477	19	55154109	43388	52558
NM_000363.4(TNNI3):c.434G>A (p.Arg145Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic/Likely pathogenic(Last reviewed: Nov 13, 2017)	criteria provided, multiple submitters, no conflicts	19	55665513	19	55154145	43384	52554
NM_000363.4(TNNI3):c.433C>T (p.Arg145Trp)	TNNI3	Familial restrictive cardiomyopathy 1|Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 12, 2017)	criteria provided, multiple submitters, no conflicts	19	55665514	19	55154146	12426	27465
NM_000363.4(TNNI3):c.433C>G (p.Arg145Gly)	TNNI3	Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	19	55665514	19	55154146	12419	27458
NM_000363.4(TNNI3):c.422G>A (p.Arg141Gln)	TNNI3	Primary familial hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	19	55665525	19	55154157	43381	52551
NM_000363.4(TNNI3):c.298C>T (p.Leu100Phe)	TNNI3	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	19	55666183	19	55154815	427955	419293
NM_198994.2(TGM6):c.172A>G (p.Met58Val)	TGM6	Spinocerebellar ataxia 35|not specified|Spinocerebellar Ataxia, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	20	2375262	20	2394616	130585	136031
NM_006392.3(NOP56):c.361A>G (p.Ile121Val)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2635212	20	2654566	129810	135256
NM_006392.3(NOP56):c.1424T>C (p.Met475Thr)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2638579	20	2657933	129808	135254
NM_006392.3(NOP56):c.1727T>C (p.Val576Ala)	NOP56	not specified	Likely benign	no assertion criteria provided	20	2638882	20	2658236	129809	135255
NM_144773.3(PROKR2):c.97T>C (p.Tyr33His)	PROKR2	Kallmann syndrome 3	Likely pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, single submitter	20	5294919	20	5314273	267202	262052
NM_018327.3(SPTLC3):c.448T>C (p.Trp150Arg)	SPTLC3	Peripheral neuropathy|Sensory neuropathy|Peripheral neuropathy	Likely pathogenic(Last reviewed: Aug 18, 2015)	criteria provided, single submitter	20	13053048	20	13072400	243088	244165
NM_033118.3(MYLK2):c.1189A>G (p.Met397Val)	MYLK2	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Feb 9, 2017)	criteria provided, single submitter	20	30414706	20	31826903	427952	419294
NM_003098.2(SNTA1):c.368C>G (p.Ala123Gly)	SNTA1	Long QT syndrome 2	Likely benign(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	20	32026775	20	33438969	427980	419295
NM_012156.2(EPB41L1):c.1844G>C (p.Ser615Thr)	EPB41L1	Mental retardation, autosomal dominant 11	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	20	34797585	20	36209663	561007	552223
NM_012156.2(EPB41L1):c.2060C>T (p.Pro687Leu)	EPB41L1	not specified	Likely benign	no assertion criteria provided	20	34797801	20	36209879	128999	134445
NM_000457.4(HNF4A):c.416C>T (p.Thr139Ile)	HNF4A	Maturity onset diabetes mellitus in young|not specified|Hyperinsulinism, Dominant|Monogenic diabetes	Benign/Likely benign(Last reviewed: Mar 31, 2017)	criteria provided, multiple submitters, no conflicts	20	43042364	20	44413724	129240	134686
NM_000457.4(HNF4A):c.505G>A (p.Val169Ile)	HNF4A	Maturity-onset diabetes of the young,  type 1|Diabetes mellitus type 2|Maturity onset diabetes mellitus in young|not specified|not provided|Hyperinsulinism, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2016)	criteria provided, conflicting interpretations	20	43043159	20	44414519	36353	45017
NM_000457.4(HNF4A):c.991C>T (p.Arg331Cys)	HNF4A	Maturity-onset diabetes of the young,  type 1|not specified|Hyperinsulinemia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2016)	criteria provided, conflicting interpretations	20	43052756	20	44424116	36364	45028
NM_000457.4(HNF4A):c.1333C>T (p.Pro445Ser)	HNF4A	not provided	Uncertain significance(Last reviewed: Jul 23, 2013)	criteria provided, single submitter	20	43058213	20	44429573	129237	134683
NM_000457.4(HNF4A):c.1387A>G (p.Ile463Val)	HNF4A	Maturity-onset diabetes of the young,  type 1|not specified|not provided	Uncertain significance(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	20	43058267	20	44429627	36345	45009
NM_001719.2(BMP7):c.900C>G (p.Ser300Arg)	BMP7	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	20	55758836	20	57183780	224336	226092
NM_001719.2(BMP7):c.752C>T (p.Thr251Met)	BMP7	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	20	55777539	20	57202483	224335	226093
NM_001719.2(BMP7):c.334A>G (p.Ser112Gly)	BMP7	Congenital anomalies of kidney and urinary tract	Uncertain significance	criteria provided, single submitter	20	55840845	20	57265789	224337	226094
NM_000744.6(CHRNA4):c.1525G>A (p.Ala509Thr)	CHRNA4	not specified|Seizures|not provided|Inborn genetic diseases	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, multiple submitters, no conflicts	20	61981238	20	63349886	128746	134195
NM_172107.3(KCNQ2):c.2613G>T (p.Arg871Ser)	KCNQ2	Early infantile epileptic encephalopathy 7|not specified|Early infantile epileptic encephalopathy	Likely benign(Last reviewed: Oct 12, 2017)	criteria provided, multiple submitters, no conflicts	20	62038003	20	63406650	129343	134789
NM_172107.3(KCNQ2):c.2339A>C (p.Asn780Thr)	KCNQ2	Benign familial neonatal seizures 1|not specified|Seizures|KCNQ2-Related Disorders	Benign(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	20	62038277	20	63406924	21779	34631
NM_172107.3(KCNQ2):c.2281G>A (p.Ala761Thr)	KCNQ2	not provided	Uncertain significance(Last reviewed: Aug 8, 2013)	criteria provided, single submitter	20	62038335	20	63406982	129334	134780
NM_172107.3(KCNQ2):c.2264A>G (p.Tyr755Cys)	KCNQ2	not specified|Seizures|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	20	62038352	20	63406999	129333	134779
NM_172107.3(KCNQ2):c.1622G>C (p.Arg541Thr)	KCNQ2	Benign familial neonatal seizures 1	Likely pathogenic(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	20	62045450	20	63414097	488537	481405
NM_172107.3(KCNQ2):c.1545G>C (p.Glu515Asp)	KCNQ2	Benign familial neonatal seizures 1|not specified|Seizures|KCNQ2-Related Disorders|Early infantile epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2017)	criteria provided, conflicting interpretations	20	62045527	20	63414174	21764	34616
NM_172107.3(KCNQ2):c.1348G>A (p.Val450Met)	KCNQ2	not specified|Seizures|KCNQ2-Related Disorders|Early infantile epileptic encephalopathy	Benign/Likely benign(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	20	62046433	20	63415080	129332	134778
NM_172107.3(KCNQ2):c.901G>A (p.Gly301Ser)	KCNQ2	Early infantile epileptic encephalopathy 7|Epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	20	62070977	20	63439624	369770	354006
NM_172107.3(KCNQ2):c.841G>C (p.Gly281Arg)	KCNQ2	Early infantile epileptic encephalopathy 7	Likely pathogenic(Last reviewed: Nov 8, 2017)	criteria provided, single submitter	20	62071037	20	63439684	488538	481406
NM_172107.3(KCNQ2):c.841G>T (p.Gly281Trp)	KCNQ2	Early infantile epileptic encephalopathy 7|not provided	Pathogenic(Last reviewed: Oct 3, 2017)	criteria provided, multiple submitters, no conflicts	20	62071037	20	63439684	216949	213659
NM_172107.3(KCNQ2):c.638G>A (p.Arg213Gln)	KCNQ2	Early infantile epileptic encephalopathy 7|not provided|Early infantile epileptic encephalopathy	Pathogenic/Likely pathogenic(Last reviewed: May 2, 2018)	criteria provided, multiple submitters, no conflicts	20	62076064	20	63444711	39760	48359
NM_172107.3(KCNQ2):c.601C>T (p.Arg201Cys)	KCNQ2	Benign familial neonatal seizures 1|Early infantile epileptic encephalopathy 7|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	20	62076101	20	63444748	205869	203792
NM_001958.3(EEF1A2):c.796C>T (p.Arg266Trp)	EEF1A2	not provided|Inborn genetic diseases|Epileptic encephalopathy, early infantile, 33	Pathogenic(Last reviewed: Oct 18, 2017)	criteria provided, multiple submitters, no conflicts	20	62122065	20	63490712	449242	446299
NM_001958.3(EEF1A2):c.208G>A (p.Gly70Ser)	EEF1A2	not provided|Intellectual disability|Inborn genetic diseases|Epileptic encephalopathy, early infantile, 33	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	20	62127325	20	63495972	100782	106647
NM_172201.1(KCNE2):c.40G>A (p.Val14Ile)	KCNE2	Long QT syndrome 6|Long QT syndrome|not specified|not provided	Likely benign(Last reviewed: Nov 28, 2017)	criteria provided, multiple submitters, no conflicts	21	35742817	21	34370518	67621	78517
NM_172201.1(KCNE2):c.80G>A (p.Arg27His)	KCNE2	Long QT syndrome 6|Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	21	35742857	21	34370558	67623	78519
NM_172201.1(KCNE2):c.161T>C (p.Met54Thr)	KCNE2	Cardiac arrhythmia|Long QT syndrome 6|not provided|Congenital long QT syndrome|KCNE2-Related Disorders	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Mar 17, 2018)	criteria provided, conflicting interpretations	21	35742938	21	34370639	6053	21092
NM_172201.1(KCNE2):c.170T>C (p.Ile57Thr)	KCNE2	Cardiac arrhythmia|Long QT syndrome 6|not specified|not provided|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2018)	criteria provided, conflicting interpretations	21	35742947	21	34370648	6054	21093
NM_172201.1(KCNE2):c.229C>T (p.Arg77Trp)	KCNE2	Long QT syndrome|not specified|Congenital long QT syndrome	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	21	35743006	21	34370707	67614	78510
NM_172201.1(KCNE2):c.230G>A (p.Arg77Gln)	KCNE2	Long QT syndrome|Congenital long QT syndrome	Uncertain significance(Last reviewed: Jun 1, 2014)	criteria provided, single submitter	21	35743007	21	34370708	67616	78512
NM_172201.1(KCNE2):c.285G>T (p.Lys95Asn)	KCNE2	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	21	35743062	21	34370763	427978	419296
NM_000219.5(KCNE1):c.374C>T (p.Thr125Met)	KCNE1	Long QT syndrome|Romano-Ward syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	21	35821559	21	34449261	132679	136427
NM_000219.5(KCNE1):c.325G>A (p.Val109Ile)	KCNE1	Long QT syndrome 5|Long QT syndrome|not specified|not provided	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, multiple submitters, no conflicts	21	35821608	21	34449310	132678	136426
NM_000219.5(KCNE1):c.273C>G (p.Asp91Glu)	KCNE1	Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Apr 30, 2017)	criteria provided, single submitter	21	35821660	21	34449362	427969	419297
NM_000219.5(KCNE1):c.226G>A (p.Asp76Asn)	KCNE1	Jervell and Lange-Nielsen syndrome 2|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 5|Arrhythmogenic right ventricular cardiomyopathy|Long QT syndrome|Romano-Ward syndrome|Brugada syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype|Sudden unexplained death|Jervell and Lange-Nielsen syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2018)	criteria provided, conflicting interpretations	21	35821707	21	34449409	13477	28516
NM_000219.5(KCNE1):c.200G>A (p.Arg67His)	KCNE1	Long QT syndrome|not specified|not provided|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2018)	criteria provided, conflicting interpretations	21	35821733	21	34449435	132661	136409
NM_000219.5(KCNE1):c.29C>T (p.Thr10Met)	KCNE1	Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Apr 5, 2018)	criteria provided, conflicting interpretations	21	35821904	21	34449606	132677	136425
NM_000219.5(KCNE1):c.23C>T (p.Ala8Val)	KCNE1	Long QT syndrome 5|Long QT syndrome|not specified|Congenital long QT syndrome|Cardiovascular phenotype	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, multiple submitters, no conflicts	21	35821910	21	34449612	132670	136418
NM_001396.3(DYRK1A):c.563A>T (p.Lys188Ile)	DYRK1A	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Sep 15, 2014)	criteria provided, single submitter	21	38858815	21	37486513	204009	200403
NM_001396.3(DYRK1A):c.734T>G (p.Leu245Arg)	DYRK1A	Mental retardation, autosomal dominant 7	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	21	38862546	21	37490244	204010	200404
NM_001396.3(DYRK1A):c.883C>T (p.Leu295Phe)	DYRK1A	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2016)	criteria provided, multiple submitters, no conflicts	21	38862695	21	37490393	204011	200405
NM_001396.4(DYRK1A):c.1037C>T (p.Ser346Phe)	DYRK1A	Mental retardation, autosomal dominant 7	Likely pathogenic(Last reviewed: Oct 19, 2016)	criteria provided, single submitter	21	38865404	21	37493102	505359	497342
NM_001396.3(DYRK1A):c.1400G>A (p.Arg467Gln)	DYRK1A	Mental retardation, autosomal dominant 7|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 19, 2016)	criteria provided, multiple submitters, no conflicts	21	38877746	21	37505443	209150	205795
NM_002240.4(KCNJ6):c.512T>G (p.Leu171Arg)	KCNJ6	Keppen-Lubinsky syndrome	Likely pathogenic	criteria provided, single submitter	21	39086948	21	37714645	431712	425231
NM_000383.3(AIRE):c.682G>T (p.Gly228Trp)	AIRE	Autoimmune polyglandular syndrome type 1, autosomal dominant	Pathogenic(Last reviewed: Feb 28, 2017)	no assertion criteria provided	21	45709569	21	44289686	3313	18352
NM_001848.2(COL6A1):c.850G>A (p.Gly284Arg)	COL6A1	Bethlem myopathy 1|Ullrich congenital muscular dystrophy 1|not provided|Ullrich congenital muscular dystrophy 1, autosomal dominant	Pathogenic(Last reviewed: Apr 13, 2018)	criteria provided, multiple submitters, no conflicts	21	47409043	21	45989129	17180	32219
NM_001849.3(COL6A2):c.2096G>A (p.Gly699Asp)	COL6A2	Bethlem myopathy 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 28, 2017)	criteria provided, conflicting interpretations	21	47545825	21	46125911	216911	213661
NM_080647.1(TBX1):c.385G>A (p.Glu129Lys)	TBX1	DiGeorge sequence|Tetralogy of Fallot	Conflicting interpretations of pathogenicity(Last reviewed: Jul 5, 2018)	criteria provided, conflicting interpretations	22	19748778	22	19761255	488618	481486
NM_006767.3(LZTR1):c.1739T>C (p.Leu580Pro)	LZTR1	Noonan syndrome 10	Uncertain significance	no assertion criteria provided	22	21348970	22	20994681	559507	550231
NM_006767.3(LZTR1):c.1904C>T (p.Pro635Leu)	LZTR1	Noonan syndrome 10	Likely pathogenic(Last reviewed: Apr 26, 2017)	no assertion criteria provided	22	21349277	22	20994988	433552	427124
NM_003073.4(SMARCB1):c.110G>A (p.Arg37His)	SMARCB1	Mental retardation, autosomal dominant 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2018)	criteria provided, conflicting interpretations	22	24133959	22	23791772	88893	94452
NM_003073.4(SMARCB1):c.1089G>T (p.Lys363Asn)	SMARCB1	Mental retardation, autosomal dominant 15	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	24175861	22	23833674	561114	552228
NM_014941.3(MORC2):c.1034G>T (p.Cys345Phe)	MORC2	Charcot-Marie-Tooth disease, axonal, type 2z	Uncertain significance(Last reviewed: Mar 20, 2018)	no assertion criteria provided	22	31333951	22	30937964	545019	535283
NM_001135774.1(SYN3):c.1441_1442delCCinsTT (p.Pro481Leu)	SYN3	Global developmental delay|Seizures|Visual impairment|Global developmental delay|Generalized hypotonia|Cerebellar vermis atrophy	Pathogenic	no assertion criteria provided	22	32914195 - 32914196	22	32518208 - 32518209	375384	362165
NM_002473.5(MYH9):c.4546G>T (p.Val1516Leu)	MYH9	Nonsyndromic hearing loss and deafness	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	22	36685142	22	36289096	164432	176262
NM_006941.3(SOX10):c.424T>C (p.Trp142Arg)	POLR2F|SOX10	Waardenburg syndrome	Likely pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	22	38379368	22	37983361	505653	497803
NM_006941.3(SOX10):c.415G>T (p.Gly139Cys)	POLR2F|SOX10	Waardenburg syndrome type 2E	Uncertain significance(Last reviewed: May 15, 2018)	no assertion criteria provided	22	38379377	22	37983370	545013	535277
NM_006941.3(SOX10):c.403A>C (p.Ser135Arg)	POLR2F|SOX10	Waardenburg syndrome type 2A	Likely pathogenic(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	22	38379389	22	37983382	488043	481058
NM_006941.3(SOX10):c.401T>C (p.Leu134Pro)	POLR2F|SOX10	Waardenburg syndrome	Likely pathogenic(Last reviewed: Mar 4, 2016)	criteria provided, single submitter	22	38379391	22	37983384	228291	231229
NM_006941.3(SOX10):c.316C>G (p.Arg106Gly)	POLR2F|SOX10	Waardenburg syndrome type 2E	Likely pathogenic(Last reviewed: Dec 30, 2014)	no assertion criteria provided	22	38379476	22	37983469	374266	361237
NM_001429.3(EP300):c.586A>G (p.Ile196Val)	EP300	Rubinstein-Taybi syndrome 1|Rubinstein-Taybi syndrome 2	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	22	41513682	22	41117678	158567	169822
NM_001429.3(EP300):c.631G>A (p.Gly211Ser)	EP300	Rubinstein-Taybi syndrome 1|Carcinoma of colon|Rubinstein-Taybi syndrome 2|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	22	41513727	22	41117723	134043	137782
NM_001429.3(EP300):c.2756G>A (p.Ser919Asn)	EP300	not specified	Likely benign(Last reviewed: May 19, 2014)	criteria provided, single submitter	22	41546141	22	41150137	158560	169828
NM_001429.3(EP300):c.2989A>G (p.Ile997Val)	EP300	Rubinstein-Taybi syndrome 1|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41548008	22	41152004	93736	99639
NM_001429.3(EP300):c.3665C>A (p.Pro1222His)	EP300	Rubinstein-Taybi syndrome 2	Uncertain significance(Last reviewed: Mar 4, 2013)	criteria provided, single submitter	22	41556720	22	41160716	158564	169832
NM_001429.3(EP300):c.3750C>G (p.Cys1250Trp)	EP300	Rubinstein-Taybi syndrome 2	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	41560078	22	41164074	561006	552232
NM_001429.3(EP300):c.6001C>T (p.Pro2001Ser)	EP300	Rubinstein-Taybi syndrome 2	Likely pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	22	41573716	22	41177712	438594	432225
NM_001429.3(EP300):c.6481A>G (p.Met2161Val)	EP300	Rubinstein-Taybi syndrome 1|not specified	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	41574196	22	41178192	134049	137788
NM_001167574.1(UPK3A):c.202G>A (p.Asp68Asn)	UPK3A	Renal adysplasia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	22	45681971	22	45286090	224348	226095
NM_033517.1(SHANK3):c.1030G>T (p.Val344Leu)	SHANK3	22q13.3 deletion syndrome	Likely pathogenic	no assertion criteria provided	22	51123079	22	50684651	375622	362436
NM_000216.3(ANOS1):c.2015A>G (p.His672Arg)	ANOS1	Kallmann syndrome 1|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2016)	criteria provided, conflicting interpretations	X	8501064	X	8533023	224350	226096
NM_000216.3(ANOS1):c.404C>T (p.Pro135Leu)	ANOS1	Kallmann syndrome 1	Uncertain significance	criteria provided, single submitter	X	8565212	X	8597171	224351	226097
NM_000109.3(DMD):c.9658T>C (p.Phe3220Leu)	DMD	Primary dilated cardiomyopathy|Becker muscular dystrophy|Duchenne muscular dystrophy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Nov 20, 2017)	criteria provided, multiple submitters, no conflicts	X	31222203	X	31204086	94856	100756
NM_000109.3(DMD):c.7547G>A (p.Arg2516His)	DMD	Duchenne muscular dystrophy|Muscular dystrophy|not specified|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	X	31747837	X	31729720	161219	171246
NM_000109.3(DMD):c.4425G>A (p.Met1475Ile)	DMD	Primary dilated cardiomyopathy	Uncertain significance(Last reviewed: Aug 1, 2016)	no assertion criteria provided	X	32407687	X	32389570	375863	362747
NM_001356.4(DDX3X):c.1703C>T (p.Pro568Leu)	DDX3X	Inborn genetic diseases|Mental retardation, X-linked 102	Pathogenic(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	X	41206199	X	41346946	375367	362169
NM_003688.3(CASK):c.1465C>T (p.Arg489Trp)	CASK	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	X	41437631	X	41578378	254208	248723
NM_021140.3(KDM6A):c.4052G>A (p.Arg1351Gln)	KDM6A	Kabuki syndrome 2|not provided	Uncertain significance(Last reviewed: Mar 26, 2015)	criteria provided, multiple submitters, no conflicts	X	44969370	X	45110125	158691	170111
NM_018094.4(GSPT2):c.1021G>A (p.Val341Ile)	GSPT2	Autistic disorder of childhood onset|Seizures|Autism|Delayed speech and language development	Pathogenic	no assertion criteria provided	X	51487743	X	51744647	375379	362170
NM_004187.3(KDM5C):c.3068A>G (p.Lys1023Arg)	KDM5C	Smith-Magenis Syndrome-like	Pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	X	53225150	X	53195968	254201	248716
NM_000169.2(GLA):c.937G>T (p.Asp313Tyr)	GLA|RPL36A-HNRNPH2	Fabry disease|not specified|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Sudden unexplained death	Conflicting interpretations of pathogenicity, other(Last reviewed: Aug 22, 2018)	criteria provided, conflicting interpretations	X	100653420	X	101398432	10738	25777
NM_178151.2(DCX):c.773G>C (p.Arg258Pro)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576314	X	111333086	158506	169854
NM_178151.2(DCX):c.751G>T (p.Ala251Ser)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576336	X	111333108	158504	169856
NM_178151.2(DCX):c.746T>G (p.Phe249Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110576341	X	111333113	158503	169857
NM_178151.2(DCX):c.724T>A (p.Phe242Ile)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Aug 27, 2013)	criteria provided, single submitter	X	110576363	X	111333135	158501	169859
NM_178151.2(DCX):c.688A>C (p.Thr230Pro)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644235	X	111401007	158500	169860
NM_178151.2(DCX):c.683T>C (p.Leu228Pro)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644240	X	111401012	158499	169861
NM_178151.2(DCX):c.667G>A (p.Gly223Arg)	DCX	Heterotopia	Pathogenic(Last reviewed: Jul 7, 2014)	criteria provided, single submitter	X	110644256	X	111401028	158496	169864
NM_178151.2(DCX):c.641T>C (p.Ile214Thr)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644282	X	111401054	158493	169867
NM_178151.2(DCX):c.628G>T (p.Val210Phe)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644295	X	111401067	158492	169868
NM_178151.2(DCX):c.614A>T (p.His205Leu)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644309	X	111401081	158491	169869
NM_178151.2(DCX):c.611C>A (p.Ala204Asp)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644312	X	111401084	158490	169870
NM_178151.2(DCX):c.608C>A (p.Thr203Lys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644315	X	111401087	158489	169871
NM_178151.2(DCX):c.607A>G (p.Thr203Ala)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644316	X	111401088	158488	169872
NM_178151.2(DCX):c.596T>C (p.Leu199Pro)	DCX	Heterotopia|not provided	Likely pathogenic(Last reviewed: Aug 8, 2016)	criteria provided, multiple submitters, no conflicts	X	110644327	X	111401099	158487	169873
NM_178151.2(DCX):c.587G>A (p.Arg196His)	DCX	Lissencephaly, X-linked|Subcortical laminar heterotopia, X-linked|Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644336	X	111401108	11609	26648
NM_178151.2(DCX):c.586C>T (p.Arg196Cys)	DCX	Heterotopia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2017)	criteria provided, multiple submitters, no conflicts	X	110644337	X	111401109	158485	169875
NM_178151.2(DCX):c.586C>G (p.Arg196Gly)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644337	X	111401109	158484	169876
NM_178151.2(DCX):c.586C>A (p.Arg196Ser)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644337	X	111401109	158483	169877
NM_178151.2(DCX):c.574C>T (p.Arg192Trp)	DCX	Lissencephaly, X-linked|Subcortical laminar heterotopia, X-linked|Heterotopia|not provided	Pathogenic(Last reviewed: Dec 22, 2016)	criteria provided, multiple submitters, no conflicts	X	110644349	X	111401121	11598	26637
NM_178151.2(DCX):c.572C>G (p.Pro191Arg)	DCX	Heterotopia|not provided	Pathogenic(Last reviewed: May 30, 2017)	criteria provided, multiple submitters, no conflicts	X	110644351	X	111401123	158481	169879
NM_178151.2(DCX):c.571C>A (p.Pro191Thr)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644352	X	111401124	158480	169880
NM_178151.2(DCX):c.557G>T (p.Arg186Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644366	X	111401138	158478	169881
NM_178151.2(DCX):c.557G>A (p.Arg186His)	DCX	Lissencephaly, X-linked|Heterotopia	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2017)	criteria provided, conflicting interpretations	X	110644366	X	111401138	158477	169882
NM_178151.2(DCX):c.556C>T (p.Arg186Cys)	DCX	Heterotopia|not provided	Pathogenic(Last reviewed: Mar 30, 2017)	criteria provided, multiple submitters, no conflicts	X	110644367	X	111401139	158476	169883
NM_178151.2(DCX):c.551T>A (p.Ile184Asn)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644372	X	111401144	158475	169884
NM_178151.2(DCX):c.538A>G (p.Lys180Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644385	X	111401157	158474	169885
NM_178151.2(DCX):c.533G>T (p.Arg178Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644390	X	111401162	158473	169886
NM_178151.2(DCX):c.532C>T (p.Arg178Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644391	X	111401163	158472	169887
NM_178151.2(DCX):c.532C>G (p.Arg178Gly)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644391	X	111401163	158471	169888
NM_178151.2(DCX):c.520A>G (p.Lys174Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644403	X	111401175	158470	169889
NM_178151.2(DCX):c.451A>G (p.Lys151Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644472	X	111401244	158465	169894
NM_178151.2(DCX):c.413A>G (p.Tyr138Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644510	X	111401282	158464	169895
NM_178151.2(DCX):c.412T>C (p.Tyr138His)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644511	X	111401283	158463	169896
NM_178151.2(DCX):c.386C>T (p.Ser129Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Aug 7, 2013)	criteria provided, single submitter	X	110644537	X	111401309	158460	169899
NM_178151.2(DCX):c.380G>A (p.Cys127Tyr)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644543	X	111401315	158459	169900
NM_178151.2(DCX):c.377T>A (p.Val126Asp)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110644546	X	111401318	158458	169901
NM_178151.2(DCX):c.364G>A (p.Gly122Arg)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653263	X	111410035	158456	169903
NM_178151.2(DCX):c.337A>T (p.Ile113Phe)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653290	X	111410062	158454	169905
NM_178151.2(DCX):c.310A>T (p.Ile104Phe)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653317	X	111410089	158453	169906
NM_178151.2(DCX):c.305G>A (p.Arg102His)	DCX	Heterotopia|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2016)	criteria provided, multiple submitters, no conflicts	X	110653322	X	111410094	82052	92943
NM_178151.2(DCX):c.304C>T (p.Arg102Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653323	X	111410095	158452	169907
NM_178151.2(DCX):c.301G>A (p.Val101Met)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653326	X	111410098	158451	169908
NM_178151.2(DCX):c.299G>T (p.Gly100Val)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653328	X	111410100	158449	169909
NM_178151.2(DCX):c.299G>A (p.Gly100Glu)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653328	X	111410100	158448	169910
NM_178151.2(DCX):c.290T>G (p.Leu97Arg)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653337	X	111410109	158447	169911
NM_178151.2(DCX):c.272T>C (p.Leu91Pro)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653355	X	111410127	158446	169912
NM_178151.2(DCX):c.266G>C (p.Arg89Pro)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653361	X	111410133	158445	169913
NM_178151.2(DCX):c.233G>T (p.Arg78Leu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653394	X	111410166	158443	169915
NM_178151.2(DCX):c.232C>T (p.Arg78Cys)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653395	X	111410167	158442	169916
NM_178151.2(DCX):c.226C>T (p.Arg76Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Apr 16, 2013)	criteria provided, single submitter	X	110653401	X	111410173	158441	169917
NM_178151.2(DCX):c.218C>T (p.Ser73Phe)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653409	X	111410181	158440	169918
NM_178151.2(DCX):c.195C>A (p.Phe65Leu)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653432	X	111410204	158438	169920
NM_178151.2(DCX):c.191A>G (p.Tyr64Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653436	X	111410208	158437	169921
NM_178151.2(DCX):c.187C>T (p.Arg63Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653440	X	111410212	158436	169922
NM_178151.2(DCX):c.185A>G (p.Asp62Gly)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653442	X	111410214	158435	169923
NM_178151.2(DCX):c.182G>A (p.Gly61Glu)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653445	X	111410217	158434	169924
NM_178151.2(DCX):c.176G>A (p.Arg59His)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653451	X	111410223	158433	169925
NM_178151.2(DCX):c.170T>G (p.Phe57Cys)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653457	X	111410229	158432	169926
NM_178151.2(DCX):c.167G>C (p.Arg56Pro)	DCX	Heterotopia	Likely pathogenic(Last reviewed: Apr 2, 2014)	criteria provided, single submitter	X	110653460	X	111410232	158431	169927
NM_178151.2(DCX):c.150G>T (p.Lys50Asn)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653477	X	111410249	158429	169929
NM_178151.2(DCX):c.128T>C (p.Leu43Ser)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653499	X	111410271	158427	169931
NM_178151.2(DCX):c.95G>A (p.Ser32Asn)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653532	X	111410304	158512	169934
NM_178151.2(DCX):c.2T>C (p.Met1Thr)	DCX	Heterotopia	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	X	110653625	X	111410397	158450	169936
NM_003491.3(NAA10):c.361C>G (p.Leu121Val)	NAA10	N-terminal acetyltransferase deficiency	Likely pathogenic	criteria provided, single submitter	X	153197549	X	153932096	431708	425234
